<i>Vibrio cholerae</i> non-01 and <i>V. mimicus</i> in diarrhoeal disease : a study of virulence factors by Said, Bengü
Open Research Online
The Open University’s repository of research publications
and other research outputs
Vibrio cholerae non-01 and V. mimicus in diarrhoeal
disease : a study of virulence factors
Thesis
How to cite:
Said, Bengu¨ (1995). Vibrio cholerae non-01 and V. mimicus in diarrhoeal disease : a study of virulence factors. PhD
thesis The Open University.
For guidance on citations see FAQs.
c© 1995 The Author
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
L. ) N-. 2 4217 46 
Vibrio cholerae non-01 and V. mimicus in diarrhoeal disease: 
a study of virulence factors 
BengU Said 
A thesis submitted for the degree of 
Doctor of Philosophy 
to the Open University 
p eq 15 4-e, ) og vloýA"4--r : 
L. 
i.. 
0ý- 's 60-b vt. 
ý, xp "m ýk ,, p 
ek-ý I 
cýýr, jxA-, oe*-, -e, -L #* & lc: 1116 
Laboratory of Enteric Pathogens 
Central Public Health Laboratory 
61 Colindale Avenue 
LONDON 
NW9 5HT March 1995 
CONTAINS 
PULLOUTS 
" The Ganges, the sacred river that flows through Calcutta has become 
contaminated with a new deadly breed of cholera bacteria ... Vibrio cholerae 
0139... "During the worst of it last month... we had 500 cholera cases arrive in one day, 
and our hospital has only 700 beds. We had to put them in the corridors, everywhere. 
They were four to a bed. I've never seen suffering on such a scale". " (McGirk 1993) 
ABSTRACT 
Vibrio cholerae non-01 and V mimicus, isolated from clinical and environmental 
sources, were examined for factors related to virulence. The aim was to identify factors which 
would distinguish pathogenic from non-pathogenic strains and to establish a correlation, if any, 
with serogroup. The lipopolysaccharide (LPS) of epidemic V cholerae belonging to serogroups 
01 and 0139 are regarded as'virulence factors. In this study certain other serogroups, such as 
02,05 and 09 were associated with diarrhoeal disease. LPS of these organisms may have a role 
in adhesion. Although 90% of V cholerae non-01 and V mimicus colonised tissue culture cells, 
neither smooth LPS, the presence of flagella nor the possession of the toxin coregulated pilus 
gene (tcpA) were essential for adhesion. Cholera toxin (CT) is the factor responsible for the 
dramatic symptoms of epidemic cholera and is produced by V cholerae serogroups 01 and 0139. 
However, less than 1% of V cholerae non-01, non-0139 and V mimicus possessed the gene for 
CT. Southern blot analysis of the CT genes revealed that most strains carried one CT gene except 
for serogroups 023 and 0139 which had two hybridising fragments. The variations in fragment 
size within the 0139 serogroup suggested that this serogroup was not strictly clonal. In addition 
to CT both V cholerae non-01 and V mimicus expressed several other toxins, often concurrently, 
which made detection of specific toxins difficult. Over 80% of strains produced haemolysin(s) 
and cytotoxin(s). The cytotoxic effects on tissue culture cells masked cytotonic effects, such as 
that caused by CT. V cholerae and V mimicus did not produce verocytotoxin (VT) and did not 
possess the genes for VT. The heat-stable enterotoxin (NAG-ST) gene was found in 3% of V 
cholerae non-01 and 12% of V mimicus strains. All V cholerae strains belonging to serogroup 
014, were NAG-ST positive and Southern blot analysis of the NAG-ST genes suggested that this 
serogroup represented a single clone. In addition to the established toxins two novel factors, 
which may contribute to the virulence of V cholerae non-01 and V mimicus, were found. A 
novel cytotoxin, produced by 16% of strains, was expressed on Vero cells causing vacuolation of 
cell cytoplasm. Another putative "toxin" found in 19% of strains was demonstrated in 
a GMI-ELISA. This "toxin" had the ability to bind ganglioside GMI and shared antibody 
binding sites with CT. V cholerae non-01 and V mimicus also expressed species specific high 
affinity iron chelating molecules; 74% of V cholerae non-01 produced enterochelin, whereas 
90% of V mimicus produced aerobactin. Aerobactin production is usually associated with 
invasive organisms and is unusual among Phrio spp. None of the virulence factors, except CT, 
was more prevalent in clinical than in environmental strains. This is perhaps not surprising as 
vibrio-associated disease is often linked with exposure to the aquatic environment or consumption 
of seafood. Within V cholerae the 01 and 0139 serogroups were linked with CT and 014 with 
NAG-ST, in future, other serogroup - virulence factor associations may be found. For V mimicus 
the main virulence factors expressed were aerobactin and NAG-ST. Therefore the pathogenicity 
of V cholerae and V mimicus appears to be multifactorial and it is likely that, as with 
diarrhoeagenic, E. coli, a heterogeneous pattern of virulence will be found. 
ii 
ACKNOWLEDGEMENTS 
I am indebted to many of the staff of the Laboratory of Enteric Pathogens (past and 
present). I am particularly grateful to Dr. Sylvia Scotland, Dr. Henrik Chart and Dr. 
Henry Smith for their invaluable support, guidance and constructive criticism. Special 
thanks are owed to Neil Stokes and Dr. Andrea Thomas. I would also like to thank; 
Tom Cheasty, Dr. Geraldine Willshaw, Jenny Frost, Dr. John Threlfall, Judi Bullen, 
Gwyneth Bertram and Rachel Wiseman. 
I thank Dr. Bernard Rowe for allowing me to carry out this study and for his help and 
advice. 
iii 
I dedicate this work to all my family, 
especially to 
Graham and Ben 
& 
Anne ve Baba. 
IV 
DECLARATION 
I declare that the work presented here has been carried out by myself or where the assistance of 
other members of the Laboratory of Enteric Pathogens has been required, this fact has been 
acknowledged in the text of the thesis. 
Bengil Said 
March 1995 
V 
POSTGRADUATE RESEARCH STUDY COURSES 
In partial fulfilment of the requirements of the degree, I have attended the following: 
Postgraduate Research Methods Course (1987/1989) at the National Institute for 
Medical Research, Mill Hill, London, NW7 IAA; 
Seminars in current research held at CPHL, London, NW9 SHT; 
Practical Workshop in Immunological Techniques (1990) at Hatfield Polytechnic; 
Radiological Workshop (1991) held at CPHL, London, NW9 5HT; 
Molecular Microbiology Discussion Group, CPHL, London, NW9 5HT. 
vi 
PRESENTATIONS AND PUBLISHED CONTRIBUTIONS 
Said B. (1991). Production of cholem toxin (CT) and other enterotoxins by Vibrio cholerae non- 
01 in relation to serogroup. PHLS 16th Annual Scientific Conference, Winchester. 
Said B. (1992). The use of gene probes and other methods for the detection of toxigenic Vibrio 
cholerae non-01. Society for General Microbiology 123rd Meeting, Trinity College, Dublin. 
Cheasty T, Said B, Rowe B and Frost J. (1993). Vibrio cholerae serogroup 0139 in England 
and Wales. British Medical Journal 307,1007. 
Threlfall EJ, Said B, Rowe B and Davalos-Perez A. (1993). Emergence of multiple drug 
resistance in Vibrio cholerae El Tor from Ecuador. The Lancet 342,1173. 
Said B, Scotland SM and Rowe B. (1994). The use of gene probes, immunoassays and tissue 
culture for the detection of toxin in Vibrio, cholerae non-01. Journal of Medical Microbiology 
40,31-36. 
Said B, Smith HR, Scotland SM and Rowe B. (1994). Polymerase chain reaction (PCR) to 
detect genes encoding cholera toxin (MB) and toxin co-regulated pili (tcpA) of Vibrio cholerae 
01 and non-01.3rd International Meeting on Bacterial Epidemiological Markers, Cambridge, 
U. K. 
Said B, Smith HR, Scotland SM and Rowe B. (1995). Detection and differentiation of the gene 
for toxin co-regulated pili (tcpA) in Vibrio cholerae non-01 using the polymerase chain reaction 
(PCR). FEAE Microbiology Letters. 125,205-210. 
Said B, Smith H, Stokes N and Rowe B. Heat-stable enterotoxin (NAG-ST) in Vibrio cholerae 
from human and environmental sources. (In manuscript). 
vii 
CONTENTS 
ABSTRACT ....................................................... 
i 
ACKNOWLEDGEMENTS ............................................ 
iii 
DECLARATION ................................................... V 
POSTGRADUATE RESEARCH STUDY COURSES ........................ vi 
PRESENTATIONS AND PUBLISHED CONTRIBUTIONS ................... vii 
CONTENTS ...................................................... viii 
LIST OF ABBREVIATIONS ......................................... xvii 
LIST OF TABLES ................................................. xx 
LIST OF FIGURES ............................................... xxii 
INTRODUCTION .................................................. 
I 
1.1 Identification, nomenclature and classification of Vibrio cholerae and 
V Mimicus . ................................................ 
1 
1.2 Ecology and epidemiology ..................................... 
6 
1.3 V cholerae and cholera ....................................... 
10 
1.4 Recent developments: the spread of V cholerae 01 to South America and 
the emergence of V cholerae 0139 ............................... 12 
1.5 V cholerae non-01, V mimkus and associated clinical disease ............ 14 
1.6 Pathogenic mechanisms and virulence ............................. Is 
1.6.1 Cholera Toxin (CT) and related heat-labile toxins .............. 22 
1.6.2 Toxins associated with CT .............................. 28 
1.6.3 Haemolysin(s) and Thermostable direct haernolysin (TDH) ....... 29 
1.6.4 Heat-stable enterotoxin (NAG-ST) ........................ 31 
1.6.5 Cytotoxins ......................................... 34 
1.6.6 Colonisation factors .................................. 35 
1.6.7 Lipopolysaccharide (LPS) and Outer membrane proteins (OMP) .... 39 
1.6.8 High affinity iron uptake . .............................. 40 
1.6.9 Extrachromosomal. elements ............................ 42 
viii 
1.7 Scope of this study .......................................... 
44 
MATERIALS AND METHODS ........................................ 
45 
2.1 Bacterial strains ............................................ 
45 
2.1.1 Storage of bacterial strains .............................. 
45 
2.1.1a Lyophilisation ................................ 
46 
2.2 Identification and typing of V cholerae and V mimicus ................ 
46 
2.2.1 Biochemistry ....................................... 
46 
2.2.2 Biotyping ......................................... 
46 
2.2.2a Haemolysis .................................. 
47 
2.2.2b Vogues-Proskauer test .......................... 
47 
2.2.3 Serology .......................................... 
49 
2.2.3a Preparation of antisera .......................... 50 
2.2.4 Phage typing ....................................... 
52 
2.2.5 Antibiotic resistance typing (R-typing) ..................... 52 
2.2.5a Polymyxin discs ............................... 52 
2.2.5b 0\129 discs .................................. 53 
2.2.5c Antibiotic strips and antibacterial plates .............. 53 
2.3 Characterisation of strains based on pathogenic properties ............... 54 
2.3.1 Toxin production .................................... 54 
2.3.1a Bacterial culture and preparation of crude toxin ......... 54 
Small-scale toxin preparation ..................... 55 
2.3.1b Tissue culture cell assays ........................ 55 
Maintenance of cell lines and preparation of cell-tests .... 55 
YI cell assays for CT and LT ..................... 56 
Vero and HeLa cell assays for cytotoxins ............. 56 
Neutralisation assays ........................... 
57 
2.3.1 c Infant mouse assay for heat-stable enterotoxin (M) ..... 57 
2.3.1d Enzyme Linked Immunosorbent Assays for CT ......... 58 
ix 
GMI-ELISA ................................. 
58 
Double sandwich ELISA ........................ 59 
2.3.1 eV cholerae enterotoxin and E. coli heat-labile 
enterotoxin - reversed passive latex agglutination test kit 
(VET-RPLA) ................................ 59 
2.3. If Passive immune haernolysis (PIH) .................. 60 
Tube assay ................................... 61 
Microtitre assay . .............................. 61 
2.3. lg Biken (modified Elek) test ....................... 62 
2.3.1 h Detection of toxin with immunoblotting ............. 62 
Colony immunoblotting ......................... 62 
Immunoblotting with supematants .................. 63 
2.3.2 DNA probes for genes encoding toxins ..................... 64 
2.3.2a Large-scale preparation of plasmid DNA .............. 64 
2.3.2b Preparation of polynucleotide probes ................. 68 
Recovery of CT fragments ........................ 68 
Recovery of VT fragments ........................ 69 
2.3.2c Random primer labelling of polynucleotide, DNA probes 
with digoxigenin ............................... 69 
Digoxigcnin-labelling of CT probes . ................ 69 
Digoxigenin-labelling of VT probes . ................ 70 
2.3.2d Preparation of cultures for DNA hybridisation . ......... 70 
2.3.2e Hybridisation with polynucleotide probes .............. 71 
Hybridisation with CTA and CTB at high stringency ...... 72 
Hybridisation with CT probes at low stringency ........ 72 
Hybridisation with VTI and VT2 probes .............. 73 
2.3.2f Synthetic Nucleic Acid Probe for LT (SNAP-LT) and 
STA (SNAP-ST) .............................. 73 
2.3.2g Oligonucleotide probes .......................... 73 
x 
GMI probe .................................. 
74 
ST probes ................................... 
74 
2.3.2h Oligonucleotide end-labelling with digoxigenin-I I-dUTP .- 74 
2.3.2i Oligonucleotide hybridisation ...................... 
75 
2.3.2j Immunological detection of hybrids .................. 
75 
2.3.3 Polymerase chain reaction (PCR) ......................... 76 
2.3.3a Detection of ctxB by PCR ........................ 76 
2.3.3b Detection of tcpA by PCR ......................... 76 
2.3.3c PCR protocol ................................. 
77 
2.3.3d Analysis of PCR products ........................ 77 
2.3.4 Preparation of chromosomal DNA and analysis by Southern blot .. - 80 
2.3.4a Preparation of bacterial chromosomal DNA ............ 80 
2.3.4b Small-scale preparation of bacterial genomic DNA 
(CTAB method) .............................. 81 
2.3.4c Detection of DNA on ethidium bromide plates .......... 82 
2.3.4d Restriction endonuclease digest of chromosomal DNA .... 82 
2.3.4e Southern blotting of DNA from agarose gels to nylon 
membrane filters .............................. 82 
2.3.4f Restriction fragment length polymorphism (RFLP) 
analysis ..................................... 83 
2.3.5 Plasmid profile analysis ................................ 83 
2.3.5a The phenol/chloroform extraction method (Kado and 
Liu) ....................................... 84 
2.3.5b The alkaline lysis method (Birnboim and Doly) ......... 84 
2.3.6 Assays for adhesins ................................... 85 
2.3.6a Adhesion to HEp-2 or Caco2 cells ................. 85 
2.3.6b Haemagglutination tests .......................... 86 
2.3.6c Detection of the gene for the toxin coregulated pilus 
(tcpA) ..................................... 87 
xi 
2.3.6d Electron microscopy ............................ 
87 
2.3.7 LPS analysis ....................................... 
87 
2.3.8 Iron chelating compounds (Siderophores) .................... 
87 
2.3.8a Enterochelin ................................. 
88 
2.3.8b Aerobactin .................................. 
89 
2.3.9 Protein analysis ..................................... 
89 
2.3.9a Whole cell protein analysis ....................... 
89 
2.3.9b Outer membrane protein profiles ................... 
90 
2.3.9c Determination of protein using the Lowry procedure ..... 91 
2.3.9d Electrophoresis of protein samples .................. 
91 
RESULTS ........................................................ 
92 
3.0 Strains of V cholerae and V mimicus used in this study ................ 92 
3.1 Typing of strains of V cholerae and V mimicus ...................... 93 
3.1.1 Biochemistry ........................................ 93 
3.1.2 Biotyping .......................................... 95 
3.1.3 Serotyping ......................................... 97 
3.1.4 Phage-typing ....................................... 100 
3.1.5 Resistance (R)-typing ................................. 105 
3.1.5a Resistance to 0/129 and polymixin ................. 106 
3.2 Detection of toxins with cultured cells ............................ 108 
3.2.1 Morphological effects of toxins, produced by V cholerae non-01, 
on Yl, HeLa and Vero cell-lines ......................... 108 
3.2.2 Toxin production in different growth media ................. 114 
3.3 Detection of Cholera toxin (CT) ................................ 
114 
3.3.1 DNA probes for CT .................................. 114 
3.3.1a Digoxigenin-labelled CTA and CTB ................ 
117 
3.3.1b GMI oligoncleotide probe ....................... 
120 
xii 
3.3.2 Immunoassays ...................................... 121 
3.3.2a GMI-ELISA 
................................. 122 
3.3.2b VET-RPLA ................................. 122 
3.3.2c Double sandwich ELISA ........................ 123 
3.3.2d Biken test ................................... 123 
3.3.2e Passive immune haernolysis (PIH) .................. 
125 
3.3.2f Colony and supernatant immundblotting .............. 126 
3.3.3 Optimising growth conditions for the production of CT ......... 126 
3.3.3a Kinetics of production of CT and LT ................ 128 
3.3.3b Are the cytotoxin and CT of V cholerae 037 
extracellular or intracellular? ......................... 134 
3.3.4 Southern blot analysis of CT genes ....................... 134 
3.3.4a CT and othcr toxins of V cholerae 0139 ............. 138 
3.3.5 PCR for CT ....................................... 142 
3.4 Detection of strains producing heat-stable toxin (NAG-ST) .............. 142 
3.4.1 Infant Mouse assay .................................. 142 
3.4.2 DNA probes for detecting strains carrying genes for ST ......... 142 
3.4.2a SNAP-ST ................................... 142 
3.4.2b Digoxigenin-labelled ST oligonucleotides ............. 143 
3.4.3 Stability of the NAG-ST gene ........................... 145 
3.4.4 Southern blot analysis of the NAG-ST gene ................. 145 
3.5 Detection of strains producing Vero-cytotoxin ....................... 149 
3.5.1 Tissue culture (Vero cell) assays for VT .................... 149 
3.5.2 DNA probes for detecting genes encoding VT ................ 149 
3.6 Ability of strains to produce Haernolysin .......................... 150 
3.6.1 Purification of haemolysin produced by V cholerae 02 ......... 151 
3.6.2 The role of iron in the regulation of expression of V cholerae 
haemolysin 
............................................ 156 
xiii 
3.7 Polymerase chain reaction (PCR) ................................ 
157 
3.7.1 PCR for CT ....................................... 
159 
3.7.2 PCR for TCP ...................................... 
159 
3.8 Adhesion ................................................ 
160 
3.8.1 Transmission electron microscopy (TEM) ................... 
164 
3.9 Plasmid analysis ........................................... 
167 
3.10 Protein analysis ........................................... 
167 
3.10.1 Whole cell protein profiles ............................ 
167 
3.10.2 Outer membrane protein (OMP) ......................... 
169 
3.11 Lipopolysaccharide (LPS) .................................... 
172 
3.11.1 Analysis of strains which were unidentifiable (0? ) ............ 
174 
3.11.2 Identification of new serogroups of V cholerae non-01 using 
SDS-PAGE analysis ...................................... 
175 
3.12 Production of siderophores ................................... 
179 
3.12.1 Aerobactin ....................................... 
179 
3.12.2 Enterochelin ...................................... 
180 
DISCUSSION ..................................................... 
181 
4.1 Identification of V cholerae and V mimicus ....................... 
181 
4.1.1 Serogrouping and association of serogroup with virulence factors .. 182 
4.1.2 R-typing and plasmid carriage ........................... 
184 
4.2 Pathogenic mechanisms and virulence ............................ 
187 
4.2.1 Cholera toxin (CT) ................................... 
187 
4.2.1 a The masking of CT by cytotoxin. ................... 
188 
4.2.1b Southern blot analysis of the CT gene ............... 
189 
4.2.2 Production of a putative toxin by strains of V cholerae non-01 
and V mimicus, as detected by GMI-ELISA ............... 
191 
4.2.3 The cytotoxins of V cholerae and V mimicus ................ 
192 
4.2.3a Vacuolating toxin production on Vero cells ........... 
193 
xiv 
4.2.4 Haemolysin(s) ...................................... 
194 
4.2.4a Iron regulation of haemolysin ..................... 
195 
4.2.5 High affinity iron uptake .............................. 
196 
4.2.6 The heat-stable enterotoxin (NAG-ST) ..................... 
197 
4.2.6a Southern blot analysis of the NAG-ST gene ........... 200 
4.2.7 Colonisation factors .................................. 201 
4.2.8 Lipopolysaccharide (LPS) and Outer membrane proteins (OMP) ... 204 
CONCLUSIONS ................................................... 
206 
APPENDIX1 ..................................................... 
210 
A. Media ................................................... 210 
A. 1 Culture maintenance media .............................. 210 
A. 2 Biochemistry ........................................ 210 
A. 3 Growth media ....................................... 217 
A. 4 Buffer solutions and miscellaneous reagents .................. 220 
B. Tissue culture .............................................. 221 
B. 1 Tissue culture cell lines ................................ 221 
B. 2 Miscellaneous tissue culture reagents ....................... 222 
C. Immunoassays ............................................. 223 
D. Solutions for probe hybridisation and Southern blot analysis ............. 224 
D. 1 Probe preparation .................................... 224 
D. 2 Solutions for preparation of colony blots .................... 224 
D. 3 Stock solutions ...................................... 224 
DA Hybridisation buffers .................................. 225 
D. 5 Immunological detection of hybrids ........................ 226 
D. 6 Southern blot analysis ................................. 226 
D. 7 Solutions for plasmid preparations ......................... 227 
E. LPS and protein analysis ..................................... 228 
xv 
F. Gel buffers and stains ........................................ 229 
F. 1 Agarose gel buffers ................................... 229 
F. 2 SDS-polyacrylainide gel solutions ......................... 230 
F. 3 Stains ............................................. 230 
APPENDIX 2- Strain catalogue ....................................... 232 
REFERENCES .................................................... 254 
xvi 
LIST OF ABBREVIATIONS 
ATP adenosine triphosphate 
BCL Boehringer Corporation Limited 
BCIP 4-bromo-chloro-indolyl phosphate 
BHI brain heart infusion broth 
BSA bovine serum albumin 
bp base pair 
0C degrees centigrade 
Caco-2 human colonic carcinoma cells 
cAMP cyclic adenosine monophosphate 
cl- chloride ion 
cm centimetre 
COC12 cobalt chloride 
CT cholera toxin 
CTAB cetyltrimethyl ammonium bromide 
CYE casamino yeast extract broth 
Dig-dUTP digoxigenin- I 1-2'-deoxy-uridine-5-triphosphate 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid, disodium salt 
ELISA enzyme-linked immunosorbent assay 
EM electron microscopy 
9 gram 
9 relative centrifugal force 
GMI gangliosides of intestinal epithelial cells (galactosyl-N- 
acetyneuraminyl-[N-acetylneurmninyll-galactosylglucosyI ceramide 
h hour 
H flagellar antigen 
HeLa Helen Lane cervical carcinoma cells 
HEp-2 carcinoma of the larynx cells 
Ig, immunoglobulin 
HCI Hydrochloric acid 
xvii 
kb kilobase 
kda, kilodalton 
I litre 
LEP Laboratory of Enteric Pathogens 
LiCI lithium chloride 
LPS lipopolysaccharide 
LT E. coli heat-labile enterotoxin 
M molar 
Mda megadalton 
Mg milligrarn 
MgCl, magnesium chloride 
min minute 
MIS millilitres 
MM millimolar 
MOPS morpholino propane sulphonic acid 
MRHA mannose resistant haemagglutination 
MSHA mannose sensitive haemagglutination 
Ne sodium ion 
NaCI sodium chloride 
NAD nicotinamide adenosine diphosphate 
NAG-ST V cholerae heat-stable enterotoxin 
NaOH sodium hydroxide 
NBT nitroblue tetrazolium 
ng nanogram 
nm nanometre 
0 somatic antigen 
0\129 pteridine compound (2,4 diamino-6,7 diisopropyl pteridine) 
OD absorbance units 
OMP Outer membrane protein 
ONPG o-nitrophenyl-B-D-galactopyranoside 
PBS phosphate buffered saline 
xviii 
PCR polymerase chain reaction 
PlH passive immune haemolysis 
PVP polyvinyl pyrolidone 
PW peptone water 
RNAase ribonuclease 
rpm revolutions per minute 
SDS sodium dodecyl sulphate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
SNAP synthetic nucleic acid probe 
SGB syncase glucose broth 
SSB syncase sucrose broth 
ST E. coli heat-stable enterotoxin 
TCM tissue culture medium 
TS tris-succinate medium 
Tris tris (hydroxymethyl) arninomethane 
TSB trypticase soy broth 
[tg microgram 
VI microlitre 
VM micromolar 
UV ultraviolet 
V volts 
Vero African green monkey kidney cells 
VET-RPLA V. cholerae enterotoxin - reversed passive latex agglutination 
VP Vogues-Proskauer test for acetylmethylcarbonil production 
VT verocytotoxin 
V/v volume to volume ratio 
WHO World Health Organisation 
w/v weight to volume ratio 
Y1 mouse adrenal cortex tumour cells 
% percent 
xix 
LIST OF TABLES 
Table I Biochemical characteristics of pathogenic Vibrio spp . ......................... 
2 
Table 2a Reference strains for serogroups 01 - 083 of V cholerae ....................... 
4 
Table 2b Reference strains for serogroups 084 - 0140 of V cholerae .................... 
5 
Table 3 V cholerae non-01 outbreaks ......................................... 
16 
Table 4 Biotypes of V cholerae 01 ........................................... 
48 
Table 5 Bacterial strains and plasmid vectors containing polynucleotide probe DNA .......... 
65 
Table 6 Oligonucleotide probe sequences ....................................... 
66 
Table 7 Strains of V cholerae belonging to serogroup non-01 isolated from extra-intestinal 
locations ........................................................ 
94 
Table 8 Biochemical differentiation of V cholerae and V mimicus ...................... 
96 
Table 9 Comparison of biotyping of V cholerae belonging to serogroups 01,0139, non-01 
and V mimicus ................................................... 
98 
Table 10 The most common serogroups of V. cholerae non-01 and association with source .... 101 
Table 11 Strains of V. cholerae associated with family outbreaks ....................... 102 
Table 12 Phage typing patterns for USSR scheme ................................. 103 
Table 13 Phage typing results with strains of V. cholerae non-01 ...................... 104 
Table 14 Resistance of V cholerae non-01 to antibiotics and commonly observed resistance 
patterns ....................................................... 107 
Table 15 Morphological effects of toxins produced by strains of V cholerae non-01 on YI, 
HeLa and Vero cells .............................................. 113 
Table 16 Incidence of CT genes in wild type strains of V cholerae and V mimicus .......... 116 
Table 17 List of CT gene positive strains of V. cholerae non-01 and V mimicus ............ 119 
Table 18 Comparison of Double sandwich ELISA, GMI-ELISA, VET-RPLA and Yl cell assay . 124 
Table 19 CT production under different growth conditions ........................... 129 
Table 20 Kinetics of production of CT and LT ................................... 130 
Table 21 Production of CT and cytotoxin by V cholerae 037; relation to growth curve ....... 132 
Table 22 CT positive V cholerae strains differentiated by southern blot analysis ............ 136 
Table 23 CT-producing strains of V cholerae 01 and 0139; differentiation by Southern blot 
analysis using HindIII, BgR1 and Xbal ................................. 140 
xx 
Table 24 List of NAG-ST gene positive strains of V cholerae non-01 and V mimicus ........ 146 
Table 25 Heat-stable enterotoxin (NAG-ST) oligonucleotide positive V cholerae non-01 
differentiated by Southern blot analysis ................................. 
147 
Table 26 Production of haernolysin by V cholerae 02; relation to growth curve ............ 154 
Table 27 Enterochelin and haernolysin production (titre/OD62, ) for strains of V cholerae 
non-01 ....................................................... 158 
Table 28 Characterisation of V cholerae strains: hybridisation with CT probe and PCR results 
for ctxB and tcpA ................................................ 161 
Table 29 Adhesion on HEp-2 and Caco2 tissue culture cell lines and haernagglutination of calf, 
guinea-pig, human and rat red blood cells by V. cholerae non-01 ............... 165 
Table 30 Outer membrane protein profiles of V cholerae and V mimicus ................. 171 
xxi 
LIST OF FIGURES 
Figure 1 Mechanism by which cholera causes diarrhoea ............................. 
24 
Figure 2 Heat-stable toxin amino acid sequences .................................. 
33 
Figure 3a Polymerase chain reaction for CT ...................................... 
78 
Figure 3b Polymerase chain reaction for TCP ...................................... 
79 
Figure 4 Serogrouping of V cholerae non-01 and V mimicus using the scheme of Sakazaki 
and Donovan (1984), incorporating antisera to serogroups 02 to 083 and 0139 ...... 99 
Figure 5 Morphological effects on the YI cell line ................................ 
109 
Figure 6 Morphological effects on the Vero cell line .............................. 
III 
Figure 7 Digoxigenin-labelled CTA and CTB probes .............................. 
118 
Figure 8 Hybridisation with digoxigenin-labelled GM1 oligonucleotide probe at 48 *C ....... 
121 
Figure 9 Kinetics of production of CT, LT and cytotoxin ........................... 
131 
Figure 10 Production of CT and cytotoxin by V cholerae 037; relation to growth curve ...... 133 
Figure 11 HindIII restriction digest, fragments hybridising with GMI oligonucleotide: a 
diagrammatic representation ......................................... 137 
Figure 12 Southern blot analysis of CT genes combined BgAl and Xbal digests of CT positive 
V. cholerae .................................................... 141 
Figure 13 HIndlII restriction digest of V cholerae non-01, fragments hybridising with NAG- 
ST (Ogawa) oligonucleotide: a diagrammatic representation ................... 148 
Figure 14 Haemolysis of rat red blood cells by V. cholerae non-01 detected using a microtitre 
assay ......................................................... 153 
Figure 15 Production of haemolysin by V cholerae 02; relation to growth curve ........... 155 
Figure 16 Differentiation of V cholerae tcpA genes by multiplex PCR and detection of ctxB 
genes ........................................................ 162 
Figure 17 Adhesion of V. cholerae non-01 on HEp-2 and Caco2 cell lines ................ 166 
Figure 18 Whole cell protein profiles of V cholerae "026" strains 334-72, E57025 and 
E55414, stained for protein, LPS and radio-immunoblotted with antiserum raised 
against 334-72 .................................................. 168 
xxii 
Figure 19 Outer membrane protein profiles of V cholerae and V mimicus ................ 170 
Figure 20 Silver stained SDS-PAGE LPS profiles ................................. 173 
Figure 21 Silver stained SDS-PAGE LPS profiles of V cholerae "024 .................... 176 
Figure 22 Silver stained SDS-PAGE LPS profiles of V cholerae "069 .................... 177 
Figure 23 Silver stained SDS-PAGE LPS profiles of V cholerae "026 .................... 178 
xiii 
I 
INTRODUCTION 
1.1 Identification, nomenclature and classification Vibrio cholerae and V. mimicus. 
The family Vibrionaceae consists of four genera; Vibrio, Aeromonas, 
Photobacterium and Plesiomonas. The genus Vibrio includes several species which are 
pathogenic to humans, and infections are usually food-bome. Of more than 30 species, II are 
associated with human disease; V cholerae, V mimicus, V parahaemolyticus, V 
alginolyticus, V hollisiae, V fluvialis, V fiurnisfl, V. vulnificus, V damsela, V metschnikovii 
and V cincinnatienisis. These divide biochemically into three groups (Table 1); Vcholerae and 
Emimicus belong to group I (Furniss et aL 1978; Brayton et aL 1986; Janda et aL 1988). 
Vcholerae and Vmimicus are short, rod-shaped (straight or slightly curved) 
gram-negative bacteria with a single polar flagellum. These organisms are facultatively 
anaerobic, oxidase positive and ferment glucose without forming gas. They grow readily on an 
agar medium at an optimal pH between 7.6 and 8.6. Colonies on agar are usually translucent 
and amorphous but sometimes wrinkled or rugose. Strains of V cholerae and V mimicus may 
produce a pellicle when grown in liquid media. Strains of V cholerae and V mimicus can 
grow in the absence of NaCl, a feature which distinguishes these bacteria from other vibrios. 
Other useful biochemical characteristics (Table 1) are; lysine decarboxylase (LDC) and 
ornithine decarboxylase (ODC) positive, but arginine dihydrolase (ADH) negative, acid from 
mannitol but not from inositol or arabinose. 
The different serogroups of V cholerae (Tables 2a and 2b) are very similar 
biochemically. However, all strains of V cholerae serogroup 01 ferment mannose, whereas the 
reaction is variable with strains of V cholerae belonging to non-01 serogroups. V mimicus is 
biochemically distinguished from V cholerae by the inability to ferment sucrose, a negative 
reaction in the Vogues-Proskauer (VP) test, a lack of amylase production and failure to 
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to haemagglutinate, chick red blood cells (Sakazaki and Donovan 1984). 
Individual strains of both species (V cholerae and V mimicus) can be 
differentiated by the structure of cell wall lipopolysaccharide, as detected by specific 
antisera prepared to the somatic ("0") antigen. Flagellar antigens are of little value for 
strain differentiation since flagellar or "H" antigens are seemingly identical for all 
strains of V cholerae and V mimicus. Early attempts to differentiate strains of V 
cholerae by serology were performed by Gardner and Venkatraman (1935), who 
successfully divided a panel of strains of V cholerae into six O-subgroups, in which 01 
was assigned to 'cholera vibrios' (Gardner and Venkatraman 1935). In addition to the 
category 'cholera vibrio', a large number of vibrios, which are biochemically similar 
but which are not agglutinated by 01 antisera, have been recognised for many years in 
cholera-epidemic areas. These have been called non-agglutinable (NAG) or non-cholera 
vibrios (NCV). Since 1972, when the International Subcommittee on Taxonomy of 
Vibrios recommended that the species V cholerae no longer be restricted to the cholera 
vibrio, they have been included in the species definition and are known collectively as 
V cholerae non-01 (Sakazaki and Donovan 1984; West and Colwell 1984). The 
antigenic scheme of Sakazaki and Donovan was extended throughout the 1970's, 
incorporating the scheme of Smith, to 83 serogroups (Table 2a) (Smith 1979; Sakazaki 
and Donovan 1984). Recent studies have further extended the scheme to show that the 
species V cholerae contains over 140 serogroups (Table 2b) (Shimada et aL 1994). 
Serogroup 01 can be divided into two biotypes, termed classical and El 
Tor. The classical biotype is differentiated from the El Tor by sensitivity to polymixin 
and to classical vibriophage IV. The El Tor biotype is sensitive to El Tor phage V and 
resistant to polymixin. In addition the El Tor biotype is usually haemolytic and can 
agglutinate chicken erythrocytes (Fumiss et aL 1978). Both classical and El Tor 
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biotypes can be further subdivided by serology into the Ogawa and Inaba subtypes; a third 
subtype, Hikojima, appears to be an unstable intermediary and is rarely seen (Sakazaki 1992). 
These subtypes are identified by 0 antigens designated a, b and c. Inaba contains somatic 
antigens a+c, Ogawa a+b and Hikojima a+b+c. The El Tor biotype, the cause of the 
seventh pandemic, is currently predominant in endemic and epidemic areas (Barrett and Blake 
1981). 
The Teference stTains of seTOgTOUPS 020 (317-71), 071 (162-78), 0101 (559- 
88), 0114 (246-79), 0115 (523-80), 0116 (980-78), 0117 (381-82), 0135 (29-92) and 0138 
(455-92) are strains of V mimicus (Table 2a and 2b). Since strains of V mimicus and V 
cholerae can belong to the same serogroups, a single scheme is applicable to both species. 
1.2 Ecology and epidemiology 
Strains of bacteria belonging to the genus Vibrio are free-living estuarine 
organisms, widely distributed throughout the world. Human pathogenic vibrios including V 
cholerae and V m1micus are naturally occurring in aquatic environments of areas free from 
endemic disease (Janda et aL 1988; West 1989; Morris 1990). The presence of these organisms 
is not always associated with faecal contamination or sporadic human infections (Feacharn et aL 
1981; Glass et aL 1983a; Miller et aL 1985), refuting the traditional concept that V cholerae 
has a limited potential for survival outside the human intestine. The occurrence of infections 
with pathogenic vibrios in the United Kingdom is relatively infrequent compared with other 
developed countries such as the USA. Most cases of vibrio-associated diarrhoea occurring in 
the UK result from travellers returning from countries where cholera and cholera-like diseases 
are prevalent, although there may be under reporting due to lack of awareness of these 
pathogens. Cases of diarrhoea usually occur following ingestion of food exposed to a 
contaminated aquatic environment or the consumption of seafood. The occurrence of these 
pathogens and epidemiology of human infections caused by them is significantly influenced by 
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their microbial ecology. 
Ecological studies indicate that water temperature, concentration of aquatic 
organic matter, salinity and the potential for association with sediments or the surfaces of higher 
organisms, significantly influence the occurrence and number of these pathogens in aquatic 
environments. Water temperature seems to be the single most important factor governing the 
incidence and density of pathogenic vibrios in natural aquatic environments. Seasonal and 
geographical variations occur which are dependent on water temperature (Roberts et aL 1982; 
West and Lee 1982; Williams and La Rock 1985; Nair et aL 1988). Most pathogenic Vibrios 
disappear from the pelagic environment at temperatures above 30T and below IOT but may 
persist in the aquatic sediments. Under favourable environmental conditions the vibrios can 
proliferate and re-emerge in the water (Hood and Ness 1982; West and Lee 1982; Williams and 
La Rock 1985). 
Pathogenic Vibrios frequently occur in brackish coastal waters ranging in 
salinity from 5% to 30% NaCl (West and Lee 1982; Bockemuhl et al. 1986; Tison et al. 1986). 
In some freshwater areas (less than 5% salinity), pathogenic vibrios may survive due to the 
interaction of high water temperature and elevated organic nutrient concentration which 
overcomes the deleterious effect of low NaCI concentrations (DePaola et al. 1983; Rhodes el al. 
1986; Nair et al. 1988). The prolonged survival of a toxigenic strain of V cholerae 01 in low 
salinity and low nutrient environments has been demonstrated (Singleton et al. 1982a; Singleton 
et al. 1982b; Miller and Mekalanos 1984). These organisms also appear able to prolong their 
existence and maintain high numbers by association with plankton, shellfish and fish. In 
particular the chitin component in plankton appears to enhance significantly the phenomenon of 
prolonged survival (Huq et al. 1984). Bivalve molluscs have been shown to concentrate and 
harbour V cholerae (DePaola et al. 1983). Storage of contaminated shellfish at inappropriate 
temperatures can lead to rapid proliferation of these bacteria within shellfish (Karunasagar et al. 
1987). Marked seasonal variations in the presence of pathogenic vibrios in filter-feeding 
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shellfish have been described, and are thought to relate to the concentration of bacteria in the 
aquatic environment (Tison et aL 1986; Kelly and Dan Stroh 1988). Crustacean shellfish, such 
as crabs, shrimps and lobsters, can also become colonised; although this appears to depend on 
the concentration of bacteria and is more frequently observed at higher ambient temperatures 
(Davis and Sizemore 1982; Huq et aL 1986). 
Both molluscs and crustaceans are implicated as vectors in food-poisoning 
incidents, with patients frequently having a history of consumption of seafood and shellfish. In 
the USA diarrhoeal disease is frequently associated with ingestion of raw shellfish, particularly 
oysters. In one study, strains of V cholerae belonging to serogroup Smith 017 (now 
incorporated in the Sakazaki scheme and designated 02), accounted for 43% of the total 
number of strains of V cholerae isolated (Morris et aL 1981). 
Within areas where cholera is endemic, strains of V cholerae harboured by 
animals are not considered as a significant cause of cholera (Sanyal et aL 1974; Miller et aL 
1985); although, strains of V cholerae non-01 have been isolated from domestic animals, 
waterfowl and other wildlife in near-shore habitats of non-endemic cholera regions (DePaola 
1981). In the UK, V cholerae was not detected in the faeces of sheep grazing adjacent to 
ditchwater containing V cholerae (Lee et aL 1982). In contrast, Rhodes et aL (Rhodes et aL 
1985) reported V cholerae non-01 associated with enteric disease in horses, lambs and bison in 
Western Colorado where the organism occurs in some freshwater environments. Evidence is 
emerging to suggest that aquatic birds may serve as vectors for the dissemination of strains of 
V cholerae. At a ditchwater site studied by Lee et al. (Lee et al. 1982) V cholerae non-01 
was isolated from freshly voided droppings of swans nesting nearby. The study also reported a 
low frequency of intestinal carriage of V cholerae non-01 in seabirds caught in the UK. Ogg 
et aL (Ogg et aL 1989) isolated toxigenic strains of V cholerae 01 and non-01 from the gut of 
aquatic birds in central regions of the USA. 
Laboratory studies have suggested another survival strategy which may be 
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adopted by vibrios; the so-called "viable but non-culturable" form. Under unfavourable 
conditions V cholerae 01 can enter a state of dormancy (Xu et aL 1983; Roszak and Colwell 
1987), with bacteria dividing normally when more favourable environmental conditions occur. 
This survival mechanism may be involved in the regular incidence of cholera epidemics in 
endemic areas, and explain how foci of V cholerae persist in developed countries, such as 
around the Gulf of Mexico in the USA, even though conventional techniques show that V 
cholerae is not continuously present. Although the survival of V cholerae in fresh water is 
limited in laboratory experiments, studies in England, Australia and the USA (Desmarchelier 
and Reichelt 1981; Roberts et aL 1982; Lee et al. 1994) indicate that the organisms persist in 
natural environments such as rivers, lakes and estuaries. 
Molecular biology techniques, such as chromosomal restriction endonuclease 
digest profiling, have established conclusively that natural aquatic environments are the 
epidemiological reservoir for toxigenic V cholerae 01 in non-endemic cholera regions. In the 
Gulf of Mexico, a single strain of toxigenic 01 was responsible for a widely distributed series 
of cholera outbreaks over a decade (Kaper et aL 1982; Lin et al. 1986). CT genes were also 
found in a few strains of V cholerae non-01 from the same area (Kaper et al. 1986). 
Strains of V cholerae belonging to non-01 serogroups occur more frequently 
and in higher numbers than strains belonging to the 01 serogroup, since 01 is but one of many 
serogroups which can be found in the aquatic environment (DePaola et aL 1983). Non-01 
serogroups may undergo bioconcentration in the aquatic environment in association with 
zooplankton and filter-feeding shellfish, similar to that described for serogroup 01 (Tison et aL 
1986). In cases of diarrhoea caused by V cholerae non-01 the patients frequently have a 
history of consumption of seafood, especially oysters and crustaceans such as crabs, shrimps 
and lobsters. A study in the USA found a strong cpidcmiologic association with the 
consumption of raw oysters (Morris et aL 1981; Wilson et aL 1981). In a study in Cancun, 
Mexico 22 of 134 persons with diarrhoea, as well as sewage samples, untreated water samples 
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and raw seafood yielded V cholerae non-01 (Finch et aL 1987). 
However, some infections caused by V cholerae non-01 do not appear to have 
a readily established link with aquatic environments (Thibaut et aL 1986; Safrin et al. 1988). It 
is therefore possible that other environmental niches exist and are yet to be fully identified. 
The capacity of V cholerae non-01 serogroups to survive and multiply in a wide range of 
foods appears to be greater than the capacity of V cholerae 01 (Roberts and Gilbert 1979), 
suggesting that non-01 serogroups may be transmitted by routes other than water or seafood in 
non-endemic areas. Humans may also act as carriers of V cholerae as established in a study in 
India (Marwah et aL 1975). The majority of carriers were short term excreters of I to 7 days 
duration, with reports of an asymptomatic carriage rate as high as 9% in the 5- 14 year old age 
group. In a study of Russian sailors it was found that the carrier state could last more than 60 
days (Blake et aL 1980). However, there is no conclusive proof of spread by direct contact and 
the most important modes of spread are through food and water. 
V cholerae non-01 can act as an opportunistic pathogen and host susceptibility 
may play an important role, especially in cases of extraintestinal illness where underlying 
disease (cirrhosis, leukaemia, malnutrition and gall bladder disease) is often present (Safrin et 
aL 1988). 
1.3 V. choterae and cholera 
Diarrhoeal diseases are a significant cause of mortality and morbidity world- 
wide, particulary in developing countries. V cholerae is an important cause of diarrhoea in both 
children and adults, particularly in Southern Asia and the Indian subcontinent where cholera 
and cholera-like diseases are endemic. Cholera is often associated with poverty, overcrowding 
and low socio-economic status. 
In the last two centuries there have been seven cholera pandemics (Barua 1992). 
The first recorded cholera pandemic was in 1817; this and the following five pandemics were 
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attributed to strains of V cholerae belonging to serogroup 01 biotype classical. The seventh 
pandernic was caused by V cholerae 01 biotype El Tor. The epidemiology and mode of 
transmission of cholera was described by Snow after the "Broad Street pump" outbreak in 1849. 
The organism was discovered and named V cholerae in 1854 by Pacini, and 30 years later, 
during the fifth pandemic, Robert Koch isolated and identified the causative agent of cholera 
(Barua 1992). When the El Tor biotype was discovered it was regarded as a harmless variant. 
However, V cholerae El Tor strains rapidly displaced the classical biotype in endemic areas, 
and proved capable of causing epidemic cholera. The seventh and current pandernic started in 
1961, and has spread from South East Asia to the Middle East and parts of Europe, reaching 
Africa in 1970 and South America in 1991 (Janda et aL 1988; Gangarosa and Tauxe 1992). 
Worldwide the number of cholera cases reported to the World Health 
Organisation, in 1993, was 376,845 in 78 countries with 6,781 deaths (WHO 1994). This 
represents a substantial decrease in the figure for 1991, when due to the spread of the seventh 
pandernic to South America, 595,000 cases were reported (WHO 1994). 
In Asia alone, there were 18,007 cases reported by 13 countries in 1989, this 
increased sharply in 1990, due to an outbreak in Nepal, to 30,979 cases reported by 12 
countries (Anonymous 1991). In 1991, there were 49,791 cases and 1,286 deaths, this declined 
in 1992 to 16,299 cases and 372 deaths. Again the difference in numbers was due to the 
continuing outbreak in Nepal which accounted for 30,000 cases in 1991 (Anonymous 1993). 
Transmission of V cholerae is generally via the oral route, and food and water 
are the most common vectors. The minimum infective dose is 10' - 10' organisms, although 
stomach acidity influences significantly the dose required to cause overt disease (Levine et al. 
1984; Drasar 1986). Strains of V cholerae which produce cholera toxin (CT) are responsible 
for the disease cholera. In its most severe form (cholera gravis) victims produce large volumes 
(exceeding one litre per hour) of faeces termed "rice water" stools, resulting in severe 
dehydration causing poor skin turgor and sunken eyes. Stool losses generally peak during the 
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first 24 hours following the onset of symptoms and if patients are left untreated, they may 
develop circulatory collapse. However, only 2 to I I% of infections, caused by V cholerae El 
Tor and classical biotypes respectively, develop the cholera gravis forni of the disease (Barua 
and Burrows 1974). Fluid and electrolyte replacement is the main form of therapy, although 
antibiotics may shorten the duration of symptoms and excretion of the organism (Mahalanabis 
et aL 1992). 
Strains not belonging to serogroup 01 (ie: V cholerae non-01) have been 
implicated in sporadic cases and outbreaks of diarrhoeal disease, sometimes indistinguishable 
from cholera (Blake et aL 1980). Strains of V cholerae belonging to serogroups other than 01, 
produce CT only rarely and until 1993 had not been associated with epidemics of cholera; 
however, strains of V cholerae belonging to serogroup 0139 changed this trend. 
1.4 Recent developments: the spread of Vcholerae 01 to South America and the 
emergence of V. cholerae 0139 
The seventh pandernic of cholera spread and increased steadily from 1961 until 
1966, and in 1970 a major upsurge occurred as countries in Africa were infected. Reviewing 
the global cholera situation in 1980, the WHO working group expressed "concern that if cholera 
should reach any of the countries of South and Central America which are considered to be 
"receptive", there could be another dramatic increase in the number of affected countries" 
(WHO Scientific Working Group 1980). In January 1991, strains of V cholerae 01 were 
isolated in Peru, the first time it had been identified in the Americas. By 1992 391,220 cases 
and 4002 deaths had been recorded (Anonymous 1992) in 14 of the 21 countries of South and 
Central America. 
Untreated drinking water was thought to be a potential vehicle of infection with 
V cholerae and the organism was also isolated from fish and seawater. The consumption of 
vegetables irrigated with raw waste water also contributed to the spread of this organism. 
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Genetic analysis revealed that strains isolated from the outbreak in South America were similar 
to strains of V cholerae isolated from the pandernic occurring in Asia and Africa, and clearly 
distinguishable from strains causing sporadic cases of cholera along the Gulf coast of the USA 
(Wachsmuth et aL 199 1; Wachsmuth et al. 1993). 
As the seventh pandernic spread through South and Central America an 
apparently "new" strain of V cholerae emerged in India and Bangladesh. The first reported 
outbreak of cholera caused by this organism occurred in October 1992 in Madras, India 
(Ramamurthy et aL 1993). The illness was clinically indistinguishable from epidemic cholera, 
except for the frequency of abdominal cramps (Bhattacharya et aL 1993). The outbreak spread 
to Calcutta (November 1992) with over 15,000 cases and 230 deaths. The number of cases of 
diarrhoea caused by V cholerae 0139 was increasing whereas the number of cases of cholera 
caused by V cholerae 01 was decreasing; by December 1992 95% of cases were due to V 
cholerae serogroup 0139. There followed outbreaks in Southern Bangladesh (December 1992) 
(Albert et aL 1993), Dhaka (January and February 1993 - 10,000 cases, 500 deaths) and a 
further major outbreak in Calcutta (February 1993) (Anonymous 1993). The outbreaks, both in 
India and Bangladesh, were apparently caused by the sarne clone of V cholerae 0139 (Shimada 
et A 1993). The severity of the illness, the high attack rate in the adult population and the 
lack of immunological protection in individuals with a history of clinical cholera suggested that 
this was a new strain, one to which the population had not been previously exposed. This was 
supported by the lack of protection conferred by vaccination with heat-inactivated whole cell V 
cholerae 01 antigen. None of the strains reacted with a panel of 138 anti-lipopolysaccharide 
antisera prepared against the first 138 strains listed in Table 2a and 2b, and all were positive for 
CT. The outbreak strain was designated as V cholerae serogroup 0139, synonym Bengal, a 
novel non-01 clone which appeared to be spreading and displacing the V cholerae 01 El Tor 
strain (Swerdlow and Ries 1993) just as the El Tor strain once superseded the classical V 
cholerae 01. Sporadic indigenous cases were also confirmed from Thailand, China, Malaysia 
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and Nepal (VMO 1994); imported cases were reported in Estonia, Germany, USA and UK 
(Anonymous 1993; Cheasty et aL 1993). This strain of V cholerae belonging to serogroup 
0139 may have the potential to cause a new pandemic, (Swerdlow and Ries 1993). 
Despite microbiological and clinical advances, cholera remains a persistent 
problem for the developing and to a lesser extent, the developed world. The emergence of 
strains of V cholerae belonging to serogroup 0139, the appearance of multiply resistant strains 
of V cholerae and the spread of the 7th pandernic to South America has lead to renewed 
interest in V cholerae. 
1.5 V. cholerae non-01, V. mimicus and associated clinical disease 
Serology has enabled strains of V cholerae and V mimicus to be divided into 
140 groups based on epitopes located on V cholerae lipopolysaccharide, also tenned the 
somatic or "0" antigens. Strains belonging to V cholerae serogroup 01 regardless of biotype 
are agglutinated by anti-01 antisera; while all other serogroups, which are not agglutinated by 
anti-Ol antisera, are designated V cholerae non-01. Strains of V mimicus, once thought to be 
a variant of V cholerae unable to utilize sucrose, have now been classified as a distinct species 
(Davis et aL 1981). 
Strains of V cholerae belonging to serogroups other than 01 have been 
implicated in sporadic cases and outbreaks of gastrointestinal disease. The symptoms vary from 
bloody diarrhoea with fever to a severe watery diarrhoea indistinguishable from cholera. In 
1986 it was reported that strains of V cholerae belonging to serogroups other than 01 were a 
significant cause of mortality in Bangladesh with 25.8% fatality (Islam and Shahid 1986). 
Volunteer studies in 1990 (Morris 1990) confirmed that strains of V cholerae non-01 can cause 
diarrhoea with a severity comparable to that seen in cholera even by strains unable to make CT, 
a key virulence property expressed by V cholerae 01. If CT is produced by non-01 
serogroups, as with the epidemic V cholerae 0139 strain, the presentation is typical of clinical 
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cholera. Reports of outbreaks possibly caused by strains of V cholerae other than 01 date 
back to 1954 (Yajnik and Prasad 1954); since then there have been several published reports of 
outbreaks of gastroenteritis attributable to strains of V cholerae non-01 and some of these 
have, retrospectively, been linked to particular O-serogroups (Donovan 1984). For example, 
during an outbreak of cholera in Czechoslovakia (1965) there were 56 cases, and V cholerae 
was isolated from 42 of the patients. Strains of V cholerae belonging to serogroup 05 were 
implicated, with potato salad as the probable vehicle of transmission (Aldova et aL 1968) 
(Table 3). Another outbreak occurred among passengers onboard an aeroplane destined for 
Australia (1973); the outbreak was linked to the consumption of chopped egg but the serogroup 
of V cholerae involved was not identified (Dakin et aL 1974). In a water-bome outbreak, 
reported in 1971, there were 544 cases and 31 fatalities. The outbreak was suspected to have 
resulted from faecal contamination of drinking water and caused by a strain of V cholerae 
serogroup 037 (Kamal 1971). 
Sporadic cases associated with V cholerae non-01 diarrhoea have also been 
reported. McIntyre reported 19 persons with sporadic illness from Bangladesh; many had 
severe dehydrating diarrhoea and 50% required intravenous fluid therapy (McIntyre et aL 
1965). Spira et al. reported on 14 adults with cholera in Bangladesh, symptoms included 
vomiting (100%), abdominal pain (71%), pyrexia (43%) and muscle cramps (21%). The mean 
duration of illness was 42 hours (Spira et aL 1978). Another study from the USA reported on 
13 patients whose symptoms included abdominal cramps (92%), nausea (77%), vomiting (69%), 
chills (64%), fever (58%), mucus in stools (30%), and bloody stools (8%); the duration was 
approximately 7 days (Hughes et aL 1978). In summary, a range of symptoms has been 
associated with cases of V cholerae non-0 I gastroenteritis, including fever and bloody 
diarrhoea which are encountered only rarely in "typical" cases of cholera. 
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V cholerae has been established as the etiologic agent of cholera and until 
recently it was generally accepted that only strains of V cholerae belonging to serogroup 01 
were responsible for causing epidemics of cholera. However, in 1992/3 a non-01 strain of V. 
cholerae emerged with epidemic, and possibly pandemic potential (see section 1.4). This strain 
of V cholerae belonging to 0139 appeared to be displacing strains of V cholerae belonging to 
serotype 01 El Tor in endemic areas, and may prove to be the cause of an eighth pandemic, the 
first caused by a non-01 strain of V cholerae (Swerdlow and Ries 1993). 
Strains of V cholerae belonging to serogroups 01 and 0139 produce cholera 
toxin, however toxin production is not a prerequisite for infection and non-toxigenic strains of 
V cholerae 01 are able to cause illness. This usually involves diarrhoea, and symptoms vary 
from the mild and transitory to an illness resembling cholera gravis. Infections with non- 
toxigenic V cholerae 01 may be of increasing prevalence (Honda et al. 1988). Most V 
cholerae non-01 do not produce CT, although other enterotoxigenic mechanisms may or may 
not be present. 
V mimicus has also been reported as a causative agent of diarrhoea (Shandera 
et aL 1983); however, as with V cholerae non-01, production of CT is rare and most strains 
produce toxins other than CT (Chowdhury et al. 1987; Ramamurthy et al. 1994). The wider 
range of presenting symptoms seen with V mimicus and V cholerae non-01 as opposed to V 
cholerae 01 infections is probably related to the presence or absence of a number of virulence 
factors. 
Strains of both V cholerae non-01 and V mimicus are also associated with 
non-gastrointestinal infections and are capable of causing extraintestinal infections. Septicaemia 
may occur, with the causative organism being present in bile, gall bladder, urine, blood, 
sputum, appendix, peritoneal fluid and cerebrospinal fluid (Safrin et aL 1988; Clark et aL 
1989). In general, patients which develop septicaernia have underlying disease, such as 
cirrhosis of the liver, or have wound infections contaminated with sea or estuary water. 
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Extraintestinal infections, due to V cholerae 01, have also been reported, although these are 
rare (Johnston et aL 1983). Where extraintestinal infections have occurred the strains of V 
cholerae were found not to produce CT indicating other factors may be involved. The 
pathogenic mechanisms possessed by strains of V cholerae causing extra-intestinal infections 
remain to be elucidated. 
1.6 Pathogenic mechanisms and virulence 
Pathogenicity describes the ability of an organism to produce disease, and 
pathogenic bacteria may show variation in pathogenicity relating to the virulence of a given 
organism. In order to produce disease a pathogen must be able to complete a defined disease 
process (Smith 1978). 
The pathogenesis of most diseases generally involves one or more of the following four steps, 
as described by Smith (1978). 
(1) Entry into a host, and colonisation of mucous membranes. 
(2) Multiplication in the physical and chemical conditions of the host 
environment. 
(3) Avoidance of the action of humoral (in body fluids) and cellular host 
defense mechanisms. 
(4) Biochemical processes resulting in host tissue damage and possibly 
fatal effects associated with the disease. 
The microbial factors responsible for these steps in disease production are 
virulence determinants or virulence factors. For an organism to cause disease, several different 
factors may be required to accomplish the full pathogenesis of disease. 
Strains of V cholerae and V mimicus are usually ingested in contaminated food 
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or water. Once inside the host the organisms must resist gastric acid, enzymes and bile, in this 
context the presence of food or NaHC03 is necessary for the organisms to survive. A prelude to 
infection involves the penetration of the gut mucous layer, the ability to resist peristalsis and 
compete favourably with commensal gut micro-organisms (for example, lactobacilli which are 
inhibitory to enteric; pathogens) (Levine et aL 1984). Properties such as motility, the production 
of mucinases and other proteolytic enzymes enable the bacteria to penetrate intestinal mucous 
and to reach enterocytes directed by a chernotactic response. Strains of V cholerae attach 
preferentially to the epithelium of the upper rather than the lower bowel. 
Other recognised bacterial pathogenic properties include long-chain 
lipopolysaccharide, capsules and extra-cellular protein layers which enable organisms to attach 
to the epithelium or resist host defences; however, for strains of V cholerae, these factors have 
not been investigated fully. Following initial adherence, organisms may proliferate on the 
epithelial surface, and may remain associated with the gut mucosa (for example Shigella 
dysenteriae) or may traverse the intestinal wall and enter the host circulation (for example 
Salmonella typhi). 
Regardless of whether pathogenic bacteria are non-invasive or extra-intestinal, 
additional pathogenic mechanisms are usually involved in pathogenesis. Although the 
manifestations of disease may result from the release of various "aggressins" (Smith 1978), a 
major pathogenic mechanism is the ability to produce toxins. A powerful heat-labile exotoxin, 
cholera toxin or CT is the main virulence factor associated with strains of V cholerae 
belonging to serogroups 01 and 0139 which cause epidemic cholera. However, strains of V 
cholerae which do not produce CT have been isolated from patients with diarrhoeal disease 
(McIntyre et al 1965; Morris et aL 1984; Batchelor and Wignall 1988) and a volunteer study 
has shown that V cholerae non-01 which do not possess the CT gene can elicit diarrhoea with 
a severity comparable to cholera (Morris et aL 1981). "Non-toxigenic" (CT negative) strains of 
V cholerae 01 have also been reported, for example a "non-toxigenic" strain was isolated 
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from a patient with severe gastroenteritis after consuming oysters (Morris et al. 1984). These 
so-called non-toxigenic strains may in fact be producing a toxin distinct from CT. Saha and 
Sanyal (1988) found evidence of the production, by an environmental V cholerae, of a second 
enterotoxin, which was different from CT in antigenic nature, receptor site, mode of action and 
genetic homology. 
Strains of V cholerae belonging to serogroups other than 01 and 0139 appear 
to cause diarrhoeal disease by mechanisms other than production of CT (Honda and Miwatani 
1988). The wide range of extracellular toxins elaborated by V cholerae non-01 strains include: 
CT and cholera-like toxin (Shankar et aL 1982; Yamamoto et aL 1983a; Yamamoto et aL 
1983b), heat-stable enterotoxin (NAG-ST) (Takao et aL 1985; Arita et aL 1986), cytotoxins 
(Janda et aL 1988), a specific cytotoxin resembling Shiga-like toxin (OBrien et aL 1984), and 
haemolysins (Nishibuchi and Seidler 1983; Datta-Roy et aL 1986) including a thermostable 
haemolysin related to the Thermostable direct haemolysin (TDH) of V parahaemolyticus 
(Honda et aL 1985; Yoh et aL 1986). The pathogenicity of V mimicus appears to be similar to 
V cholerae non-01. Production of, CT (Spira and Fedorka-Cray 1984; Chowdhury et aL 
1987), ST (Arita et aL 1991), cytotoxins (Ramamurthy et aL 1994) and TDH (Nishibuchi et aL 
1990) by strains of V mimicus have been described. 
Of the toxins known to be expressed by strains of V cholerae, not all are 
expressed by all strains, although certain strains may produce more than one toxin. 
Bhattacharya et aL (Bhattacharya et aL 1992) reported a strain of V cholerae belonging to 
serogroup 05 which caused severe watery diarrhoea and dehydration in an Australian tourist, 
who required hospital isation. This strain was negative for CT and NAG-ST but produced a 
haemolysin and a cytotoxin, suggesting that these toxins may be involved in pathogenesis. 
Strains of V mimicus producing more than one toxin have also been reported (Ramamurthy et 
aL 1994). There appears to be geographic variability in the frequency with which strains 
produce certain toxins. Production of CT is rare among clinical isolates in the USA (Morris et 
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aL 1981; Roberts et aL 1982), but has been described in 30-40% of clinical isolates from India 
and Bangladesh (Blake et aL 1980; Datta-Roy et al. 1986). 
A variety of animal models has been used to assess the production of toxins. 
They include rabbit ligated intestinal loop (ileal loop, De test), infant rabbit (Dutta. test) and 
infant mouse assays (Ichinose et aL 1987). Even when cell-free supernatants have failed to 
produce detectable enterotoxin-like activity, the ability of live cultures to produce fluid 
accumulation in rabbit ileal loops has been demonstrated with V cholerae non-01 (Madden et 
aL 1981; Simpson et aL 1987). Cell tests and immunological tests can also be used to detect 
some toxins. Optimal cultural conditions for toxin production can vary from strain to strain as 
toxin production is affected by the culture medium used, pH, requirement for NaCl, aeration 
versus static incubation and addition of lincomycin (Yamamoto et al. 1981; Nishibuchi and 
Seidler 1983; Turnbull et aL 1985). Tissue culture methods using YI mouse adrenal cells or 
Chinese hamster ovary cells are generally used to detect the closely related heat-labile 
enterotoxins LT and CT (Donta el al 1974; Guerrant et aL 1974). Although tissue culture tests 
are sensitive and relatively easy to perform, they require cell maintenance and the proteases/ 
haemolysins of some strains may mask the detection of cytotonic; enterotoxin activity. Where 
sera are available enzyme linked immunosorbent assays (ELISA) and latex agglutination tests 
can be used but they may detect inactive, partial toxin (choleragenoid) as opposed to whole 
toxin. Gene probes are specific, as well as sensitive, and now that non-radioactive labelling 
methods are available the only drawback may be that the gene detected is inactive. In addition 
to toxin production V cholerae and V mimicus may possess a number of other virulence 
determinants, including: cell-associated haemagglutinins, flagella and fimbriae, a range of outer 
membrane proteins and high affinity iron uptake systems. The precise role of many of these 
factors in disease is not known (Robins-Browne et al. 1977; Shehabi and Richardson 1985; 
West 1989; Ramamurthy et al. 1994). The most extensively studied virulence factor produced 
by strains of V cholerae is the ability to produce a potent exotoxin, CT. 
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1.6.1 Cholera Toxin (CT) and related heat-labile toxins 
The characteristic symptoms of cholera result from the action of a single toxin. 
The production of this powerful exotoxin was first shown by De et aL (De and Chatterjee 1953; 
De 1959); a ligated segment of small intestine in a living rabbit filled with fluid following 
intraluminal injection of V cholerae or sterile culture filtrates. The toxin was purified in 1969 
by Finkelstein (Finkelstein and Lo Spalluto 1969). The mode of action of CT was first 
suggested by the work of Field et al. who measured the potential difference across stripped 
segments of ileal mucosa using an Ussing chamber (Field et al. 1971). They found that the 
addition of cyclic adenosine monophosphate (cAMP) caused the direction of chloride ion (Cr) 
transport to be reversed, so that there was active secretion of Cl- from the mucosal surface. 
Absorption of sodium ions (Ne) was also reduced. The net result of such changes in ion 
balance was a passive efflux. of water from the mucosal surface of the tissue. Under the same 
conditions sterile culture filtrates of Vcholerae mimicked the effects of cAMP thus causing 
diarrhoea. Using purified CT it was shown that CT stimulates adenylate cyclase activity in the 
intestinal tract, leading to increased levels of cAMP and thereby altering ion transport at the 
mucosal surface (Stephen and Pietrowski 1981). 
CT is a protein toxin consisting of two subunits: a single A (active) subunit of 
molecular weight 28,000 which is covalently attached to a 58,000 aggregate of five B (binding) 
subunits, each with a molecular weight of 11,600 (Holmgren 1981). The five B subunits form 
a stable ring pentamer structure. The A subunit is linked to and partially inserted into the B 
ring. The B subunit is responsible for specific high affinity binding of the toxin to the GMI 
gangliosides of intestinal epithelial cells (Holmgren et aL 1973; van Heyningen et aL 1974; 
Svennerholm and Holmgren 1978). The A subunit is synthesised as a single polypeptide chain 
and penetrates the cell membrane to initiate activation of adenylate cyclase. Once penetration 
has occurred the A subunit is split into fragments, At (22,500) and A2 (5,500), by "nicking" 
between two cysteine residues. This releases the At fragment from the A2 portion which 
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attaches it to the B pentamer (Gill 1976). The reduction of the disulphide bond between the Al 
and A2 fragments appears to be necessary for the activity of the toxin on adenylate cyclase. 
The activation depends on NAD, undefined cellular cytosol factors, and ATP, in addition to the 
Al fragment of CT and the cell membrane (Gill and King 1975). CT has ADP- 
ribosyltransferase activity and catalyses the reaction: NAD + acceptor protein -> ADP-ribose- 
acceptor protein + nicotinamide +W (Moss and Vaughan 1977). The acceptor protein is the 
guanylnucleotide-binding component (the G, protein) of the membrane-bound adenylate cyclase 
(Pfeuffer and Cassel 1978). Adenylate cyclase is active while GTP is bound to the G, protein 
but becomes inactive when GTP is hydrolysed to GDP. CT, therefore, stabilises adenylate 
cyclase in an active conformation (Figure 1). 
CT is closely linked with V cholerae serogroups 01 and 0139 which cause 
epidemic cholera. The pathogenicity of V cholerae 01 has been comprehensively reviewed 
(Levine et aL 1984; Mekalanos et aL 1988; Holmgren 1992). Other V cholerae serogroups 
also possess the CT gene and produce CT. CT production in strains of V cholerae non-01 has 
been reported from Bangladesh and India; Datta-Roy (Datta-Roy el aL 1986) found an 
incidence of 26% (9/34) in clinical isolates and 10% (1/10) in environmental isolates. The 
incidence in other parts of the world is lower. A study in Thailand (Hanchalay et aL 1985) 
found none of 44 human isolates and 2% (5/237) of environmental isolates were CT positive. 
In a study of environmental isolates from the Louisiana Gulf coast (Roberts et al. 1982) it was 
found that only 0.3% (7/2500) produced CT. A study of 790 V cholerae non-01 strains from 
50 countries, isolated from both environmental and human sources also found a low incidence 
(0.25%) of the CT gene (Said et aL 1994). 
However, cholera-like diarrhoea has been associated with CT-negative strains of 
both V cholerae 01 and non-01 (Spira and Fedorka-Cray 1983; Spira et aL 1986). Production 
of a CT-like toxin was first suggested by Zinnaka & Carpenter (Zinnaka and Carpenter 1972) 
and Ohashi et A (Ohashi et aL 1972). CT-like toxins have been found in some strains of 
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Figure 1: Mechanism by which cholera causes diarrhoea. 
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V cholerae non-01 and V mimicus (Shankar et al. 1982; Spira and Fedorka-Cray 1983; 
Yamamoto et aL 1983b; Spira and Fedorka-Cray 1984; Yamamoto et aL 1985; Spira et aL 
1986). The ability to produce CT-like toxin appears to be clinically relevant (Zinnaka and 
Carpenter 1972; Zinnaka et aL 1973; Spira and Daniel 1979). 
CT and the heat-labile enterotoxin (LT) of Escherichia coll share similar modes 
of action, common antigenic determinants and possess extensive homology of amino acid 
sequence (Holmgren et aL 1973; Gill and Rappaport 1979). CT and LT are part of a 
heterogeneous family of enterotoxins and different forms of LT have been described ie: LTh-1, 
LTp-1, LTIla and LTIlb (Guth et aL 1986). Similarly different forms of CT may exist with 
differences in molecular structure between enterotoxins produced by different serogroups of V 
cholerae (Finkelstein et aL 1987). 
A variety of techniques including antigenic similarity, biologic activity and 
electrophoretic mobility in gels have been used to detect these toxins. Homologous or closely 
related gene sequences have been detected by hybridisation to the CT and LT probes (Moseley 
and Falkow 1980; Kaper et aL 1981). Yamamoto and colleagues found toxin purified from V 
cholerae non-01 from Louisiana was indistinguishable from cholera toxin, but that another V 
cholerae non-01, from a patient with diarrhoea, produced a toxin biologically and 
immunologically similar but not identical to CT in molecular structure (Yamamoto et aL 
1983b). Spira & Fedorka-Cray reported CT-like toxin from V mimicus (Spira and 
Fedorka-Cray 1984). The purified toxin was biologically, immunologically and 
physicochemically identical to CT except that it appeared to be secreted with an unnicked A 
subunit. A number of functions have been attributed to these enterotoxins; fluid accumulation 
in animal models, the ability to elicit diarrhoea in suckling mice and elongation of Chinese 
hamster ovary cells (De et aL 1960; Finkelstein et aL 1964; Guerrant et aL 1974; Baselski et aL 
1977). 
The CT operon is situated in the V cholerae chromosome and may be present 
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in multiple copies in strains of the classical biotype, but in a single copy in most strains (70%) 
of the El Tor biotype (Moseley and Falkow 1980; Kaper and Levine 1981). Duplication of the 
CT genes (ctx, 4 and ctxB) in the classical biotype and 2 or more ctx copies present on tandemly 
repeated genetic elements (7kb or 9.7kb) in some strains of the El Tor biotype, have been 
reported (Mekalanos 1983). 
The first DNA probes used to detect genes encoding CT were cloned fragments 
encoding the closely related LT of enterotoxigenic E. coli (Moseley and Falkow 1980; Kaper et 
aL 1988a). The DNA probes for the A and B subunits of LT only hybridised to V cholerae 
under low stringency conditions. These probes gave the first indication that more than one 
copy of the CT gene existed in some strains of V cholerae, a phenomenon confirmed by 
Mekalanos (Mekalanos 1983). An LT-A probe was also used to show that nontoxigenic strains 
lacked any toxin gene sequences and therefore could not revert and serve as a reservoir of 
cholera (Kaper et aL 1981). In molecular epidemiology studies probes were used to 
demonstrate that 01 strains from the USA had identical restriction fragment patterns 
homologous to the LT probe and that this pattern was not seen elsewhere in the world. Thus, 
the restriction fragment length polymorphisms (RFLP) detected by the toxin gene probe 
demonstrated that a single endemic strain has persisted in the US since at least 1973 and is 
responsible for sporadic cases of cholera (Kaper el aL 1982). With the cloning and sequencing 
of genes encoding cholera toxin (ctx) (Lockman and Kaper 1983; Mekalanos 1983; Lockman et 
aL 1984) the LT probe has been replaced by the CT probe for screening V cholerae. The 
sequence data showed that LT and CT shared approximately 76% homology. A convenient CT 
probe was found in the plasmid pCVD27 which contained a 554 bp Xbal-Clal fragment 
encoding 94% of the A subunit gene, ligated to EcoRI linkers and cloned into pBR325. CT 
probes have confirmed and extended observations made with the LT gene probe. Cook et d 
(Cook et aL 1984) using a CTA probe and HindIll digests showed the classical biotype 
possessed 2 fragments, the El Tor biotype from eastern countries I fragment and the El Tor 
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biotype from the USA 2 fragments. Similarly Australian V cholerae 01 were found to be 
genetically diverse and unrelated to strains from Singapore, Jakarta and Louisiana 
(Desmarchelier and Senn 1989). A large survey of Louisiana isolates yielded a number of V 
cholerae non-01 and V mimicus which hybridised with the CT probe. The RFLP in these 
strains differed from that seen with the Gulf Coast 01 and showed greater genetic diversity than 
the highly conserved 01 strains (Kaper et al. 1986). Based on the toxin gene RFLP and total 
chromosomal restriction patterns at least two separate clusters of V cholerae non-01 could be 
distinguished in addition to a distinct cluster of V mimicus strains. 
Strains have been attenuated for use in vaccine development by constructing 
specific deletions in the genes encoding CT. The cloned CT genes were mutated in vitro by 
removing a 554 bp Xbal-Clal fragment containing sequences encoding the A subunit. The 
promoter for the ctx operon and the B subunit sequence were retained, thus allowing the 
production of the nontoxic B subunit without the A subunit. This mutation was then introduced 
into the chromosome of virulent V cholerae strains by homologous recombination, specifically 
replacing the active toxin genes without affecting the other genes encoding critical antigens. 
The desired mutation was detected using the 554 bp probe to screen for the absence of this 
sequence. Antibodies directed against the B subunit will prevent binding of CT to intestinal 
cells. Vaccine candidates derived by this method have proven to be highly immunogenic in 
volunteers and have conferred excellent protection against challenge with virulent V cholerae 
(Kaper et aL 1984; Kaper et aL 1988b). Miller and Mekalanos (Miller and Mekalanos 1984) 
used a probe for the toxR sequence which encodes a positive regulator of CT and possibly other 
products of V cholerae. When both nontoxigenic and toxigenic strains were probed a 3.9 kb 
EcoRI fragment hybridised to toxR sequences in all strains, suggesting that an intact regulatory 
system for ctx genes is present in naturally occurring nontoxigenic strains of both V cholerae 
01 biotypes. 
Although CT is the main virulence factor in cholera, other extracellular products 
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may also be involved in the disease process. Recent evidence suggests that CT is part of a 
"cassette" of virulence factors, including at least two other toxins, Zonula Occludens Toxin 
(Zot) and Accessory cholera toxin (Ace) (Fasano et aL 1991; Baudry et aL 1992; Truckis et al. 
1993). 
1.6.2 Toxins associated with CT 
CT genes (ctx) are inherited as part of a chromosomal "virulence cassette" 
along with other factors, including Ace and Zot (Fasano et aL 1991; Baudry et aL 1992; 
Truckis et aL 1993). 
Zot is a toxin which increases the permeability of the small intestinal mucosa 
by affecting the structure of the intracellular tight junction, or zonula occludens; the mechanism 
is not known. Zot was first discovered in a strain developed for use as a vaccine, CVDIOI, a 
CT negative strain of V cholerae, which still caused symptoms including abdominal cramps, 
vomiting and diarrhoea (Fasano et al. 1991). Zot may act by allowing uptake of bacterial 
endotoxin or other products due to the increased permeability of the tight junctions. The gene 
encoding Zot was cloned and found to be located immediately upstream of the ctx locus 
(Baudry et aL 1992). The zot gene encodes a polypeptide of approximately 44 kda. The 
predicted amino acid sequence shows no homology to any other bacterial toxin, however 
homology was found with the gene I product of a filamentous bacteriophage believed to be an 
ATPase (Koonin 1992); the significance of this is not known. The zot gene has been found in 
both V cholerae 01 and non-01, and does not appear to occur independently from ctx 
scqucnccs (Johnson el aL 1993; Karasawa el aL 1993). 
Another potential enterotoxin is Ace (Truckis et d 1993). The gene for this 
toxin, ace, is located on a 4.5 kb core region which also encodes CT and Zot. The ace gene 
potentially encodes aII kda peptide with a predicted amino acid sequence which has homology 
with a family of eukaryotic ion-transporting ATP-ases, and sequence similarity with a virulence 
protein of Salmonella dublin, SpvB (Krause el al. 1991). Ace may act by aggregating and 
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inserting into the eukaryotic membrane to form an ion channel (Kaper et aL 1994). 
The genes encoding ace, zot and ctx are located in tandem on the 4.5 kb core 
region which is flanked by repetitive sequences (RS I elements). This arrangement can lead to 
amplification or deletion of all three toxins as a unit (Goldberg and Mekalanos 1986). This 
region was shown also to contain a gene encoding an intestinal colonisation factor cep (core 
encoded pilin) (Pearson et al 1993). Interestingly CVD I 10, aV cholerae 01 El Tor, in which 
the sequences for Zot, Ace, haemolysin-cytolysin as well as the CT A subunit are deleted, still 
caused mild to moderate diarrhoea with abdominal cramps and fever when fed to volunteers 
(Tacket et aL 1993). This indicates that the organism possesses other factors that give it 
diarrhoeagenic potential. 
1.6.3 Haemolysin(s) and Thermostable direct haemolysin (TDII) 
Haemolysins or cytolysins are thermolabile proteins commonly produced by a 
number of vibrio species. These extracellular enzymes possess lytic activity against eukaryotic 
cell lines including erythrocytes and are commonly referred to as haemolysins. V cholerae 01 
biotype El Tor was originally distinguished from the classical biotype by haemolysis of sheep 
erythrocytes (Furniss et aL 1978). Strains of V cholerae non-01 produce a haemolysin which 
appears to be indistinguishable from haemolysin produced by strains of V cholerae El Tor 
(Brown and Manning 1985; Yamamoto et aL 1986; Ichinose et aL 1987). Also, strains of V 
mimicus produce a haemolysin which has partial identity with these haemolysins (Shinoda et aL 
1993; Uchimura et aL 1993). Purified haemolysin. produced by strains of V cholerae El Tor is 
lethal for mice, causes increased vascular permeability in rabbits and lyses erythrocytes (Honda 
and Finkelstein 1979). The haemolysin causes fluid accumulation in ligated rabbit ileal loops 
and, in contrast to the watery fluid produced in response to CT, the fluid is bloody with mucus 
(Ichinose et aL 1987). 
A cytolysin that is cytotoxic for YI adrenal and CHO cells, and causes fluid 
30 
accumulation in rabbit ileal loops has been described by McCardell et aL and Spira et aL 
(McCardell et aL 1985; Spira et aL 1986). This cytolysin was thought to be identical to El Tor 
haernolysin. However this cytolysin has recently been shown to form anion-selective channels 
in planar lipid bilayers (Krasilnikov et aL 1992). 
V cholerae and V mimicus probably produce more than one haemolysin or 
nut 
.,. olysin. 
Haemolysins arc possible virulence factors, particularly for V cholerae non-01 and 
V mimicus that do not produce CT. The hIyA gene encoding haemolysin, is found in both 
biotypes of V cholerae 01 and in V cholerae non-01 (Brown and Manning 1985). The hIyA 
gene has been cloned by several groups (Goldberg and Murphy 1984; Manning et aL 1984) and 
its DNA sequence has been determined. DNA sequence analysis of the hIyA gene predicts a 
precursor protein of 82 kda which is processed by proteolysis to a final active fori-n. of 65 kda 
(Hall and Drasar 1990). Using a 6.2 kb Pstl probe with Southern blots, Brown & Manning 
(Brown and Manning 1985) have shown homologous sequences in chromosomal restriction 
digests of V cholerae non-01 strains. Both haemolytic and non-haernolytic strains possess 
sequences homologous to the probe suggesting mutations in a regulatory rather than structural 
gene. Differences in sizes of restriction fragments hybridising with the haemolysin probe can 
distinguish haemolytic from non-haemolytic strains of both 01 and non-01 V cholerae. 
However the importance of haemolysin in diarrhoea remains uncertain; in volunteer studies, 
ingestion of aV cholerae 01 vaccine strain not producing CT and mutated in the hIyA gene by 
deletion of a 400 bp Hpal fragment, still caused diarrhoea in 33% of the subjects (Levine et aL 
1988). 
Another well-characterised haernolysin known as the Thennostable Direct 
Haemolysin (TDH), is associated with the pathogenesis of Vibrio parahaemolyficus. It can be 
detected by the Kanagawa phenomenon in which lysis is shown on Wagatsuma agar containing 
human blood. V cholerae non-01 produce a TDH which has been designated NAG-rTDH and 
resembles the TDH of V parahaemolyticus (Vp-TDH) (Honda et aL 1985; Yoh et aL 1985; 
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Yoh et al. 1986). TDH was purified using immunoaffinity column chromatography and anti- 
(Vp-TDH)-antibody (Honda et aL 1985). The electrophoretic mobilities of Vp-TDH and 
NAG-rTDH haemolysin arc similar on SDS-slab electrophoresis. Their lytic activities on 
erythrocytes of various animals arc also similar; rabbit, chicken and human erythrocytes are 
very sensitive whereas horse erythrocytes are completely resistant. Vp-TDH and NAG-rTDH 
are also closely related immunologically. 
NAG-rTDH genes are carried on a large plasmid in V cholerae non-01 (Honda 
et aL 1986). This is of special interest as Vp-TDH is chromosomal (Nishibuchi et aL 1985). 
Transmission of the Idh gene could explain the presence of TDH-related haemolysins in V 
cholerae non-01, V mimicus and V hollisae (Yoh et aL 1986; Nishibuchi et aL 1990; Terai et 
aL 1990). 
1.6.4 Heat-stable enterotoxin (ST) 
Spira and Daniel (Spira and Daniel 1979) and Nishibuchi et aL (Nishibuchi et 
aL 1983) both reported the production of a toxin with activity in the infant mouse assay. Spira 
and Daniel found V cholerae non-01 strains which produced ST similar to that of E. coli with 
a peak fluid accumulation (FA) by 4 hours in the suckling mouse assay and the rabbit ileal loop 
assay. However, the factor responsible for FA in the study of Nishibuchi et aL was only 
detected when whole cell cultures were administered and not in filtrates of bacterial cultures. 
The FA in the latter study could have been caused by a number of virulence factors but 
probably not an ST-like toxin. ST comprise an expanding family of structurally, functionally 
and immunologically related peptide toxins (Figure 2) which bind specifically and reversibly to 
a receptor found in the microvillus membranes of the intestinal cell brush border stimulating 
fluid secretion via receptor-mediated activation of guanylate cyclase (Field 1978). 
The presence of a heat-stable enterotoxin has been demonstrated in V cholerae 
non-01 (Honda et aL 1985; Arita et al. 1986) and in V mimicus (Arita et aL 1991). These two 
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heat-stable toxins were designated NAG-ST and VM-ST respectively. Both NAG-ST and VM- 
ST were indistinguishable on HPLC column chromatography suggesting their close similarity. 
NAG-ST is a 17 amino acid protein which is immunologically related to the ST of 
enterotoxigenic E. coll (ETEC) (Honda et al. 1985). ETEC ST causes diarrhoea which may be 
severe (Sack 1975) and it is possible that NAG-ST plays a part in the severe watery diarrhoea 
induced by some V cholerae non-01. Amino acid sequences of purified NAG-ST and VM-ST 
toxin were found to be similar to that of E. coli ST which is a known virulence factor. From 
position 3 to 15 (shown as the boxed area in Figure 2) the sequence is almost identical, 
suggesting that this sequence is essential for expression of enterotoxic activity (Takeda et al. 
1979; Takao et al. 1983; Yoshimura et aL 1986). The traditional method for detecting STI 
type toxins (STh and STp) in ETEC has been the infant mouse assay (Dean et aL 1972). Using 
this method Arita et aL found 55% (55/100) human and 62% (5/8) of V cholerae non-01 from 
the environmental sources in Southeast Asia produced NAG-ST (Arita et aL 1986). However, 
by hybridisation with a mixed oligonucleotide probe, Hoge et aL found only 6.8% (7/103) of 
the V cholerae non-01 isolates from Thailand, and none of the 78 isolates from Mexico and 
USA, were positive for NAG-ST (Hoge et aL 1990). The nucleotide sequence for this mixed 
oligonucleotide probe was deduced from the amino acid sequences of E. coll STh and STp. 
Although the amino acid sequences of the ST family are similar (Takao et aL 1985) the 
nucleotide sequences of the genes encoding them are distinctly different, with only 50% 
homology (Ogawa et aL 1990). This may explain the failure to detect NAG-ST using E. coli 
ST probes (Seriwatana et aL 1987; Sommerfelt et aL 1988). In 1990 the NAG-ST gene was 
cloned and sequenced enabling the construction of a 271 bp cloned fragment of the NAG-ST 
gene (Ogawa el aL 1990). Recently Pal et aL used this cloned DNA probe to assess the 
prevalence of NAG-ST among environmental strains isolated in Calcutta (Pal et aL 1992). 
They found 2.3% (12/521) of strains hybridised and suggested that there might be a correlation 
between serogroup and NAG-ST. Although it is exceedingly uncommon to find ST 
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in V cholerae 01 one study did identify this toxin in I of 197 isolates of V cholerae 01 
(Takeda et aL 1991). The gene encoding the ST of 01 was cloned and found to be similar to 
the NAG-ST gene (Takeda et aL 1991). The ST of V m1micus and the Hakata group of V 
cholerae non-01 (now designated serogroup 0140) were analysed with respect to their amino 
acid sequences. Vm-ST was identical to NAG-ST (Arita et al, 1991) whereas Hakata-ST was 
one amino acid longer (Dohi et aL 1993). 
Although, studies using gene probes for ST have only found a low incidence of 
the ST gene in V. cholerae (Hoge et al. 1990; Pal et al. 1992), strains which produce this toxin 
have the potential to produce severe diarrhoea. It was demonstrated that aV cholerae non-01 
strain which produced NAG-ST caused severe diarrhoea in a volunteer study (Morris et al. 
1981). 
1.6.5 Cytotoxins 
Cytotoxins are biologically and physiologically distinct from cytolysins. In 
contrast to cytolysins, cytotoxins have been described in only a limited number of vibrio 
species, including V cholerae and V fluvialis, and are characterised principally by their ability 
to cause cell death without lysis (Janda et aL 1988). Most V cholerae non-01 strains produce 
cytotoxin(s), including the CT producing strains (Said et aL 1994). When cytotoxic activitY is 
produced it will often mask the rounding effects of cytotonic toxins like CT. The V fluvialis 
cytotoxin is a heat-labile substance which causes elongation of CHO cells (Lockwood et al. 
1982; Wall 1984). 
A specific cytotoxin related to Shiga-like toxin or Vero cytotoxin (VT)-like 
toxin appeared to be demonstrated in cell lysates of V cholerae and V parahaemolyticus, using 
cytotoxicity tests and neutralisation assays with anti Shiga-toxin antiserum (O'Brien et al. 
1984). It is possible that this toxin may play a role in bloody or dysentery-like diarrhoea 
occasionally associated with V cholerae non-O 1. 
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1.6.6 Colonisation factors 
Colonisation of the cpithelial mucosa of the small intestine appears to be a 
critical step in the ability of organisms, such as V cholerae 01 and V cholerae non-01, to 
elicit diarrhoea (Spira and Fedorka-Cray 1983). A number of possible mechanisms involved in 
the penetration of the mucous layer and the colonisation of the epithelial cells have been 
proposed, these include; chemotaxis, motility through a single polar flagellum, haemagglutinins, 
outer membrane proteins, lipopolysaccharides and pili or fimbriae. However, investigations into 
cell-associated factors have been complicated by the difficulty of linking the presence of such 
factors in infecting strains, with overt pathogenesis. Virulence factors may have multiple 
biologic functions or properties, thereby making the study of such factors even more difficult. 
The mucous layer wbich protects the small intestine is chemotactic to vibrios 
(Freter and Jones 1976; Freter 1981) and these organisms are known to produce proteolytic 
enzymes including mucinase (Booth and Finkelstein 1986). These factors may be important in 
allowing vibrios to traverse the mucous layer. 
It has also been hypothesised that the flagellum plays a key role in adhesion by 
aiding both, penetration of the mucous barrier and colonisation of the epithelial surface (Freter 
1981; Attridge and Rowley 1983). Early studies suggested that non-motile variants of V 
cholerae 01 were less virulent. The flagellum may function merely as an agent of motility, 
serving to promote interaction between cell-surface adhesins of vibrios and the intestinal surface 
(Guentzel 1975). Alternatively this structure may bear the adhesins and thus be more directly 
involved in the actual binding event (Jones and Freter 1976). The study of Jones & Freter 
demonstrated that non-motile variants derived from motile strains of V cholerae lacked the 
capacity of the parental strain for binding to isolated brush-border membranes or ileal slices in 
vitro (Jones and Freter 1976). Using antisera, of different specificities Attridge & Rowley 
demonstrated independently both binding and motility functions associated with the flagellar 
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structure (Attridge and Rowley 1983). The observation of immobilized yet adherent vibrios, or 
alternatively motile nonadherent ones, showed that motility was neither necessary nor sufficient 
for in vitro attachment. Other studies have failed to corroborate the findings that non-motile 
strains were less virulent (Teppema et aL 1987). On scanning electron micrographs flagella are 
clearly protruding into the luminal space and not involved in attachment (Sack 1992). 
The most recent research suggests that pili are the critical factors in 
colonisation. Several groups have reported the presence of pili in V cholerae 01 (Ehara, et aL 
1987; Taylor et al. 1987; Hall et aL 1988; Pearson et aL 1993), V cholerae non-01 (Honda et 
aL 1988) and V mimicus (Uchimura and Yamamoto 1992). These filamentous surface 
organelles mediate the specific binding and colonisation of host tissue and are essential 
components in the virulence of many pathogenic bacteria (Beachey 1981). The best 
characterised pilus of V cholerae is the toxin co-regulated pilus (TCP) (Taylor et aL 1987; 
Attridge and Voss 1993). Under the electron microscope each pilus is 5-7 nm in width and 10- 
15 ýLm in length and due to their hydrophobic nature they aggregate to form large bundles. The 
expression of TCP bundles causes autoagglutination and sedimentation in broth culture as well 
as conferring the ability to haemagglutinate erythrocytes from CD-I mice in the presence of 
fucose or mannose. These sugars inhibit the majority of other V cholerae haernagglutinins. As 
the name implies TCP is co-regulated with CT. At the molecular level the synthesis of the 20.5 
kda protein pilin subunit (designated TcpA) is coordinately expressed within a virulence regulon 
by the transmembrane DNA-binding regulatory protein ToxR and by a recently identified global 
regulator ToxT. The role of TCP in colonisation has been established for both V cholerae 01 
biotypes in volunteer studies. Mutant strains which did not produce pili failed to colonise the 
intestine and failed to produce an effective immune response (Herrington et aL 1988). 
Immunoblotting has shown that TcpA is expressed in vivo (Kauffman and Taylor 1994). The 
receptors for TCP have not been identified. TcpA shows homology to type IV pilins, which are 
produced by a number of bacterial pathogens including E. coli (Giron et aL 1991), 
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Pseudomonas aeruginosa (Sastry et al. 1983) and Nelsseria gonorrhoea (Meyer et aL 1984). 
Type IV pili are thought to be critical for virulence in E. coli, P. aeruginosa and N. 
gonorrhoea. 
Another pilus which is closely associated with CT is the recently identified 
core-encoded pilus (cep) which is found alongside ar, ace and zot (Pearson et aL 1993). V 
cholerae 01 also produce other pili which have haernagglutinating activity, but no apparent role 
in colonisation (lwanaga et al. 1989). Likewise V cholerae non-01 have been shown to 
produce pili which are closely related to the TCP pili but which have no role in colonisation 
(Nakasone and Iwanaga 1990). 
The role of other attachment structures such as adhesins (Faris et aL 1982; 
Kabir and Ali 1983), some of which mediate the agglutination of erythrocytes, is less clear 
since they are found in a broad range of serogroups of diverse origin (Booth and Finkelstein 
1986) and fail to show a distinct association with the infectious process (Attridge and Rowley 
1983). 
A protease, which may also play a role in dissolving the intestinal mucous gel 
(Finkelstein and Hanne 1983), and cell-associated soluble haernagglutinins (Hanne and 
Finkelstein 1982) have the potential to be involved in the adherence or colonisation. of V 
cholerae. A protease similar to that of V cholerae 01 has been described in V cholerae non- 
01 (Booth and Finkelstein 1986; Honda et al. 1987). Booth & Finkelstein (Booth and 
Finkelstein 1986) examined the distribution of a variety of haernagglutinins as potential 
colonisation factors in strains of V cholerae 01 and non-01. V cholerae 01 secrete a major 
protease which is also a haemagglutinin (HA/protease). HA/protease has been characterised as 
a zinc-dependent metalloprotease (Booth et aL 1983) with the ability to nick (activate) the A 
subunit of CT (Booth et al. 1984) and to cleave or digest other putative physiologically 
important substrates, including mucin, fibronectin and lactoferrin (Finkelstein et aL 1983). 
Protease deficient mutants are known to be less virulent (Schneider and Parker 1978). 
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Additionally it has been suggested that cell-associated mannose-sensitive, fucose-sensitive, and 
mannose-fucose-resistant haemagglutinins may be virulence factors in pathogenic V cholerae 
(Jones and Freter 1976; Bhattacharjee and Srivastava 1978; Hanne and Finkelstein 1982; 
Attridge and Rowley 1983). Booth & Finkelstein concluded that although the HA/protease and 
cell-associated haemagglutinins were widely distributed in V cholerae 01 and non-01, these 
factors are not sufficient for virulence. Interestingly HA/protease has been shown to be related 
to the elastase of Pseudomonas aeruginosa (Hase and Finkelstein 1990). Elastase also has both 
proteolytic and haernagglutinating activity, and appears to be involved in tissue destruction in 
Pseudomonas infection. Cholera is not an invasive process, and there is no evidence that tissue 
damage is involved. The HA/protease may serve functions other than tissue damage, such as 
participation in adherence and detachment in V cholerae 01 infections. Although the 
organisms which cause cholera are not invasive, other pathogenic vibrios involved with 
extraintcstinal disease with a potential for invasiveness (Booth and Finkelstein 1986) may use 
HA/protease in a destructive way. 
A neurarninidase (NANase) found in V cholerae 01 may have a role both in 
adhesion and in binding and penetration of CT into intestinal epithelial cells 
(Holmgren 1975). NANase catalyses the conversion of higher order gangliosides to toxin 
receptor GMI (Holmgren 1975). Galen et aL demonstrated that deletion of NANase does not 
decrease the biological activity of CT (Galen et aL 1992). The production of CT and 
expression of TCP are regulated by diverse environmental signals (Miller and Mekalanos 1984; 
Waldor and Mekalanos 1994), it appears that when environmental conditions do not promote 
optimal expression of CT or TCP the ability of NANase to enhance binding of CT could 
contribute to the pathogenic process (Galen et aL 1992). V cholerae 01 biotype El Tor 
produce higher ratios of mild or asymptornatic infections than classical strains (Gangarosa and 
Moseley 1974). The El Tor biotype also produces less NANase with lower specific activity 
than that produced by classical strains (Kabir 1984). Thus NANase may be an accessory 
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virulence factor of V cholerae which enhances pathogenicity when the influence of primary 
factors is reduced. 
A recent report (Panigrahi et al 1990) suggested that pathogenic 
V cholerae non-01 could be distinguished from non-pathogenic strains by adhesion on Caco2 
cells. This is a human enterocyte-like cell line derived from a moderately differentiated human 
colonic adenocarcinoma. It has proved a useful in vitro model for adhesion of pathogens such 
as Listeria monocytogenes and E. coll. Although the mechanisms of colonisation of V cholerae 
are not fully characterised, it may be that, similar to diarrhoeagenic K coli, more than one 
mechanism of adherence will be found. 
1.6.7 Lipopolysaccharide (LPS) and Outer membrane proteins (OMT) 
The ability of strains of V cholerae to express long-chain lipopolysaccharide is 
only poorly understood, although strains belonging to serogroups 01 and 0139 are thought to 
express LPS. For these organisms, the ability to produce LPS may be considered a virulence 
factor since only strains of V cholerae belonging to serogroups 01 and 0139 cause epidemic 
cholera. Purified V cholerae 01 LPS has been found to cause haemagglutination, which can 
be inhibited by monoclonal antibodies directed against LPS (Booth et al. 1986). Although the 
role of LPS as an adhesive factor has not been established, antibodies produced against V 
cholerae LPS are protective in animal models, and the observed protection may involve 
interference with LPS during mucosal colonisation (Booth and Finkelstein 1986). 
The somatic antigen or LPS may be a useful indicator of diarrhoeagenic 
potential within the V cholerae non-Ol. In 1980 the WHO (WHO Scientific working group 
1980) reported a prevalence of the 05 serogroup in gastrointestinal disease and 08 in the 
environment, while Donovan (Donovan 1984) found 02,05,07 and 037 predominated in 
gastrointestinal disease and 04 predominated in the environment. It remains to be determined 
whether certain serogroups are inherently more pathogenic than others, and whether certain 
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serogroups are more prevalent in certain geographic areas. The frequency of certain serogroups 
as a cause of gastroenteritis may indicate a more virulent group or simply reflect their common 
occurrence in environmental samples. 
The outer membranes of vibrios, like most grain-negative bacteria, contain 
several major proteins (OMP) some of which are strongly antigenic, (Kabir 1980; Sengupta et 
aL 1989). Kabir reported a major protein which migrated on SDS-PAGE gels as a band of 48 
kda, which was common to all strains of V cholerae 01. Kelley & Parker found a 45 kda 
major protein which appeared to be the major structural protein of the outer membrane (Kelley 
and Parker 1981). Using SDS-PAGE, strains of V cholerae have a distinct OMP pattern when 
compared to many other gram-negative bacteria (Manning et aL 1982). SDS-PAGE profiles of 
OMs produced from strains of V cholerae 01 are generally comprised of OMPs in the range 
25 - 45 kda range, and also additional minor proteins. V cholerae non-01 are considerably 
more heterogeneous. Nevertheless, a protein which migrates during SDS-PAGE as a band of 
25 kda appears to be common to all strains of Vibrio (Manning and Hayes 1984). 
Some studies have suggested that the flagellar sheath is a continuation of the 
outer membrane lipid bilaycr in that it contains LPS (Fuerst and Perry 1988) and specific 
proteins (Hranitsky et aL 1980). Although the significance of most of these OMPs in virulence 
is not known, a role in colonisation has been suggested for an iron-regulated OMP (Goldberg et 
aL 1990). It has also been reported that OMPs are regulated by the ToxR gene which regulates 
a variety of virulence factors including CT and TcpA (Taylor et aL 1987). 
1.6.8 High affinity iron uptake. 
Iron is an essential clement for most aerobic organisms. Pathogenic bacteria 
must be able to obtain iron from the host for bacterial multiplication to occur. Iron in the ferric 
form is almost completely insoluble in aqueous solutions, and specialised transportation and 
storage mechanisms have evolved. In the mammalian host, iron forms an integral part of haem 
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molecules in erythrocytes. In addition, iron is also stored intracellularly in the liver, as 
hemosiderin and ferritin; whilst in blood and mucus iron is transported by specialised iron- 
binding glycoproteins, transferrin and lactoferrin. To obtain sufficient iron from the host, 
pathogenic bacteria must either be able to compete for iron bound to transferrins, and/or obtain 
iron from iron-containing compounds such as haemoglobin. Haemolytic toxins or haemolysins 
may make iron available to an invading pathogen by releasing intracellular iron compounds 
such as haemoglobin, heme or ferritin. The synthesis of some toxins has been shown to be 
regulated by iron, and maximal expression occurs at low iron concentrations. 
Most pathogenic bacteria possess at least one high affinity iron uptake system, 
which involves the production of low molecular weight, high affinity iron chelating molecules 
(termed siderophores) and inducible outer membrane protein receptors for binding ferric- 
siderophores (Lankford 1973; Neilands 1981). Siderophores have an iron binding affinity 
considerably higher than host iron transport glycoproteins and can effectively remove iron from 
the host iron stores for transport into the bacterial cell. These low molecular weight compounds 
have extremely high affinities for iron and are synthesised in response to iron limitation. The 
two major siderophores are the phenolic compound enterobactin and the hydroxamate 
siderophore aerobactin. The synthesis, transport and regulation of expression of two of these 
compounds, criterobactin and aerobactin, and their role in pathogenicity has been studied in 
detail in E. coh. The siderophore enterobactin, formed from chorismic acid, has the highest 
iron binding affinity known; however, in removing iron from ferric-enterobactin the molecule 
becomes destroyed as an active iron carrying ligand. In contrast, aerobactin has a much lower 
affinity for iron than enterobactin, but has the advantage of being reusable. Indeed, most 
invasive bacteria have been shown to express an aerobactin-mediated iron uptake system, 
suggesting that possessing a recyclable iron uptake system may be advantageous. Although 
iron transport systems are less extensively characterised in other bacterial species, there appears 
to be considerable variety in the mechanisms by which pathogenic bacteria acquire essential 
iron. 
42 
In vibrios iron acquisition systems have been investigated in 
V anguillarum, V vulnifilcus and V parahaemolyticus (Crosa 1980; Andrus et aL 1983; 
Tomalsky and Crosa 1984; Chart and Griffiths 1985; Morris et aL 1987). The role of iron 
transport has been most clearly defined for V anguillarum and less clearly defined for other 
vibrio species. V cholerae produces a phenolic siderophore, vibriobactin (Payne and 
Finkelstein 1978; Griffiths et al. 1984) that is unusual in that it contains norspermidine, a 
polyamine rarely found in bacteria (Griffiths et aL 1984). Biosynthesis of the vibriobactin 
moiety shares similarities with enterobactin synthesis. Mutants of V cholerae blocked in 
chorismate synthesis fail to produce vibriobactin (Sigel et al. 1985), and the cloned vibriobactin 
genes complement E. coli entA, C mutations. In addition to the siderophore, at least five outer 
membrane proteins (Sigel and Payne 1982) and haemolysin (Stoebner and Payne 1988) are 
maximally expressed under iron-limiting conditions. V cholerae isolated from the intestinal 
lumen of infected rabbits express outer membrane proteins that are induced in vitro under iron- 
restricted conditions indicating that iron limitation occurs in vivo (Sciortino and Finkelstein 
1983). However, synthesis and transport of vibriobactin are not essential for in vivo 
multiplication or virulence. When tested in vivo in the infant mouse model, mutants defective 
in vibriobactin synthesis or transport retained the ability to multiply and cause diarrhoea (Sigel 
et aL 1985). V. cholerae is a noninvasive surface pathogen and may be able to acquire 
sufficient iron in the intestine in the absence of siderophore synthesis. V cholerae was found 
to use haernin or haernoglobin as a sole source of iron by a siderophore-independent mechanism 
and may acquire iron from these compounds in vivo (Stoebner and Payne 1988). 
1.6.9 Extrachromosomal elements 
The genetic basis for the production of many of the putative virulence factors 
of V cholerae non-01 is not known. However, all the virulence factors so far examined in V 
cholerae 01 are encoded on a chromosome of approximately 2.8 x 103 kb and the gene 
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structure is similar to that found in other enteric bacteria (Kaper and Baldini 1992). 
Plasmid carriage is infrequent among Vibrionaceae. Most are of low molecular 
weight and are cryptic (Janda el aL 1988). High molecular weight, multiple-antibiotic 
resistance plasmids are occasionally found in V cholerae. V cholerae can stably maintain 
plasmids belonging to the incompatability group IncC and rarely IncJ (Hedges et aL 
1977). 
Multiple drug resistance, encoded by conjugative plasmids belonging to IncC has been reported 
in strains from Bangladesh (Glass et aL 1983b). The first outbreak of multi-resistant V 
cholerae 01 El Tor occurred in Tanzania in 1977. Subsequently there have been outbreaks 
in 
Bangladesh. In both instances the resistance was encoded by a 100 Mda conjugative plasmid 
belonging to the Inc C group (Threlfall et aL 1980; Threlfall and Rowe 1982). The emergence 
of multiresistant strains of V cholerae 01 has also been reported from Ecuador (Threlfall et aL 
1993). Attempts to correlate extrachromosomal elements with phenotypic or virulence 
characteristics have been unsuccessful (Newland et aL 1984). Hamood et al. (Hamood et al. 
1986) demonstrated that the R factor pVH2 (a large conjugative plasmid of compatibility group 
C (Threlfall et aL 1980)) of V cholerae enhanced virulence in infant mice but this effect was 
not related to CT, haemolysin or colonisation factors. Conversely the sex factor P of V 
cholerae causes a decrease in pathogenicity by reducing CT production (Newland et aL 1984; 
Guidolin and Manning 1987). The only toxin shown to be extra-chromosomal in V cholerae 
non-01 is the thermostable direct haemolysin (NAG-rTDH) (Honda et aL 1986). The gene, 
tdh, was shown to exist on a large, 33 kb, plasmid by hybridisation with a tdh gene probe 
derived from an internal region of the V parahaemolyticus tdh structural gene (Nishibuchi et 
al. 1985; Nishibuchi and Kaper 1985). The tdh gene present on a large plasmid in V cholerae 
may have originated from the chromosome of V parahaemolyticus. The transmission of tdh 
may be plasmid mediated and take place in the aquatic environment. This transfer of genetic 
material may be infrequent as the incidence of NAG-rTDH among V cholerae non-01 clinical 
isolates is quite low (Yoh et al. 1985). The molecular basis for the exclusion and instability of 
most plasmids in V cholerae is not known, and the apparent lack of plasmids may be related to 
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the practical difficulty in isolating extrachromosomal material from vibrios. 
The cross-resistance of trimethoprim and 0/129 of strains of V cholerae is 
associated with the acquisition of a trimethoprim resistant dihydrofolate reductase. 
Transposable elements have been isolated from V cholerae 01; the resistance of an El Tor 
strain to trimethoprim and the vibriostatic agent 0/129 (pteridine compound 2,4 - diamino - 6,7 
-diisopropyl pteridine) 
is due to a transposon inserted into the chromosome (Goldstein et aL 
1986). An 0/129 resistant V cholerae non-01 has been isolated from a patient with 
gastroenteritis, this strain was also resistant to trimethoprim (Abbott et al. 1992). 
A 2.7 kb element designated RS I (repetitive sequence 1) is found flanking the 
gene for CT. Transposition of this element has been observed and this element appears to be 
involved in the amplification of ax (Mekalanos 1983; Betley 1986). 
1.7 Scope of this study 
Little is known about the virulence determinants of strains of V cholerae non- 
01 and the closely related V mimicus. The ability of these organisms to produce CT is clearly 
involved in the pathogenesis of cholera and cholera-like diseases; however, the pathogenic 
mechanisms of V cholerae non-01 and V mimicus have not been fully elucidated. During the 
last decade, however, it has been recognised that other factors may be involved in the virulence 
of these organisms. Although epidemic strains (01 and 0139) are closely associated with CT, 
some outbreaks and many sporadic infections are caused by "non-toxigenic" serogroups, other 
than 01 or 0139. A number of toxins, other than CT, and a number of possible adhesive 
factors have been postulated as having a role in the disease process. 
The aim of this investigation was to identify virulence properties associated 
with V cholerae non-01 and V mimicus, and to establish a correlation, if any, with serogroup. 
Strains were characterised by biotype and serotype. Appropriate strains were surveyed to detect 
toxins and other known virulence factors. The work included; development of techniques and 
identification of new virulence factors. 
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MATERIALS AND METHODS 
2.1 Bacterial strains 
Strains of V cholerae non-01 and V mimicus, from human and environmental 
sources, were from the Laboratory of Enteric Pathogens (LEP) culture collection (Appendix 2- 
Strain catalogue). Strains of V cholerae 01 were also from the LEP culture collection. 
A panel of reference strains of V cholerae belonging to serogroups 02 - 0139, 
and a rough strain (CA385) were kindly provided by Dr. R. Sakazaki and Dr. T. Shimada 
(Sakazaki and Donovan 1984; Shimada et aL 1994). The strains are listed in Table 2a and 2b. 
V cholerae strain WBDV-IOIE (serogroup 049, CT+), was kindly provided by 
Dr. P. Echeverria, and used as a CT-positive non-01 control strain. V cholerae strain E51116 
(01 classical from Bangladesh CT+) from the L. E. P. culture collection, was used as a CT- 
positive V cholerae 01 control. Escherichia coli strain B7A (0148: H28) (Dupont et aL 1971) 
was used as an LT and ST positive control. 
Strains of V cholerae belonging to serogroups 06 and 023 and known to 
produce CT, had been isolated in Australia and were kindly provided by Dr. P. Desmarchelier. 
Strain NAG 8-2E derived from A5 (Arita et aL 1986), kindly provided by Dr. T. Honda, was 
used as a NAG-ST positive V cholerae non-01 control strain. 
2.1.1 Storage of bacterial strains 
All strains of V cholerae were maintained on nutrient agar slopes at room 
temperature. E. coli strain B7A was stored on a Dorset Egg slope at room temperature. Strains 
which were of particular interest, such as toxin positive strains, were also freeze-dried 
(lyophilised). 
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2.1.1a Lyophilisation 
Cultures were inoculated onto agar slopes and incubated (37 OC, 16 h). The 
resultant cell growth suspended in 2 mls Difco nutrient broth containing 0.5% inositol. 0.2 ml 
of these suspensions was added to freeze-drying tubes (100mm x 7mm) which were plugged 
with sterile cotton wool prior to a preliminary drying for 4h using an Edwards model 5PS 
freeze drying machine. After this the tubes were replugged with sterile cotton wool and the 
neck of the tubes constricted between the plug and the top and put on a multiple drier for a 
further 20 h. After the second drying period tubes were sealed at the constriction and stored in 
the dark. Freeze dried cultures were checked for serogroup and toxin type to ensure that strains 
had retained their original phenotype. 
2.2 Identification and typing of V. cholerae and V. mimicus 
Strains of V cholerae and V mimicus were identified biochemically and 
characterised with respect to biotype, serotype, phage-type and antibiotic resistance type (R- 
type). 
2.2.1 Biochemistry 
Bacterial strains were tested for their ability to utilise mucate and to ferment 
adonitol, arabinose, cellobiose, dulcitol, glucose, glycerol, inositol, inulin, lactose, maltose, 
mannitol, raffinose, rhamnose, salicin, sorbitol, sorbose, sucrose, trehalose and xylose. They 
were also tested for their biochemical reactions in the following tests: ONPG (o-nitrophenyl-B- 
D-galactopyranoside) test, citrate utilization on Simmons citrate and Christensens citrate agar 
slopes, acetate utilization on sodium acetate agar slopes, urease activity, arginine dihydrolase 
production, lysine and omithine decarboxylase production, indole production, hydrogen sulphide 
AS) production in glucose iron agar, growth in the presence of potassium cyanide (KCN), 
malonate utilization, PPA test (deamination of phenylalanine to phenylpyruvic acid), gluconate 
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oxidation, aesculin hydrolysis, gelatin hydrolysis, motility, oxidation-fermentation test in two 
tubes of Hugh & Leifson medium, nitrate reduction, Vogues-Proskauer test 
(acetylmethylearbonit production), oxidase activity, and 0\129 sensitivity. (See Appendix I for 
further details). 
2.2.2 Biotyping 
Strains of Vcholerae belonging to serogroup 01 are designated as classical and 
El Tor biotypes on the basis of six minor biochemical characters, as shown in Table 3 (Fumiss 
et aL 1978). Vcholerae non-01 and Vmimicus were also tested for these characteristics. 
2.2.2a Haemolysis 
Haernolytic properties were detected using horse red blood cells (rbc), freshly 
washed in saline and suspended in saline to give a blood cell concentration of 20%. AI ml 
volume of this was added to 20 mls of saline. The suspension was mixed with melted nutrient 
agar (4%), equilibrated to 60 T to avoid blood cell denaturation, and poured into sterile 
petri-dishes and allowed to dry. 10 ýd volumes of a3h bacterial culture, grown in nutrient 
broth, were spotted onto the plate alongside haemolysis positive and negative control strains. 
After incubation at 37 T overnight plates were examined for lysis. Any haemolysis visible by 
eye was recorded as positive. The size of the zone of haemolysis in mm. was measured and it 
was noted if there was any "greening", complete clearing or opacity. 
Haemolysis of rbe's, other than those from horse, was tested using a microtitre 
method. Equal volumes (25 ý11) of 1% washed rbc and bacte al iltrates were mixed gently d ri f an 
the plate incubated at 37 T for 4 h. When lysis of cells occurred the well contents retained a 
red/brown colour; when the well contents became clear with the cells forming a pellet in the 
base of the well, the strain was considered non-haemolytic. 
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Table 4: Biotypes of V. cholerae 01 
Biochemical tests classical EI Tor 
Haemolysis + 
VP + 
Chick cell agglutination + 
Polymyxin SR 
classical phage 3SR 
El Tor phage 4RS 
sensitive 
resistant 
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2.2.2b Vogues-Proskauer test 
Strains were grown in 3 mls alkaline peptone, water for 3h and approximately 
100 gl "stabbed" into tubes of Vogues-Proskauer (VP) agar medium using a sterile pasteur 
pipette, prior to incubation at 30 T overnight. For the VP test, 0.2 mls of solution A 
(Appendix 1) and 0.1 mls of solution B (Appendix 1) were added to the tubes and left at room 
temperature for 15 min. The appearance of a deep red ring at the top of the agar indicated a 
positive reaction. 
2.2.3 Serology 
Strains of Vcholerae were serotyped, based on the somatic or '0'-antigens, 
according to the method of Sakazaki and Donovan (Sakazaki and Donovan 1984). There are 
140 known serogroups of V cholerae (Shimada et aL 1994); however, for this study sera 
against only the first 83 serogroups and 0139 were available. Antisera were produced to 
strains of V cholerae belonging to serogroups 01 to 083 and 0139, using heat-killed 
organisms. The O-antigen is thermostable (100 T for 2 h) but there is a reduction in 0- 
agglutinability after 30 min. Live cultures were not used as these may not be agglutinated by 
O-antiserurn due to the presence of a surface mucoid substance. Strains of V cholerae which 
did not produce O-antigen, termed "O-rough", give identical serology results. This was thought 
to be due to cross-reactions with core-LPS antigens. To avoid these cross-reactions, antisera 
were all absorbed with an O-rough type strain (CA385) prior to use. 
Flagellar or 'H' antigens are heat-labile, and incubating bacterial preparations at 
100 T for 2h enables the detection of O-antigen agglutination reactions in the absence of H- 
agglutination. Members of the genus Vibrio share common H-antigens, therefore anti-flagellar 
antibodies have little value for the serotyping of strains of V cholerae or V mimicus. 
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2.2.3a. Preparation of antisera. 
For the preparation of bacteria for producing rabbit antibodies to the somatic 
antigens, strains of V. cholerae were grown on nutrient agar slopes (37 T, overnight). For each 
strain, the cell mass was washed from agar slopes into 12 mls of 1% aqueous saline. These 
bacteria were incubated at 100 T for 2h to denature flagellar antigens and the cells sedimented 
by centrifugation at 2000 g for 30 min. The supernatants were discarded and the procedure 
repeated twice. The cells were then suspended in 25 mls 1% saline. Antisem were prepared in 
New Zealand White Rabbits, which were chosen for their large size and well developed ear 
veins. For each antigen a rabbit was immunised with the above heat-treated suspensions by 
injection via the marginal ear vein as follows: 
Day 1 0.5 ml bacterial suspension 
Day 5 1.0 ml it 
Day 10 2.0 mis of 
Day 15 2.0 mls of 
Day 20 2.0 mls 11 
On day 25,40 mls of blood were removed form the marginal ear vein and used for the 
preparation of serum. On day 35 the rabbit was exanguinated under tenninal anaesthesia 
(Animal work was performed under Home Office licence PPL 70/03323). 
For the preparation of sera, red cells were allowed to clot at room temperature 
prior to overnight incubation at 4T to shrink the resultant blood clot. Sera were decanted, and 
the yields from both bleeds were pooled and preserved by the addition of merthiolate (0.1 
mg/ml). All antisera were absorbed with a reference strain which did not express LPS to 
remove antibodies binding nonspecifically to core-LPS. This was done by mixing an excess of 
bacteria with each antiserum. The rough strain (reference strain CA385) was grown in peptone 
51 
water (37 'C, overnight), and 200 gl of bacterial suspension spread over each of seven 15 cm 
diameter agar plates. These plates were incubated overnight at 37 C and the cell harvest mixed 
with 5 mls of antiserum for 2h at 50 *C. Bacteria were sedimented by centrifugation at 2000 g 
for 30 min and the antiserum removed. These sera were used in agglutination reactions with 
both the homologous strain, used to prepare a respective serum, and for reactions against 
heterologous strains to detect any antigenic cross-reactions. Initially the sera were tested in 
microtitre plates against broth cultures of all available reference strains. The individual serum 
titre against its homologous O-antigen was determined in WHO plates; doubling dilutions of 
serum (starting at 1150) were prepared, equal volumes of broth culture was added. Both 
microtitre and WHO plates were placed at 50 'C for 18 h. The plates were examined for 
agglutination; the titre was the highest dilution at which agglutination was seen. Having 
determined the titre of the serum against its homologous 0 serogroup, sera were stored at 
-10 'C until required. 
When sera were found to cross-react with strains of V cholerae expressing 
heterologous somatic antigens, sera were absorbed with the cross-reacting strain to produce 
specific or "pure" antisera. The absorbing strain was prepared and harvested as described 
above, except two 15 cm agar plates were used for each cross-reacting strain. The absorbed or 
pure antiseruin was tested against the cross-reacting strains and the homologous strain used to 
prepare the serum, to ensure the specificity of the serum prepared to the homologous strain. 
A single serogrouping scheme can be applied to strains of both Vcholerae and 
Ymimicus. Some serogroups are known to cross-react, indicating that they share certain factors 
in common. Known reciprocal relationships are: 02 - 09; 013 - 029; 015 - 025; 022 - 
0139; 023 - 073; 027 - 0109; 032 - 068; 034 - 075; 065 - 080; 079 - 083; 092 - 
0 140; 0 110 -0 128; 0 115 - 0126; 0 127 - 0129 (Shimada et aL 1994). 
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2.2.4 Phage typing 
A phage typing scheme has been developed for Vcholerae 01 (Drozhevkina, 
and Artuyunov 1979; Bertram 1990), and strains of V cholerae non-01 were initially examined 
for sensitivity to phages termed "USSR classical phage 3" and "USSR El Tor phage 4". For 
certain strains, the full bacteriophage typing scheme, of seven USSR phages (1 -7) and three 
phages (designated phage 9,10 and 11) isolated by G. Bertram, was used. 
Phage typing was performed by flooding nutrient agar plates with a3h 
bacterial culture (in nutrient broth) of a given test strain, and phages were spotted onto the 
resultant lawn of bacteria using a Lidwell phage-typing machine. The plates were examined for 
lysis after incubation overnight at 37 'C, and the phage type determined by referring to patterns 
produced by strains of known phage type (Table 12, p103). 
2.2.5 Antibiotic resistance typing (R-typing) 
The resistance of bacteria to selected antibacterial agents can be used for strain 
characterisation. For the purpose of R-typing, nutrient agar plates were flooded with a3h 
bacterial culture (in nutrient broth) of a given test strain, and strips or discs, impregnated with 
antibiotics (see 2.2.5c, below) were placed on the plate prior to incubation at 37 *C, overnight. 
The sensitivity or resistance of a given bacterial strain to a panel of antibacterial agents was 
determined by the presence (sensitive) or absence (resistant) of a zone of inhibition. 
2.2.5a Polymyxin discs 
Filter paper discs containing Polymixin B (50 lUs per disc) were obtained from 
a commercial source (Oxoid Ltd. ). Sensitivity to polymixin was determined as described above 
(2.2.5). 
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2.2.5b 0\129 discs 
Filter paper discs impregnated with 2,4-diamino-6,7-diisopropyl-pteridine 
(0/129), were obtained from Oxoid Ltd. Discs containing two concentrations of 0\129 were 
used; 10 gg (0129 DD14) and 150 gg (0129 DD15) per disc. Sensitivity to 0\129 was tested 
on agar plates as described above (2.2.5). 
2.2.5c Antibiotic strips and antibacterial plates 
Resistance to ampicillin (A), chloramphenicol (C), colomycin (Co), 
ciprofloxacillin (Cx), furazolidone (Fu), gentamicin (G), kanamycin (K), streptomycin (S), 
sulphathiazole (Su), spectinomycin (Sp), tetracycline (T) and trimethoprim (Tm) were tested. 
The diffusion method described by Anderson and Threlfall (Anderson and 
Threlfall 1974) was used to test antibiotics A (200 9gIml), C (60 gg/ml), G (60 ttg/ml), K 
(1000 ýLg/ml), S (500 [Lg/ml) and T (5000 gg/ml). Paper strips, impregnated with antibiotic at 
the concentration stated in parentheses, were used. Strains were streaked onto a nutrient agar 
plate and the antibiotic strips were placed at right angles to the bacterial inoculurn. across the 
plate. Each test plate also contained a control Exo1i K12 strain (LEP strain 14R525), which 
was known to be sensitive to all of the antibiotics. The plates were incubated overnight at 
37*C. 
Antibacterial plates were used to test the following antibacterial agents, Co (2 
Wml), Cx (I gg/ml), Fu (20 ýLg/ml), Su (100 99/ml), Sp (100 gg/ml) and Tm (0.5 gglml). The 
media were prepared to give the final concentration stated. Strains to be tested were diluted to 
104and spotted onto these plates. The plates were incubated overnight at 37 T. 
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2.3 Characterisation of strains based on pathogenic properties 
Strains of V cholerae and V mimicus must possess essential pathogenic 
mechanisms to enable these organisms to cause disease. Pathogenic mechanisms, such as the 
ability to produce toxins or adhesive factors, or the expression of high affinity iron uptake 
compunds were used to characterise strains further. 
2.3.1 Toxin production 
Strains of V cholerae and V mimicus were assayed for the ability to produce 
toxin(s) using Yl, HeLa and Vero cell-lines. In addition immunoassays were used to detect CT 
and the infant mouse test was used for the detection of ST. 
2.3.1a Bacterial culture and preparation of crude toxin 
Strains were grown in 10 mls of culture medium in Erlemneyer flasks (250 mls) 
for 18-24 h at 30 T or 37 *C with rotary mixing (120 cycles/min) or statically. Bacteria were 
sedimented by centrifugation (17,000 g, 30 min, 4 T), and supernatants sterilized by millipore 
filtration (0.2 [im). Bacterial filtrates were stored at 4 T. A sample of each filtrate was 
incubated at 100 T for 15 min to denature heat-labile toxins. The resultant filtrates and heated 
samples were used for both tissue culture tests and immunoassays. All tests were done in 
duplicate and the results were compared with control strains V cholerae 01 (E51116 CT+) and 
E. coll (B7A LT+). 
To assess optimal conditions for CT production, culture filtrates were prepared 
after growing the organisms in various media; Syncase sucrose broth (SSB) (Finkelstein et al. 
1966), Syncase glucose broth (SGB) (O'Brien et aL 1984), Trypticase Soy broth (TSB) (Donta 
et aL 1974), Brain Heart Infusion broth (BHI) (Nishibuchi and Seidler 1983) and Casamino 
yeast extract broth (CYE) (Craig et aL 1981) (Appendix 1). 
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Small-scale toxin preparation 
For the testing of large numbers of bacterial strains, a simpler method of toxin 
detection was devised requiring small volumes of medium and no Millipore filtration. The 
resultant preparations were used in the GMI-ELISA or VET-RPLA. For this rapid method of 
toxin detection, bacteria were grown in I ml volumes of SS broth in universal bottles (120 rpm, 
37 OC). Broth cultures were transferred to sterile microcentrifuge tubes and bacteria 
sedimented using a microcentrifuge (12,000 g, 10 min). Supernatants were removed and any 
residual bacteria were killed with 0\129 (150 ýtg/ml). 
2.3.1b Tissue culture cell assays 
Three cell lines, Yl, Vero and HeLa (Appendix 1) were used to examine 
bacteria for the ability to produce toxins. 
Maintenance of cell lines and preparation of cell-tests 
Cell-lines were maintained by regular sub-culturing, and cells were used 
following growth for a standard period of time for toxin tests. For subculturing; cell 
monolayers were initially washed (x2) with Dulbecco's phosphate buffered saline without 
calcium and magnesium (DPBS). I ml of 0.125% (w/v) trypsin in 0.02% (w/v) versene buffer 
was added and poured off after I min, and monolayers incubated at 37 T until cells became 
detached (ca 5 min). Cells were suspended in 5 mls of growth medium containing foetal calf 
serum (Appendix 1) and 1.5 mls of cell suspension was added to 12 mls of growth medium in a 
tissue culture flask (75 cm) and incubated at 37 T. This procedure was carried out twice 
weekly. 
Cells required for toxin testing were obtained, when cell lines were being 
subcultured, and distributed to 96-well tissue culture plates (Falcon Micro Test 11). The cells 
were diluted in tissue culture medium (TCM) to obtain a final concentration of 2.5 x 10' cells 
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ml. In practice an approximation to this required concentration was obtained by mixing I ml of 
resuspended cells with 20 mls TCM. 200 ýtl of this diluted suspension was distributed in each 
well of a 96 well tissue culture plate. Each plate was seated with pressure sensitive film 
(Falcon) suitable for tissue culture plates and incubated at 37 T until growth was confluent, 
usually 3 days. 
YI cell assays for CT and LT 
The YI mouse adrenal cell test (Donta. et aL 1974) was used, in which the 
presence of CT or LT results in morphological changes in the shape of the YI cells. 
A monolayer of YI cells which had been growing for seven days was 
resuspended after trypsin-versene treatment and test plates prepared as described above. Toxin 
was assayed for by adding 25 gi of culture supernatant to duplicate wells, alongside 25 [it of 
heated preparations. Plates were resealed and incubated for 24 h at 37 T. Morphological 
changes were observed by removing the culture medium and fixing cells with methanol (5 min) 
and staining with Giemsa's stain (5% v/v in phosphate buffer) for 45 min. Stained cells were 
washed with distilled water and plates dried prior to examination by light microscopy. 
Monolayers showing signs of rounding in more than 90% of cells indicated the presence of CT 
or LT. Heated preparations were used for comparison to ensure that cell rounding was due to a 
heat-labile factor. 
Vero and Hela cell assays for cytotoxins 
Cells were split and seeded into microtitre plates as described for YI cells. 
Filtrates were prepared and tested for cell rounding (cytotonic effect) and cell death (cytotoxic 
effect), except that the plates were incubated for I day or 3 days and then stained. 
t 
. 4' 
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Neutralisation assays 
Neutralisation tests with specific antisera, prepared to CT, LT and VT were 
performed to confirm the specificity of the cell effects described above. The basis for the 
neutralisation test was that antibody binding to specific epitopes on toxin molecules, inhibits the 
ability of toxin molecules to function correctly. For these tests, 25 ýtl samples of filtrate were 
placed in wells of a 96-well tissue culture plate and incubated with 25 gl antiserurn (diluted 
1/200 in TCM) in 200 gl of TCM for 3h at 37 T. The contents of each well was then 
transferred to the respective well in a 96-well plate containing a given cell monolayer. 
2.3.1c Infant mouse assay for heat-stable enterotoxin (M) 
The infant mouse test was first described by Dean et aL for detecting 
E. coli STa (Dean et al. 1972). As STa and NAG-ST are closely related the same test was 
used to detect NAG-ST. The work was performed under Home Office Licence PPL 70/03323. 
For each test two infant Schofield mice were used. The culture filtrate was prepared as 
described in 2.3.1 a. To 0.5 ml of filtrate, 0.04 ml Pontamine blue (2% w/v) was added in 
order to facilitate the intragastric injections. A 0.1 ml portion of filtrate containing Pontamine 
blue was injected directly into the stomach, through the abdominal wall. After 4h at 30 *C the 
mice were killed with chloroform and the intestine examined for distension. The ability of 
strains to produce toxin was determined by weighing the intestines and mice from each group 
of mice, a intestine weight/body weight ratio of greater than 0.1 was considered positive for 
STa and a ratio of less than 0.08 was considered negative. Any tests which gave a ratio 
between 0.08 and 0.1 were repeated. Tests were also repeated if the ratio failed to confirm the 
visual observation. 
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2.3.1d Enzyme Linked Immunosorbent Assays for CT 
GMI-ELISA. 
The GMI-ELISA was based on the methods described by Svennerhohn & 
Holmgren and Sack et aL (Svennerholm and Holmgren 1978; Sack et aL 1980), and depends 
on the ability of the GMI ganglioside to bind CT. ELISA plates (Dynatech Immulon) were 
coated with 100 Rl of a preparation of ganglioside GMI (2 gg/ml, Supelco) in PBS, covered by 
a plastic film and incubated at room temperature overnight. Unbound ganglioside GMI was 
removed by washing plates (0) with PBS containing 0.05% (vIv) Tween 20 (PBST). To avoid 
non-specific binding of toxins or antibodies, each well was blocked by adding 200 gl of 1% 
(w/v) bovine serum albumin (Sigma) dissolved in PBS (30 min, 37 *C). Plates were washed 
(0) with PBST prior to the addition of 100 RI culture filtrate to duplicate wells and incubation 
at room temperature for 2 h. After washing (0) with PBST, 100 RI of the appropriate 
antiserum was added. Antisera, were diluted 1/200 in PBS and comprised a rabbit- anti-CT 
(LEP), goat-anti-CTB (Novabiochem Ltd) or rabbit-anti-LT (LEP). The plates were covered 
with a plastic film and left at room temperature overnight. After three washes with PBST, 
wells received either 100 pl of a goat-anti-rabbit IgG antibody conjugated with alkaline 
phosphatase for detecting binding of antibodies to CT or LT, or a rabbit-anti-goat IgG antibody 
conjugated with alkaline phosphatase, for detecting goat anti-CTB antibodies. Antibody 
conjugates were diluted 1/1000 in PBST, and 100 gl of preparation was added to the respective 
wells and the plates incubated at room temperature for 2 h. Plates were finally washed (0) 
with PBST and 200 ld of p-nitrophenyl phosphate (I mg/ml) in diethanolamine buffer was 
added and plates incubated at room temperature, in the dark, for exactly 100 min. At this time, 
alkaline phosphatase activity was stopped by the addition of 25 RI IM NaOH to each well, and 
the absorbance read was read at 405 nm. A positive control filtrate was included on each plate, 
and consistently gave a reading of >1.0 (OD403)' 
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Double sandwich ELISA 
In this ELISA antibodies prepared to LT, CT or CTB were used to coat ELISA 
plates. Each antibody was diluted 1/200 in freshly prepared coating buffer (1.59 g Na2CO3, 
2.93 g NaHC03per litre, pH 9.6). 100 ýtl of antibody preparation was added to each well and 
the plate covered with a plastic film and placed at 4T overnight. Plates were washed and 
blocked with BSA as described for the GMI ELISA (above). An appropriate second ligand (ie: 
an antiserum prepared in a different animal from the first antiserurn which was used to coat the 
plate) and the appropriate conjugate to detect the second ligand was used. Therefore, if the first 
ligand was anti-LT or anti-CT the second ligand was anti-CTB, detected using a rabbit-anti-goat 
IgG antibody conjugated with alkaline phosphatase; if the first ligand was anti-CTB then either 
anti-LT or anti-CT could be used as the second antibody and both of these could be detected 
using a goat-anti-rabbit IgG antibody conjugated with alkaline phosphatase. 
2.3. le V. cholerae enterotoxin and E. coU heat-labile enterotoxin - reversed passive latex 
agglutination test kit (VET-RPLA) 
A reversed passive latex agglutination (VET-RPLA) kit (Oxoid) was also used 
for the detection of CT and LT. The test uses polystyrene latex particles which were sensitised 
with purified antiserum. taken from rabbits immunised with purified V cholerae CT. CT and 
E. coli LT have a similar antigenic structure therefore the antiserum raised against CT will react 
with both CT and LT. 
In a standard agglutination a soluble antibody reacts with particulate antigen, for 
example bacterial cells. In the VET. RPLA the agglutination is said to be reversed because the 
antibody attached to the latex particles reacts with a soluble antigen. The latex particles play a 
passive role in the agglutination; the so -called "latex agglutination" results from cross-linking 
of the particles by specific antigen-antibody reaction. 
Culture filtrates (crude antigen/toxin preparations) were prepared as described 
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for the GMI ELISA (above). The test was performed in plates with "W-shaped wells (Sterilin) 
according to the manufacturer's protocol. Doubling dilutions of filtered supernatants were 
made in two rows of wells using the diluent (phosphate buffered saline containing bovine serum 
albumin) provided with the VET-RPLA kit, to give a final volume of 25 ý11 in each well. An 
equal volume of latex beads was added to each well, sensitised beads (latex sensitised with 
specific rabbit IgG against CT) were added to the first row and control beads (latex sensitised 
with non-immune rabbit globulins) were added to the second. A CT positive control provided 
by the manufacturer was included on each plate. The contents of each well were mixed by 
hand agitation taking care that there was no spillage, the plate was covered with a lid and left 
on a dark vibration free surface at room temperature for 24 hours. 
Each well was then examined for agglutination against a dark, preferably black, 
background. If CT or LT was present in the prepared filtrate agglutination occurred and the 
appearance was of a diffuse layer on the base of the well. If the toxin was absent or at a 
concentration below the assay detection level (the sensitivity of the test kit was I-2 ng/ml of 
CT), no cross-linking occurred and a tight button was seen. Results in the row of wells 
containing control beads should all be negative. 
2.3.1f Passive immune haemolysis (PIH) 
The PlH test was originally developed for the detection of the heat-labile 
enterotoxin (LT) of enterotoxigenic E. coli (Evans and Evans 1977) and later used to detect the 
cholera-like enterotoxin of V cholerae non-01 (Yamamoto et A 1981). Passive immune 
haemolysis is the complement-mediated lysis of LT-sensitised sheep red blood cells (SRBC) by 
antitoxin. The direct assay for LT using PIH described by Evans utilises the fact that SRBC 
are readily sensitised by LT in culture filtrates. The presence of toxin in the filtrates is detected 
when complement and antitoxin are added causing haemolysis of sensitised SRBC. Similarly 
CT can be detected by PIH. 
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Stock SRBC were obtained commercially (Tissue Culture Services Ltd) and 
washed twice with PBS prior to dilution in PBS to give a preparation 10% of the original 
concentration. Immediately before use, this preparation was diluted 1/10 in PBS. Lyophilised 
guinea pig complement (Gp-C') (Tissue Culture Services Ltd), was resuspended in 2 nils PBS 
and stored in aliquots of 0.5 ml at -10 T. For use in the PIH test the Gp-C' was diluted 1/10 
dilution in PBS. The anti-toxin was rabbit anti-CT (LEP) used at a 1/100 dilution in PBS. 
Tube assay. 
40 ýd PBS, 10 ýtl toxin preparation (filtrate made as described in section 2.4.2) 
and 50 gl of SRBC were mixed together in a tube and incubated with shaking at 37 *C for 30 
min in order to allow CT if present to adsorb to the SRBC. 50 RI of antitoxin (1/100) was then 
added and the mixture was incubated for an hour at 37 T to allow the antibody to react with 
the CT-SRBC complexes. Next 50 gI of GP-C' (1/10) was added and the tubes were retumed 
to 37 T for a further hour. The reaction mixture (0.2 ml) was diluted tenfold by the addition 
of 1.8 mls PBS. After centrifugation at 200 g for 10 min to sediment the remaining SRBC the 
haemoglobin concentration in the supernatant was determined at 420 nm with PBS in the 
reference cell. 
Microtitre assay. 
Exactly the same reagents were used as in the tube assay, above. Two-fold 
dilutions of 25 pl portions of crude toxin preparation (filtrate) were performed in PBS in a U- 
well microtitre plate. 25 til of washed 1% SRBC were added and the plate was incubated at 37 
T for 30 min to allow adsorption of CT if present. 25 til of antitoxin (1/100) were added and 
the plate incubated for a further 30 min at 37 T to allow the antibody to react with any CT- 
SRBC complexes present. Finally 25 gl Gp-C' (1/10) were added and after incubation for Ih 
at 37 OC the haemolysis was read visually. The titre recorded as the highest dilution eliciting a 
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greater than 50% haernolysis of SRBC. 
2.3. lg Biken (modified Elek) test 
The Biken test was described by Honda et aL (Honda et aL 1981); this test is 
based on the principles of the Elek test and Ouchterlony double-gel diffusion test. Bacteria 
growing on Biken agar release LT which reacts with a specific antiserum placed in a well to 
give a line of precipitation. The formation of the precipitin line between the test colonies and 
anti-LT could be read by eye or observed using a light-box. 
The strains to be tested were inoculated on Biken agar plates (15mis Biken agar 
containing 0.1 ml lincomycin (13.5 mg/ml) solution was used per plate, see appendix 1). Four 
strains were inoculated on each plate and incubated for 48 h at 37 *C, to obtain four large 
"colonies" grouped about a central site where a well was punched. The inner edge of the final 
growth was about 4mm from the central well position. After 48 h the central well was punched 
and a polymixin B disc (500 units) was placed on top of each colony. The plate was incubated 
for 5h and then 20 gl of rabbit-anti-CT or rabbit-anti-LT, was added to the central well and 
the plate was incubated for 24 h at 37 T. The plate was then examined in a light box for 
precipitin lines. The precipitin lines could be enhanced by a further 24 h incubation. 
2.3.1h Detection of toxin with immunoblotting 
Colony immunoblotting 
Test strains of V cholerac were grown in nutrient broth and spotted onto 
nutrient agar plates in a grid pattern (a maximum of 25 strains) prior to incubation at 37 T for 
6 h. Positive (WBDV-IOIE 049, CT+; E51116 01, CT+) and negative controls (E. coli LEP 
14R519) were included on each membrane. A nitrocellulose membrane (Hybond C-extra), 
marked to indicate membrane orientation, was placed onto the network of bacterial colonies, 
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and the membrane gently rubbed with a glass spreader to ensure contact between the membrane 
and the bacterial colonies. After 5 min membranes were peeled from the agar plate and placed 
in plastic boxes containing 5% (w/v) dried milk powder in PBS, blocking was maximised by 
shaking boxes for 30 min. Membranes were transferred to plastic bags, up to 8 membranes per 
bag, containing 20 mls of fresh blocking solution. Antiserum was used at a dilution of 1/200 in 
blocking solution and both anti-CT (LEP) and anti-CTB (Novabiochem) were used. Bags were 
heat-sealed and incubated, with shaking, for 2h at room temperature, after which they were 
transferred to a plastic box and washed (3 x 10 min) in PBS. Antibodies binding to toxin 
molecules were detected with an alkaline phosphatase conjugated goat anti-rabbit 
immunoglobulin for rabbit antibodies to CT, diluted 1/7000 in blocking buffer. Similarly, an 
alkaline phosphatase conjugated rabbit anti-goat immunoglobulin for goat-anti-CTB antibodies, 
diluted 1/3000 in blocking buffer. Membranes were mixed with conjugated antibodies in 
polythene bags for 2 h. Membranes were washed for 3x 10 min in PBS and rinsed briefly in 
alkaline phosphatase buffer (0.1 M Tris-HCI, 0.1 M NaCl, 0.05 M MgCl2, pH 9.5). The 
substrate solution was 69 gl NBT (75 mg/ml nitroblue tetrazolium, in 70% diniethyl formamide) 
and 54 gl BCIP (50 mg/ml 4-bromo-3-chloro-indolyl phosphate in water) to 15 mls buffer (this 
was sufficient for eight membranes). Dark purple spots developing in 5 min indicated a 
positive reaction, indicating the presence of toxin. The reaction was stopped after 30 min or as 
desired by washing in water. 
Immunoblotting with supernatants 
This method was essentially the same as the colony immunoblotting, except that 
supernatants were used. It is a modification of the method of Qu et aL (Qu et aL 1991). The 
strains to be tested were grown in syncase sucrose broth as described in section 2.3. Ia. 10 VI 
of the undiluted supernatants were spotted onto nitrocellulose (Hybond C-extra) membranes. 
The blocking procedure, addition of antiserurn and detection were as described above. 
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2.3.2 DNA probes for genes encoding toxins 
Polynucleotide and oligonuelcotide probes were used to detect the genes for CT 
and ST. Polynucleotide probes were used to detect VT genes. Details of polynucleotide, probes 
used are given in table 4 and details of oligonucleotide probes are given in table 5. 
2.3.2a Large-scale preparation of plasmid DNA 
The method used for the production of large amounts of plasmid DNA was 
based on the method of Birnboim and Doly (1979) as described by Maniatis et aL (Maniatis et 
aL 1982). Strains of Exo1i K12 carrying plasmids with cloned gene sequences were used to 
prepare large quantities of covalently closed circular DNA. 
Ecoli K12 strains containing plasmid DNA were grown in 50 mls of nutrient 
broth at 37 *C overnight with shaking. These starter cultures were added to 450 ml volumes of 
nutrient broth in 2 litre conical flasks and grown with shaking for I-2h until log phase 
growth was reached. The optical density of cultures was read immediately after inoculation, 
using nutrient broth as a blank in a Klett-Summerson Photoelectric Colorimeter. When the 
bacterial cell density attained an optical density of 140 Klett units, each culture was split into 3 
equal volumes and the cells sedimented at 16,000 g for 5 min. Cells from each batch were 
resuspended in 10 mls of 50 mM glucose, 25 rnM Tris-HCI, pH 8,10 mM EDTA and 50 mg 
of lysozyme, and 5 mis was placed into two 50 mls centrifuge tubes. Following incubation at 
room temperature for 5 min, 10 mls of freshly made 1% SDS (sodium dodecyl sulphate) in 
OIN NaOH were added to each tube and mixed thoroughly by inversion. 7.5 mls of ice-cold 5 
M potassium acetate, pH 4.8 were added, mixed and the tubes placed in ice for 10 min. Cell 
debris was precipitated by centrifugation (38,000 g, 20 min at 4 'C) and supernatants pooled in 
a 100 mls measuring cylinder. 0.6 volumes of isopropanol were added and mixed well. The 
mixture was divided equally between two poly-carbonate centrifuge tubes and placed at 4T 
overnight. Precipitated plasmid DNA was sedimented by centrifugation (8,000 g, 20 min at 
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room temperature). The supernatant was discarded and the pellet was washed in 70% ethanol. 
As much of the ethanol as possible was removed and the pellet was resuspended in 4 mls of 
Tris EDTA (TE) buffer (10 mM Tris, I mM EDTA, pH 8). The DNA/TE solution was 
transferred to a pre-weighed 10 mls polycarbonate centrifuge tube and the weight made up to 5 
g with TE buffer. To this was added 5.2g of caesiurn chloride and 0.4 ml of 10 mg/ml 
ethidium bromide. Tubes were centrifuged in a Beckman L8-70M centrifuge at 
16,000 g for 30 min and the supernatant was transferred to 10 mls polyallomer tubes. The 
density of caesiurn chloride was checked by measuring the refractive index using a 
refractometer. The refractive index of the solution was ad usted to 1.395 by the addition of j 
caesium chloride (if too low) or water (if too high). The tubes were capped and paraffin was 
added to fill up the tube avoiding air bubbles. Grub screws were fitted and the tubes weighed 
to check the balance of the pair. The gradient was formed by centrifugation in a Beckman or 
MSE65 centrifuge at 195,000 g at 20 *C for 60 h. 
Tubes were examined under UV light (385 nm) to visualise the two bands. The 
upper band was open closed circular plasmid DNA and linear (chromosomal) DNA, while the 
lower band contained the covalently closed circular DNA which was recovered. The lower 
band of DNA was carefully removed from the tube by inserting a syringe needle through the 
side of the tube. Ethidium. bromide was extracted from closed circular DNA by adding an 
equal volume of isopropanol, shaking and removing the upper layer containing the ethidiurn 
bromide. This procedure was repeated two or three times to ensure all the ethidium bromide 
was removed. The DNA was dialysed in 2 litre of TE buffer at 4T for 6h to remove any 
contaminating ions. The size and purity of the plasmid DNA was checked by agarose gel 
electrophoresis. Plasmid DNA was stored at -20 T until required. 
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2.3.2b Preparation of polynucleotide probes. 
To prepare probes for use in hybridisation experiments, probe fragments were 
digested from plasmid vectors using restriction enzymes. 
Recovery of CT fragments. 
The CT gene sequence from Vcholerae El Tor 62746 (Kaper and Levine 1981) 
cloned into plasmid pBR325 (pCVD27) in E. coll K12 was provided by J. B. Kaper (Kaper and 
Levine 1981). A 554 bp CTA probe fragment was cut from pCVD27 after digestion with 
EcoRI (BRL): three aliquots of 40 RI of pCVD27 were digested with 20 units of EcoRI 
(Gennaro, et aL 1982). 
The recombinant plasmid pCT19 is known to contain sequences encoding CTB 
and part of CTA (Dallas and Falkow 1979); the gene sequences were cloned and subcloned 
from V cholerae 1621 into pACYC 184 as described by Germaro, et aL (Gennaro et aL 19 82). 
A 550 bp CTB probe fragment was cut from plasmid pCT19 after digestion with Xbal and 
Hinell: three aliquots of 40 ýd of pCT19 were digested with 20 units each of Xbal and HincIl. 
Probe fragments were separated by electrophoresis and on a 1% agarose gel in 
Tris acetate buffer at 20 V overnight. A lambda Pal molecular weight marker was run on the 
same gel. The gel was stained in ethidium, bromide and fragments were cut out of the gel 
under long wave UV light into a preweighed screw cap Eppendorf tube. Four or five gel slices, 
weighing in total between 0.4 and 0.5 g, were pooled and the DNA was recovered from the gel 
and purified using the Geneclean Bio 101 kit (Stratech Scientific Limited) following the method 
provided by the manufacturer. A volume of sodium iodide (three times the weight of the 
slices) was added to the gel. The gel was dissolved by incubation at 50 T for 2 min. If the 
amount of DNA was unlikely to exceed 5 ýtg, 5 ýtl glass milk were added to bind the DNA by 
placing on ice for 5 min. The DNA bound to the glass milk, was washed three times by 
pelleting the glass milk for 5 sec, followed by resuspension in 500 gl NEW wash buffer 
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(supplied by the manufacturer; Tris/EDTA, NaCl, ethanol, water). The DNA was then eluted 
by resuspending the pellet in 5 ýtl TE at 50 OC for 3 min, followed by centrifugation for 30 sec. 
This was repeated twice to give a total of 15 ýtl DNA. A volume of I gl was run on an 
agarose gel to check its size and concentration. 
Recovery of VT fragments. 
The VTI DNA probe is a 750 bp Hinc 11 fragment from plasmid NTP705 
(Willshaw et aL 1985), and the VT2 probe is a 850 bp Sma I- Pst I fragment from plasmid 
pDEP28 (Thomas et aL 1991). The fragments were separated on an agarose gel and probe 
DNA excised as described above. 
2.3.2c Random primer labelling of polynucleotide DNA probes with digoxigenin. 
The cloned polynucleotide probes were labelled with digoxigenin, based on the 
protocol provided with the Digoxigenin labelling and detection kit (Boehringer Corporation 
Ltd). I pl of purified DNA was run on a gel to check size and intensity. Increased yields of 
labelled probe could be obtained by increasing the volume of the labelling reagents, whilst 
keeping the amount of DNA the same. 
Digoxigenin-labelling of CT probes. 
7.5 pi of purified DNA were denatured by boiling for 10 min followed by 
rapid cooling on ice, 5 pt hexanucleotide primers (2 mg/ml), 5 RI nucleotides (I mM dATP, 
0.65 mM dTTP, I mM dGTP, I mM dCTP and 0.3 5 mM digoxigenin- II- dUTP) and 2.5 ýtl 
Klenow polymerase enzyme (2 U/[LI) were added. Labelling took place overnight at 37 T. 
The reaction was stopped by adding 5 gI 0.2 M EDTA (pH 8). 
To remove unincorporated nucleotides the labelled probe was precipitated and 
then cleaned using a QIAGEN-tip 5 (DIAGEN, Dusseldorf). The precipitation step involved 
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adding 2.5 ýtl 4M LiCl and 75 jil prechilled ethanol and mixing well. After a minimum period 
of 2h at -20 T, the probe was centrifuged at 10,000 g for 5 min. The pellet was washed with 
70% chilled ethanol and centrifuged. The ethanol was removed and the pellet allowed to dry. 
The probe was resuspended in 50 ýtl TE containing 0.1% SDS. To use the QIAGEN-tip 5, the 
volume was made up to 150 gI with distilled water. 18 ýd 5M NaCl and 10 ýtl IM MOPS 
was added. The QIAGEN tip was equilibrated using kit buffer A (see appendix 1), 500 RI 
were allowed to pass through by gravity flow. The labelled probe suspension was loaded onto 
the matrix and allowed to pass through under gravity. The matrix was washed with 2 mls, kit 
buffer B. The probe was elutcd with 600 RI of kit buffer F and collected in a microcentrifuge 
tube. The total volume was typically 800 ýLl. 10 ýfl 20 mg/mI yeast tRNA was added as a 
carrier molecule, followed by 0.6 x volume of isopropanol. After precipitation at 4 OC, the 
probe was centrifuged at 10,000 g for 10 min and resuspended in 100 ýtl TOM% SDS. 
Labelled probe was stored at -20 OC. 
Digoxigenin-labelling of VT probes. 
In a standard labelling reaction 3 gl of purified DNA were used. The DNA 
was made up to 15 gl with distilled water, boiled for 10 min to denature and cooled rapidly on 
ice. The following were added; 2 [11 hexanucleotides, 2 gI nucleotides (dATP, dTTP, dGTP, 
dCTP and digoxigenin- II -dUTP), I gi Klenow polymerase giving a total volume of 20 gl. 
Labelling took place overnight at 37 T overnight. The labelling reaction was stopped by 
adding 2 til, 0.2 M EDTA. Unincorporated nucleotides were removed as described and the 
labelled probe was stored at -20 T. 
2.3.2d Preparation Of cultures for DNA hybridisation. 
Bacterial cultures, grown overnight in nutrient broth, were spotted onto nylon 
membranes (Hybond N Amersham) placed on nutrient agar plates. Colonies were grown at 37 
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*C for 6 h, the cells were then lysed and DNA denatured by the following procedure. The 
membranes were laid onto 3 mm blotting paper soaked in 10% SDS for 10 min; 0.5 M NaOIv 
1.5 M NaCl for 20 min; neutralising solution (1 .5M NaCl/ 0.5 M Tris HCI, pH 8) for 10 min 
and 2x SSPE for 10 min. DNA was fixed to the membrane by baking for 2h at 80 'C. 
2.3.2e Hybridisation with polynucleotide probes. 
Hybridisations were performed either in heat-sealed plastic hybridisation bags 
placed on a shaker in a water bath or in a hybridisation oven. Small scale experiments were 
performed to select the appropriate temperature and optimise conditions. (Detection procedures 
are described in 2.6.7). The hybridisation procedure was essentially the same for water-bath or 
oven (both are described below). 
To use a water bath the membranes were soaked in 2X SSC then placed in a 
plastic box and covered with hybridisation solution (approximately 20 mls per 100 Cm 2 
membrane). The box was shaken for 1h at the hybridisation temperature. After lh the 
membranes were gently wiped with a damp tissue to remove cellular debris. The membranes 
were replaced in the box for pre-hybridisation with a freshly prepared solution, containing 10 
ýLl/ml denatured salmon sperm DNA, for a further I-2h with shaking. The probe to be used 
and 10 ýLl/ml salmon DNA, were denatured by boiling for 5- 10 min and placed on ice. The 
membranes were placed in heat-sealable plastic bags, ensuring that they did not overlap. For 
every 100 cm2 of membrane, 2.5 mls of hybridisation solution containing 26 ng/mI of labelled 
denatured probe (typically 5- 10 ýtl) were added. The bags were sealed and placed in another 
bag in the water bath. Hybridisation was carried out overnight with shaking at the appropriate 
temperature. The probe was removed and stored at -20 T for further use. The membranes 
were placed in a box for washing. 
To use a hybridisation oven, the oven was pre-heated to the hybridisation 
temperature with the safety thermostat set at a few degrees above. Pieces of HYBAID nylon 
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mesh were cut according to bottle size and number of membranes to be tested. Both the mesh 
and the membranes were soaked in 2X SSC. The membranes were placed on the mesh, 
ensuring there was no overlap, and rolled up. The roll was placed in the bottle and enough 
hybridisation solution added to fill about 1/4 of the bottle. The bottle was gently rolled to 
unwind the membranes, before placing in the preheated oven. After Ih rotation, membranes 
were wiped and pre-hybridised for a further I- 2h, followed by hybridisation overnight. 
Smaller volumes (2 -5 mls ) of hybridisation solution and probe could be used in the oven as 
good contact was achieved with the membranes. After removal of the probe solution washes 
could be carried out with the membranes still in the bottle. 
Hybridisation with CTA and CTB at high stringency. 
Hybridisation was carried out at 68 "C, with stringent washing conditions which 
allowed the detection of DNA sequences with more than 80% homology. 
The hybridisation solution was; 5x SSC, 0.1% sodium-laurylsarcosine, 0.02% 
SDS, 1% blocking reagent (BCL). Hybridisation procedures were as described, above. Post- 
hybridisation washes were 2x SSC/ 0.1% SDS for 5 min at room temperature followed by two 
washes of 15 min each with 0.1% SSC/ 0.1% SDS at 68 *C. Detection was carried out as 
described by BCL. The probe could be saved and reused. 
Hybridisation with CT probes at low stringency. 
Selected V cholerae non-0 I strains were also tested under lower stringency 
conditions (37 *C), which allowed the detection of both CT and Ecoli LT. The protocol for 
hybridisation at 37 T was as described above, however the hybridisation solution was 25% 
formamide/ 5x SSC/ 1x Denhardts solution/ 0.1% SDSI I mM EDTA. The post-hybridisation 
washes were 5x SSC/ 0.1% SDS at 54.5 T briefly and then for I h, followed by 2x SSC at 
room temperature briefly. Detection was carried out as described by BCL. The probe could be 
saved and reused. 
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Hybridisation with VTI and VT2 probes. 
The hybridisation temperature was 68 T. The hybridisation solution and post- 
hybridisation washes were as described for high stringency CTA and CTB. Detection was 
carried out as described by BCL. The probe could be saved and reused. 
2.3.2f Synthetic Nucleic Acid Probe for LT (SNAP-LT) and STA (SNAP-ST) 
Alkaline-phosphatase labelled enzyme-linked oligonucleotide probes were 
obtained from DuPont NEN Products (Boston, USA). The SNAP-ST kit incorporated both 
STAI and STA2 (Scotland et aL 1989). 
The SNAP probes were used at a concentration of 50 nglml. The procedure 
was that provided by the manufacturer. Hybridisations were performed at 50 *C and the 
hybridisation buffer was 5x SSC, 1% SDS, 0.5% BSA, 0.5% polyvinylpyrolidone (PVP). 
Post-hybridisation washes were; two 5 min washes in Ix SSC/ 1% SDS (at 50 *C for SNAP- 
ST and at 40 T for SNAP-LT), two 5 min washes in Ix SSC/ 1% Triton (at 50 *C for SNAP- 
ST and at 40 *C for SNAP-LT), followed by two washes in Ix SSC at room temperature. 
After the washes a direct detection was carried out by adding the substrates (15 mls alkaline 
phosphatase buffer, 66 gI nitroblue tetrazolium (NBT), 50 gI 5-bromo-4-chloro-3 indolyl 
phosphate (BCIP)). After 3h or time for the purple coloration to appear the filters were 
washed in distilled water and dried between filter paper sheets. The filters were stored in 
plastic folders in the dark. 
2.3.2g Oligonucleotide probes 
Oligonucleotides were synthesised by the Virus Reference Division, CPHL, 
using an Applied Biosystems DNA synthesiser. The sequences were evaluated for the 
possibility of dirner and loop formation using OLIGO Primer Analysis Software (MedProbe, 
Norway). 
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GMI probe 
The GMI probe was a mixed oligonucleotide based on the sequence in Calva el 
al. (Calva et al. 1989; Chopra et al. 1991): 
S' TTr A/GTT A/GTT CCA TAC ACA TAA C/TTT 3' 
ST probes 
For the ST probes two different oligonucleotides based on the sequences of 
Hoge et aL and Ogawa et aL were used: 
GAT TGC TGT GAA ATT TGT TGT AA (Hoge et aL 1990) 
GAC TGC TGC GAA ATA TGT TGC AAT (Ogawa et al. 1990) 
2.3.2h Oligonucleotide end4abelling with digoxigenin-11-dUTP 
The DNA concentration (C) of each oligonucleotide synthesised on a Applied 
Biosysterns DNA synthesiser was calculated using the formula 
OD = e. C 
The optical density (OD) was measured for each oligonucleotide (I OD was equivalent to 
approximately 33 gg ss DNA). 
The extinction coefficient (e) was the sum of the number of each base multiplied by the 
appropriate extinction coefficient: dGTP = 11.7 mV gMol; dCTP = 7.3; dATP = 15.4; dTrP 
8.8. 
Single stranded probe DNA was stored in water at -20 T. For BCL reagents 
the labelling reaction was: 4 gl tailing buffer, 4 gl CoC12 (25 mM), 100 pMoles 
oligonucleotide, I gl I mM Dig-dUTP and I gl terminal transferase (50 U/gl) were mixed 
together in a microcentrifuge tube. The volume was made up to 20 gl with distilled water and 
incubated for 1.5 h at 37 T, then placed on ice. I gI glycogen (20 mg/ml) was mixed with 
200 gl EDTA (0.2 M pH 8), and a2 gl aliquot added to the mixture to stop the reaction. The 
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labelled oligonucleotide was precipitated with 2.5 gI LiCl (4 M) and 75 jil pre-chilled ethanol, 
this was mixed well and left for 2h at -20 T. The precipitate was pelleted by centrifugation 
and washed with 70% ethanol. The pellet was resuspended in an appropriate volume of 
distilled water and stored at -20 T. To check the labelling, 5 ý11 of probe were run on a 3% 
agarose mini-gel using borate buffer and 100 V for Ih with Orange G as the dye marker. The 
probe was transferred to a nylon membrane by Southern blotting and a BCL direct detection 
was performed to visualise labelled probe. 
2.3.2i Oligonucleotide hybridisation 
The OLIGO Primer Analysis Software (MedProbe, Norway) program was used 
to calculate the melting temperature (Tm) from which subsequent hybridisation temperatures 
were derived. The hybridisation temperature was 5- 10 T below the Trn of the sequence and 
the probe concentration used was 50 ng/ml in the appropriate hybridisation buffer. 
Colony blot membranes were prepared as described in section 2.3.2d. DNA 
was fixed to the membranes by baking at 80 OC for 2 h. The membranes were pre-washed in 
hybridisation solution at 50 - 65 *C for I-2h. This was followed by gentle wiping of the 
membranes with a damp tissue to remove cellular debris. The membranes were pre-hybridised 
for I-2h with hybridisation solution, and then hybridised overnight with 2 mls hybridisation 
solution containing probe equivalent to 50 ng/mI for each 5 OCM2 membrane. All steps were 
performed in heat sealable plastic bags with gentle shaking, or using a hybridisation oven. The 
detection procedure was carried out as described by BCL. (For blocking solutions, 
hybridisation buffers and wash solutions see-appendix 1). 
2.3.2j Immunological detection of hybrids. 
The detection procedure was carried out as described by BCL. All steps were 
carried out at room temperature on a shaker, unless otherwise stated. Fresh blocking solution 
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was made as described in appendix 1. The membranes were washed briefly in buffer 1, then 
placed in 100 mls buffer 2 for 30 min. The conjugate was diluted from 1: 5000 (4 ýLl in 20 
mls) in buffer 1,20 mls is sufficient for 100 crn' of membrane. The membranes were removed 
from buffer 2, washed briefly in buffer 1, and placed in conjugate solution for 30 min. 
Membranes were transferred to a fresh box and equilibrated with buffer 3 for 2 min. 
Membranes were then placed in 10 mls colour solution in the dark without shaking. Once 
purple/brown colour appeared, membranes were rinsed with water, dried in the dark and stored 
in plastic folders away from the light. 
2.3.3 Polymerase chain reaction (PCR) 
The PCR was used to amplify ctxB and tcpA sequences in Vcholerae, see 
Figure 3a and 3b. 
2.3.3a Detection of clxB by PCR 
Primers for ctxB were from Olsvik et aL (Olsvik et aL 1993): 
CTX7 5' GGT TGC TTC TCA TCA TCG AAC CAC 3' 
CTX9B 5' GAT ACA CAT AAT AGA ATT AAG GAT G 3' 
Primer CTX7 is the antisense strand and CTX9B is the sense strand. These oligonucleotide 
primers target the ctxB sequence. 
2.3.3b Detection of tcpA by PCR. 
Primers for tcpA are from Keasler & Hall (Keasler and Hall 1993): 
tcpI classic S' CAC GAT AAG AAA ACC GGT CAA GAG 3' 
tcp2 classic S' ACC AAA TGC AAC GCC GAA TGG AGC 3' 
tcp3 El Tor 5' GAA GAA GTT TGT AAA AGA AGA ACA C 3' 
tcp4 El Tor 5' GAA AGG ACC TTC TTT CAC GTT G 3' 
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Primers tcpI and tcp3 are the sense strands, tcp2 and tcp4 are the antisense strands. These 
oligonucleotide primers exploit sequence differences between the IcpA of the El Tor and 
classical biotypes of V cholerae 0 1. 
2.3.3c PCR protocol 
Small batches of tubes were prepared containing all components except the 
nucleotides which were added with the template prior to performing the PCR in the 
thermocycler. 
Tubes were prepared in a laminar flow cabinet. Stocks of primers, dNTP's and 
other reagents were prepared in advance. To a sterile tube the following were added; 250 ýd 
Bioline 10 x buffer, 75 gl MgC12 (50 mM), 250 gl primer 1 (10 ýM), 250 gl primer 2 (10 
gM), 10 gI Biotaq (5 U/gl) 415 gI sterile glass distilled water. This was then aliquoted 25 ýd 
per tube and I drop of Sigma oil was added to each. The tubes were stored at -10 T. For use 
the required number of tubes were thawed and 5 gI dNTP mix (final concentration of each 
dNTP was 200 ýM) was added to each tube. The culture (or template) was prepared by 
subculturing an overnight broth into fresh nutrient broth, and growing for 2-4h. 2 gI of 
template were added to the PCR reaction mix and made up to the correct volume by adding 18 
gI sterile glass distilled water. The cycling conditions using a Quatro TC-401 were as follows: 
5 min 95 T; 
25 cycles of I min 95 T, I min 50 *C and I min 72 'C; 
10 min 72 T. 
2.3.3d Analysis of PCR products 
Water (10 gl) and Orange G (3 gl) were added to 20 ýtl of product and run on 
a 1.5 - 3% gel (depending on expected product size; a 2% gel was appropriate for an expected 
product size of 450 bp). Electrophoresis was carried out in Tris-Borate buffer at 100 V for 
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2-3h. The DNA was visualised by ethidiurn bromide (0.5 Pg/ml) staining and bands 
confirmed by oligonucleotide probe hybridisation. 
2.3.4 Preparation of chromosomal DNA and analysis by Southern blot 
Chromosomal DNA was prepared from strains shown to possess the genes for 
CT or ST. The DNA was analysed by digesting with restriction endonucleases and Southern 
blotting, followed by hybridisation with the appropriate probe. 
2.3.4a. Preparation of bacterial chromosomal DNA 
Chromosomal DNA was extracted using the method of D. Platt, as described in 
G. Bertram, MPhil. (Bertram 1990). Strains were grown in 3 mls nutrient broth at 37 'C 
overnight. 200 ýd of culture were subcultured into 10 mls nutrient broth and incubated at 37 T 
for 2h with shaking. Cells were harvested by centrifugation for 10 min at 3,000 rpm in a 
Sorvall 6000 centrifuge and the cell pellet was washed in I ml of TE50 buffer (50 mM 
Tris-HCI, 50 mM EDTA; pH 7.8). The suspension was pelleted in an Eppendorf 
micro-centrifuge and the supernatant was removed. The pellet was resuspended in 0.5 ml of 
TE50 buffer and 50 gl of fungal proteinase K (10 mg/ml) was added to the suspension. 15 RI 
of SDS (20% w/v) was added, mixed gently and then incubated at 55 *C for 4h to lyse cells. 
To precipitate cell debris, the suspension was emulsified with 0.5 ml of freshly prepared 
phenol/chloroform. The emulsion was broken by centrifugation for 10 min in an Eppendorf 
microcentrifuge and the upper aqueous layer was removed to a clean Eppendorf tube. To 
recover the maximum amount of DNA, a further 200 gI of TE50 buffer were added to the 
Eppendorf tube and emulsified. The emulsion was again broken by centrifugation and the 
aqueous layer was removed and pooled with the first supernatant. The chromosomal DNA was 
precipitated by adding 0.5 MI of isopropanol and vortexed. The DNA was left in isopropanol at 
room temperature for 10 min to allow complete precipitation. The chromosomal DNA was 
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pelleted by centrifugation for 10 min and the isopropanol was discarded. The pellet was 
resuspended in 0.3 ml of TE 10 buffer (10 mM Tris-HCl, 10 mM EDTA; pH 7.8), vortexed 
thoroughly and left to stand at room temperature for 5 min to allow the DNA to resuspend. 
i0o ýd of 7.5 M ammonium acetate were added and mixed. DNA was precipitated by adding 
0.6 ml of ethanol (95% w/v) and placed at 4 *C overnight. The precipitate was pelleted by 
centrifugation in an Eppendorf microcentrifage for 15 min. The supernatant was discarded and 
the DNA was resuspended in 0.3 ml of TEIO buffer and allowed to stand at room temperature 
for 5 min. 20 ýd of heat-treated RNase (I mg/ml, boiled for 10 min) was added and incubated 
at 37 OC for Ih to remove RNA from the chromosomal preparation. The phenol/ chloroform 
extraction was repeated as described above and the DNA was precipitated by repeating the 
isopropanol and ethanol steps. The DNA was placed at 4T overnight, then pelleted by 
centrifugation for 15 min in a microcentrifuge. The supernatant was discarded and the pellet 
was resuspended in 50 ýd of TE buffer. 
2.3.4b Small-scale preparation of bacterial genomic DNA (CTAB method) 
This method uses proteinase K to remove proteins and cetyltrimethylammoniurn 
bromide (CTAB) to remove cell wall debris, polysaccharides and remaining proteins. High 
molecular weight DNA was isolated by isopropanot precipitation. 
The test organisms were grown overnight in nutrient broth. The cells were 
concentrated by centrifuging 1.5 ml of broth in a microcentrifuge. After resuspending in 579 
gi TE, 15 gI 20% SDS and 6 gI proteinase K (10 mg/ml) were added and the mixture was 
placed at 37 T. After Ih 110 gI 5M NaCt and 80 gI CTAB/NaCI mix (10% CTAB in 0.7 M 
NaCl) were added and incubated for 10 min at 65 T. The DNA was extracted by adding equal 
volumes of chloroform/ isoamyl alcohol (24: 1) followed by phenoV chloroform/ isoamyl 
alcohol (24: 24: 1). The DNA was transferred to a fresh tube and precipitated by adding 
isopropanol at room temperature for 15 min. Then the DNA was spun for 10 min in a 
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microcentrifuge. There was a clearly visible pellet which was then washed with 70% ethanol. 
After drying the pellet was resuspended in 50 gl TE/RNase and incubated at 37 T for 30 min. 
The DNA was stored at 4 T. 
2.3.4c Detection of DNA on ethidium bromide plates 
This was useful as an approximate guide to how much DNA had been extracted 
from each strain. Ethidium bromide plates were prepared as described bY Maniatis (Maniatis et 
al. 1982). 3 ýLl of sample DNA and standard concentrations of 5,10,15,20 25 and 30 gglýd 
of herring sperm DNA were spotted on 1% agarose plates containing 0.5 gg/ml ethidium 
bromide and incubated at 37 T for 15 min. The plates were then placed under a UV 
transilluminator and the fluorescence of the sample DNA was compared to that of the standard 
concentrations. 
2.3.4d Restriction endonuclease digest of chromosomal DNA 
Chromosomal DNA from each strain was digested with various restriction 
endonucleases: EcoRl, HindIll, Bglll and Pstl (Bethesda Research Laboratories, BRL). For 
each digest, 20 gl of DNA were digested with 20 units of enzyme. 4 ýtl of the appropriate 
reaction buffer (supplied with the enzyme) was added and the reaction mix was incubated at 37 
OC for 6 h. Digested DNA was run alongside a lambda Pal digest control in a 1% agarose gel 
made up in Tris acetate buffer (0.04 M Tris acetate, 0.002 M EDTA, pH 8) at 20 V overnight 
on a midi gel system (BRL). 
2.3.4e Southern blotting of DNA from agarose gels to nylon membrane filters 
After staining the gel with ethidium bromide, the gel was photographed and the 
sides, bottom and unwanted tracks were removed. The top of the gel was not trimmed but the 
top right hand comer was cut off as an orientation mark. The gel was transferred to a plastic 
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box and treated with 0.25 N HCI for 20 min. The gel was rinsed in distilled water, then soaked 
in denaturing solution for 40 min with one change of solution (500 mls was sufficient for a 
full-sized gel). The gel was rinsed again with distilled water and soaked in neutralising solution 
for 40 min with one change of solution. The gel was accurately measured and a piece of nylon 
membrane (Hybond N) cut to the same measurements. 
The blotting apparatus was assembled as follows: a plastic box was used as a 
reservoir; it containing the blotting solution (6 x SSC). An appropriately sized glass plate was 
placed over the reservoir and the wicks, two sheets of 3 MM paper which reached the bottom 
of the reservoir, were placed on top of the glass plate. The gel was placed on the wet wicks 
avoiding air bubbles or stretching the gel. The gel surface was moistened with 6x SSC and the 
nylon transfer membrane placed on the gel, this was gently smoothed out to remove any air 
bubbles. A blotting stack was built up, starting with 6-8 sheets of 3 MM paper cut to exact 
size, and continuing with absorbent paper towel, folded or cut, to fit accurately. A thick glass 
plate was placed on top and plastic film was wrapped round to retain moisture. The blot was 
left overnight. The next day, the apparatus was taken apart and the right side of the nylon 
membrane marked in pencil. The DNA was fixed by baking at 80 T for 2 h. 
2.3.4f Restriction fragment length polymorphism, (RFLP) analysis. 
The Southern blots were hybridised with the appropriate probe as described in 
section 2.3.2. The probes used for RFLP were polynucleotides CTA+B and oligonucleotides 
GMI and ST. 
2.3.5 Plasmid profile analysis 
DNA was extracted by the methods of Kado and Liu (1981) or Bimboim and 
Doly (1979) (Bimboim and Doly 1979; Kado and Liu 1981). 
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2.3.5a The phenol/chloroform extraction method (Kado and Liu) 
Cultures were grown in 3 mls of nutrient broth at 37 T. 1.5 mls of culture 
were centrifuged for 2 min in a microcentrifuge. The supernatant was discarded and the cell 
pellet resuspended in 20 pl of 50 mM Tris /I mM EDTA, pH 8.100 gi of 0.05 mIvv 3% SDS 
pH 12 was added and mixed with care. The samples were incubated at 55 'C for 45 min. 100 
gl of freshly made phenol/chloroform (50% w/v phenol in chloroform isoamyl alcohol (24: 1) 
saturated with 10 mls of 10 mM Tris-HCI, pH 8 containing I mM EDTA) was added and 
emulsified by vortexing thoroughly. After centrifugation for 10 min to precipitate cell debris, 
the upper aqueous layer was transferred to a fresh Eppendorf tube. The precipitation was 
repeated by adding a further 100 pI of phenol/chloroform. The samples were centrifuged for a 
further 10 mins and the upper layer was removed to a fresh Eppendorf tube. 7 pI of 
bromophenol blue was added to 40 gI of supernatant and loaded onto a 0.8% agarose gel made 
up in Tris borate buffer (0.089 M Tris, 0.089 M Boric acid, 0.008 M EDTA) and 
electrophoresed at 120 V for 3 h. 
2.3.5b The alkaline lysis method (Birnboim and Doly) 
As recovery of plasmid DNA by this method was inefficient samples were 
prepared in quadruplicate and the DNA was pooled at a later step. 
A cell pellet was obtained as described in section 2.3.5a and resuspended in 100 
ýtl of 10 mM EDTA, 50 MM glucose in 25 mM Tris-HCI buffer, pH 8 and incubated on ice for 
30 min with 2 mg/mI lysozyme. Bacterial lysis was completed by adding 200 ý11 of 1% SDS in 
0.2 N sodium hydroxide and mixing gently. To precipitate chromosomal DNA, 150 ýtl of 3M 
sodium acetate was added and the samples were placed on ice for 90 min. The chromosomal 
DNA and cell debris were removed by centrifugation for 10 min and the supernatant was 
transferred to a fresh Eppendorf tube. Any remaining precipitate was removed by emulsifying 
the supernatant in 0.5 ml phenol/chloroform and centrifuging the sample for 10 min. The 
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supernatant was removed to a clean Eppendorf tube. DNA was precipitated by the addition of 
I ml of absolute ethanol and held at -20 *C for 30 min. The DNA was pelleted by 
centrifugation for 5 min and the ethanol was discarded. The precipitate was dissolved 
in 100 ýtl 
of 100 mM/ 50 mM Tris-HCI and samples were pooled. Two volumes of 95% ethanol were 
added and the precipitation was repeated at -20 T for 10 min. The plasmid DNA was pelleted 
by centrifugation for 2 min and the ethanol discarded. DNA was dissolved in 50 ýfl of TE 
buffer (10 mM Tris-HCI, pH 8 containing I mM EDTA) and electrophoresed as described 
previously. 
Gels from both methods were stained in 300 mls of ethidium bromide solution 
(I gg/ml) for 30 min. Gels were examined under ultraviolet light and photographed. 
2.3.6 Assays for adhesins 
The presence of cell-associated factors, such as pili and haernagglutinins, which 
have been implicated in adherence, was investigated using tissue culture cell assays, 
haemagglutination, PCR (for tcpA genes) and electron microscopy (EM). 
2.3.6a Adhesion to HEp-2 or Caco2 cells 
Adhesion tests were performed using HEp-2 cell and Caco2 cell tissue culture 
systems. The method was based on that of Cravioto et aL (Cravioto et aL 1979). In some tests 
1% D-mannose, which prevents attachment in E coli strains to the tissue culture cells or other 
surfaces due to type I pili, was added. Maintenance of the tissue culture cells was as 
described in section 2.3.1. The HEp-2 cells were maintained in Basal Medium Eagle with 
Hank's salts and the Caco2 cells were maintained in Dulbecco's medium (see appendix 1). 
Two days prior to the test a monolayer of the appropriate cells was resuspended after trypsin 
treatment in growth medium without antibiotics. Sterile plastic tissue cluster plates containing a 
single sterile round coverslip per well, were seeded with 1.5 mls of tissue culture suspension 
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and incubated at 37 T for 18 - 36 h until a monolayer of cells had grown. 
The bacterial strains to be tested were grown overnight at 37 T in peptone 
water, with or without mannose (1%). Prior to the test the tissue culture monolayers were 
washed with Earles Balanced Salt Solution (EBSS) and 0.25 ml bacterial culture were added to 
each well. For routine tests the monolayers were incubated for 3h at 37 T and washed 3 
times with EBSS. The monolayers were fixed with methanol and then stained with 10% (v/v) 
Giemsa stain. The monolayers on the glass coverslips were cleared by dipping into acetone, 
acetone-xylene and xylene solutions, mounted onto glass slides using depex mountant and 
examined under oil immersion with a light microscope at 1000 x magnification. A minimum of 
loo tissue culture cells was examined for each test. A test was considered positive when at 
least 40% of the tissue culture cells had 10 or more bacteria. Any tests with intermediate 
results were repeated, and the subsequent result was usually clearly positive or negative. 
For certain tests the incubation was stopped at shorter times; for other tests the 
tissue culture medium was replaced at 3h and incubation was continued for a further 3 h. 
2.3.6b Haemagglutination tests. 
The strains were grown overnight at 37 *C on slopes of CFA agar (Evans et aL 
1977) or in peptone water. For the haemagglutination test the bacterial growth or bacterial 
pellet (from peptone water) was suspended in 0.15 M saline to give a concentration of 2x 10' 
bacteria / ml. Fresh human, guinea-pig and rat blood were obtained by veno-puncture and 
cardiac puncture, respectively, and suspended in 0.4% (w/v) solution of sodium citrate in 
distilled water. Fresh bovine, horse and sheep whole blood cells in Alsevers solution were 
obtained from Tissue Culture Service. The blood was washed 3 times with PBS pH 7.4, and 
resuspended in PBS to make a 50% (v/v) stock suspension. This was used to make a 3% (v/v) 
suspension in saline. To assess the effect of mannose on haernagglutination, 0.5% (w1v) D- 
mannose was added to some tests. Using a pasteur pipette, one drop of bacterial suspension 
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and one drop of the 3% rbc suspension were mixed in a depression on a white porcelain tile. 
The tile was rocked by hand for 2 min. If no haernagglutination was seen the tile was placed 
on ice and rocked intermittently for a further 10 min. Haemagglutination was seen as a coarse 
clumping of the erythrocytes within one minute, but some strains gave only a fine granularity 
after 20 min. When haemagglutination took place with the red blood cell suspension which did 
not contain mannose, but not in that which did contain mannose, this reaction was recorded as 
mannose-sensitive (MSHA). Agglutination of rbcs suspended in saline containing mannose was 
called mannose-resistant (MRHA) (Duguid et aL 1979). 
2.3.6c Detection of the gene for the toxin coregulated pilus (tcpA) 
The gene for TCP (tcpA) was detected by a polymerase chain reaction described 
in section 2.3.3. 
2.3.6d Electron microscopy 
EM was used to examine strains for the presence of flagella and adhesive 
structures (pili). Strains for examination by EM were grown on CFA or nutrient agar at 37 -C 
for 24 h and subcultured for another 24 h incubation period. A thick suspension of the culture 
c. 10" cells/ml) was made in peptone water containing 4% formaldehyde. The suspension 
was diluted 1: 2 in distilled water and I drop was applied to a Forval-carbon coated EM grid 
(400 mesh) for 3 min. Excess fluid was removed by blotting with filter paper, and a drop of 
1% phosphotungstic acid, pH 6.4, was placed on the grid for I min before excess fluid was 
blotted as before. The grids were examined by transmission EM. 
2.3.7 LPS analysis 
A sensitive silver stain method was used for detecting lipopolysaccharide in 
SDS-polyacrylamide gels. (Tsai and Frasch 1982). 
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Bacteria were grown overnight on blood agar plates. The sample was prepared 
by weighing out approximately 10 mg of bacteria in a microcentrifuge tube. The sample was 
adjusted to I mg per 30 ýd of solubilisation buffer (reagents are described in the appendix) and 
boiled at 100 OC for 15 min. An equal volume of proteinase-K in solubilisation buffer (I 
mg/ml) was added and the sample was placed at 60 T for I h. The proteinase-K digested the 
outer membrane proteins, leaving the LPS intact. 30 gl of digested material (equivalent to 
approximately 500 gg cells) was run on an SDS-PAGE gel. After electrophoresis (50 mAmp, 
3.25 h), gels were fixed in 40% methanol/ 10% acetic acid, overnight. The next day the gel 
was placed in 0.7% periodic acid in fix solution (5 min). Then the gel was washed three times 
(15 min each) with distilled water. Silver stain was freshly prepared: 2 mls concentrated 
ammonium solution was added to 28 mls 0.1 M NaOH, then 5 mls 20% silver nitrate solution 
was added while stirring, the stain was made up to 150 mls with distilled water. The get was 
stained for 10 min with vigorous agitation, then washed three times (10 min each) with distilled 
water. The colour was developed by reacting in 200 mls developer (50 mg citric acid and I ml 
37% formaldehyde in II water). The colour took at least 5 min to appear and the reaction was 
stopped by placing the gel in 10% acetic acid. The gels were photographed as soon as possible 
before discolouration occurred. 
2.3.8 Iron chelating compounds (Siderophores) 
Tris-succinate medium, as described by Braun (Braun 1981), was used to detect 
production of siderophores. This medium forces bacteria to use succinate as the major energy 
source, causing an apparent iron shortage due to excessive use of the cytochrome system. Also, 
this medium has the advantage of being colourless and does not interfere with subsequent 
colour reactions used for detecting siderophores. 
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2.3.8a Enterochelin 
Enterochelin or enterobactin comprises catechol. The method of Amow (Amow 
1937), used for the detection of catechols, can be used for the detection of enterobactin. 
Bacteria were grown in Tris-succinate medium at 37 T with vigorous shaking. When cultures 
became turbid, bacteria in 2 mls of culture were sedimented (12,500 g, 10 mins). To I ml of 
supernatant was added I ml 0.5 M HCl, I ml nitrite/ molybdate reagent and I ml 1M NaOH. 
A positive reaction gave a dark pink colour, the OD could be read at 505 nrn using tris- 
succinate medium as a blank. In practice the test was easy to read by eye. 
2.3.8b Aerobactin 
The ferric perchlorate test for the detection of aerobactin was perfonned as 
previously described (Atkin et aL 1970; Payne 1980). The bacteria were grown in tris- 
succinate medium, as described above, and I ml of 5 mM ferric perchlorate in 0.14 M 
perchloric acid was added to I ml of supernatant. Aerobactin reacted to give a reddish colour, 
the test was read visually and at 
OD480' 
Both the aerobactin and enterochelin tests were successfully performed in 
microtitre (using 50 gl amounts). This had the advantage of allowing many strains to be tested 
and using less of the reagents. The microtitre tests were read visually. 
2.3.9 Protein analysis 
Whole cell and outer membrane protein analyses were carried out using 
variations of the methods of Laemmli (1970) as described by Chart and Griffiths (1985) 
(Laemmli 1970; Chart and Griffiths 1985). 
2.3.9a Whole cell protein analysis 
0.5 mls of an overnight culture was subcultured into 10 mls nutrient broth and 
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incubated at 37 *C for 4h with shaking. The cells were harvested by centrifugation (3,000 g, 
10 min) in a Sorvall 6000 centrifuge and the cell pellet was resuspended in I ml. of PBS and 
transferred to a screw-cap Eppendorf tube. The cells were pelleted by centrifugation (12,500 g, 
10 min) in an Eppendorf microcentrifuge and resuspended in I ml of distilled water. The cells 
were again centrifuged in an Eppendorf microcentrifuge for 2 min and 0.5 ml of lysis buffer 
(8% distilled water, 2% mercaptoethanol, 20% glycerol, 0.8 g SDS, 70% 0.5 M Tris/ HCI, pH 
6.8) were added and mixed gently. The lysate was heated at 95 *C for 5 min in a Techne 
Dri-Block DB-I (Jencons Scientific). 0.5 ml of distilled water was added and the tubes were 
returned to the block for a further 5 min. The lysate was centrifuged for 5 mins in an 
Eppendorf microcentrifuge and 0.8-1 ml of supernatant was transferred to a clean screw-cap 
Eppendorf tube. 10 gl of bromophenol blue (5 mls lysis buffer, 5 mls distilled water, 10 gg 
bromophenol blue) was added and samples were stored at -20 T. 
2.3.9b Outer membrane protein profiles 
150 mls of an overnight broth culture were pelleted in a MSE centrifuge (6 x 
250 ml rotor) at 5000 g for 30 min. The supernatant was discarded and the pellet resuspended 
in 5 mls of ice-cold Tris-HCI, pH 7.4 containing I mM EDTA. The suspension was placed in 
sonicator vials pre-cooled on ice and sonicated at 150 Watts for 3 min (Heat Systems, 
Ultrasonics, Inc) until a clear solution was obtained indicating cell lysis. The sonicated 
preparation was poured into a 50 mls centrifuge tube containing 20 mls ice-cold 25 mM 
Tris-HCI, pH 7.4 and unbroken bacteria were sedimented by centrifugation at 5000 g for 20 
min in an MSE HS16 using the 8x 50 ml rotor. Supernatants were poured into clean 
centrifuge tubes and cell envelopes were pelleted by centrifugation at 40,000 g for Ih in an 
MSE HS16 at 4T using the 8x 50 ml rotor. Outer membranes were separated from inner 
membranes by digesting the inner membranes with sodium lauryl sarcosinate (Sarkosyl). The 
envelope pellet was suspended in 20 mls of Tris-HC1, pH 7.4 and the protein content estimated 
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by measuring the OD280 (I unit of OD280 approximately equals I mg protein ml preparation). 
For every I mg of protein, 20 ýLl of Sarkosyl were added and the tubes were incubated at room 
temperature for 30 min with vigorous shaking. Outer membranes were sedimented by 
centrifugation at 40,000 g for Ih at 4 'C and the pellet was resuspended in 20 mls Tris-HCI, 
pH 7.4. Outer membranes were pelleted as before and the pellet was resuspended in 100 ý11 of 
Tris-HCL, pH 7.4, and stored at -20 T. 
2.3.9c Determination of protein using the Lowry procedure 
Protein concentration was estimated using the method of Lowry et al. (Lowry el 
al. 1951). 20 gl of outer membrane protein preparations were added to 0.98 ml of distilled 
water. A protein standard of bovine serum albumin was also diluted in distilled water to give 
concentrations of 50,100,150 and 200 gg protein/ml. 5 mls of Lowry solution C (50 mls 
solution A+I ml solution B; see Appendix 1) were added to each tube, mixed thoroughly and 
left for 10 min. 0.5 ml of solution D (I N Folin-Ciocalteau reagent) was added to each tube, 
mixed and left for 30 min. The optical density was read at 500 nm. OD500 was plotted against 
gg protein and the concentration of protein in each sample was calculated. 
2.3.9d Electrophoresis of protein samples 
30 tig of protein sample were run on a SDS-PAGE gel. The resolving gel was 
made in Tris-HCI, pH 8.6 with 12.5% acrylamide and the stacking gel in Tris-HCI, pH 6.8 with 
5% acrylamide. The gel was run at 50 mA constant current per gel; the starting voltage was 
between 80-100 V and the final voltage 310 V. Gels were stained in a mixture containing 
0.1% Page Blue 83 (BDH) in 25% solvent methanol, 10% glacial acetic acid and 65% distilled 
water. Before use, the stain was filtered through a 32 cm Whatman filter paper and the gels 
were allowed to stain overnight. Gels were destained by washing in several changes of staining 
mixture excluding the Page Blue 83. 
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RESULTS 
- 
3.0 Strains of V. cholerae and V. mimicus used in this study. 
A total of 1323 strains of V cholerae non-01 and V mimicus was used for this 
study, and which had been referred to the Laboratory of Enteric Pathogens (LEP). This group 
of organisms comprised: - 1177 strains of V cholerae serogroup non-01 and V mimicus and 
146 reference or control strains. These had been isolated from a range of sources and from 69 
different countries (for more detail, please refer to Appendix 2). One hundred and thirty- nine 
strains were the reference strains for the serogrouping scheme of Sakazaki and Donovan 
(Sakazaki and Donovan 1984; Shimada et aL 1994) and the remaining 7 strains were control 
strains (WBDV-IOIE and NAG-ST) and five CT+ Australian strains described in section 2.1. 
For comparison a total of 88 strains of V cholerae belonging to serogroup 01 
was also screened for CT and ST in this study; two strains (01 Ogawa, and 01 Inaba) were 
reference strains for the serogrouping scheme and one (E51116) was a CT+ 01 control, the 
remaining 85 were V cholerae 01 referred to the LEP between 1985 and 1994. 
The environmental isolates of V cholerae non-01 and V mimicus, which 
account for 39% of strains, were from seafood (640/6), water (31%) and sewage (4%). The 
remaining 1% of environmental strains were isolated from miscellaneous sources, including; 
gull liver, chicken feed and fish tanks. The seafood sources comprised a variety of fish and 
shellfish, however prawns and shrimps accounted for 86% of the total. The isolates from water 
were from both "fresh" water sources (27%), such as rivers and ponds, and from "salt"/ sea 
water sources (73%). 
The human isolates of V cholerae non-01 and V mimicus, 61%, were isolated 
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from the faeces of patients with diarrhoea, who had returned from abroad. Of these, more than 
half (520/o), had visited one of four countries: these were India (116 cases), Kenya (115), 
Tunisia (80) or Thailand (64). 
Fourteen of the human isolates were non-faecal isolates from extraintestinal 
disease, all these were V cholerae non-0 I (Table 7). Strains of V cholerae belonging to 
serogroup 01 and V mimicus strains were not isolated from extraintestinal sites. 
3.1 Typing of strains of V. cholerae and V. mimicus 
The panel of strains of V cholerae and V mimicus which formed the basis for 
this study was typed by standard methods prior to use for further investigation. 
3.1.1 Biochemistry 
All strains of V cholerae and V mimicus were differentiated from other 
members of the genus Vibrio by salt (NaCl) requirement and the ability of strains to produce 
arginine dihydrolase. Strains of V cholerae and V mimicus are non-halophilic and arginine 
dihydrolase negative. 
Strains of V cholerae and V mimicus produced oxidase. Strains of V cholerae 
and V mimicus always produced acid (shown by pink coloration in the alkaline peptone water 
sugars containing Andrades indicator) in glucose, mannitol, maltose and trehalose. The 
following biochemical tests were also positive for these organisms; Christensen's citrate (bright 
pink coloration in the slope), indole (dark pink ring observed after the addition of Kovac's 
reagent), lysine decarboxylase (purple colour), gelatin (due to the production of gelatinase the 
solid medium was liquefied) and nitrate (the bright red colour observed after the addition of 
indicator reagents A and B showed the reduction of nitrate to nitrite). 
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Table 7: Strains of V. cholerae belonging to serogroup non-01, 
isolated from extra-intestinal locations 
Refno. serogroup location* countryl Patient details 
diaý agel sex 
E43504 0? appendix Saudi Arabia ? ? ? 
E39404 0? bile Iran N 84 M 
E39381 05 blood ? ? 75 F 
E43854 Oil blood Arab Emirates ? ? ? 
E48238 08 blood Jordan ? ? ? 
E55130 042 blood India ? ? ? 
E87187 O-rough blood Caribbean ? ? ? 
E87739 0? blood Saudi Arabia ? 29 F 
E94383 O-rough blood ? ? 78 M 
E68192 051 ear ? ? 19 M 
E73275 0? ear ? ? 22 F 
E55414-6 0? ? wound ? ? 46 M 
E91926 0? wound ? ? ? M 
E100095 0? blood North Africa ? ? M 
Site of isolation 
Country visited prior to infection 
Presence or absence of diarrhoea 
Patient's age in years 
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Strains of V cholerae and V mimicus did not produce gas from glucose 
(observed in a Durhams tube), and did not utilize the following sugars by fermentation (the 
Andrades indicator remained pale yellow); raffmose, salicin, dulcitol, inositol, adonitol, sorbitol, 
arabinose, rhainnose, xylose, inulin, sorbose and melibiose. V cholerae and V. mimicus were 
also negative in the following biochemical tests; mucate (the test remained blue), urea (no pink 
coloration was observed), arginine dihydrolase (yellow colour), 
H2Sproduction (no blackening 
of the glucose iron agar slope was observed), KCN (these organisms did not grow in potassium 
cyanide), malonate and PPA (no colour changes observed in medium or after addition of 
indicator reagents for PPA reaction). 
V cholerae and V mimicus could be distinguished from each other by VP 
(Vogues-Proskauer), sucrose fermentation and ONPG (0-nitrophenyl-B-galactosidase) (Table 8). 
3.1.2 Biotyping 
Strains of V cholerae belonging to serogroup 01 can be differentiated into two 
biotypes, classical and El Tor by: haemolysis of horse red blood cells (rbc), chick rbc 
haernagglutination, VP test, PB 50 sensitivity (polymixin B discs at 50 Units per disc obtained 
from Oxoid) and sensitivity to phage 3 (classical phage) and phage 4 (El Tor phage) of the 
USSR V cholerae phage typing scheme. 
Strains of V cholerae serogroup non-01, and V mimicus did not react with 
either the classical or El Tor phages. With respect to haemolysin production on horse rbc 
(section 3.6) and polymixin sensitivity most V cholerae non-01, including 0139, and V 
mimicus were "El Tor-like" (Table 9). The VP reaction was variable for strains of V cholerae 
non-01, but all strains of V mimicus were negative with the VP test. The ability of strains of 
V cholerae non-01 and V mimicus to haernagglutinate chick erythrocytes was not tested. 
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Strains of V. cholerae belonging to classical and El Tor biotypes, did not agglutinate chick red 
blood cells. 
3.1.3 Serotyping 
All test strains of V cholerae could be identified by serology using the scheme 
of Sakazaki and Donovan (Sakazaki and Donovan 1984). The scheme was also applied to 
strains of V mimicus but not to the halophilic vibrios. The serogrouping scheme was used with 
1177 strains of V cholerae non-01 and V mimicus, and the results are depicted in Figure 4. 
of these strains, 343 (30%) were shown to belong to 59 distinct serogroups; 663 (56%) strains 
were unidentifiable (0? ) with antisera raised against serogroups 01 (Ogawa and Inaba), 02 
through to 083,0139 and a presumptive serogroup 5609 (see 3.11.2) and the remainder (171 
(14%)) were considered rough. As these results are only based on the limited antisera available 
for evaluation (belonging to serogroups from 02 through 083 and 0139) the typability of the 
scheme may be improved by the recently expanded scheme described by Shimada et al 
(Shimada et aL 1994). 
Fifty-five strains of V mimicus were also examined with this serogrouping 
scheme. Thirty-five (64%) strains were unidentifiable, none were rough and 20 (36%) were 
agglutinated by test sera. These strains reacted with sera prepared to serogroups 06 (2 strains), 
014 (3), 020 (3), 034 (1), 039 (3), 041 (1), 043 (4), 071 (1) and 5609 (2), the number of 
strains reacting with the given serum is shown in parentheses. None of the represented 
serogroups was exclusive to V mimicus. 
It appeared that certain serogroups were associated with strains isolated from 
either the environment or from patients. Strains of V cholerae belonging to serogroup 019 
were most frequently isolated from environmental sources, whereas strains belonging to 
serogroups 02,05,09,011,013,024,034,037 and 0139 were isolated predominantly from 
cases of diarrhoea (Table 10). Seventy percent (238/343) of the strains which could be 
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Table 9: Comparison of biotyping of strains of V. cholerae belonging 
to serogroups 01,0139, non-01 and V. mimicus. 
IV cholerae V mimicus 
01 classical 01 El Tor 0139 non-01 
Haemolysin* ++ +(90%) +(900/0) 
VP ++v 
PB 501 sRRvR 
Phage 3+ 
Phage 4+ 
production of haernolysin as detected with horse red blood cells 
polymixin B discs 
v= variable; S= sensitive; R= resistant 
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cholerae non-01 and V. mimicus using Figure 4: Serogrouping of V 
the scheme of Sakazaki & Donovan (1984), 
incorporating antisera to 
Human Enviromnental 
Typable 30% 15% 15% 
Unidentifiable 56% 28.5% 27.5% 
Rough 14% 6.5% 7.5% 
strains isolated fom clinical sources 
strains isolated from environmental sources 
serogroups 02 to 083 and 0139. 
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identified by this serogrouping scheme belonged to the 20 serogroups (one of which was 
presumptive serogroup, 5609, identified in this study, 3.11.2) listed in Table 10. 
Strains of V cholerae belonging to serogroup 02 (25 strains, 21 of which were 
isolated from patients with diarrhoea) and 09 (24 strains, 17 of which were isolated from 
patients with diarrhoea) were most commonly encountered, and both serogroups have been 
responsible for family outbreaks (Table I I). AV cholerae 02 caused diarrhoea in a mother 
and her two young children who had visited Egypt and aV cholerae 09 caused diarrhoea in a 
mother and daughter who had visited Tunisia. None of these strains possessed the genes for 
either CT or ST. 
All the strains listed in Table II were implicated in family outbreaks, however, 
serogrouping and R-typing demonstrated that the isolates from three of these "outbreaks" were 
not the same. Of the three strains from Malta, although only 2 had an identical R-type, all 3 
strains were indistinguishable by serogrouping (all 0? ) and identical by LPS analysis (3.11.1). 
3.1.4 Phage-typing 
Strains of V cholerae were also typed using the USSR phage typing scheme as 
described by G. Bertram, M. Phil. (Bertram 1990; Drozhevkina and Artuyunov 1979). Seven 
phages were used; phages 1,2,3 and 7 were Mukerjee phages for the typing of the classical 
biotype and phages 4,5 and 6 were specific for the El Tor biotype. The phages were used at 
the dilution which gave semi-confluent lysis on an indicator strain, this dilution is the routine 
test dilution. A phage reaction ranging from greater than 20 plaques to confluent lysis was 
considered positive. The pattern of lysis given by the 7 phages determined the phage type; 
phage types I to 6,17 and 19 were associated with the classical biotype of serogroup 01, while 
phage types 10 to 16 and 18 were associated with the El Tor biotype (Table 12). If the strain 
reacted with the phages but did not give a known pattern it was recorded as non-confortning 
(NC). If there was no reaction with the phages the strain was considered untypable (U). 
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Table 10: The most common serogroups of v. cholerae non-01 and 
association with source. 
Serogroup No. isolated from No. isolated from Total 
patients environment mo 
02 21 4 25 
03 4 3 7 
05 11 1 12 
06 4 4 8 
09 17 7 24 
Oil 8 1 9 
013 10 2 12 
014 4 7 11 
019 1 12 13 
024 11 0 11 
034 10 3 13 
037 9 3 12 
039 5 6 11 
041 3 4 7 
049 2 4 6 
058 3 9 12 
076 4 4 8 
079 4 5 9 
0139 13 0 13 
5609 7 8 15 
Total =238 (70%) 
Other serogroups 59 46 105 (30%) 
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Table 13: Phage typing results with strains of V. cholerae non-01. 
Ref No. serogroW phagely pe (1)- Dhagelype (2) 
CA385 0-rough 3 3 
B4202-64 05 NC 6? 
7007-62 06 19 u 
10317-62 08 NC NC 
112-68 09 NC NC 
218-68 010 NC NC 
317-71 023 19 u 
12795-62 030 19 u 
171-68 032 NC u 
151-68 033 NC NC 
1322-69 037 NC NC 
112-73 044 2? 17 
122-73 045 19 u 
128-73 046 19 NC 
133-73 048 19 NC 
1463-76 057 19 u 
113-79 073 17 u 
1421-77 oso 19 u 
E38780 026 19 u 
E38820 02 15 u 
E39056 0? 15 u 
E39719 0-rough NC u 
E39974 022 15 14 
E40016 07 15 u 
E40387 0? 19 u 
E40454 0? 19 u 
E41307 0? NC Not Done 
E42751 041 NC u 
E42869 0? NC Not Done 
E42994 0? NC u 
E43640 02 19 u 
E43867 0? 19 u 
E45312 041 NC u 
E46846 076 14 or 16 14 
E46989 0? phage 10 + u 
E48238 08 phage 11 + phage 1 l+ ES4918 0-rough phage 11 + u 
E54381 037 phage 11 + u E54048 0? phage 11 + u E55879 0? NC NC 
The first 18 strains are reference strains and all E numbers are wild type strains NC non-conforming. 
U untypable. 
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A panel of reference strains comprising strains belonging to serogroups 02 
through to 083, O-rough and 0139 were phage-typed (Table 13). Of these 84 reference 
strains, 18 (21%) initially reacted with the test phages and of these 11 strains gave results 
correlating with established phage lysis patterns. The O-rough reference strain (which was 
originally derived from a serogroup 01, classical biotype) was the only strain to give a 
consistent phage type (PT 3). 
The first 500 wild-type strains of V cholerae non-01 (see Appendix 2) were 
also phage-typed; 22 (4.4%) initially reacted with the panel of phages, and of these only 10 
gave phage, reactions which conformed to known patterns (Table 13). A further 5 strains were 
positive with "new" phages described by G. Bertram (Bertram 1990); phage 10 was a variant of 
the USSR phage 5 and phage II was a carried phage isolated from a serogroup 01 biotype El 
Tor strain from Hong Kong. 
The reproducibility of phage results was examined by repeating the phage, 
typing procedure. Results in Table 13, column designated "phage-type (2)", show that the 
results of phage typing were not consistent and therefore the scheme was not considered 
reproducible for strains of V cholerae belonging to serogroups other than 01. 
3.1.5 Resistance (R)-typing 
A total of 300 strains of V cholerae non-01, isolated during the 2 year period 
1992-94, was tested for resistance to arnpicillin (A), chloramphenicol (C), colomycin (Co), 
ciprofloxacillin (Cx), furazolidone, (Fu), gentarnicin (G), kanamycin (K), streptomycin (S), 
sulphthiazole (Su), spectinomycin (Sp), tetracycline (T) and trimethoprim (Tm). 
Of these 300 strains, 8% (25/300) were sensitive to all 12 antibiotics tested, the 
remaining strains showed varying degrees of resistance. The most common resistance pattern 
observed, in 56% (169/300) of strains, was resistance to colomycin only. A further 24% 
(72/300) of strains showed resistance to colomycin along with resistance to other antibiotics. 
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The only other single antibiotic resistance pattern observed was for ampicillin, and 3% (10/300) 
of strains were resistant to this antibiotic alone. Ampicillin resistance along with resistance to 
other antibiotics was observed in 10% (311300) of strains. The commonly observed resistance 
patterns and the percentage of strains resistant to each antibiotic tested are shown in Table 14. 
There appeared to be no correlation of R-type with serogroup, except for strains 
of V cholerae belonging to serogroup 0139. Strains of V cholerae 0139 were consistently 
found to be resistant to CoSSuTm; three strains including the type strain were also resistant to 
Fu and one strain was also resistant to Sp and T (ie: COSSUSPTFm). The CoSSuTm resistance 
pattern was distinctive and closely associated with the 0139 serogroup, however, the same 
resistance pattern was also found in four other strains (E80120 (0? ), E90655 (038), E90645 
(0? ), and E97773 (0? )) all isolated from patients who had recently returned from India. 
CT-positive strains belonging to other serogroups other than 0139 were not 
found to be multiply resistant to antibiotics (section 3.3). 
3.1.5a, Resistance to 0/129 and polymixin. 
In general, strains of V. cholerae and V mimicus were sensitive to the 
vibriostatic agent 0/129; however, approximately 15% of strains were resistant. Resistance to 
0/129 was closely associated with resistance to trimethoprim, and all strains of V cholerae 
belonging to serogroup 0139 were resistant to 0/129. 
Polymixin sensitivity of V cholerae and V mimicus was described in section 
3.1.2. 
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Table 14: Resistance of V. cholerae non-01 to antibacterial drugs 
and commonly observed resistance patterns. 
Antibiotic % of V. cholerae non-01 resistant 
A= ampicillin 13% 
C= chloramphenicol 2% 
Co = colomycin 80% 
Cx = ciprofloxacillin 8% 
Fu = furazolidone 9% 
G= gentarnicin 0 
K= kanamycin 0 
S= streptomycin 10% 
Su = sulphthiazole 13% 
Sp = spectinomycin 3% 
T= tetracycline 1% 
Tm = trimethoprim 5% 
Resistance pattem number of strains Mol 
CO 169(56%) 
sensitive 25 (8%) 
CoSSuTm 14(5%) 
A 10 ( 3%) 
ACo 6 (2%) 
AFu 6 (2%) 
cosu 6 (2%) 
cocx 5 (2%) 
other 59 (20%) 
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3.2 Detection of toxins with cultured cells. 
3.2.1 Morphological effects of toxins, produced by V. cholerae non-01, on YI, HeLa and 
Vero cell-lines. 
Cell tests were performed using culture filtrates as described (Section 2.3.1 a). 
Reference strains of V cholerae belonging to serogroups 02 to 040, and 200 wild type strains 
(5 V mimicus strains and 195 V cholerae non-01 strains) were used for these experiments. 
The LT+ E. coli 137A, CT+ V cholerae 049 (WBDV-IOIE) and three V cholerae 01 (E51116 
CT+, 10954/1 Ogawa CT+, 8457/5 Inaba CT-) were also included. 
The protocol described for detecting E. coli LT (Section 2.3.1b) formed the 
basis for detecting toxins produced by strains of V cholerae. Crude preparations of toxin were 
prepared from broths following growth of strains in TSB. Preparations were added to Yl, 
HeLa and Vero cells, and plates stained with Geimsa's stain and examined after I day and 3 
days. The effect of the heated preparation was compared with that of the unheated to ensure 
that the observed effects of the unheated preparation on the tissue culture cells was due to a 
heat-labile factor. All the effects, described below, were heat-labile. A test was scored as 
negative if the cells remained intact at the end of the test. 
CT and E. coll LT characteristically lead to rounding of the Yl cells. In the 
presence of CT or LT the test was very clear with over 90% of cells rounded (Figure 5). This 
rounding effect was a cytotonic response which was reversed if the Y1 cell test was extended to 
3 days. E. coli B7A, V cholerae O-rough (reference strain CA385) and V cholerae 01 
(reference strain 10954/1) produced the typical cell rounding effect on YI cells. However, the 
CT-negative V cholerae 01 (reference strain 8457/5) and the CT-positive V cholerae non-01 
strains (reference strain 1322-69 (037) and control strain WBDV-IOIE (049)) were cytotoxic. 
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The observed effects with 88% of culture filtrates of CT-negative V cholerae non-01 were also 
cytotoxic (irreversible cell damage, leading to cell death) varying from slight elongation of cells 
to complete cell destruction with plate wells becoming devoid of cells (Figure 5). It was not 
possible to tell if the different morphological appearances on YI cells (elongation, "ghosting" 
and "shrivelling") were different stages of a single cytotoxic effect or if the effects were distinct 
from each other, therefore all these effects were recorded as cytotoxin (c). In the presence of 
cytotoxin(s) between 80% and 100% of Y1 cells were found to be affected. Both the rounding 
effect of LT and CT and the cytotoxic effects were seen after I day in Y1 cells. True rounding 
was confirmed as CT or LT by neutralisation tests (2.3.1b) using antisera, raised against these 
toxins, cytotoxic effects were not neutralised by the antisera. Three strains of V cholerae non- 
01 (E60391, E60393, both 0? isolated from shrimps, and E42878, an 013 isolated from a 
patient who had been travelling in India) produced a "rounding" effect which could not be 
neutralised by antisera to LT or CT and was irreversible, that is cytotoxic rather than cytotonic. 
These 3 strains also produced cytotoxic; effects on Vero and HeLa cells, they were therefore 
regarded as cytotoxin producers. The Vero cell line was also sensitive to LT and CT, in the 
presence of these toxins the cells rounded up and become partially detached from each other, 
however this effect was only seen in aI day test, by 3 days the monolayer had recovered ftorn 
these cytotonic toxins. In the presence of cytotoxin the entire Vero cell monolayer became 
detached and few cells were left (Figure 6). In the absence of cytotoxin the monolayer 
remained intact. As well as the cytotoxic effect another distinct irreversible heat-labile effect 
was the vacuolation (v) of Vero cells (Figure 6). 
The Vero cell line is usually used to detect the Vero cytotoxin (VT) of E. coli 
(Konowalchuk et aL 1977; Scotland et aL 1980). VT is part of a group of toxins which are 
closely related to the Shiga toxin of Shigella qýsenteriae type I the causative organism of 
dysentery, therefore VT is also known as Shiga-like toxin (SLT). VTs are cytotoxic for Vero 
cells and these toxins cause death of Vero cell monolayers. Neutralisation tests using antisera, 
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prepared against VT (VT1 and VT2) did not neutralise the cytotoxic effect produced 
by V 
cholerae non-01 culture filtrates on Vero cells. It was concluded that the cytotoxic effect 
observed was probably not due to the activity of VT or VT-like toxins (see also VT probe, 
3.5.2). 
The HeLa cell line was the most resistant to morphological effects produced by 
the culture filtrate preparations. The cells of the HeLa monolayer have a rounded appearance 
which made it difficult to distinguish rounding of the HeLa cells in response to LT or CT. In 
the presence of cytotoxin more than 50% of the cells became detached, the remaining cells 
often appeared to have lost their characteristic round shape and had "protrusions" extending 
from the cell. 
Using the three cell lines (YI, Vero and HeLa) there were six observed patterns 
of cytotoxin production (Table 15). The most common pattern observed was cytotoxicity on all 
three cell lines (47%), only 12% were negative (no cytotoxin production detected on the 3 cell 
lines). The vacuolating toxin was produced on Vero cells by 16% of V cholerae non-01 
strains, this was most commonly associated with a shrivelled appearance on YI cells, with no 
observed effect on HeLa cells. All five V m1micus strains tested were cytotoxic on all three 
(ccc) cell lines. There was no apparent correlation of cytotoxic pattern with serogroup. 
Cytotoxin production was most frequently observed with strains of V cholerae belonging to 
serogroups 02 (10 cytotoxic strains/10 strains tested), 05 (6/6) and 019 (6/9). Strains 
belonging to serogroups commonly isolated from patients with diarrhoea (02,05,013 and 
034) were cytotoxic on YI cells and belonged to patterns 1,3,4 and 5 (Table 15). Of the 
strains belonging to the 019 serogroup, commonly isolated from environmental sources, only I 
was cytotoxic on all three cell lines (pattern 1), 3 strains were negative and the remaining 5 
strains belonged to pattern 2 (c-c). 
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Table 15: Morphological effects of toxins produced by strains of 
V. cholerae non-01 on Y1, HeLa and Vero cells. 
Pattern No. of strains (%) Vero Hela, Yl 
1 112(47%) c 
2 21(9%) 
3 10(4%) 
4 29(12%) 
5 38 (16%) 
6 29(12%) 
c= cytotoxin 
v= vacuolating toxin 
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3.2.2 Toxin production in different growth media. 
As described above (3.2.1) E. coli B7A and certain V cholerae strains (0-rough 
CA385 and 01 10954/1) produced the typical cell rounding effect on YI cells when grown in 
TSB. However, the CT production of known CT-probe-positive (3.3.1) V cholerae non-0 I 
(037 1322-69 and 049 WBDV-IOIE) was not demonstrated, due to the production of 
cytotoxin, which masked CT production. The use of different culture media and different 
growth conditions were used to optimise conditions for the production of CT (this is described 
in more detail in section 3.3.3). Although the masking effect of the cytotoxin could not be 
overcome, it was found that V cholerae non-01 toxin titres were highest when grown in 
Syncase Sucrose broth at 37 *C with aeration. 
3.3 Detection of cholera toxin (CT) 
Due to the fact that certain strains produced cytotoxin(s), it was difficult to 
detect CT using tissue culture cell assays (3.2). To avoid this problem, specific DNA probes 
and immunoassays for CT were used. 
3.3.1 DNA probes for CT 
The possession of CT genes, by strains of V cholerae non-01 and 
V mimicus was investigated using polynucleotide probes CTA and CTB, described in 2.3.2b, 
SNAP-LT (a commercial kit) described in 2-3.2f, and an oligonucleotide probe GMI, described 
in 2.3.2g. 
The first probe used was an "S labelled polynucleotide probe to CTB, prepared 
by Dr. G. Willshaw and described by G. Bertram, M. Phil (Bertram 1990). It was found that 
approximately 80% of the "S was incorporated into the probe, which could be used for up to 3 
months. For colony hybridisation broth cultures of test strains were "spotted" onto nylon 
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membranes, as described (2.3.2d). The radio-labelled CTB probe was hybridised with nylon 
membranes at 42 T and 37 T to test type strains (0-rough, 02 - 083) at both "high" and 
"low" stringency. Reference strains of V cholerae O-rough and 037 were positive with this 
probe at both temperatures. Forty four strains of V cholerae non-01, isolated from humans 
and 45 strains isolated from environmental sources, were also tested using high and low 
stringency temperatures. All 89 strains were found not to react with the gene probe. 
With the aim of finding a safer alternative to using radio-labelled probes, the 
use of cnzyme-labelled probes was investigated. A commercially available synthetic nucleic 
acid (SNAP) probe designed to detect the LT of E. coli was tested. This SNAP-LT kit was 
compared with the "S-labelled CTB probe for the detection of CT, in addition to the detection 
of LT gene sequences. With the SNAP-LT kit only LT-positive E. coli tested positive, all 172 
strains of V cholerae tested were negative, including known CT-positive strains of V cholerae 
belonging to serogroups 01,037 and O-rough. In contrast the radio-labelled probe detected 
both LT and CT positive strains. It was concluded that the SNAP-LT probe was inappropriate. 
for testing strains of V cholerae. 
It was decided to enzyme-label the polynucleotide CT probes which were 
available. The first enzyme-labelling system used was a biotin label with the polynucleotide 
CTA probe, as described by G. Bertram, M. Phil (Bertram 1990). However, it was found that 
the colony blot results were difficult to interpret and chromosomal blots gave false positive 
results. An alternative enzyme-labelling method, using digoxigenin (2.3.2c), was tried and was 
found to detect CTA and CTB genes sequences using colony blots. The digoxigenin labelling 
system was also successful with oligonucleotide probes, such as GMI, therefore this labelling 
procedure was used for subsequent studies. 
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Table 16: Incidence of CT genes in wild type strains of 
V. cholerae and V. mimicus 
Total no. tested CTA CTB CT+ % 
V cholerae 01 85 74 74 87% 
V cholerae non-01 1122 15 15 1% 
V mimicus 55 0 0 0% 
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3.3.1a Digoxigenin-labelled CTA and CTB 
Strains of V cholerae, belonging to serogroups 01 (85 strains) and non-01 
(1122 strains), and V mimicus (55 strains) were tested for the possession of genes encoding CT 
using digoxigenin-labelled CTA and CTB polynucleotide probes (Table 16). Initially, strains 
were tested in parallel with probes for both CTA and CTB; however, since the strains either 
reacted with both or did not react with either probe, a mixed CTA+B probe (equal volumes of 
CTA and CTB) which gave strong positive results (Figure 7) was used for further screening. 
When CT-positive strains were detected, these were tested with the separate CTA and CTB 
probes to ensure genes for both toxin subunits were present. All strains detected with the 
mixed CTA and CTB probes were found to have the genes for both CTA and CTB. 
The combined CTA+B probe was also used at "low" stringency, which allowed 
both LT and CT gene sequences to be detected (Figure 7). Any strains of V cholerae non-01 
or V mimicus possessing gene sequences related to CT and LT should be detected at low 
stringency. Strains which were positive in the GMI-ELISA (see Section 3.3.2) but CT-probe- 
negative at high stringency were suspected of producing a CT-like toxin, however, 119 GMI- 
ELISA positive strains were tested at low stringency with the CTA+B probe and all were 
negative. The number of strains reacting with the DNA probes was not increased when the 
stringency was lowered. None of the V m1micus strains tested and only 1% of V cholerae 
non-01 (13 of these belonged to serogroup 0139) tested were CT-positive (a full list of CT- 
positive strains is given in Table 17). 
The 141 reference strains belonging to serogroups 01 Inaba, 01 Ogawa, 0- 
rough and 02 to 0139 (the non-01 reference strains comprise 131 V cholerae, and 9V 
mimicus) were also examined for reaction with CTA+B probes. Of 141 strains 6 were positive 
(Table 17), 5 positive strains were V cholerae and I strain was aV mimicus. The possession 
of the genes for CT was found to correlate with the somatic antigens expressed by test strains. 
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Figure 7: DigOxigenin-labelled CTA and CTB probes 
Hybridisation of combined CTA+B gene probe at 68 'C. 
The positive colony blot is V cholerae 037 (1322-69), the remaining 
colony blots are CT-negative V cholerae non-01 and an LT-positive 
E. coli B7A. 
,I 
a 
Hybridisation of combined CTA+B gene probe at 37 'C showing 
LT-positive E coli. 
The positive colony blots are V cholerae strains 01 (E51116), 037 (1322-69). 
0? (E55879), 0? (E66371) and 049 (WBDV-IOIE) and an LT-positive E. coli B7A, 
the remaining colony blots are CT-negative V. cholerae non-01. 
2J/1 
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Table 17: List of CT gene positive strains of 
V. cholerae non-01 and V. mimicus 
(Including reference strains and control strains). 
Reference No. Serogroup Country of origin Patient details 
diarrhoea/age/sex* 
or 
source of strain 
CA385 O-rough ? reference strain 
10954/1 01 Ogawa ? reference strain 
1322-69 037 ? reference strain 
571-88 0105 ? reference strain 
523-80 (V mimicus) 0115 ? reference strain 
M045 0139 ? reference strain 
E51116 01 Ogawa Bangladesh control strain 
WBDV-IOIE 049 ? control strain 
N2 06 Australia isolated from water 
N87 06 Australia isolated from water 
N7 023 Australia isolated from water 
N9 023 Australia isolated from water 
N92 023 Australia isolated from water 
E85943 0139 ? D? ?* 
E86270 0139 Bangladesh D36M 
E87509 0139 India D 68 ? 
E87954 0139 India D 25 F 
E88131 0139 India D 19 M 
E89007 0139 India D30M 
E90067 0139 Pakistan D? ? 
E90070 0139 Pakistan D? ? 
E90171 0139 Pakistan D? ? 
E90251 0139 Thailand D25F 
E92660 0139 Bangladesh D54M 
E99892 0139 Pakistan D 33 F 
E100069 0139 India D 33 F 
E55879 0? Egypt D 22 M 
E66371 0? Tunisia D46M 
Patient details; ?= unknown, D= diarrhoea, age = stated in years, 
M= male, F= female 
120 
Of the strains of V cholerae belonging to serogroup 01,87% (74) were found to possess the 
genes encoding CT, and 100% of strains of V cholerae belonging to serogroup 0139 carried 
genes encoding CT. In contrast, <1% of V mimicus (a single strain; 523-80 the reference strain 
for 0115) and V cholerae non-01/non-0139 reacted with the probes. 
3.3.1b GM1 oligonucleotide probe 
The B-subunits of CT bind to the ganglioside, GMI, and the DNA sequence 
encoding this Part of the CTB molecule has been determined. An oligonucleotide probe to the 
GMI ganglioside binding part of the CT gene, was labelled with digoxigenin and used in 
hybridisation studies. The GMI probe hybridised with strains of E. coll producing LT and CT- 
producing strains of V cholerae at 48 'C (Figure 8). Of the 500 V cholerae non-01 (including 
the 119 CT probe-negative, GMI-ELISA positive strains (Section 3.3.2a), only the strains 
known to be CT-positive from previous hybridisation experiments were positive with this probe. 
3.3.2 Immunoassays 
As tissue culture cell assays could not be used to demonstrate CT production 
due to the masking effect of cytotoxins, immunoassays were used as an alternative means of 
demonstrating CT production by strains of V. cholerae and V mimicus. Small scale filtrates 
(described in section 2.4.2a) were used to test large numbers of strains in these immunoassays. 
ELISA and VET-RPLA assays confirmed the CT-positive strains. All CT probe negative 
strains tested were also negative in the VET-RPLA. However, in the GMI-ELISA some CT- 
negative strains gave reproducible positive results and these strains were investigated further 
using probe tests (see 3.3.1a and 3.3.1b above) and other immunoassays, such as PIH, Biken 
assay and colony immunoblotting in an attempt to confirm the production of a CT related heat- 
labile toxin. 
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Figure 8: Hybridisation with digoxigenin-labelled 
GMI oligonucleotide probe at 48 'C 
The positive colony blots are V cholerae strains belonging to 
serogroups 01 (E51116), 037 (1322-69), 049 (WBDV-IOIE), 0139 
(M045, E85943, E86270, E87509, E87954, E88131, E89007), O-rough 
(CA385) and LT-positive E. coli B7A. The remaining strains are 
CT-negative V cholerae non-01. 
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3.3.2a GMI-ELISA 
The GMI-ELISA uses the ganglioside GMI to coat ELISA plates and "capture" 
toxin in sterile culture filtrates. The probe positive V cholerae non-01 strains, the V cholerae 
01 (Table 17) and E. coli strain B7A were tested in the GMI-ELISA using antisera raised 
against CT (LEP), CTB (Novabiochem) and LT (LEP). All CT-positive and LT-positive strains 
were positive in the GMI-ELISA test; positive culture filtrate consistently gave a reading of 
>1.0 (OD405)' 
Culture supernatants, prepared from 630 probe-negative strains of 
V cholerae non-Ol were also tested using the anti-CT, anti-CTB and anti-LT. Of the 630 
strains, 119 (19%) gave a positive result with anti-CT and anti-CTB, but gave a negative result 
with an antiserum prepared to LT (LEP). It was concluded that this putative toxin had the 
ability to bind the ganglioside GMI and shared antibody binding sites with CT, and more 
specifically with CTB. 
Strains of V cholerae, giving positive results with the GMI-ELISA, were 
reacted with the CTA+B combined probe at low stringency (3.3.1a) and with the GM1- 
oligonucleotide at 48 T (3.3.1b), however all strains remained probe-negative. 
3.3.2b VET-RPLA 
The VET-RPLA was a reversed passive latex agglutination kit (2.3.1e) which 
was used to detect CT and LT. The 119 probe-negative, GMI-ELISA positive strains of V 
cholerae (3.3.2a) were negative by latex agglutination. All CT-probe positive strains (listed in 
Table 17) and the E. coli LT-positive strain (B7A) were, as expected, positive by VET-RPLA. 
The VET-RPLA was also used to assess the effect of different growth 
conditions on CT-probe-positive V. cholerae (3.3.3). 
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3.3.2c Double sandwich ELISA 
Selected probe-negative, GMI. -ELISA positive strains (which consistently gave 
OD405 of 1.8 - 2.0), were tested in another ELISA system where the antisera raised against LT 
(LEP), CT (LEP) and CTB (Novabiochem) were used as first ligand, replacing the GMI 
ganglioside. An appropriate second ligand, dependent on the antiserum chosen as first ligand, 
was used (2.3.1d). Four different combinations were possible (Table 18), a positive filtrate 
gave a reading of >0.9 at OD4.5. 
CT-probe positive strains V cholerae 049 (WBDV- 10 1 E), V cholerae 01 
(E51116), LT-positive E. coll B7A and 8 strains of probe-negative, GMI-ELISA positive V 
cholerae non-01 were used in these experiments. Syncase sucrose broth (SSB) was used as a 
negative control. The culture filtrates were prepared after growth in SSB and toxin production 
was also tested in the GMI-ELISA (using anti-CT), the VET-RPLA and the YI cell assay 
(Table 18). The most successful double sandwich ELISA used anti-LT as first ligand and anti- 
CTB as the second. The two ELISA tests in which anti-CTB was used as a first ligand were 
totally negative. The OD403for the double sandwich ELISAs were lower than in the GMI- 
ELISA and three strains gave results which were indeterminate (OD405>0.5 and <0.9). 
3.3.2d Biken test 
The Biken test detects the LT of E. coli by the formation of a prccipitin line 
between test colonies and antisera, raised against the toxin to be detected (eg: anti-LT). Three 
test strains of V cholerae and a positive control strain E. coli B7A were included on each plate. 
The line of precipitation was observed in a light-box. 
This test worked well with LT-positive E. coli B7A using either anti-LT (LEP), 
anti-CT (LEP) or anti-CTB (Novabiochem). Two CT-positive V cholerae 01 (E51116 and 
10954/1), 3 CT-positive V cholerae non-01 (1322-69, WBDV-IOIE and E55879), 10 probe- 
negative, GMI-ELISA-positive V cholerae non-01 and 2 probe-negative, GMI-ELISA- 
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negative V cholerae non-01 strains were tested against the 3 antisera. All V cholerae strains 
grew poorly on the Biken agar compared with the growth of the E. coll strain and all were 
negative with anti-LT and with anti-CTB. However, with anti-CT weak precipitin lines were 
observed with the CT-probe-positive strains, and some weaker precipitin lines were observed 
with two of the probe-negative, GMI-ELISA-positive strains (E47279 and E46827). 
3.3.2e Passive immune haemolysis (PHD 
The PlH test (2.3.1f) was also originally developed for the detection of LT, 
however this test has been used to detect CT-like, toxin of V cholerae non-01 (Yamarnoto et 
aL 1981). Six strains of V cholerae non-01 (all GMI-ELISA positive), V cholerae 01 
(E51116), V cholerae 037 (1322-69) and E. coli B7A were used. The LT and CT positive 
strains were tested in the tube assay to ensure the system would detect LT and CT, then all the 
strains were tested in microtitre. 
Although Yamamoto et aL (Yamamoto et aL 1981) found they could use this 
system with their strains and the LT positive could be detected in both the tube and microtitre 
systems; neither the tube nor the microtitre PlH method was appropriate for the V cholerae 
tested. This was because these strains produced haemolysin in their culture filtrates in addition 
to CT, therefore, the SRBC were lysed before the end of the antibody adsorption period (ie: 
before the test could be completed). The culture filtrates of the V. cholerae strains were also 
titrated in the microtitre system using doubling dilutions, the wells were examined for 
haemolytic activity before and then after the addition of complement. All the strains gave 
haemolytic, titres of 1/20 or greater before and after addition of complement, one strain E55879 
(0?, CT+) was the only strain which showed an increased haemolytic titre after the addition of 
complement, from 1/20 to 1/80, this increase may have been due to PIH induced by CT. 
'Ii 
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3.3.2f Colony and supernatant immunoblotting 
The colony immunoblotting technique relies on the transfer of protein toxin, in 
this case CT or CT-related toxins, to Hybond-C extra nitrocellulose membranes, the toxin is 
detected using antisera and alkaline-phosphatase conjugated IgG. Colony immunoblotting was 
used together with antiserum raised against CT (LEP) and CTB (Novabiochem). Twenty-three 
V cholerae non-01 strains were grown on nutrient agar plates for 6 h, a nitrocellulose 
membrane was placed gently onto the colonies for 5 min, and the procedure carried out as 
described (section 2.3.1h). Seventeen strains were probe-negative, GMI-ELISA positive, 4 
strains were positive for both CT probe and ELISA and 2 strains were negative in both tests. 
However, all 23 strains gave a positive reaction with both anti-CT and anti-CTB (a strong dark 
purple colour), within 5 min. 
In order to remove cell debris which may be interfering with the colony 
immunoblotting, the same strains were grown in SSB and filtered supernatants prepared 
(2.1.3a). The supernatants were spotted directly onto the nylon membranes and the detection 
procedure carried out as for colony immunoblotting. However, the results were the same, all 
23 were positive, indicating that the reaction may not be specific. 
3.3.3 Optimising growth conditions for the production of CT. 
The culture conditions used for growing strains of V cholerae non-01 
influenced the result of the tissue culture tests. In particular the masking of CT production by 
cytotoxin in the YI cell assay was a problem (3.2.1). Therefore, with the aim of optimising 
culture conditions for CT production, the use of different culture media and different growth 
conditions was assessed. Strains of V cholerae which possessed CT genes (CT-probe-positive) 
and produced CT as detected by immunoassays (VET-RPLA and ELISA positive), were used. 
Strains were as follows: reference strain V cholerae 037 (1322-69), control strain V cholerae 
049 (WBDV-IOIE), Vcholerae non-01 wild strain E55879 (0? ), V cholerae 01 (E51116) and 
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E. coli (B7A). Culture filtrates of these strains were prepared after growing the organisms in 
Syncase sucrose broth (SSB), Syncase glucose broth (SGB), Trypticase soy broth (TSB), Brain 
heart infusion broth (BHl) and Casamino yeast extract broth (CYE) (2.3.1a). The culture 
conditions, for each culture medium, were varied by temperature (30 T or 37 *C) and by 
growing statically or with aeration. Doubling dilutions of filtrate were used to determine titres 
of heat-labile enterotoxin and cytotoxin. The titre is the reciprocal of the highest final dilution 
in each respective test causing toxic effect. Neutralisations with antiserum against CT or LT 
were performed to confirm specificity of the rounding. The effect of media and different 
growth conditions on toxin production was assayed using Y1 cells, neutralisation assays, VET- 
RPLA and GMI-ELISA (Table 19). 
V cholerae non-01 strains produced cytotoxin(s) which made it impossible to 
detect the true rounding of CT on YI cells under any of the growth conditions used, even when 
filtrates were diluted to 1/156250, cytotoxin was still present. 'Me cytotoxic effect present in 
the filtrates was destroyed by heating at 100 T for 15 min (as was CT) but the effect was not 
neutralised by anti-cholera toxin. The control V cholerae 01 (E51116) strain did not produce 
cytotoxin under these same conditions, but did cause typical rounding of the cells which was 
confirined as CT by neutralisation. Similarly, E. coli strain B7A produced rounding typical of 
LT and this effect was neutralisable. For the V cholerae 01 strain the highest CT titre (2560) 
was obtained at 30 T in SSB with aeration. E. coli B7A gave the highest titre (156,250) at 
37 OC with aeration, in either SSB or TSB. 
The effect of growth conditions on CT production by the probe positive strains, 
could easily be detected and quantified in the immunoassays. As shown in Table 19, there 
were conditions under which no toxin production could be detected by either immunoassay 
(ELISA or VET-RPLA). The highest CT titrcs for V cholerae non-01 strains, as detected by 
VET-RPLA, were obtained with SSB at 37 'C, with aeration: these were titres of 32 for wild 
type strain E55879 (0? ) and 64 for both reference strain 1322-69 (037) and control strain 
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WBDV-IOIE (049). Although the masking effect of the cytotoxin could not be overcome, it 
was concluded that V cholerae non-01 toxin titres were highest when grown in SSB at 37 IIC 
with aeration. 
3.3.3a Kinetics of production of CT and LT 
Bacteria were grown in 20 ml volumes of SSB with aeration at 37 T. At 2,4, 
6,8,12 and 24 hours post inoculation, 2 ml volumes were removed, bacteria sedimented and 
the supernatants filtered through 0.2 ýtrn Millipore filters. The filtrates were assayed for CT or 
LT in GMI-ELISA, VET-RPLA and YI cell assay; the production of cytotoxin was detected on 
YI cells. The strains used were; V cholerae 01 (E51116), V cholerae 037 (1322-69) and E. 
col! B7A (Table 20 and Figure 9). 
The ELISA and VET-RPLA tests confinned the production of LT and CT, even 
in the filtrate of the 037 strain which also produced a cytotoxin thus masking the CT effect on 
Y1 cells. The production of CT in 01 and 037 as detected by VET-RPLA gave identical 
titres, detectable LT levels lagged behind CT. LT, CT and cytotoxin curves (titres measured in 
Yl cell assay and shown in Figure 9) were different from each other. CT and the cytotoxin 
were first detected at 4 h, but while the CT titre levelled out at 1/320 from 8 h, the cytotoxin 
titre continued to rise and was 1/1280 at 24 h when the final sample was taken. The LT titre 
rose steadily from 1/80 at 6h to 1/1280 at 24 h, as detected by YI cell assay. 
To elucidate the production of CT and cytotoxin in relation to bacterial growth, 
the experiment was repeated using V cholerae 037. The bacterial cell density was measured 
(OD6,, )prior to the preparation of culture filtrates for samples taken at 2,4,6,8,10,12,14, 
18,20,24 h, cytotoxin production was measured in the YI cell assay and CT with the VET- 
RPLA (Table 21 and Figure 10). 
The expression of toxin (CT and cytotoxin) was found to correlate with the 
exponential growth phase of the organism. By late log phase of growth, 12 and 14 h post- 
inoculation, the production of CT peaked giving titre of 1/64 (as detected by VET-RPLA), with 
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Figure 9: Kinetics of production of CT, LT and cytotoxin 
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The titre of CT, LT and cytotoxin as detected by the YJ cell assay is shown. 
The CT and cytotoxin titres are identical at for the first 8 h, then the 
cytotoxin levels continue to rise as the CT titre levels off. 
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Table 21: Production of CT and cytotoxin by V. cholerae 037; 
relation to the growth curve. 
Time (h) 
2468 10 12 14 18 20 24 
OD621 0.17 0.95 1.42 3.81 5.99 7.58 7.81 7.97 8.13 8.13 
VET-RLPA 0248 16 32 64 64 64 32 
Y1 cells 0 40 40 160 320 320 640 1280 1280 320 
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Figure 10: Production of CT and cytotoxin by V. cholerae 037; 
relation to growth curve. 
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The expression of CT and cytotoxin correlates with the exponential 
growth phase of the organisms. 
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a slight decrease in toxin titre by 24 h. The production of cytotoxin (detected in the YI cell 
assay) peaked at around 16 h, with a substantial drop in titre between 20 and 24 h. 
3.3.3b Are the cytotoxin and CT of V. cholerae 037 extracellular or intracellular? 
V cholerae 037 was grown in 10 mls SSB medium as described above. After 
8h post-inoculation a3 mls sample was aseptically removed and a sterile culture filtrate 
prepared, this was designated filtrate I ("extracellular toxin"). Polymixin B (I mg/ml) was 
added to the remaining culture and incubated for 10 min at 37 T, 3 mls of this was used to 
prepare filtrate 11 ("intracellular toxin"). The filtrates were titrated in the VET-RPLA (for CT) 
and on YI cells (for cytotoxin). Filtrate I gave a titre of 1/32 in the VET-RPLA test and a 
cytotoxic titre of 1/320 on the YI cells; in contrast filtrate 11 gave a titre of 1/2 in the VET- 
RPLA and was negative on the YI cells. The results indicated that both CT and cytotoxin were 
exported out of the periplasm, although there was detectable intracellular CT, the cytotoxin was 
not found in filtrate 11. 
3.3.4 Southern blot analysis of CT genes 
The CT genes of probe positive V cholerae non-01 were analysed by Southern 
blot, to look for differences in the CT genes, by size of hybridising fragment. DNA 
preparations were made initially by the GES (2.3.4a) and then by the CTAB methods (2.3.4b). 
The GES method was lengthy and difficult to use with V cholerae and was 
soon replaced by the simpler and more effective CTAB method, which produced DNA 
preparations of good quality. The GES method was not found to have any advantages over the 
CTAB method, therefore the DNA preparations used for Southern blot analysis were made by 
the CTAB method. 
DNA preparations were made of CT-probe-positive strains; V cholerae 
reference strains 01 Ogawa biotype El Tor (10954/1), O-rough (CA385), 037 (1322-69), 0105 
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(571-88), 0115 (523-80, aV mimicus), 0139 (M045), control strains 
V cholerae 01 Ogawa biotype classical (E51116), V cholerae 049 (WBDV-IOIE), the 5 
Australian V. cholerae strains (2 belonging to serogroup 06 and 3 to serogroup 023, P. 
Desmarchelier) and 6 wild type strains of V cholerae (4 belonging to serogroup, 0139 and 2 
unidentifiable (07)). A DNA preparation of E. coli B7A was also made. The DNA was 
digested with HindIll, run on a 1% agarose gets (2.3.4d) and Southern blots prepared (2.3.4e). 
The blots were probed with either CTA or CTB polynucleotide or GMI oligonucleotide probes; 
the results were the same for all three probes. 
The CT-positive V cholerae strains could be differentiated into 7 different 
patterns by size of hybridising fragment (Table 22 and Figure 11). An eighth pattern 
(designated 115) belonged to the only CT-positive V mimicus (reference strain 523-80, 
serogroup 0 115) found in this study. A single hybridising band of approximately 22 Kb, 
designated pattern H3, was found in 6 CT-positive V cholerae non-01, belonging to serogroups 
06,049 and 0105. This band appeared to be similar or identical to the single band of V 
cholerae 01 (10954/1). Patterns HI - H5 had only I hybridising fragment of different sizes; 
patterns H6 and H7 had 2 hybridising fragments and pattern H8 had 3 fragments indicating the 
presence of more than one CT gene in these strains. Pattern H6 was exclusive to serogroup 
0139 (although I strain of serogroup, 0139 was designated H2 because it only possessed one of 
the hybridising fragments) and pattern H7 was exclusive to serogroup, 023 (Table 22). 
Southern blots of the E. coli B7A strain would only hybridise with the CTA and CTB probes at 
low stringency (37 *C) or the GMI oligonucleotide at 48 *C, under these conditions a faint 2 kb 
hybridising fragment was found (figure 11). 
Southern blot analysis and hybridisation with the GMI oligonucleotide was 
also used for probe-negative, but GMI-ELISA-positive strains (3.3.2a). The GMI 
oligonucleotide is directed against the part of the CT gene which determines the ability to bind 
GMI. The probe-negative, GMI-ELISA-positive strains produce a presumptive 
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Table 22: CT positive V. cholerae strains differentiated 
by Southern blot analysis 
Strain 
_Source* 
Countly SerogrouI2 Southem blot 
1322-69 RS Asia 037 HI (>25 kb) 
E89007 D India 0139 H2 (23 kb) 
10954/1 RS Asia 01 Ogawa H3 (22 kb) 
N2 w Australia 06 H3 
N87 w Australia 06 H3 
WBDV-lOlE D Thailand 049 H3 
571-88 RS ? 0105 H3 
E55879 D Egypt 0? H3 
E66371 D Egypt 0? H3 
CA385 RS Asia O-rough H4 (20 kb) 
523-80 RS 7 0115 H5 (17 kb) 
M045 RS India 0139 H6 (25 and 23 kb) 
E85943 D ? 0139 H6 
E86270 D Bangladesh 0139 H6 
E87509 D India 0139 H6 
N7 w Australia 023 H7 (9 and 4 kb) 
N9 w Australia 023 H7 
N92 w Australia 023 H7 
E51116 ? Bandadesh 01 Ogawa H8 (22,20 and 17 kb) 
RS = reference strain 
D= strain isolated from a case of diarrhoea 
W= strain isolated from water 
?= source or country unknown 
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Figure 11: HindIll restriction digest, 
fragments hybridising with GMI oligonucleotide: 
a diagrammatic representation. 
HI H2 H3 H4 H5 H6 H7 H8 B7A MW (kb) 
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heat-labile toxin distinct from CT but with the ability to bind ganglioside GMI, and may 
therefore have a DNA sequence similar to that encoded by the GMI oligonucleotide (3.3.1b). 
Ten of the probe-negative, GMI-ELISA-positive V cholerae non-01 strains were tested but no 
hybridising fragments were detected, this was expected as colony hybridisation with the GMI 
oligonucleotide was negative. 
3.3.4a CT and other toxins of V. cholerae 0139 
Strains of V cholerae belonging to serogroup 0139 are a group of CT- 
producing bacteria which first emerged in India and Bangladesh in 1992/3. To date, 13 strains 
of V cholerae 0139 have been referred to the LEP, and these strains were all CT-probe- 
positive, ST-probe-negative and positive in the VET-RPLA and GMI-ELISA. These strains 
also produced a true rounding effect on Y1 cells (CT titres of 1/160 were found in the I day 
test), which could be neutralised by antibodies raised to CT. However, the neutralisation was 
incomplete (ie; a titre of 1/160 could be reduced to 1/20) and if the cell test was continued for 
4 days (when the cytotonic effect of the CT is reversed) the presence of a cytotoxin was also 
detected (cytotoxic titres were also in the order of 1/160). It was thought that the cytotoxin 
produced by strains of V cholerae 0139 differed from the cytotoxin of other V cholerae non- 
01 examined because it does not appear to mask the CT effect. 
The CT genes of V cholerae 0139 strains were also exwnined by Southern blot 
and hybridisation with CT and GMI probes, as described above (3.3.4). The DNA preparations 
were digested with HindIll and also with BgIlI, Xbal and a combination of BgIlI and Xbal 
(Table 23). For comparison two V cholerae 01, E51116 (classical biotype) and E51165 (EI 
Tor biotype) both originating from Bangladesh, were also investigated. 
The patterns obtained with Hindlll were designated as above (3.3.4, Table 22). 
The patterns observed with Bglll were designated; BI (one band 7 kb), B2 (2 bands of >25 kb 
and 7 kb), B3 (14 kb and 7.8 kb) and B4 (7.8 kb and 7 kb). The patterns observed with Xbal 
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were designated; XI (>25 kb), X2 (10.5 kb), X3 (7.7 and 9.3 kb) and X4 (>25 kb, 7.7 kb and 
9.3 kb). When Xbal and BgIlI were used in combination as recommended by Das et al (Das el 
aL 1993), the result was a complex series of bands ranging from 7 kb to > 25 kb. The fainter, 
higher molecular weight bands, may be partial digest products (Figure 12); the two main 
hybridising fragments, however (7 kb and 7.8 kb) appeared to be identical or similar to the 
bands obtained (pattern B4) when BgRI was used on its own. 
The HindIll digest differentiated the V cholerac 0139 strains from the V 
cholerae 01 strains. The V cholerae 0139 strains all belonged to the H6 pattern (2 
hybridising bands of 25 and 23 kb) with the exception of E89007 which only appeared to have 
the 23 kb band. The V cholerae 01 strains hybridised with bands of 22 kb (E51165) and 22, 
20 and 17 kb (E51116). The results indicate that the 0139 strains and the classical 01 strain 
have at least 2 copies of the CT gene. 
Using Bglll 8 of the 10 V cholerae 0139 strains gave 2 main hybridising bands 
of 7 and 7.8 kb (pattern B4), the exceptions were E87509, which only bad I hybridising band 
at 7 kb (B I) and E87954, which had 2 hybridising bands at 7 kb and >25 kb (B2) (Figure 12). 
in comparison the V cholerae 01 strains, E51116 and E51165, had 2 (7.8 kb and 14 kb) and 1 
(7 kb) hybridising fragments, respectively. The majority of V cholerae 0139 strains, therefore, 
possessed a hybridising band which was identical or similar to the single band (7 kb) found in 
the El Tor strain and a hybridising band identical or similar to one of the hybridising bands (7.8 
kb) found in the classical strain. 
Using Xbal 8 of the 10 V cholerae 0139 strains gave a pattern (M) which 
appeared to be identical to that of V cholerae 01 (classical biotype), the exceptions were 
M045 which appeared to have an extra hybridising fragment at >25 kb, and E87954 which 
only appeared to have one hybridising fragment at >25 kb. 
The variation in the size of hybridising fragment indicates that serogroup 0139 
strains are not strictly clonal in origin, however, there is no evidence to suggest that specific 
clones are associated with certain geographical areas. 
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Figure 12: Southern blot analysis of CT genes 
combined Bglll and Xbal digests of CT positive V. cholerae 
iIi 
16mma 
6m" 
600m# 
XýV 
Lane 1 10 V cholerae 0139; M045, E85943, E86270, E87509, 
E87954, E88131, E89007, E90067, E90070, E90251. 
Lane 11 12 V cholerae 01; E51116, classical biotype (2 bands) 
E51165, El Tor biotype (I band) 
Lane 13 MW markers (kb) 23,9.4,6.5,4.3,2.3,2.0. 
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3.3.5 PCR for CT 
See section 3.7.1. 
3.4 Detection of strains producing heat-stable toxin (NAG-ST) 
3.4.1 Infant Mouse assay 
This assay was used successfully to detect STA produced by strains of 
E. coli and has also been reported for NAG-ST producing V cholerae non-01 (Arita et aL 
1986). The filtrates prepared in section 3.2.1 for reference strains of V cholerae 02 - 040 
were tested in the infant mouse assay (2.3.1c); the intestine weight/body weight ratios obtained 
were all negative (between 0.042 and 0.078), suggesting that ST toxin was not expressed by the 
strains of V cholerae examined. These filtrates had been prepared after growth in TSB 
(following the protocol for E. coll ST). Brain Heart Infusion broth containing 0.5% NaCl was 
also used to growing test strains V cholerae and E. cot! prior to performing the infant mouse 
test. The strain of E. coli was positive for ST toxin in all three media giving ratios of 0.108 
(TSB), 0.116 (BHl) and 0.095 (BHI+0.5% NaCl). The V cholerae non-01 strain (NAG-82E) 
gave indeterminate ratios (there was no obvious fluid accumulation seen) of 0.076 (TSB), 0.078 
(BHI) and 0.080 (BHI+0.5% NaCl). As the use of BI-H+0.5% NaCI did not yield positive 
results with the V cholerae NAG-ST control strain, in this study, it was decided to try a 
different approach. 
3.4.2. DNA probes for detecting strains carrying genes for ST 
3.4.2a SNAP-ST 
The production of NAG-ST by strains of V cholerae non-01 could not be 
demonstrated (3.4.1), however, strains of V. cholerae non-01 could be screened for the 
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presence of the NAG-ST gene. The first probe used was a commercially available SNAP 
(synthetic nucleic acid probe) developed for the detection of E. coli ST (2.3.2f). The reference 
strains of V cholerae belonging to serogroups 02 - 083, the O-rough reference strain, the 
NAG-ST control strain of V cholerae non-01 (NAG-82E), and 89 strains of V cholerae non- 
01 (44 from human and 45 from environmental sources) were tested with the SNAP-ST probe. 
None of the strains of V cholerae examined, gave a positive reaction with the SNAP-ST test 
(an ST-positive E. coli strain was positive with this probe). 
3.4.2b Digoxigenin-labelled ST oligonucleotides 
Since the infant mouse and the SNAP-ST tests did not detect strains of V 
cholerae producing ST or carrying genes encoding ST, it was decided to examine additional 
probes to examine strains of V cholerae non-01. Oligonucleotides were synthesised based on 
sequences published by Hoge et al (Hoge et aL 1990) and Ogawa et al (Ogawa. et aL 1990). 
The two oligonucleotides described by these workers were similar in being 23 and 24 bases in 
length respectively, but varied by 4 bases (2.3.2g). Small scale hybridisation experiments 
(quarter membranes, spotted with 8V cholerae non-01, the NAG-ST control strain of V 
cholerae non-01 (NAG-82E) and an ST-positive E. coh) were performed at 50 T, 55 T, 60 
OC and 65 T. 
Hybridisation experiments using the probe described by Hoge et al were not 
satisfactory because the V cholerae NAG-82E control strain was not positive at any of the 
temperatures and the results with other strains of V cholerae non-0 I were difficult to read. In 
contrast, the probe described by Ogawa et al gave a clear, unequivocal positive result at 60 T 
and 65 T (a dark purple colour), and weak positive results at 50 OC and 55 T, with the V 
cholerae NAG-82E control strain. The optimal hybridisation temperature for the Ogawa probe 
was 65 T, this gave clear purple coloured positive reactions without much background colour. 
For all oligonucleotide hybridisations it was essential to obtain good lysis of the V cholerae 
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colonies on the membranes, hence the 20 min lysis described in 2.3.2d, rather than the 10 min 
recommended for E. coli colonies. The maintenance of a high probe concentration (50 ng/ml 
for each 50 cm, 2 membrane) was also important in getting clear results. 
Of 637 strains of V cholerae non-Ol tested 19 (3%) hybridised with the Ogawa 
NAG-ST oligonucleotide. None of II strains of V cholerae non-01, which were previously 
positive for CT, were NAG-ST-positive. All 88 strains of V cholerae 01 (including reference 
strains NCTC 10954/1 and NCTC 8457/5 and control strain E51116) were also NAG-ST probe- 
negative. Of 246 V cholerae non-01 strains from environmental sources 13 (5%) were NAG- 
ST probe-positive, whereas of 391 clinical isolates only 6 (1%) were NAG-ST probe-positive. 
There also appeared to be a correlation with serogroup 014; all 7V cholerae strains belonging 
to the 014 serogroup (4 strains from the environment and 3 strains of human origin) were 
NAG-ST probe-positive. In contrast to the 014 serogroup, NAG-ST probe-positive strains 
were the exception in other serogroups. The other NAG-ST probe-positive strains were: 6 
unidentifiable (0? ) strains, one each of serogroups, 06,018,037,051,058 and an O-rough 
strain (Table 24). 
A total of 60 V mimicus strains was also tested for hybridisation with the 
NAG-ST probe, this comprised 9 reference strains and 51 wild type strains (3 from clinical 
sources and the 48 from environmental sources). Seven (11.7%) V. mimicus strains hybridised 
with the NAG-ST probe, these are listed in Table 24. Of the NAG-ST probe-positive strains, 3 
were reference strains (serogroups 020,0101 and 0 116) and 4 were isolated from prawns, 
with 2 of the isolates originating from India (for the other 2 isolates the country of origin was 
not known). The 3 strains from clinical sources, all were NAG-ST probe-negative (2 strains 
(E63453 and E82245) were unidentifiable (0? ), and I (E54122) belonged to serogroup 020). 
There were also 3V mimicus strains which belonged to serogroup 014, however, in contrast to 
the V cholerae 014 strains, these were NAG-ST probe-negative. 
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3.4.3 Stability of the NAG-ST gene. 
As there were NAG-ST probe-positive and probe-negative representatives from 
the serogroups 06,018,037,051 and 058, the stability of the NAG-ST characteristic was 
investigated. To determine stability of the NAG-ST gene in V cholerae non-01, positive 
representatives of the strains belonging to serogroups 014 (E54931), 037 (E70397) and 058 
(E85071) and probe-negative representatives of 058 (E85055, E85056, E850720) and 037 
(E70398) were tested. Colonies were replicated from spread plates (approximately 100 colonies 
per plate) onto nylon membranes and these were processed as described (2.3.2d), and 
hybridised with the Ogawa NAG-ST probe. No individual colonies were found which varied 
from parent strain with respect to the NAG-ST characteristic. 
3.4.4 Southern blot analysis of the NAG-ST gene. 
Southern hybridisation analysis was used to differentiate the NAG-ST probe- 
positive V. cholerae non-01 strains, by hybridising fragment size. Genomic DNA preparations 
were made by the CTAB method (2.3.4b) and digested with the RE HindIll. The Southern 
blots were hybridised with the NAG-ST oligonucleotide probe of Ogawa et al and found to 
hybridise with a single chromosomal restriction fragment after digestion with HindIII. The size 
of the restriction fragment varied from 2.2 kb to 19 kb (Table 25 and Figure 13). Strains gave 
single bands of different sizes, with the exception of an unidentifiable (0? ) V cholerae strain 
(E47276) that had 2 hybridising fragments (8 kb and 2.3 kb), this strains appears, therefore, to 
have 2 copies of the NAG-ST gene. Further evidence for E47276 possessing 2 gene copies was 
obtained by repeating the digest and Southern blot using a different RE, Pstl; this confirmed 
that there were 2 hybridising fragments present. The size of the hybridising fragment allowed 
the NAG-ST probe-positive strains of V cholerae to be differentiated into 8 groups (Table 25). 
The fragment with the highest molecular weight (19 kb), designated HI, was found in all 
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Table 24: List of NAG-ST gene positive strains of 
V. cholerae non-01 and V. mimicus 
(Including reference strains and control strains). 
Reference No. Serogroup Country of origin Patient details 
diarrhoea/age/sex* 
or 
source of strain 
V. cholerae strains 
E54933 O-rough Italy water 
E54873 06 Italy water 
NAG-82E 014 ? control strain 
E49108 014 Malta D/52/17 
E51711 014 ? prawn 
E51712 014 ? prawn 
E54931 014 Italy water 
E54947 014 Italy water 
E70003 014 Pakistan D/35/M 
E89755 014 India D/23/M 
E52779 018 ? prawn 
E70397 037 ? prawn 
E82290 051 Tunisia D/46/F 
E85071 058 ? water 
563-88 0102 ? reference strain 
E47169 0? ? prawn 
E47276 0? ? prawn 
E51707 0? ? prawn 
E72253 0? Chile water 
E89693 0? Tunisia D/54/F 
E90680 0? Tunisia D/41/M 
V mimicus strains 
10332-62 020 ? reference strain 
559-88 0101 ? reference strain 
980-78 0116 ? reference strain 
E57204 0? ? prawn 
E57205 0? ? prawn 
E57591 0? India prawn 
E76337 0? India prawn 
Patient details; ?= unknown, D= diarrhoea, age = stated in years, M= male, F =female 
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Table 25: Heat-stable enterotoxin (NAG-ST) oligonucleotide 
positive V. cholerae non-01 strains differentiated 
by Southern blot analysis 
Strain Serogroup Southem blot 
NAG8-2E 014 HI (19 kb) 
E49108 014 HI 
E70003 014 HI 
E89755 014 Hl 
E51711 014 HI 
E51712 014 HI 
E54931 014 HI 
E54933 O-rough HI 
E54947 014 HI 
E47169 0? H2 (15 kb) 
ES 1707 0? H2 
E72253 0? H3 (10 kb) 
E52779 018 H4 (5 kb) 
E54873 06 H5 (3.4 kb) 
E90680 0? H5 
E70397 037 H6 (2.3 kb) 
E82290 051 H6 
E89693 0? H6 
E85071 058 H7 (2.1 kb) 
E47276 0? H8 (8 kb and 2.2 kb) 
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Figure 13: HindIll restriction digest of V. cholerae non-01, 
fragments hybridising with NAG-ST (Ogawa) oligonucleotide: 
a diagrammatic representation. 
HI H2 H3 H4 H5 H6 H7 H8 MW (kb) 
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strains of serogroup 014, including the NAG-82E control strain, and an O-rough strain. 
This 
O-rough strain may have derived from an 014 strain as the HI pattern was otherwise exclusive 
to serogroup 014. The III pattern was found regardless of source or geographical origin, 
indicating that the V cholerae 014 serogroup is a single clone. The other V cholerae non-01 
strains belonged to Southern blot patterns as shown in Table 25, these patterns did not appear to 
coffelate with serogroup. 
3.5 Detection of strains producing Vero-cytotoxin 
3.5.1 Tissue culture (Vero cell) assays for VT. 
Toxins expressed by strains of V cholerae non-01 affect Vero cell monolayers, 
in two ways (see also section 3.2.1 a). Firstly, the toxin(s) can have a cytotoxic effect, resulting 
in the detachment of the entire monolayer of Vero cells, or they can cause a vacuolation effect 
(3.2.1 a, figure 6). Vero cells have principally been used to detect VT produced by strains of E. 
coli (VTEC) and the production of a VT-like toxin by V. cholerae non-01 has been reported 
(O'Brien et aL 1984). However, the cytotoxic effect observed on Vero cells in this study was 
not neutralised by antibodies to VT. 
3.5.2 DNA probes for detecting genes encoding VT. 
Although VT production could not be detected on Vero cells, 150 strains of V 
cholerae non-01 and 10 strains of V mimicus were examined for the presence of VT genes 
using a combined VTI and VT2 polynucleotide probe (2.3.2b). None of the strains tested 
hybridised with the VTI+2 probe. 
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3.6 Ability of strains to produce Haemolysin 
Strains of V cholerae and V mimicus were examined for the ability to lyse red 
blood cells using agar plates containing 1% horse blood, a strain was considered as haemolytic 
when a readily observable zone of haernolysis was present around bacterial colonies. 
Haemolysis of red blood cells other than those from horse, calf, sheep, human and rat, were 
tested using a microtitre method. All the strains used in this study (Appendix 2) were tested on 
horse blood agar. Of the strains of V cholerae non-01 and V. mimicus tested, 90% of both 
species were haemolytic on horse blood agar. Haemolytic strains generally produced B- 
haemolysis (complete lysis, clearing, on horse blood agar), with zone sizes varying from >5 
mm to <I mm. Many strains also produced cc-haemolysis (greening on horse blood agar) and 
a possible third haemolysin was observed with 5% of strains, with haemolysis appearing as a 
double zone. 
Haemolysins are heat-labile toxins which are secreted by strains of V cholerae 
and V mimicus and can be detected in culture filtrates prepared as previously described from 
organisms grown in Syncase sucrose broth (2.3.1a). Fifty strains of V cholerae non-01 were 
examined for the quantitative expression of a haemolysin active on rat rbcs, using a microtitre 
method. Volumes of culture filtrate (50 gl) were diluted, by doubling dilution in saline, in a 
96-well tissue culture plate. An equal volume of 1% washed rbcs was added to each well and 
the plate was incubated at 37 T for Ih and then at 4T overnight. The titre was measured by 
noting the lowest dilution at which haemolysis was present. In the microtitre system if 
haemolysin was produced there was no cell pellet and the well was a red/brown colour due to 
the release of haemoglobin from the ruptured cells; if there was no haemolysin production the 
intact rbcs formed a tight pellet and the colour of the liquid in the well was clear to pale orange 
(Figure 14). Titres ranged from 1/32 to 1/128 and five strains were negative for haemolysis on 
rat blood, even though all but one of these strains were all B-haemolytic on horse blood agar 
plates. The culture filtrates of these strains were also tested in YI tissue culture cells and there 
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was no apparent correlation of haemolysin with cytotoxic effects 
in cell tests. It was found that 
strains which did not express a haemolysin produced a cytotoxin causing a ghosting effect on 
YI cells, whilst culture filtrates, prepared from strains producing haemolysin, did not affect the 
appearance of Yl cells. 
The ability of 8 B-haemolytic strains of V cholerae, belonging to serogroups 
associated with clinical disease (02,05,034 and 037), to lyse rbcs from other animals, was 
further investigated. The 8 strains were; E38820 (02), E54117 (05), E60150 (034), E54418 
(037) and the reference strains for these serogroups NCTC 4711 (02), B4202-64 (05), 152-68 
(034) and 1322-69 (037). Rat, guinea pig, calf, sheep and a human rbc's were tested using the 
rnicrotitre method. All strains tested produced the highest titre of haernolysin with rat rbcs, 
with decreasing titres with guinea pig, followed by human and then bovine and then sheep. 
The reference strain of V cholerae for serogroup 034 did not produce detectable haemolysis 
with calf or sheep rbcs. These same strains were used to investigate whether haernolysin 
produced by V cholerae non-01 was iron-regulated (see 3.6.2). 
3.6.1 Purification of haemolysin produced by V. choterae 02. 
The reference strain of V cholerae for serogroup 02 (NCTC 4711) was used to 
determine optimum growth conditions for the production of haemolysin, with the aim of 
purifying and raising antiserum to this haemolysin. It was envisaged that the antiserum could 
be used to investigate the haemolysin(s) produced by other V cholerae non-01 and the closely 
related V mimicus. An antiserum would also be useful in elucidating the relationship, if any, 
between haemolysin(s) and cytotoxin(s). 
To determine optimal growth conditions for haernolysin production 
V cholerae 02 (NCTC 4711) was grown in Syncase sucrose broth (S SB) at 30 *C and 37T 
(both static and with aeration). The culture filtrates were tested in the microtitre system with 
1% rat blood, as described above (3.6). The highest titre (1/64) was obtained at 37 T, with 
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aeration. V cholerae 02 (NCTC 4711) was also grown in different growth media at 
37 'C, 
with aeration, these growth media were; Trypticase soy broth (TSB), Brain 
heart infusion broth 
(BIB), Nutrient broth (NB), Tris succinate medium (TS) and SSB containing I mg/ml desferal. 
Since the expression of certain haernolysins is regulated by the availability of iron, Tris 
succinate medium (TS) and SSB containing I mg/ml desferal were also used (see also sections 
3.6.2 and 3.12). Haemolysin production was reduced to levels below detection when V 
cholerae 02 was grown in SSB +I mg/mI desferal. Culture filtrates from TSB and BHI both 
had haemolytic titres of 1/16, filtrates from SSB and TS medium both had haemolytic titres of 
1/64 and filtrates from NB gave the highest haemolytic titre at 1/128. Haemolysin production 
appeared to be inoculum dependent; haemolytic titres were increased at least two-fold if a 
starter culture (an overnight PW) was used and diluted 1/10 in fresh NB and the strain grown at 
37 OC with aeration for 6-8h. The haemolytic titre in relation to the growth curve of V 
cholerae 02 is shown in Figure 15.20 mls NB was inoculated with 2 mls of starter culture, 
0.5 mls samples were removed every hour and the OD62, taken as a measure of cell density, the 
sample was centrifuged and filtered through a 0.2 gm Millipore filter and tested for haemolytic 
activity in microtitre with 1% rat rbcs (Table 26). The haemolysin peak occurred at 5-6h, 
followed by a decline in detectable haemolysin coinciding with the end of the log phase of 
growth. The loss of haemolytic activity may be due to the release of proteases and other 
enzymes as cell death occurs (Figure 15). 
The optimal conditions described above, 2 mls of starter culture in 20 mls NB 
at 37 T with aeration for 6 h, were used to produce a culture filtrate for toxin purification. 
Haemolysin was partially purified using by passing the crude toxin preparation through a 
chromatography column containing Sephadex. G200. Eluted toxin was detected using 1% rat 
blood in a microtitre assay, and the positive fractions (25,26,27 and 28; wells A2-A5 in 
Figure 14) were pooled and Iyophilised. The procedure was repeated to obtain at least three 
batches of Iyophilised partially purified haemolysin. An antiserurn was prepared to the crude 
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Table 26: Production of haemolysin by V. cholerae 02; 
relation to the growth curve. 
Time (h) 
1 2 3 4 5 6 7 8 10 12 
OD621 0.25 0.35 1.15 2.45 3.00 3.45 4.00 3.55 3.55 3.40 
Haemolytic 
titre 224 32 512 256 64 800 
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Figure 15: Production of haemolysin by V. cholerae 02; 
relation to growth curve. 
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toxin using a New Zealand White rabbit (animal work was performed under Home Office 
licence PPL 70/03323). One of the three batches of toxin preparation was dissolved in 0.25 
mls distilled water and mixed with 0.25 mls Freund's complete adjuvant, emulsified with brief 
sonication. The first 0.5 mls injection was administered intra-dermally, followed 20 days later 
by two 0.25 mls intra-muscularly, on day 31 a test bleed was taken. A pre-bleed and the test 
bleed were tested for the presence of neutralising antibody (25 RI antiserum double diluted in 
saline in a microtitre plate was incubated with 25 RI of filtrate for 3h at 37 T, then 50 RI 1% 
rat blood was added). As expected the pre-bleed serum did not neutralise haemolysis, however 
the test bleed serum also had no effect on haemolysis. The rabbit was boosted with toxin 
preparation in 0.5 mls distilled water intra-venously on day 33 and a second test bleed taken on 
day 45, the serum from this test bleed also showed that no antibodies had been raised against 
the haemolysin. A final 0.5 mis intra-venous injection was given and a test bleed taken on day 
67, unfortunately this too was negative for antibodies to haemolysin and the experiment was 
terminated on day 77. 
3.6.2 The role of iron in the regulation of expression of V. cholerae haemolysin 
Expression of haernolysins by certain strains of, for example, E. coli has 
been shown to be iron-regulated. In this section of the study, the role of iron in the ability of 
different serogroups of V cholerae to produce haemolysin was examined (see also 3.12). Eight 
B-haemolytic strains of V cholerae belonging to serogroups associated with clinical disease 
(02,05,034 and 037) which were examined (section 3.6) for haemolysis on different rbcs, 
were also used for these experiments. Test strains, E38820 (02), E54117 (05); E60150 (034), 
E54418 (036) and the reference strains for these serogroups were grown in SSB +I mg/ ml 
desferal and in Tris succinate medium. Strains grew poorly or not at all in the presence of 
desferal; in contrast bacteria grew comparatively well in Tris succinate and this medium was 
used to provide iron limited conditions for subsequent experiments. Bacteria were grown in 
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Tris succinate medium and siderophores detected as described (2.3.8). Although strains of V 
cholerae non-01 grew in Tris-succinate medium, these bacteria grew particularly well in the 
presence of added iron (5 ýtg FeC'3'ml) at 37 *C with aeration. Growth in Tris-succinate 
medium resulted in the expression of the siderophore enterochelin; however, under these culture 
conditions haemolysin was not produced. When the same strains were grown statically in Tris- 
succinate medium with added iron (5 gg/ml FeClA enterochelin was not produced but 
haemolysin was detected. An exception to this was V cholerae strains E38820 and E54117 
which produced both enterochelin and haernolysin (Table 27). Reference strain 1322-69 (037), 
a CT probe-positive strain, did not grow, and reference strain 152-68 (034) grew very poorly in 
Tris-succinate medium, even with the addition of FeCl3, and it was not possible to detect 
haemolysin production (or enterochelin for the 037 strain) under these conditions. Both strains 
produced haemolysin under optimal conditions. Based on these results production of 
haemolysin appears not to be iron regulated. 
3.7 Polymerase chain reaction (PCR) 
PCR was used for the detection of the cholera toxin gene, clxB, and for the 
detection and differentiation of the toxin co-regulated pilus gene, tcpA. 
The PCR for ctxB was used with CT-probe-positive strains, to determine 
whether the CT gene could be differentiated by CT-PCR and with CT-probe-negative, GMI- 
ELISA-positive strains, to determine if gene sequences similar to CTB could be detected by 
these primers. The strains examined by ctxB PCR were 22 CT-probe -positive V cholerae non- 
01 (Table 28), 12 CT-probe-negative, but GMI-ELISA-positive strains (of which 3 are 
included in Table 28,8457/5 (01), E54418 (037) and 1154-74 (049)) and the only CT-probe- 
positive V mimicus (reference strain 0 115). 
The PCR for tcpA has been used to differentiate the tcpA of the 2 biotypes of 
V cholerae 01 (El Tor and classical), in this study the PCR for tcpA was used to determine if 
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Table 27: Enterochelin and haemolysin production (titre/OD62, ) 
for strains of V. cholerae non-01 
Ref. No. Serogroup shaken/unshaken enterochelin titre haemolysin titre 
OD621 OD621 
NCTC 4711 02 s 0.015 
u - 25.8 
E38820 02 s 0.016 
u 0.040 7.55 
B4202-64 05 s 0.027 
u - 29.63 
E54117 05 s 0.033 
u 0.027 5.41 
152-68 034 s 0.031 
u 0.007 
E60150 034 s 0.085 
u 0.076 2.17 
1322-69 037 s ND ND 
u ND ND 
E54418 037 s 0.042 
u 0.037 40.00 
* 152-68 (034) grew poorly and no haemolysin was detected. 
ND = not done, because 1322-69 (037) did not grow in this medium. 
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tcpA sequences were present in all CT-probe-positive V cholerae non-01 and if these 
sequences could be differentiated. The strains used for the tcpA PCR were; 34 V cholerae 
non-01,22 of which were CT-probe positive, and 3V cholerae 01 strains of which 8 were 
CT-probe positive. The strains were selected because they were CT-probe-positive or because 
they were CT-probe-negative strains representatives belonging to the same serogroups (Table 
28). There were 3 CT-probe-negative, GMI-ELISA-positive strains; 8457/5 (01), E54418 
(037) and 1154-74 (049). The CT-probe-positive V mimicus was also examined by the PCR 
for tcpA. For all PCR assays the annealing temperature was 55 T and the procedure was that 
described in section 2.3.3. The expected sizes of the amplified fragments were 460 bp for ctxB 
and 617 bp and 471 bp for tcpA (classical and El Tor, respectively). The three sets of primers 
(2.3.3) were not used simultaneously in the same reaction, because it was difficult to distinguish 
the 460 bp ctxB and the 471 bp El Tor tcpA amplicons which comigrate during electrophoresis. 
3.7.1 PCR for CT 
The cIxB PCR confirmed the probe results for all V cholerae strains (Table 
28); all CT-probe-positive V cholerae, regardless of serogroup gave the expected amplicon of 
460 bp (Figure 16, lanes 6- 8). The 12 CT-probe-negative, but GMI-ELISA-positive strains 
and the CT-probe-positive V mimicus (reference strain 0115) were negative in the PCR assay 
for ctxB, that is no detectable fragments were amplified. The CT gene sequence for V mimicus 
must differ sufficiently from those of V cholerae CT to render V mimicus CT undetectable in 
this PCR. 
3.7.2 PCR for TCP 
The PCR for tcpA exploits the sequence difference between the tcpA of the El 
Tor and classical biotypes of V cholerae 01. It was confirmed that the tcpA genes of biotypes 
El Tor and classical, of the 01 serogroup, were differentiated in the PCF, by amplicon size 
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(Figure 16, lanes I and 2). The V cholerae non-01 strains could similarly be differentiated in 
this PCR by type of tcpA into two groups (Figure 16, lanes 3 and 4). The fragment amplified 
was identical to the tcpA generated from either biotype El Tor or classical. The apparent 
doublet band produced by the reference strain 0139 (Figure 16, lane 3) may be due to 
overloading of the gel. The CT-negative strains did not react in the tcpA PCR (Table 28). 
Serogroups 023,037 and a rough strain possessed a tcpA identical to the tcpA of classical 
strains, whereas serogroups 06,0139 and two strains with untypable 0 antigens possessed a 
tcpA identical to El Tor tcpA (Table 28). Only one ctxB positive strain, WBDV-IOIE, 
belonging to serogroup 049 was negative for tcpA by PCR. This strain may either have lost 
the gene for tqpA or it may possess a novel tcpA which is sufficiently different from the El Tor 
and classical tcpA to render it undetectable by the primers used in this PCR. The V mimicus 
(0 1 IS) strain was negative for tcpA, as it was for ctxB, by PCR, indicating that this strain 
possesses ctxB and possibly, 1qpA, sufficiently different from the V cholerae genes to render 
the genes undetectable by the primers used in these PCR assays. All TCP positive strains 
possessed either El Tor or classical type TCP, therefore, CT-positive V cholerae can be divided 
into two groups by type of TCP regardless of serogroup (Table 28). 
3.8 Adhesion 
The ability of bacteria to adhere to host tissues is a recognised pathogenic 
mechanism, and the use of cultured cell lines, such as HEp-2, have been useful for studying 
bacterial adhesion in vitro. Recently, it has been suggested that pathogenic V cholerae non-01 
could be distinguished from non-pathogenic strains by adhesion on the Caco2 cell line 
(Panigrahi et aL 1990). In the present study, both tissue culture cell lines were used to test 4 
strains of V cholerae non-01; ST-positive strain NAG-82E (014), an environmental strain 
isolated from cockles E52369 (0? ) and two clinical isolates E65313 (02) and E63807 (014). 
161 
Table 28: Characterisation of V. cholerae strains: 
hybridisation with CT probe and PCR results for ctxB and tcpA 
Strain Source' Country Sero- Probe PCR 
group CT CtXB tCPAb 
10954/1 R ? 01 Ogawa + + E 
8457/5 R ? 01 Inaba 
E51116 ? Bangladesh 01 Ogawa + + C 
E46949 D India 06 
E48065 D Sri Lanka 06 
E58892 S Malaysia 06 
N2 W Australia 06 + + E 
N87 W Australia 06 + + E 
317-71 R ? 023 
N7 W Australia 023 + + C 
N9 W Australia 023 + + C 
N92 W Australia 023 + + C 
1322-69 R ? 037 + + C 
E54380 D India 037 
E54381 D Tunisia 037 
E54418 D Tunisia 037 
1154-74 R ? 049 
E58864 S S. E. Asia 049 
WBDV-IO IE 7 ? 049 + + 
E73467 D India 049 
E85943 D ? 0139 + + E 
E86270 D Bangladesh 0139 + + E 
E87509 D India 0139 + + E 
M045 R ? 0139 + + E 
E87954 D India 0139 + + E 
E88131 D India 0139 + + E 
E89007 D India 0139 + + E 
E90067 D Pakistan 0139 + + E 
E90070 D Pakistan 0139 + + E 
E90158 D ? 0139 + + E 
E90159 D ? 0139 + + E 
E90251 D Thailand 0139 + + E 
E55413 D Egypt 0? 
E55879 D Egypt 0? + + E 
E66371 D Tunisia 0? + + E 
E66824 D Tunisia 0? 
CA385 R 9 O-rough + + C 
R reference strain; W strain isolated from water; ?= source or country unknown; D strain isolated from a case of diarrhoea; S= strain isolated from shellfish 
tcpA PCR results recorded as: C, 617 bp amplicon identical to tcpA of the classical biotype; 
E, 471 bp amplicon identical to tcpA of the El Tor biotype; -, negative, no amplicons detected. 
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Figure 16: Differentiation of V. cholerae tcpA genes by multiplex 
PCR and detection of ctxB genes. 
bp 
617 
471 0 
Lanes I-4 IcpA PCR (1) E51116 01 classical, (2) E51165 01 El Tor, (3) M045 0139, (4) 1322-69 037 
Lanes 6-8 cIxB PCR (6) E51116, (7) M045 0139 (8) 1322-69 037 
MW markers (bp), 1114,900,692, (500,489), 404,320,242,190,147,110,67. 
Negative control, sterile glass distilled water (lane 9). 
1 
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Suspensions of bacteria (approximately 10" bacteria/ml) grown on CFAB agar and strains grown 
statically in peptone water with and without mannose (overnight, 37 'C) were used. The 
procedure was performed as described in section (2.3.6a). These strains were also tested for 
haernagglutination using calf, guinea pig, human and rat rbcs. (2.3.6b). The different growth 
conditions did not have obvious effects on the results of adhesion tests; however, the presence 
of mannose did affect the haernagglutination of rbcs. It was found that both the HEp-2 and 
Caco2 adhesion tests were best performed as 3 h, rather than the conventional 6h test 
standardly used for strains of E. coli, since V cholerae were found to be cytotoxic for these 
cell lines. The results are shown in Table 29. All 4 strains showed MS haernagglutination on 
guinea pig rbcs and MR haernagglutination on human rbcs, 3 of the strains were negative on 
calf rbcs and MR on rat rbcs, only the NAG-82E strain was negative on rat and MR on calf 
All 4 strains were adherent to both cell lines. The adhesion tests were repeated in the presence 
of sugars other than mannose; no inhibition of adhesion due to mannose, fucose or rhamnose 
was found. 
Forty-four strains of V cholerae non-01 from both environmental and human 
sources, including the 4 strains used previously, were grown statically in peptone water and 
tested in Caco2 and HEp-2 assays and for haernagglutination (in the presence and absence of 
mannose). All 44 strains adhered avidly to both cell lines except for CA385, the O-rough 
reference strain (Figure 17). As none of the other strains tested were O-rough strains, there was 
the possibility that the possession of smooth LPS was necessary for adhesion. To investigate 
the role of LPS further, 12 wild-type O-rough strains were tested on both cell lines; all 12 were 
positive, indicating that smooth LPS is not a requirement for adhesion. 
In addition to the wild-type strains of V cholerae, the reference strains 02 to 
083 were also tested for adhesion on HEp-2 cells only and for haernagglutination. All strains 
except for those belonging to serogroups 033 (151-68) and 036 (1321-69) were positive for 
adhesion. The haernagglutination did not appear to correlate with adhesion tests; although the 
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O-rough reference strain (CA385) was negative for both haernagglutination and adhesion, the 
033 and 036 reference strains both gave haernagglutination in the absence of adhesion. Other 
strains were positive in the adhesion tests but negative for hacmagglutination. Due to the avid 
nature of the adherence observed with V cholerae non-01 strains, it was difficult to attribute 
any pattern such as localised, diffuse or aggregative (as assigned for E. coli strains). No 
differences were found between environmental and diarrhoea associated strains. Adhesion was 
not specific as positive strains attached to both cell lines and glass only; the bacteria would 
attach to glass coverslips in the absence of tissue culture cells, in a time course experiment 
bacteria were found to attach to glass only in 5 min, increasing to give full attachment by 90 
min. 
As it has been postulated that motility (97% of the strains in this study were 
motile) and, therefore, the possession of flagella might be involved in adhesion of V cholerae 
to host cells. The role of motility was examined using 23 non-motile strains of V cholerae 
non-01 and 1 strain O-rough strain of V cholerae, CA385 (0-rough). One strain of non-motile 
Emimicus was also tested in HEp-2 adhesion tests. All strains, except V cholerae strain 
CA385, were positive, indicating that motility is not a requirement for adhesion. 
3.8.1 Transmission electron microscopy (TEM). 
TEM (described in 2.3.6 d) was used to examine 4V cholerae strains for the 
presence of pili and flagella. The strains used were a non-adhesive CA385 (0-rough reference 
strain) and 3 strains positive in the adhesion test, E60544 (0-rough), E55879 (0? ) and 334-72 
(026 reference strain). Flagella were not observed on the adhesion-negative, non-motile 0- 
rough strain (CA385); however, flagella were observed on all 3 strains positive in the adhesion 
test. Pili were not seen on any of the bacteria examined. 
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Figure 17: Adhesion of V. cholerae non-01 on 
HEp-2 and Caco2 cell lines. 
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(ii) Adhesion on HEp-2 cells 
(iv) Adhesion on Caco2 cells (iii) Normal Caco2 cell monolayer 
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3.9 Plasmid analysis 
Although plasmids appear to be uncommon among V cholerae, multiple drug 
resistance encoded by high molecular weight conjugative plasmids has been reported and in V 
cholerae non-01 the carriage of the gene for the thermostable direct haernolysin (tdh) is linked 
to the possession of a large 33 kb plasmid. Plasmid DNA was extracted using a 
phenoVchlorofonn extraction method and an alkaline lysis method (described 2.3.5). 
A total of 38 strains, 36 V cholerae non-01 and 2V mimicus, wcre testcd 
using both methods to extract plasmid DNA. As both methods seemed to give the same result 
the method of Kado & Liu, which was simpler to perform, was preferred. Only 6 of the 38 
strains tested possessed plasmid DNA, and three of these were strains isolated from the same 
patient from a wound (ES5414, E55415 and E55416 (0? ); two plasmids of 5.0 and 4.6 Mda). 
The other three strains carrying plasmids were: the CT-probe-positive 037 reference strain 
(1322-69) carrying a 26 Mda plasmid; a strain belonging to presumptive serogroup 5609 
isolated from prawn (E47270) carrying a 4.2 Mda plasmid; and an unidentifiable (0? ) clinical 
isolate from a patient with diarrhoea (E56566) carrying three plasmids of 5.2,3.7 and 3.0 Mda. 
All, except the 26 Mda plasmid of strain 1322-69, were small cryptic plasmids (of 
approximately 5 Mda or less) and all were of unknown significance. The plasmids did not 
appear to be linked to drug-resistance; the strains E55414-6 and E56566 were sensitive to all 
drugs tested and 1322-69 and E47270 were both resistant to kanamycin only. Plasmids were 
not detected in the 2V mimicus strains tested. 
3.10 Protein analysis 
3.10.1 Whole cell protein profiles 
Whole cell protein profile analysis (described in 2.3.9a) was used to examine 
strains of serogroup "026". The 026 serogroup was at one time the largest non-01 serogroup, 
with over 40 strains assigned as 026 by serogrouping, but when these strains were examined by 
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Figure 18: Whole cell protein profiles of V. cholerae "026" strains 
334-72, E57025 and E55414, stained for protein, LPS and 
radio-immunoblotted with antiserum raised against 334-72. 
coomassie blue stain (2) silver stain 
for protein for LPS 
The radio-immunoblot only reacts with the four "paired" bands of 334-72 
(026 reference strain) which are darkly stained with silver stain. 
(3) immunoblot 
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whole cell protein profiles and by LPS analysis (see below) the strains showed marked 
heterogeneity. V cholerae strains 334-72, E55414 and E57025 were also examined by whole 
cell protein profile analysis using SDS-polyacrylamide gel electrophoresis. Whole cell profiles 
were run in triplicate, and a third of the get was stained with coomassie brilliant blue (for 
protein bands), a third with silver stain (for LPS) and a third was used for immunoblot analysis. 
The gel was blotted onto nitrocellulose and reacted with antiserum raised against the 026 
reference strain (334-72), after washing, antibody binding was detected using an anti-rabbit IgG 
immunoglobutin conjugated with radioactive iodine (this procedure was carried out with 
assistance from Henrik Chart, LEP). As shown in Figure 18, only the 4 paired LPS bands 
shown by strain 334-72 reacted on immunoblot, even though the other two strains were 026 
positive by standard serogrouping methods. 
3.10.2 Outer membrane protein (OMP) 
The outer membranes of vibrios contain several proteins (OMPs) which are 
strongly antigenic, V cholerae 01 possess 4 different OMP in the 25 - 45 kda range. Outer 
membrane proteins were examined for strains of V cholerae non-01. Outer membranes were 
isolated from 12 reference strains of V cholerae with 0-groups: O-rough (CA385), 01 
(E51116), 02 (NCTC 4711), 044 (112-73), 025 (14821-62), 027 (10432-62), 053 (1157-74), 
056 (475-75), 062 (1-76), 078 (27-76) and 2V mimicus strains 020 (317-71) and 071 (162- 
78). These were examined by SDS-PAGE using 12.5% separation gels (2.3.9b). Among these 
12 strains there were 7 different OMP profiles designated by the size of the major OMP (Figure 
19). Six strains belonged to profile OMPI, and the other 6 strains belonged to profiles OMP2 - 
OMP7 (Table 30). The most common major OMP (approximately 38 kda) was found in 8 
strains; V cholerae 01,0-rough, 044,053,056,062 and in V mimicus 020 and 
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Table 30: Outer membrane protein profiles of 
V. cholerae and V. mimicus. 
ReE N'- Serogron OMP prorile 
V cholerae CA385 O-rough OMP 1 (38 kda) 
E51116 01 OMPI 
NCTC 4711 02 OMP6 (no major OMP) 
112-73 044 OMP2 (40 and 38 kda) 
14821-62 025 OMP4 (3 5 kda) 
10432-62 027 OMP7 (no major OMP) 
1157-74 053 OMPI 
475-75 056 OMPI 
1-76 062 OMPI 
27-76 078 OMP5 (36 kda) 
V mimicus 317-71 020 OMP3 (38 and 37 kda) 
162-78 071 OMPI 
172 
V. mimicus 071. V cholerae 044 and V mimicus 020 differed from the other 6 strains 
because they both had two major OMP bands, in addition to the 38 kda band. V cholerae 044 
had a second major OMP at approximately 40 kda (OMP2) and V mimicus 020 had a second 
major OMP at approximately 37 kda (OMP3). V cholerae 025 and 078 had 1 OMP each at 
approximately 35 kda and 36 kda, respectively. The most unusual strains were V cholerae 02 
and 027, which did not appear to possess major OMP but were designated different OMP 
profiles by their minor OMP patterns. There appears to be considerable diversity in OMP of V 
cholerae and V mimicus, with the majority having a major OMP at around 38 kda. 
3.11 Lipopolysaccharide (LPS) 
The LPS of V cholerae 01 and 0139 are important protective antigens and 
considered virulence factors. The results presented in the section on scrogrouping (3.1.3) 
indicate the association of certain non-01 and non-0139 serogroups, such as 02, and 05, with 
diarrhoeal disease. A sensitive silver staining method was used for detecting LPS in SDS- 
polyacrylamidc gels, as described in 2.3-7. 
SDS-PAGE analysis of the lipopolysaccharide of V cholerae non-01 has 
proved a useful technique for confinning outbreaks of otherwise untypable strains and for 
clarifying problems with identification of serogroups, such as 026. Several serogroups showed 
marked heterogeneity, rather than identity of LPS on silver stained SDS-polyacrylamide gels. 
On further investigation several new serogroups were identified and antisera raised to these 
presumptive serogroups (eg: presumptive serogroup 5609, which arose from the 026 
investigation). It was also of interest that certain serogroups, in particular 01 and 0139, 
proved particularly difficult to analyse by this technique; instead of the expected sequence of 
bands a smear was observed, which may possibly due to capsular material. Rough strains also 
did not give any banding but, the appearance was clear not smeared, with a very darkly staining 
area at the end the gel lane. In general the LPS of V cholerae and V mimicus was identical 
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within serogroups, the patterns obtained had an atypical appearance in that they were 
irregular, 
the LPS bands of organisms such as E. coli give regular "ladder" structured LPS (Figure 20). 
Serogroups gave different patterns, the 0? strains in Figure 20 were all distinct from each other 
indicating that they belong to different serogroups. Strains belonging to the same serogroup, 
such as 014 (Figure 20 lanes 4 to 7) gave identical reproducible, LPS profiles. Serogroups 
02, 
05,06,08,010,011,014 and 037 were tested and all were identical within respective 
serogroups. In contrast certain serogroups 013,024,026 and 069 were heterogeneous and 
therefore were investigated further (3.11.2). 
3.11.1 Analysis of strains which were unidentifiable (0? ). 
Selected strains which were unidentifiable (0? ) with antisera raised against 
serogroups 01 to 083 and 0139 were examined by LPS analysis, to identify any common 
serogroups. The 2 0? CT probe-positive strains, E55879 and E66371, were shown to have 
different LPS profiles and therefore belonged to different serogroups. CT probe-negative, but 
GMI-ELISA positive 0? strains were also examined to see if they belonged to common 
serogroup(s), but the LPS was heterogeneous in all 20 strains tested and no obvious common 
groups were found. 
Strains originating from family outbreaks (section 3.1.3, Table 11) were also 
examined; by conventional serogrouping different serogroups were identified in 3 "outbreaks" 
(this was confirmed by LPS analysis), the remaining 2 outbreaks were caused by serogroup 02 
(LPS identity was confirmed on SDS-PAGE) and serogroup 0?. The 3 0? strains in this 
outbreak from Malta appeared indistinguishable by conventional serogrouping, however, the R- 
type result showed that while 2 strains were colomycin and ciprofloxacillin resistant, I strain 
was colomycin and ampicillin resistant. When these three strains were run on an SDS-PAGE 
and silver-stained, the LPS profiles were identical, indicating that the 3 strains probably 
belonged to the same serogroup. 
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The LPS profiles of a group of V mimicus 0? strains were also investigated. 
These 5 strains, 4 from the environment (E40213 from seawater, E5 8894, E64109 and E641 10 
from seafood) and I clinical isolate (E63453, from a patient with diarrhoea, returned from 
Thailand) had the same LPS profile, indicating that they belonged to the same serogroup. 
These same 5 strains were the only V mimicus found to be aerobactin negative (3.12.1). 
3.11.2 Identification of new serogroups of V. cholerae non-01 using SDS-PAGE analysis. 
On further examination of strains belonging to serogroups 013,024,026 and 
069 it was found that the 013 and 024 serogroups could both be split into 2 distinct groups 
(Figure 21 shows the 2 profiles found within the "024" serogoup), and this could be confirmed 
by conventional serology which showed that the cross-reactions could be absorbed out of the 
013 and 024 antisera respectively. The 026 and 069 strains were very heterogeneous groups 
all different from the reference strain (Figure 23 and 22). 
The 069 serogroup was one of the commonest typable O-groups, with isolates 
from mainly environmental, but also human, sources. There were 20 strains found to be 069 
by serology, however, by LPS profile this group was shown to be heterogeneous and none of 
the 19 wild type strains were identical to the reference strain. Although none of the strains 
were identical to the reference strain some wild type strains gave LPS profiles identical to each 
other, these were; (1) E46805 and E46806 both clinical isolates from Thailand, (2) E52349 
(isolated from cockles, country of origin unknown) and E72237 (isolated from a river in Chile) 
and (3) E72241 and E72246 (both from Chilean river water). The LPS profile results were 
confirmed in conventional serology by absorbing the antiserurn with the cross-reacting strains. 
As stated in 3.10.1, above, the 026 serogroup was at one time the largest non- 
01 serogroup, with over 40 strains assigned as 026 by conventional serogrouping. By LPS 
analysis there were more than 8 different LPS profiles. The most common profile (15 strains) 
was identical to E55609, antiserum was raised against E55609 and strains designated as 
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Figure 21: Silver stained SDS-PAGE LPS profiles of 
V. cholerae non-01 identified as serogroup 024 could be divided into 
two separate groups by LPS analysis, the two groups had distinct LPS profiles. 
(1) 14438-62 (024 reference strain) 
(2) E50053 
(3) E54402 
(4) E48223 
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presumptive serogroup 5609, see appendix 2. There was only I wild type strain (E81243) 
which was identical to the 026 reference strain (334-72). The "026" LPS profile results were 
confirmed in conventional serology by absorbing the antiserurn with the cross-reacting strains. 
The remaining strains could not be identified and were assigned as OT 
3.12 Production of siderophores 
Siderophores are low molecular weight, high affinity iron binding compounds 
which form part of an inducible iron uptake system expressed by most aerobic bacteria. 
Although a family of siderophores are recognised, the two major siderophores are the phenolic 
enterobactin (enterochelin) and the hydroxamate aerobactin. Both siderophores bind to 
membrane protein receptors; however, aerobactin is recycled. The role of these chelators in 
bacterial virulence has been well established for certain strains of E. coli. However, although 
strains of V cholerae have been shown to produce a phenolic siderophore, vibriobactin, the role 
of siderophores in the virulence of strains of V cholerae and V mimicus remains to be 
elucidated. In the present study strains of V cholerae non-01 and V mimicus were tested for 
the presence of these iron chelating compounds using the procedures described in section 2.3-8. 
3.12.1 Aerobactin 
The ferric perchlorate test was used for the detection of aerobactin (2.3.8b), 
aerobactin present in culture media binds iron from the ferric perchlorate forming ferric 
aerobactin which has a distinctive red colour. A total of 82 strains of V cholerae and 50 
strains of V mimicus was tested. The V cholerae comprised, 48 V cholerae non-01 clinical 
isolates of which 14 were from extraintestinal sites, 34 V cholerae non-01 from isolated from 
the environment and one V cholerae 01 (E51116). The 50 strains of V mimicus were all from 
environmental sources except for 2 strains isolated from patients with diarrhoeal disease. Strains 
were grown in Tris-succinate medium prior to the ferric perchlorate test. 
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None of the V cholerae strains was positive for aerobactin, however 45/50 
(90%) of the V mimicus produced aerobactin. The 5 aerobactin negative strains were all 0? 
(unidentifiable), but all had the same LPS profile (3.11.1) and therefore belonged to a distinct 
serogroup. 
The ability of bacteria to produce aerobactin has been associated with the ability 
to produce extra-intestinal infections. To examine this using strains of V mimicus, 6 strains 
were tested for lethal dose (LD50) in BALB/C mice (conducted under Home Office licence: 
70/03323). The strains belonged to serogroups 039 (aerobactin positive strain E64754; 
aerobactin negative strains E60392 and E64692) and 014 (aerobactin positive strain E45521 
and aerobactin negative strains E47169 and E63807). Groups of 5 mice were injected inter- 
peritoneally with 0.1 mis of bacterial suspension (10'/ml). The experiment was terminated on 
day 14, with none of the mice showing any adverse reaction. The production of aerobactin by 
V mimicus did not appear to be linked to virulence in mice. 
3.12.2 Enterochelin 
The same strains as used for the aerobactin test were used to examine for the 
production of enterochelin. Strains of V mimicus did not produce the siderophore enterochelin, 
including the 5 strains which did not produce aerobactin. Of the V cholerae strains examined, 
the strain of V cholerae belonging to serogroup 01 produced enterochelin, as did 50/67 (741/6) 
of non-01 strains isolated from the environment (24/33) and from patients with diarrhoea 
(25/34). There was no obvious association of enterochelin production with source of isolate or 
with serogroup. Of the 14 isolates from patients with extraintestinal disease only 3 (21%) 
produced enterochelin. From this limited study, only strains of V mimicus produced 
aerobactin, and enterochelin was produced only by strains of V cholerae. Therefore, these tests 
are discriminatory between strains of V mimicus and V cholerae. 
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DISCUSSION 
4.1 Identification and typing of V. cholerae and V. mimicus. 
Over 1000 strains of V cholerae serogroup non-01 and V mimicus were used 
in this study. These strains were isolated from a range of sources and from 69 different 
countries. The present study found that diarrhoeal disease caused by these organisms in the UK 
was not an indigenous problem but associated with travellers returning ftom abroad. In 
particular, diarrhoeal disease was associated with travel to India, Kenya, Tunisia or Thailand. 
The environmental strains of V cholerae non-01 and V mimicus, used in this study, were 
principally isolated from crustacean shellfish, especially shrimps and prawns, which originated 
from abroad. These initial findings reflect those of previous studies; both V cholerae and V 
mimicus are found to be naturally occurring in aquatic environments, widely distributed 
throughout the world and most cases of diarrhoea occurring in the UK result from travellers 
returning from areas, such as Africa and Asia, where cholera and cholera-like diseases are 
prevalent (Janda et aL 1988; West 1989; Morris 1990). Cases of diarrhoea caused by V 
cholerae non-01 and V mimicus have been associated with a history of consumption of 
seafood, especially oysters and crustaceans (Morris et al. 1981; Wilson et aL 1981). There 
was not an indigenous problem in the UK, despite the presence of V cholerae non-01 in the 
environment (Lee et al. 1982). This may be due to a number of reasons, including, differences 
in cooking and eating habits and under-reporting due to these organisms not being suspected in 
patients who have no history of travel abroad. It may also be that though the organisms are 
present in the UK, the environmental conditions, such as water temperature, may not favour 
proliferation. Previous studies have shown that the colonisation of crustacean shellfish, such as 
crabs, shrimps and lobsters depends on the concentration of bacteria and is observed more 
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frequently at higher ambient temperatures (Davis and Sizemore 1982; Huq et aL 1986). 
Fourteen strains of V cholerae non-01, which were included in the present 
study, were from cases of extraintestinal disease. More than half of these patients with 
extraintestinal illness had a known history of travel abroad. These extraintestinal strains were 
not found to produce CT or heat-stable toxin (NAG-ST). There were no strains of V cholerae 
belonging to serogroup 01 or V mimicus isolated from extraintestinal sites in this study, 
however, previous studies have reported the isolation of V cholerae 01 and V mimicus from 
extraintestinal sites. These studies have also found that where extraintestinal infections have 
occurred, the strains of V cholerae and V mimicus did not produce CT, indicating the 
involvement of other pathogenic factors (Johnston et aL 1983; Saffin et A 1988; Clark el aL 
1989). The factors possessed by strains of V cholerae and V mimicus causing extraintestinal 
infections are still to be elucidated; it may be that these organisms are acting as opportunistic 
pathogens and that host susceptibility plays a major role (Saffin et aL 1988). 
All the strains used in the present study were identified biochemically as V 
cholerae and V mimicus, and characterised by serogroup and biotype, before representative 
strains were selected for further detailed study of virulence attributes. Strains of V cholerae 
and V mimicus were distinguished from other vibrios using the biochemical tests described 
(section 2.2.1). Biochemical differences within V cholerae and V mimicus were very limited 
and they were differentiated primarily by VP (Vogues-Proskauer) and sucrose fermentation. 
Within V cholerae the different serogroups could not be distinguished biochemically, although, 
all strains of V cholerae serogroup 01 fermented mannose and this reaction was variable with 
the non-01 serogroups. 
Neither biotyping nor phage typing, which have been used to differentiate V 
cholerae 01 (Fumiss et aL 1978), were found to be useful in differentiating V. cholerae non- 
01 and V mimicus. Both V cholerae non-01 and V mimicus were, with respect to haemolysin 
production on horse rbc, polymixin sensitivity and for V cholerae non-01 the VP reaction (all 
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strains of V mimicus, were by definition, VP-negative), "El Tor-like". Only 4.4% of V 
cholerae non-01 reacted in the phage-tying scheme, and the phage typing results were 
inconsistent for serogroups other than 01. In a previous study, 14.3% of V cholerae non-Ol 
reacted with the phages (Frost and Rowe 1987), however, only 56 strains were tested, compared 
to the 500 V cholerae non-01 tested in the present study. 
4.1.1 Serogrouping and association of serogroup with virulence factors. 
The single serogrouping scheme based on the O-antigen (Sakazaki and Donovan 
1984) was found to apply to both V cholerae and V mimicus strains. Other vibrio species 
(data not presented) did not react with the antisera raised to reference strains in this study, and 
therefore could not be serogrouped within the scheme. The majority (56%) of V cholerae non- 
01 and V mimicus strains tested were unidentifiable (07) using antisera raised against 01 to 
083 and 0139. An extended serogrouping scheme, incorporating 141 serogroups (01 - 0140) 
has recently been published and this should reduce the number of unidentifiable strains 
(Shimada et aL 1994). Of the identifiable serogroups, 01 and 0139 were found to be exclusive 
to the species V cholerae. The serogroups expressed by V mimkus, were also found in V 
cholerae. The identifiable V. cholerae non-01 and V mimicus strains (30%) were 
differentiated into 59 distinct serogroups using 83 antisera raised against serogroups 02 - 083 
and 0139. Seventy percent of these identifiable strains belonged to only 20 serogroups. Some 
serogroups, 02,05,09,011,013,024,034,037 and 0139, were associated with clinical 
isolates from diarrhoeal disease and serogroup 019 was commonly isolated from the 
environment. Representatives of most serogroups were found from both clinical and 
environmental sources. The most common serogroups of V cholerae associated with diarrhoeal 
disease, excluding 01 and 0139, were serogroups 02 and 09, both serogroups were also 
associated with family outbreaks. Strains belonging to serogroups 02 and 09, although closely 
associated with diarrhoeal disease did not possess toxin genes for CT or NAG-ST, indicating 
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these strains possessed unknown factors which caused diarrhoeal disease. The present study 
suggests that the somatic antigen could be a useful indicator of diarrhoeagenic potential within 
Vcholerae non-01. Other studies have previously suggested the prevalence of the 02,05,07 
and 037 serogroups in gastrointestinal disease and 04 and 08 in the environment (WHO 
Scientific Working Group 1980; Donovan 1984). In a study conducted in the USA, strains of 
V cholerae belonging to serogroup 02, accounted for 43% of the total number of strains of V 
cholerae isolated (Morris et aL 1981). Outbreaks attributable to strains of V cholerae non-01, 
have retrospectively, been linked to serogroups 05 and 037 (Donovan 1984); a food-bome 
outbreak in Czechoslovakia was caused by V cholerae 05 (Aldova, et al. 1968) and a water- 
bome outbreak was caused by a CT-producing V. cholerae 037 (Kamal 1971). 
The 01 and 0139 serogroups of V cholerae produce CT, the main virulence 
factor involved causing the dramatic symptoms of epidemic cholera. V cholerae non-01 and 
V mimicus also cause sporadic cases and occasionally outbreaks of diarrhoeal disease, which 
may be indistinguishable from cholera (Blake et aL 1980), however, as shown in this study they 
rarely produce CT. Therefore, other pathogenic factors are probably involved and these factors 
may also have associations with serogroup. The correlation of NAG-ST with serogroup and 
with V mimicus has been suggested (Pal et aL 1992). In the present study a correlation was 
found between serogroup 014 of V cholerae and NAG-ST. In addition the species V mimicus, 
regardless of serogroup, was associated with two possible virulence factors; the possession of 
the NAG-ST gene and the production of aerobactin, a powerful iron chelator. 
4.1.2 R-tying and plasmid carriage 
Strains of V cholerae non-01 and V mimicus were examined for resistance to 
antibacterial agents, and for plasmid carriage. The presence of plasmids has often been linked 
to both resistance and to the acquisition of virulence factors in other organisms. 
Strains of V cholerae 0139 were consistently found to be resistant to 
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CoSSuTni (colomycin, streptomycin, sulphathiazole and trimethoprim), the same distinctive R- 
type pattern was found in four other strains, all of which were unidentifiable (0? ) strains 
isolated from patients who had recently returned from India. The same R-type pattem was not 
found in other V cholerac or V mimicus or from other parts of the world. CT-positive strains, 
belonging serogroups other than 0139, were also used in this study, but none were found to be 
multiply resistant to antibiotics. There was no apparent correlation of R-type pattern with other 
serogroups. The most common resistance of V cholerae non-01 and V mimicus was to Co 
(80% of strains tested) and the most common R-type pattern was a single resistance to Co 
(56%). 
The multiple resistance of the V cholerae 0139 serogroup is interesting, 
because it is so distinctive. It is possible that the multiple drug resistance and the CT gene 
were somehow acquired to "create" this novel serogroup, which did not appear to be present 
before 1992. In the present study, all unidentifiable (0? ) V cholerae non-01 strains, received 
in the LEP since 1985, were retrospectively examined with antisera raised against 0139 and 
none reacted (Cheasty et al. 1993), indicating that this serogroup had not been found before. 
Indeed, it has been suggested that the 0139 serogroup is derived from aV cholerae 01 biotype 
El Tor, this is supported by, possession of ax and tcpA genes, patterns in multilocus enzyme 
electrophoresis, ribotyping and pulse field gel electrophoresis (Cravioto et aL 1994; Hall et aL 
1993; Calia et aL 1994; Berche et aL 1993; Albert 1994). A recent study suggested probable 
progenitor strains for 0139, which were 01 but neither truly classical nor truly El Tor in their 
biotype attributes (Pajni et aL 1995). The 0139 strains do appear to be related to 01 El Tor, 
however, there are differences which indicate that they are not derived from 01, these include; 
the presence of capsule, the absence of 01 biosynthetic genes, the lack of reaction with the El 
Tor phage and with antiserum raised against the 01 antigen (Johnson et aL 1994; Albert 
1994). The high attack rate in adults, indicating the ineffectiveness of pre-existing immunity 
from 01, also suggests that 0139 is a novel strain (Mandal 1993). The results obtained in the 
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present study using serogrouping, Southern blot analysis of CT genes and PCR of ctxB and 
tcpA, suggest that 0139 is a novel non-0 I serogroup. 
Multiple antibiotic resistance is often linked to plasmid carriage. High 
molecular weight, multiple-antibiotic resistance plasmids are occasionally found in V cholerae 
01. Multiple resistance, encoded by a 100 Mda Inc C conjugative plasmid, has been found in 
V cholerae 01 outbreaks (Threlfall et aL 1980; Threlfall and Rowe 1982) and recently the 
emergence of multiresistant strains of V cholerae 01 has also been reported from Ecuador 
(Threlfall et aL 1993). However, the multiple resistance of V cholerae 0139 strains does not 
appear to be linked to plasmid carriage, as the examination of 0139 strains revealed that only 
the reference strain (M045) carried plasmids (personal communication Dr. J. Threlfall). Other 
V cholerae, non-01 and non-0139, and V mimicus were examined for plasmid carriage in the 
present study (section 3.9). V mimicus did not carry plasmids and only 15% of V cholerae 
strains carried small cryptic plasmids of approximately 5 Mda or less. Only one V cholerae 
non-01 strain carried a larger plasmid, this was the CT-probe-positive 037 reference strain 
(1322-69) which carried a 26 Mda plasmid, of unknown significance. Plasmid carriage in these 
strains did not seem to be linked to drug-resistance nor to pathogenic factors. Previous studies 
have also found that plasmid carriage is infrequent among V cholerae and most plasmids are 
cryptic and of low molecular weight (Janda et al. 1988). Attempts to correlate 
extrachromosomal elements with phenotypic or virulence characteristics have generally been 
unsuccessful (Newland et aL 1984). Although the thermostable direct haemolysin (NAG-rTDH) 
is plasmid-mediated in V cholerae non-01 (Honda et aL 1986). The tdh gene is encoded on a 
large 33 kb plasmid in V cholerae and probably originated from the chromosome of V 
parahaemolyticus (Nishibuchi et aL 1985; Nishibuchi and Kaper 1985). The strains in the 
present study were not examined for TDH, however, of the strains which were examined for 
plasmid carriage none possessed a large 33 kb plasmid. 
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4.2 Pathogenic mechanisms and virulence 
Pathogenicity is the ability to produce disease, and pathogenic bacteria may 
show variation in pathogenicity relating to the virulence of a given organism. A range of 
symptoms has been associated with cases of V cholerae non-01 gastroenteritis, including fever 
and bloody diarrhoea which are encountered only rarely in "typical" cases of cholera. The 
wider range of presenting symptoms seen with V mimicus and V cholerae non-01 as opposed 
to V cholerae 01 infections is probably related to the presence or absence of a number of 
virulence factors. 
4.2.1 Cholem Toxin (CT) 
The characteristic symptoms of clinical cholera result from the action, on the 
gut mucosa, of a single subunit protein toxin, CT. In this study tissue culture cell assays, 
specific DNA probes and immunoassays were used to detect CT. 
The CT genes of V cholerae and V mimicus were detected using 
polynucleotide probes CTA and CTB and an oligonucleotide, probe GMI. The possession of 
the genes for CT correlated with the somatic antigens expressed; 87% of V cholerae 01 and 
100% of V cholerae 0139 carried the CT genes. In contrast, < 1% of V cholerae non-01, 
non-0 139 and V mimicus hybridised with the probes. All CT positive strains possessed the 
genes for both A and B subunits. Previous studies have reported CT production in strains of V 
cholerae non-01 from Bangladesh and India; Datta-Roy (Datta-Roy et aL 1986) found an 
incidence of 26% (9/34) in clinical isolates and 10% (1/10) in environmental isolates. The 
incidence in other parts of the world is lower. A study in Thailand (Hanchalay et aL 1985) 
found none of 44 human isolates and 2% (5/237) of environmental isolates were CT positive. 
In a study of environmental isolates from the Louisiana Gulf coast (Roberts et al. 1982) it was 
found that only 0.3% (7/2500) produced CT. The present study also found a low incidence of 
CT-positive strains (0.25%) in V cholerae non-01, non-0139 (the incidence increases to 2% if 
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0139 strains are included); all CT-positive strains of V cholerae non-01 were clinical isolates 
from cases of diarrhoea and no CT-positive strains were found from environmental sources. 
A polymerase chain reaction was also used to detect the ctxB gene in CT- 
positive strains and to look for ax-related genes in other V cholerae non-01, in particular the 
CT-probe-negative, but GMI-ELISA positive strains (Said et aL 1994; Said et al. 1995). The 
putative toxin produced by these strains may share epitopes with CTB and related gene 
sequences. All CT-probe-negative strains were negative by PCR for axB and therefore did not 
possess related gene sequences. CT-positive Vcholerae non-01 ctxB was identical to the MB 
of V. cholerae 01 strains. A multiplex polymerase chain reaction (PCR) directed against CT 
gene, ctxA, and the TcpA gene, tcpA, has been used to differentiate biotypes of V cholerae 01 
(Keasler and Hall 1993). The CT-positive V cholerae non-01 could be similarly differentiated 
by tcpA PCR (Said et aL 1995). 
The production of CT was demonstrated directly using immunoassays, VET- 
RPLA and ELISA, for all CT-probe positive strains. However, the use of tissue culture assays 
for the detection of CT was limited to V cholerae 01, the reference strain O-rough (CA385), 
which was originally derived from an 01 strain, and the V cholerae 0139. Other V cholerae 
non-01, which were CT-positive, produced a cytotoxin which masked CT production. Even 
when different culture media and different growth conditions were used to optimise conditions 
for the production of CT, the masking effect of the cytotoxin could not be overcome. 
4.2.1a The masking of CT by cytotoxin 
The production of CT in 01 (E51116) and 037 (1322-69) as detected by VET- 
RPLA (section 3.3.3a) gave identical titres. CT and cytotoxin titres were compared in YI cell 
assay, both toxins were heat-labile and first detected soon after the beginning of the log phase 
of growth. However, the CT titre levelled out earlier than the cytotoxin titre, therefore, the 
cytotoxic titre was always greater and able to mask the CT titre in V cholerae 037. Both CT 
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and cytotoxin were exported out of the periplasm (3.3.3b), but CT was present intracellularly 
whereas no intracellular cytotoxin was found, this difference may be due to the way in which 
CT and cytotoxin are exported. The titres of both toxins were also found to decrease after the 
end of the log phase of growth, at this stage the organisms probably stop actively producing 
toxins and the exported toxins begin to break down due to the presence of proteases and other 
enzymes. 
The cytotoxin produced by V cholerae 0139 differed from the cytotoxin of 
other V cholerae non-01 examined, in that it did not mask the CT effect. It may be that V 
cholerae 0139 are producing much larger amounts of CT, or conversely lower amounts of 
cytotoxin, than other V cholerae non-01. 
4.2.1b Southern blot analysis of the CT gene. 
DNA preparations were made of CT-probc-positive strains and the chromosomal 
DNA digested with HindIll. Southern blots were prepared and hybridised with CTA+B 
polynucleotides or GMI oligonucleotide probes. The CT-positive V cholerae strains could be 
differentiated into 7 different patterns by size of hybridising fragment. An eighth pattern 
belonged to the only CT-positive V mimicus (reference strain 523-80, serogroup 0 115) found 
in the present study. A single hybridising band of 22 Kb was found in 6 CT-positive V 
cholerae non-01, belonging to serogroups 06,049 and 0105. This band appeared to be 
similar or identical to the single band of V cholerae 01 El Tor (10954/1). Strains belonging to 
serogroups 0139 and 023 had 2 hybridising fragments and V cholerae 01 classical (E51116) 
had 3 fragments indicating the presence of more than one CT gene in these strains. 
The DNA preparations of V cholerae 0139 were also digested with BgIlI and 
Xbal. When Xbal and BgIII were used in combination as recommended by Das et al (Das et 
al 1993), the result was a complex series of bands ranging from 7 kb to > 25 kb. The fainter, 
higher molecular weight were thought to be partial digest products; there were two main 
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hybridising fragments (7 and 7.8 kb), confirming the HindIII digest result of at least 2 gene 
copies. The V cholerae 0139 were not all identical, and this variation in the size of 
hybridising fragment indicated that serogroup 0139 strains are not strictly clonal in origin. 
However, there was no evidence to suggest that specific clones are associated with certain 
geographical areas. 
Previous studies have shown that the CT operon is situated in the V cholerae 
chromosome and may be present in multiple copies in strains of the classical biotype, but in a 
single copy in most strains (70%) of the El Tor biotype (Moseley and Falkow 1980; Kaper and 
Levine 1981). Another study hybridised HindIll digests with a CTA probe and found that 
classical biotype possessed 2 hybridising fragments, the El Tor biotype from eastern countries I 
fragment and the El Tor biotype from the USA 2 fragments (Cook et aL 1984). Similarly 
Australian V cholerae 01 were found to be genetically diverse and unrelated to strains from 
Singapore, Jakarta and Louisiana (Desmarchelier and Senn 1989). A survey in Louisiana found 
that V cholerae non-01 and V mimicus which hybridised with the CT probe, showed greater 
genetic diversity than the highly conserved USA V cholerae 01 strains (Kaper et al. 1986). 
Based on the toxin gene RFLP and total chromosomal restriction patterns at least two separate 
clusters of V cholerae non-01 were distinguished in the Louisiana study, in addition to a 
distinct cluster of V mimicus strains. The present study demonstrated at least 3 distinct clusters 
of V cholerae non-01 and an additional V. mimicus pattern. The CT of V cholerae non-01 
and V mimicus is located on the chromosome usually as a single gene copy but in certain 
serogroups, 023 and 0139 as multiple copies. Duplication of the CT genes in the classical 
biotype and 2 or more ctx copies present on tandemly repeated genetic elements (7kb or 9.7kb) 
in some strains of the El Tor biotype have been reported (Mekalanos 1983). Similarly 
tandemly repeated ctx copies have been reported to occur in V cholerae 0139 (Das et al. 
1993). 
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4.2.2 Production of a putative toxin by strains of V. cholerae non-01 and V. mimkus, as 
detected by GMI-ELISA. 
Strains of V cholerae which do not produce CT have been isolated from 
patients with diarrhoeal disease (McIntyre et aL 1965; Morris et aL 1984; Batchelor and 
Wignall 1988) and a volunteer study has shown that V cholerae non-01 which do not possess 
the CT gene can elicit diarrhoea with a severity comparable to cholera (Morris et aL 1981). 
These so-called non-toxigenic strains may be producing a toxin distinct from CT and evidence 
has been found of the production, by an environmental V cholerae, of a second enterotoxin, 
which was different from CT in antigenic nature, receptor site, mode of action and genetic 
homology (Saha. and Sanyal 1988). 
Of the V cholerae non-Ol and V mimicus strains, which did not possess the 
gene for CT, 19% were, nevertheless, found to be positive in the GMI-ELISA assay. A 
positive result was obtained with antisera against CT and CTB, but a not with an antiscrum 
prepared against LT. These strains were, therefore, suspected of producing a putative toxin 
which had the ability to bind the ganglioside GMI and shared antibody binding sites with CT, 
and more specifically with CTB. The B subunit of CT is responsible for specific high affinity 
binding of the toxin to the GMI gangliosides of intestinal epithelial cells (van Heyningen et aL 
1974; Holmgren et aL 1973; Svennerholm and Holingren 1978). Therefore, the strains 
expressing the putative toxin were tested with a specific GMI oligonucleotide probe, but none 
of the strains hybridised with this probe. When strains were tested in a double sandwich 
ELISA, in which GMI was not used, the most successful ELISA used anti-LT as the first 
ligand and anti-CTB as the second ligand, even though anti-LT gave a negative test when used 
in a GMI-ELISA. Interestingly, the two ELISA tests which used anti-CTB as the first ligand 
were totally negative, the reasons for these differences are not known but may be due to the 
conformation of the protein, which could be effected by the different antisera. 
The GMI-ELISA positive strains were also tested with the CTA+B combined 
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polynucleotide probe at low stringency, which allowed detection of LT and CT gene sequences. 
CT and the LT of E. coli are part of a heterogeneous family of enterotoxins and different forms 
of LT have been described ie: LTh-1, LTp-1, LTIIa and LT11b (Guth et d 1986). Similarly 
different forms of CT may exist with differences in molecular structure between enterotoxins 
produced by different serogroups of V cholerae (Finkelstein et al. 1987). A previous study has 
demonstrated that toxin purified from aV cholerae non-01 from Louisiana was 
indistinguishable from cholera toxin and that another toxin purified from aV cholerae non-01, 
from a patient with diarrhoea, was biologically and immunologically similar but not identical 
to CT in molecular structure (Yamamoto et al. 1983b). However, none of the strains producing 
the putative toxin in the GMI-ELISA hybridised with the CTA+B probe at low stringency, this 
may be because there is insufficient homology in the gene sequences of the putative toxin and 
CT, despite both being detected by the GMI-ELISA. 
Attempts were made to provide further evidence for the existence of the 
putative toxin using other immunoassays, such as PIH, colony immunoblotting and the Biken 
assay, however, none of these tests demonstrated the presence of the putative toxin. Southern 
blot analysis and hybridisation with the GMI oligonucleotide was also used for probe-negative, 
but GMI-ELISA-positive strains, but no hybridising fragments were detected. 
4.2.3 The cytotoxins of V. cholerae non-01 and V. mimkus 
The presence of cytotoxin which masks CT production has been described 
above 4.2.1a. Strains of V cholerae non-01 and V mimicus produced cytotoxic effects on all 
three cell lines, Yl, Vero and HeLa, used in the present study. Six patterns of cytotoxin 
production were observed using these 3 cell lines, indicating that more than one cytotoxin was 
produced by these strains. The most common pattern (47%) was cytotoxicity on all 3 cell lines. 
There was no apparent correlation of cytotoxic pattern with serogroup, however, cytotoxin 
production may be important for virulence as representatives of all the serogroups commonly 
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isolated from patients with diaffhoea (02,05,013 and 034) were cytotoxic on YI cells. 
The Vero cell line has been used to detect the Vero cytotoxin (VT) of E. coil 
(Konowalchuk et aL 1977; Scotland et aL 1980). VT belongs to a group of toxins which are 
closely related to the Shiga toxin of ShIgella dysenteriae type 1. VT causes cell death of Vero 
cell monolayers; however, the cytotoxin produced by V cholerae non-01 strains in the present 
study was not neutralised by anti-VT. Therefore, the cytotoxic effect was probably not due to 
the activity of VT or VT-like toxins. A previous study reported the presence of a specific 
cytotoxin related to VT or Shiga-like toxin. The toxin appeared to be demonstrated in cell 
lysates of V cholerae and V parahaemolyticus, using cytotoxicity tests and neutralisation 
assays with anti Shiga-toxin antiserurn (O'Brien et aL 1984). VT production could not be 
detected on Vero cells, in the present study, however, if VT and a second cytotoxin were 
produced simultaneously by V cholerae non-01, the VT effect could have been "masked" 
(similar to the masking of CT). Therefore, strains of V cholerae non-01 and V mimicus were 
examined for the presence of VT genes using a combined VTI and VT2 polynucleotide probe, 
however, none of the strains hybridised with this probe. 
4.2.3a Vacuolating toxin production on Vero cells. 
As well as the cytotoxic effect another distinct irreversible heat-labile effect was 
the vacuolation of Vero cell cytoplasm. The Vacuolating toxin was produced on Vero cells by 
16% of V cholerae non-01 strains, this was most commonly associated with a shrivelled 
appearance on YI cells, with no observed effect on HeLa cells. There was no apparent 
correlation between production of vacuolating toxin and source of isolates or serogroup. 
Although there have been no other reports of vacuolating toxin production by V cholerae or V 
mimicus, a similar vacuolation in tissue culture cell assays has been reported for Helicobacter 
pylori (associated with gastritis and duodenal ulcers) (Cover et al. 1990; Cover et al. 1991; 
Schmitt and Haas 1994) and the food poisoning organism Bacillus cereus (Hughes et al. 1988). 
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It is may be of significance that both these organisms are involved in causing forms of 
gastrointestinal illness. The vacuolating toxin of V cholerae non-01 strains should be 
investigated further; in future studies comparisons could be made with the vacuolating toxins of 
H. pylori and B. cereus. 
4.2.4 Haemolysin(s) 
Haemolysins are thennolabile proteins which lyse cells, including red blood 
cells. Strains of V cholerae and V mimicus were examined for the ability to produce 
haemolysin(s) using 1% horse blood agar plates. With the established protocol, 90% of strains 
examined produced haemolysin(s). Strains produced B-haemolysin, cc-haemolysin and a 
possible third haemolysin which appeared as a double zone. The production of oc- and B- 
haemolysins by bacteria has been well recognised; however, the basis for the double halo of 
haemolysis is poorly understood. Although this would require further investigation, it is 
possible that the double halo effect was caused by strains producing two distinct haernolysins 
concurrently. This double zone effect does not appear to have been reported previously, 
however, V alginolyticus also produce this effect (personal communication Dr. Henrik Chart). 
V chokrae and V mimicus were also tested for haernolysis of calf, sheep, 
human and rat rbe's, and for cytotoxicity on YI cells. The observation that test strains 
produced haemolysins which were able to lyse a range of red cell types, suggested that the 
haemolysin(s) were probably non-specific lysins. Haemolysin(s) lysed rat cells in preference to 
those of guinea pig, human, calf and sheep, the basis for this remains unknown but may relate 
to the numbers or types of haemolysin receptors present on the various red blood cells. 
An attempt was made to purify and raise antibodies to the haemolysin of V 
cholerae 02. The poor rabbit immune response to the antigen challenge was thought to be as a 
result of the very low amounts of actual protein toxin used. Had antibodies to V cholerae 
toxin been available, this would have been a useful tool to investigate the haemolysin(s) and 
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cx, f toxin(s) produced by other V cholerae non-01 and the closely related V mimicus. . 7.0 
Previous studies have found that strains of V cholerae non-01 produce a 
haemolysin which is indistinguishable from haemolysin produced by strains of V cholerae 01 
biotype El Tor (Brown and Manning 1985; Yamamoto et aL 1986; Ichinose et aL 1987). Also, 
that strains of V mimicus produce a haemolysin which has partial identity with these 
haemolysins (Sasahara 1993 41151; Shinoda et aL 1993; Uchimura et al. 1993). Although the 
role of haemolysin in pathogenesis is still uncertain, haemolysins are possible virulence factors, 
particularly for V cholerae non-01 and V m1micus that do not produce CT. 
4.2.4a Iron regulation of haemolysin. 
The synthesis of several haernolysins are iron regulated, with maximal 
expression of haemolysin occurring at very low iron concentrations. During pathogenesis, 
haemolysins may involve the release of iron-containing compounds such as haern available to 
pathogenic bacteria. The role of iron in the expression of haernolysins requires the bacteria 
under investigation to be grown in media with either low levels of available iron, or in media 
which causes apparent low iron conditions to occur. Whether or not bacteria are growing under 
conditions of low iron can be assessed by looking for the production of low-iron-inducible 
chelators such as enterobactin or aerobactin. In the present study, the ability of V cholerae 
non-01 to produce haemolysin in the light of expressing the iron chelators, enterochelin and 
aerobactin, was examined. V cholerae non-01 did not produce aerobactin, but did produce 
enterochelin. The medium Tris-succinate was used to give apparent conditions of iron shortage, 
with the sole carbon source, succinate, causing iron shortage in the cytochrome system. The 
growth of bacteria in Tris-succinate medium was compared with Tris-succinate medium with 
added iron in the form of FeC'3. Strains of V cholerae non-01 were grown in this medium 
statically and with aeration. In general, strains grown statically produced haemolysin but not 
enterochelin. This suggested that the bacteria were not growing under conditions of iron 
196 
deficiency. However, aerating these cultures and providing a highly aerobic culture caused 
strains to produce enterochelin but not haemolysin. This suggested that the haemolysin was not 
induced by conditions of low iron. For other strains, both enterochelin and haemolysin were 
produced at the same time, it was concluded that production of haemolysin was not iron- 
regulated. 
4.2.5 High affinity iron uptake 
Iron is an essential element for most aerobic organisms. Most pathogenic 
bacteria possess at least one high affinity iron uptake system, which involves the production of 
low molecular weight, high-affinity iron chelating molecules, known as siderophores. 
Siderophores have extremely high affinities for iron and are synthesised in response to iron 
limitation. The two major siderophores are the phenolic compound enterobactin (or 
enterochelin) and the hydroxamate siderophore aerobactin. 
In the present study, strains of V mimicus were found not to produce 
enterochelin; however, 74% of V cholerae non-01 strains did produce this siderophore. There 
was no obvious association of enterochelin production with source of isolate or with serogroup. 
In contrast, none of the V cholerae strains were positive for aerobactin, but 90% of V mimicus 
produced aerobactin. The ability to produce aerobactin has been linked to virulence for 
invasive bacteria such as E. coli which have been shown to express an aerobactin-mediated iron 
uptake system. However, when aerobactin positive strains of V mimicus were tested in 
BALB/C mice, none showed any adverse reaction. The production of aerobactin by V mimicus 
did not appear to be linked to virulence in mice. The production of aerobactin appears to be 
exclusive to V mimicus and the production enterochelin appears to be exclusive to V cholerae 
strains therefore, these tests are discriminatory between V mimicus and V cholerae. 
A recent study has identified the siderophores from V hollisae and V mimicus 
as aerobactin, this appears to be the first report of aerobactin production outside the family 
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Enterobacteriaceae except for a halophilic pseudomonad (Okuji and Yamamoto 1994). 
Previous studies have demonstrated that V cholerae produces a phenolic siderophore related to 
enterochelin, known as vibriobactin (Payne and Finkelstein 1978; Griffiths et aL 1984). In 
addition haernolysin (Stoebner and Payne 1988) is maximally expressed under iron-limiting 
conditions. The present study did not find that haemolysin was iron regulated; however, it is 
possible that more than one haemolysin is expressed by V cholerae and that not all 
haemolysin(s) are iron-regulated. 
4.2.6 The heat stable enterotoxin (NAG-ST) 
NAG-ST may be an important virulence factor of CT-negative strains of V 
cholerae and V mimicus. NAG-ST producing strains of V cholerae non-0 I have been 
implicated in an epidemic in a Khmer camp in Thailand (Bagchi et aL 1993) and human 
volunteer studies have shown that NAG-ST positive strains can cause diarrhoea of a severity 
comparable to that of cholera (Morris et aL 1990). Heat-stable enterotoxins are recognised 
virulence factors of E. coll and Yersinia enterocolitica and NAG-ST belongs this family of 
enterotoxins. These enterotoxins probably evolved from a common ancestral gene (Arita et aL 
1986; Takao et aL 1985; Ogawa et aL 1990) and transpostion may be a possible mechanism for 
the spread of these ST genes, as the gene for Exo1i STI has been located within a transposon, 
Tn1681 (So and McCarthy 1980). In addition it has suggested that the NAG-ST may have 
originated in V mimicus (Pal et aL 1992; Ramamurthy et aL 1993). 
In the present study the production of NAG-ST by strains of V cholerae non- 
01 could not be demonstrated in the infant mouse assay. V cholerae non-01 gave 
indeterminate FA ratios and there was no obvious fluid accumulation seen, even with a control 
NAG-ST positive V cholerae strain (NAG-82E). The infant mouse assay was traditionally 
used to detect STA of E. coli (Dean et aL 1972) and has been successfully used to detect NAG- 
ST producing V cholerae non-01 in a previous study (Arita et aL 1986; Spira et A 1979). 
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The presence of VM-ST, which appears to be identical to NAG-ST, in V mimicus has also 
been demonstrated (Honda et aL 1985). The failure to detect NAG-ST in the present study 
may be due to the growth conditions used, however, several different cultural conditions 
including those suggested by Arita el aL were tried without success. 
Although NAG-ST production could not be demonstrated strains of V cholerae 
non-01 could be screened for the presence of the NAG-ST gene. Initially a commercially 
available SNAP (synthetic nucleic acid probe) developed for the detection of E. coli ST was 
used, however, this probe did not hybridise with any of the strains of V cholerae examined. 
Although the amino acid sequences of NAG-ST and VM-ST toxin were similar to that of E. 
coli ST (Takao et aL 1985) the nucleotide sequences of the genes encoding them are distinctly 
different, with only 50% homology (Ogawa et aL 1990). This probably explains the failure to 
detect NAG-ST using the SNAP-ST probe, other studies using E. coli ST probes also failed to 
detect NAG-ST (Sommerfelt et aL 1988; Seriwatana et aL 1987). 
Two oligonucleotides were synthesised based on sequences published by Hoge 
et al., a mixed oligonucleotide probe deduced from the amino acid sequences of E. col! STh 
and STp (Hoge et aL 1990) and Ogawa et al., a nucleotide sequence based on the NAG-ST 
gene (Ogawa et al. 1990). The mixed oligonucleotide probe of Hoge et aL has been used to 
study V cholerae non-01 isolates from Thailand (6.8% were NAG-ST positive) and from 
Mexico and USA (none were positive for NAG-ST) (Hoge et aL 1990). However, the 
hybridisation experiments using the probe described by Hoge et al. in the present study were 
not satisfactory because the V cholerae NAG-82E control strain did not hybridise. In contrast, 
it was found that the probe described by Ogawa et al. gave a clear positive result with the V 
cholerae NAG-82E control strain. 
Using the Ogawa oligonucleotide, all V cholerae 01 were NAG-ST probe- 
negative, as were all CT-positive V cholerae non-01. These findings, that strains possessing 
the gene for NAG-ST do not possess the gene for CT and vice versa, are in agreement with Pal 
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et aL (Pal et aL 1992). However, one study has identified the NAG-ST toxin in I of 197 
isolates of V cholerae 01 (Takeda. et aL 1991). 
In the present study, 3% of the CT-negative V cholerae non-01 strains 
hybridised with the Ogawa NAG-ST oligonucleotide. Of the environmental isolates of V 
cholerae non-01,5% were NAG-ST probe-positive, compared with only 1% NAG-ST probe- 
positive from clinical sources. There also appeared to be a correlation with serogroup 014; all 
7V cholerae strains belonging to the 014 serogroup (4 strains from the environment and 3 
strains of human origin) were NAG-ST probe-positive. In contrast to the 014 serogroup, 
NAG-ST probe-positive strains were the exception in other serogroups. Recently Pal et aL used 
a 271 bp cloned NAG-ST DNA probe to assess the prevalence of NAG-ST among 
environmental strains isolated in Calcutta (Pal et aL 1992). They found 2.3% (12/521) of 
strains hybridised and suggested that there might be a correlation between serogroup and NAG- 
ST. The present study suggests the correlation of the NAG-ST virulence factor with V 
cholerae serogroup 014. 
As well as a correlation with the 014 serogroup of V cholerae non-01, NAG- 
ST (or VM-ST) was associated with the species V mimicus. Nearly 12% of V mimicus strains 
hybridised with the NAG-ST probe, interestingly none of 3V mimicus strains which belonged 
to serogroup 014 hybridised with the NAG-ST probe. A study using thirteen strains of V 
mimicus (Ramamurthy et aL 1994), demonstrated that these organisms were capable of 
producing several toxins simultaneously; including CT, NAG-ST, TDH and cytotoxin. They 
suggested that V mimicus may act as a "courier" of virulence factors among vibrios using 
transposons as a means of transferring genetic material. In particular it was suggested that V 
mimicus acts as an important reservoir for NAG-ST genes. Although, the present study found 
that the NAG-ST gene was present more frequently in V mimicus (12%) than in V cholerae 
non-01 (30/6), there is insufficient evidence to suggest that V mimicus is the main reservoir for 
NAG-ST. Both V mimicus and V cholerae non-01 from both clinical and environmental 
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sources had the capacity to express several toxins and these toxins could be expressed 
concurrently. This may suggest that both species could act as reservoirs of toxins, or that these 
factors are required for these organisms to exist successfully in their natural environment. 
4.2.6a Southern blot analysis of the NAG-ST gene. 
The NAG-ST gene appears to be a stable factor which is chromosomally 
encoded. Genomic, DNA preparations were made and digested with HindIII. The Southern 
blots were hybridised with the NAG-ST oligonucleotide probe of Ogawa et aL and found to 
hybridise with a single chromosomal restriction fragment, of between 2 and 19 kb. All V 
cholerae non-01 strains gave single bands of different sizes, with the exception of an 
unidentifiable (0? ) V cholerae strain (E47276) that had 2 hybridising fragments (8 kb and 2.3 
kb), indicating that this strains possessed 2 copies of the NAG-ST gene. The NAG-ST probe- 
positive strains of V cholerae were differentiated into 8 groups by the size of the hybridising 
fragment. All strains of the 014 serogroup, regardless of source or geographical origin gave a 
single hybridising fragment of 19 kb. The presence of the same size of hybridizing fragment in 
all 014 strains, and the fact that this fragment does not occur in other serogroups, may indicate 
that NAG-ST positive 014 represents a single clone. This could explain the close association 
of this serogroup of V cholerae with NAG-ST. Two patterns (H5 and H6) were found in 
strains from a variety of serogroups. The incorporation of the NAG-ST gene at identical 
chromosomal sites, possibly arising by transposition, may account for the serogroup 
heterogeneity found within these patterns. 
It would also be interesting to analyse the NAG-ST positive strains of V 
mimicus found in the present study by Southern blot analysis. A comparison of the size of 
hybridising fragment may begin to clarify the relationship, if any, between the NAG-ST 
positive V cholerae non-01 and V mimicus. 
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4.2.7 Colonisation factors 
The ability of bacteria to adhere to host tissues is a recognised pathogenic 
mechanism, and the use of cultured cell lines, such as HEp-2, have been useful for studying 
bacterial adhesion in vitro. Recently, it has been suggested that pathogenic V cholerae non-01 
could be distinguished from non-pathogenic strains by adhesion on the Caco2 cell line 
(Panigrahi et al. 1990). In the present study, both Caco2 and HEp-2 tissue culture cell lines 
were used to test V cholerae non-01. The adhesion tests on both, HEp-2 and Caco2 cell lines, 
were best performed as 3h rather than the conventional 6h test used for E. coli as the V 
cholerae strains produced cytotoxins which destroyed the cell monolayer. The strains were also 
tested for haemagglutination using calf, guinea pig, human and rat rbc's. The different growth 
conditions did not make any obvious difference in the adhesion results obtained on the cell 
lines, however, the presence of mannose did affect the haemagglutination of rbc's. Strains 
tested gave mannose-sensitive (MS) haemagglutination on guinea pig rbc's and mannose- 
resistant (MR) haemagglutination on human rbcs. The adhesion tests were repeated in the 
presence of sugars other than mannose; no inhibition of adhesion due to mannose, fucose or 
rhamnose was found. The present study found no correlation between haemagglutination and 
adhesion. Neither the possession of smooth LPS, nor flagella appeared to be necessary for 
adhesion. Both environmental and diarrhoea-associated strains were found to adhere avidly, not 
only to both cell lines, but also to glass only, indicating that the adherence is non-specific. 
The use of the Caco2 cell, a moderately differentiated human colonic adenocarcinoma, which 
has proved a useful in vitro model for adhesion of pathogens such as Listeria monocytogenes 
and E. coli, did not appear to distinguish pathogenic V cholerae non-01 from non-pathogenic 
strains as suggested by Panigrahi et al. (Panigrahi et al. 1990). 
Colonisation, of the epithelial mucosa. of the small intestine appears to be a 
critical step in the ability of organisms, such as V cholerae 01 and V cholerae non-01, to 
elicit diarrhoea (Spira and Fedorka-Cray 1983). A number of factors have been associated with 
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the colonisation of epithelial cells, these include; motility through a single polar flagellum, 
haemagglutinins, outer membrane proteins, lipopolysaccharides and pili. 
Early studies suggested that non-motile variants of V cholerae 01 were less 
virulent and that the flagellum plays a key role in adhesion by aiding both, penetration of the 
mucous barrier and colonisation of the epithelial surface (Freter 1981; Attridge and Rowley 
1983). Other studies have failed to corroborate the findings that non-motile strains were less 
virulent (Teppema et aL 1987). Attridge and Rowley demonstrated both binding and motility 
functions associated with the flagellum (Attridge and Rowley 1983). The present study 
suggests that motility is not a requirement for adhesion, however, strains which possess flagella 
can be non-motile hence the flagellum may still play a role in adhesion. 
Previous studies have examined the distribution of a variety of haernagglutinins 
as potential colonisation factors in strains of V cholerae 01 and non-01 (Booth and 
Finkelstein, 1986). It has been suggested that cell-associated mannose-sensitive, fucose- 
sensitive, and mannose-fucose-resistant haernagglutinins may be virulence factors in pathogenic 
V. cholerae (Hanne and Finkelstein 1982; Jones and Freter 1976; Bhattacharjee and Srivastava 
1978; Attridge and Rowley 1983). However, Booth and Finkelstein concluded that although 
cell-associated haernagglutinins were widely distributed in V cholerae 01 and non-01, these 
factors are not sufficient for virulence (Booth and Finkelstein 1986). In the present study there 
did not appear to be an association with haernagglutination and adhesion on the HEp-2 and 
Caco2 cell lines. 
The most recent research suggests that pili are the critical factor in colonisation. 
In the present study no pili were seen by transmission electron microscopy, however, CT- 
positive strains of V cholerae non-01 were shown by PCR to possess the gene for the toxin 
co-regulated pili. Several groups have reported the presence of pili in V cholerae 01 (Ehara et 
aL 1987; Hall et al. 1988; Taylor et aL 1987; Pearson et al. 1993), V cholerae non-01 (Honda 
et aL 1988) and V mimicus (Uchimura and Yamamoto 1992). The best characterised pilus of 
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V cholerae is the toxin co-regulated pilus (TCP) (Taylor et aL 1987; Attridge et al. 1993). 
These hydrophobic pili have been observed to form large bundles under the electron microscope 
and the expression of these TCP bundles causes autoagglutination, sedimentation in broth 
culture and the ability to haemagglutinate mice rbc's in the presence of fucose or mannose. 
The role of TCP in colonisation has been established for both V cholerae 01 biotypes in 
volunteer studies; mutant strains which did not produce pili failed to colonise the intestine and 
failed to produce an effective immune response (Herrington et aL 1988). In the present study, 
CT-probe-positive strains of V cholerae non-01 were shown, by PCR, to possess the gene for 
tcpA, however the CT-negative strains of V cholerae non-01 and V mimicus did not appear to 
possess the tcpA gene, however, as these strains adhere to the tissue culture cells they 
presumably do so by some other mechanism. 
The present study demonstrated that all V cholerae 0139 possess a tcpA 
identical to El Tor tcpA and that a similar association exists between other non-01 serogroups 
and type of tcpA. However, confirmation of this would require greater numbers of CT positive 
strains belonging to these serogroups and originating from different geographical areas to be 
tested. Based on restriction fragment patterns by pulse field electrophoresis and on PCR 
directed against dxA and tcpA, it has been suggested that strains of serogroup 0139 are El Tor 
variants (Hall et aL 1993). In the present study, however, ctxB and tcpA gene amplicons of 
0139,01 biotype El Tor and certain 06 and 0? strains are indistinguishable in size. Rather 
than suggesting that CT positive non-01 are variants of 01, it may be that transfer of CT and 
TcpA genes has occurred several times from 01 to non-01 strains and that CT positive strains 
of a particular serogroup may be members of a clone resulting from this event. 
The mechanisms of colonisation. of V cholerae non-01 and V mimicus are not 
fully characterised, it may be that, similar to diarrhoeagenic E. coli, more than one mechanism 
of adherence will be found. 
204 
4.2.8 Lipopolysaccharide (LPS) and Outer membrane proteins (OMT) 
LPS and OMP have been implicated as virulence factors in V cholerae 
diarrhoea; both have been associated with colonisation of the epithelial mucosa of the small 
intestine (Spira and Fedorka-Cray 1983). The LPS and many of the OMP of V cholerae are 
highly immunogenic (Manning and Haynes 1984; Kabir 1986; Sears et aL 1984). The outer 
membranes of vibrios contain several proteins (OMPs) which are strongly antigenic, V cholerae 
01 possess 4 different OMP in the 25 - 45 kda range. Outer membrane proteins were 
examined for strains of V cholerae non-Ol. 
In the present study V cholerae non-01 and V mimicus showed considerable 
diversity in their OMP, with the majority having a major OMP at around 38 kda. Strains of V 
cholerae belonging to 02 and 027 appeared not to express porins. This is difficult to explain, 
but has been observed in Vcholerae 01 previously (Bertram 1990). The OMP of V cholerae 
non-01 and V m1micus may reflect the types of toxin elaborated by particular strains, for 
example, strains which produce particular toxins may have the same OMP profiles because of 
the need to excrete proteins or toxin. The lack of a porin in the V cholerae 02, particularly if 
this was shown to be serogroup related, may also be of interest as the 02 serogroup does 
appear to be associated with diarrhoeal disease. Further investigation would be required into 
both these aspects. 
Previous studies have found a major protein which migrated on SDS-PAGE 
gels as a band of 48 kda, which was common to all strains of V cholerae 01 (Kabir 1986). 
Kelley and Parker found a 45 kda major protein which appeared to be the major structural 
protein of the outer membrane (Kelley and Parker 1981). The OMP of V cholerae were 
compared to the OMP of other gram-negative bacteria and were found to have a distinct OMP 
pattern (Manning et aL 1982). Strains of V cholerae 01 generally contain OMP in the range 
25 - 45 kda, and also additional minor proteins and V cholerae non-01 appear to be more 
heterogeneous; a protein at 25 kda appears to be common to all strains of Vibrio (Manning and 
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Hayes 1984). The present study also found a single major OMP (although this was at 
approximately 38 kda), and also some unusual OMP profiles with no apparent major OMP, this 
is extremely unusual and should be investigated further. 
The LPS of V cholerae 01 and 0139 are important protective antigens and, as 
these serogroups are the only V cholerae known to cause epidemic cholera, are considered 
virulence factors. The present study indicates the association of certain non-01 and non-0139 
serogroups, such as 02, and 05, with diarrhoeal disease and also the association of certain 
serogroups with the possession of toxin genes; 01 and 0139 with CT, and 014 with NAG-ST. 
Although the role of LPS as an adhesive factor has not been established, 
antibodies produced against V cholerae LPS are protective in animal models, and the observed 
protection may involve interference with LPS during mucosal colonisation (Booth et aL 1986). 
However, the present study found that the possession of smooth LPS was not required for 
adhesion on HEp-2 and Caco2 tissue culture cell lines, indicating that long chain LPS is not a 
prerequisite for adhesion. 
In the present study, SDS-PAGE analysis of the LPS of V cholerae non-01 has 
proved useful in confirming outbreaks of otherwise unidentifiable strains and for clarifying 
problems with identification of serogroups, such as 026. The appearance of V cholerae LPS is 
unusual, if a "ladder" structure can be seen it is usually irregular, however, the pattern observed 
within a particular serogroup is indistinguishable. Several serogroups, though did show marked 
heterogeneity, rather than identity of LPS. On further investigation a number of new 
serogroups were identified and antisera raised to these presumptive serogroups. The ability of 
strains of V cholerae to express long-chain LPS is only poorly understood, although strains 
belonging to serogroups 01 and 0139 are thought to express LPS, these serogroups proved to 
be among the serogroups from which LPS could not be readily identified. The "smear" seen on 
SDS-PAGE gels of these serogroups may be due to the presence of capsular material. 
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CONCLUSIONS 
Vibrio cholerae non-01 and the closely related V mimicus, were characterised by 
serogroup and biotype and examined for factors related to virulence. Serogrouping was a 
reliable means of differentiating strains, although only 30% of strains could be identified using 
sera raised against 02 - 083 and 0139, this would doubtless be improved by the expanded 
scheme of Shimada et aL which recognises 141 serogroups (01 - 0140). All V cholerae 01, 
all sub-serogroups (Ogawa, Inaba or Hikojima) and both biotypes (classical and El Tor) were 
typable within the scheme of Sakazaki and Donovan. The serogrouping scheme also applies to 
the closely related V mimicus but not to any of the halophilic vibrios. 
Strains were examined for the possession of genes and the production of toxins 
as well as cell-associated factors. Cholera toxin (CT), the main virulence factor responsible for 
the dramatic symptoms of epidemic cholera, is produced by V cholerae 01 and 0139, but is 
rarely found in V mimicus and V cholerae belonging to other serogroups. The CT-positive 
strains were differentiated by Southern blot analysis of CT; most strains had a single 
hybridising fragment suggesting the presence of a single copy of the CT gene. The CT-positive 
strains belonging to serogroups 023 and 0139 strains had more than one hybridising fragment 
indicating the presence of more than one CT gene. V cholerae 0139 also showed variation in 
the size of hybridising fragment, suggesting that 0139 strains were not clonal in origin. The 
CT genes of the only CT-positive V mimicus strain appeared to be distinct from the CT genes 
of V cholerae non-01 both in the size of the single hybridising fragment in Southern blot 
analysis and in the fact that it could not be detected by PCR for CT. 
The heat-stable enterotoxin (NAG-ST) is another established virulence factor 
which has been described. In this study 3% of V cholerae non-01 possessed the gene for 
NAG-ST and all V cholerae strains belonging to the 014 serogroup were NAG-ST positive. 
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By Southern blot analysis of the NAG-ST gene a single identical hybridising fragment was 
found in the 014 strains. This fragment did not occur in other NAG-ST positive strains, 
therefore, V cholerae 014 probably represents a single clone. NAG-ST may be important in 
the virulence of V mimicus as 12% of strains possessed the gene. 
The majority of V cholerae non-01 and V mimicus strains produced 
cytotoxins, however, none of the strains produced verocytotoxin (VT) or possessed the gene for 
VT. The low incidence of established toxins (CT, NAG-ST and VT) in V cholerae non-01, 
non-0139 and V mimicus suggests that other virulence factors are involved. Both V cholerae 
non-01 and V mimicus were capable of producing many extracellular products, including 
cytotoxins and haemolysins. These factors were often produced concurrently and led to 
problems in creating the optimal conditions and choosing the appropriate assay for the factor 
being investigated. Over 80% of strains produced cytotoxin(s) as detected by YI cells, and 
nearly 50% of strains were cytotoxic on all three cell lines (YI, HeLa and Vero). The 
cytotoxic effect masked the cytotonic effect of CT produced by V cholerae non-01, non-0139. 
Haemolysin(s), a-, B- and an unusual double zone haemolysin, were produced by 90% of V 
cholerae non-01 and V mimicus. The role of cytotoxins and haemolysins in diarrhoeal disease 
needs to be further elucidated. 
Two novel toxins were found in this study. The first was a cytotoxin which 
produced vacuolation of Vero cell cytoplasm and was expressed by 16% of strains; this toxin 
may be related to toxins observed in Helicobacter pylorl and Bacillus cereus, which produce a 
similar vacuolation. The second putative toxin, which was expressed by 19% of strains, was 
demonstrated in an ELISA assay, this "toxin" was distinct from the cytotoxin and vacuolating 
toxin, had the ability to bind ganglioside GMI and shared antibody binding sites with CT. 
High affinity iron chelating compounds (siderophores) can be important in 
bacterial virulence; both V cholerae non-01 and V mimicus express siderophores. Seventy- 
four percent of V cholerae non-01 produce enterochelin while 90% of V mimicus produce 
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aerobactin. The production of aerobactin is unusual in Vibrio spp. and has been linked to the 
virulence of invasive bacteria. 
Adhesion by more than 90% of V cholerae non-01 and V mimicus strains was 
demonstrated on both HEp-2 and Caco2 cell lines. However, the mechanism by which this 
adherence occurs remains to be elucidated. The present study found that neither smooth LPS, 
nor flagella are essential for adhesion. The toxin coregulated pili probably have a role in 
colonisation for CT-positive strains; CT-positive strains of V cholerae non-01 were shown by 
PCR to possess the gene for the toxin coregulated pilus QqpA). Of the two types of tcpA 
(identical to either tcpA found in classical or El Tor biotypes of V cholerae 01), all V 
cholerae 0139 possessed a tcpA identical to El Tor-type of tcpA. A similar association also 
appears to exist between other CT-positive non-01 serogroups and type of tcpA. However, CT- 
negative strains did not possess the tcpA gene and pili were not seen by transmission electron 
microscopy, therefore some other mechanism must be involved in the adhesion of these strains. 
V cholerae non-01 and V mimicus also showed considerable diversity in their 
outer membrane proteins (OMP), with the majority having a major OMP at around 38 kda. 
Strains of V cholerae belonging to 02 and 027 were particularly unusual because they 
appeared not to express porins. 
The somatic antigen may be a useful indicator of diarrhoeagenic potential 
within Vcholerae non-01. Serogroups, 02,05,09,011,013,024,034,037 and 0139, 
were associated with clinical isolates and serogroup 019 was commonly isolated from the 
environment. The most common serogroups of V cholerae associated with diarrhocal disease, 
excluding 01 and 0139, were serogroups 02 and 09. The LPS of V cholerae 01 and 0139 
are important protective antigens and are considered to be virulence factors. The present study 
indicates the association of certain serogroups with the possession of toxin genes (01 and 0139 
with CT and 014 with NAG-ST) and also the association of certain non-01, non-0139 
serogroups, with diarrhoeal disease. 
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Many of the factors described in this study need further investigation, in 
particular the two novel toxins the vacuolating toxin and the ELISA "toxin". The vacuolating 
toxin could be compared to the toxins of H. pylori and B. cereus which cause similar 
vacuolation in tissue culture cells. Further work could also be done on differentiating the 
haemolysins and cytotoxins produced by these strains, the "double zone" haemolysin(s) is 
unusual and may be of particular interest. The mechanisms of colonisation and further 
investigations into the LPS and OMP of V cholerae non-01 and V mimicus and possible iron 
regulation of these factors could be undertaken. Future studies could focus on the virulence 
attributes of specific serogroups found to be associated with diarrhoea, such as 02,05,09, 
024 and 037. 
The pathogenicity of V cholerae and V mimicus appears to be multifactorial 
and further work could be done to identify these factors and establish further correlations with 
serogroup. None of the virulence factors produced by these strains, including CT, is found 
exclusively in human rather than environmental isolates. The presence of toxins and cell 
associated factors in environmental strains could account for human infections as water and 
seafood appear to be the main vehicles of transmission for vibrio-associated infections. It will 
probably not be possible to identify a single characteristic that differentiates virulent strains of 
V mimkus and V cholerae non-01 from avirulent strains. It is more likely that heterogeneous 
patterns of virulence, similar to the heterogeneity seen among diarrhoeagenic E. coli, will be 
found. 
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Appendix 1 
A. Media 
All media were prepared by the Media Department, CPHL. Tests were carried out at 37'C 
unless, otherwise stated. 
References: 
Cowan and Steel's Manual for the identification of Medical Bacteria. 'Ibird Edition. Edited by 
G. I. Barrow & R. K. A. Feltham. Cambridge University Press. 
Edwards and Ewings Identification of Enterobacteriaceae. Fourth Edition. W. H. Ewing. Elsevier. 
A. 1 Culture maintenance media 
Nutrient agar medium 
25 g Oxoid Nutrient Broth No2 CM67 
15 g Japanese agar 
II distilled water. 
Dorset Egg medium 
25 g sterilised egg mixture (Lab-Lemco powder) 
12.5 % NaCl 
II distilled water. 
Freeze-drying medium 
Difco, nutrient broth containing 0.5% inositol 
A. 2 Biochemistry 
Alkaline Peptone Water 
10 g Oxoid peptone L37 
5g NaCI 
II distilled water, pH 9.2 
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Peptone Water Sugars with Andrade's indicator 
900 mls peptone water 
10 mls Andrade's indicator, pH 7.5. 
The sugars were dissolved and sterilised by filtration, then added aseptically to the sterilised 
peptone water with indicator. The following sugars were used; adonitol, arabinose, cellobiose, dulcitol, 
glucose, glycerol, inositol, inulin, lactose, maltose, mannitol, raffinose, thamnose, salicin, sorbitol, sorbose, 
sucrose, trehalose and xylose. The glucose PW also contained an inverted inner (Durham) tube to test for 
gas. Sugars used for testing vibrios also had 1% NaCl added. Positive = pink (gas bubble in Durham tube). 
Negative = colourless, after 14 days. 
ONPG (o-nitrophenyl-fi-D-galactopyranoside) 
250 mls ONPG solution (6 g ONPG, I 10.01 M Na2HP04, pH 7.5) 
750 mls peptone water. 
Positive = yellow colour in solution. Negative = solution remains colourless, after 2 days. 
Citrate utilization 
Christensen's citrate 
3g Sodium citrate 
0.2 g Glucose 
0.5 g Yeast Extract 
0.1 g L-cysteine hydrochloride 
Ig KHPO,, 
5g NaCI 
20 g Agar 
6 mls Phenol red (0.2% solution) 
II distilled water, pH 6.8 - 6.9. 
Positive reaction = pink colouration of slope. Negative = original yellow colour of slope, after 7 days. 
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Simmons' citrate 
5g NaCI 
0.2 9 MgS04.7H20 
Ig NH4H2PO4 
Ig K2HP04 
2g Citric acid, 
20 mls bromothymol blue (0.4% solution) 
20 g Agar 
II distilled water. 
Positive = bright blue colouration of slope. Negative = original blue/green colour of slope, after 7 days. 
Acetate utilization 
Sodium acetate 
This medium is the same as Simmons' citrate agar, except that 0.25% sodium acetate is used instead of 
citrate. Postive = bright blue colour. Negative = original blue/gree colour of slope, after 7 days. 
Urease activity 
Urea medium 
Ig Peptone 
5g NaCI 
2g KH2P04 
20 g Agar 
II distilled water, pH 6.8. 
Sterilise then add Ig glucose and 6 mIs phenol red (0.2% solution), steam for Ih before 
adding 100 mls sterile urea (20% solution). Positive = pink colour. Negative = original colour of slope, 
after 7 days. 
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Arginine dihydrolase production, lysine and ornithine decarboxylase production 
Moller's medium 
5g Peptone 
5g meat extract 
5 mg pyridoxal 
0.5 g glucose 
2.5 mls bromothymol purple (0.2% solution) 
2.5 mls Cresol red (0.2% solution) in II distilled water. 
For use add 1% L-arginine hydrochloride or 1% L-lysine hydrochloride or 1% L-omithine hydrochloride as 
required, adjust to pH 6. A control tube, with no addition, is included in the test. 
Positive = purple colour. Negative = yellow colour (NB: the control tube must be yellow), after 4 days. 
Indole production. 
The strain to be tested is grown in peptone water for 2 days, then a few drops of Kovac's reagent (5 g p- 
dimethylarninobenzaldehyde dissolved in 75 mls amyl alcohol, 25 mls conc HCI) is added. Positive = dark 
pink ring. Negative = yellow ring. 
Hydrogen sulphide (H2S) production in glucose iron agar 
3g beef extract 
3g yeast extract 
15 g peptone 
5g proteose peptone 
10 g glucose 
0.2 g ferrous sulphate 
II distilled water. 
Positive = blackening. Negative = original red/orange colour of slope, after 7 days. 
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Growth in potassium cyanide (KCN). 
KCN base 
3g peptone 
5g NaCI 
0.225 g KH2P04 
5.64 g NaHP04.2H20 
II distilled water, pH 7.6. 
For use add 1.5 mls 0.5% KCN in sterile distilled water to 100 mIs of base. The strain to be tested 
is inoculated into I ml base containing KCN and I ml base without KCN in seperate bijou bottles. After 
2 days the bottles are examined for growth. Positive = growth in the base with and without KCN. Negative 
= growth in base without KCN only. 
Combined Malonate utilization and PPA test (deamination ofphenylalanine to phenylpyruvic acid) 
2g (NH4)2SO4 
0.6 g K2HP04 
0.4 g KH2pO4 
2g NaCt 
3g sodium malonate 
2g DL-phenylalanine 
Ig yeastrel 
5 mls bromothymol blue (0.5% w/v) 
II distilled water. 
The medium is inoculated and incubated overnight. 
Malonate test 
Positive = blue. Negative = original green colour of solution. 
PPA test 
After recording malonate result, acidify with 10 N HCI ( few drops) until the colour of the medium changes 
to yellow. Add 4-5 drops of 10% (w/v) ferric chloride. Positive = dark green. Negative = yellow (may 
be cloudy). 
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Gluconate oxidation 
1.5 g peptone 
Ig yeastrel 
Ig K2HP04 
40 g potassium gluconate in II distilled water, pH 7. 
1 ml volumes in tubes are inoculated with the strain(s) to be tested and incubated for 2 days. A "Clinitest" 
(Miles Ltd, Ames Div, Slough) tablet for reducing sugars is added to each tube. Positive = dark green or 
purple or brown precipitate. Negative = bright blue. 
Aesculin hydrolysis 
Aesculin slopes 
40 g ox bile dehydrated 
Ig aesculin 
0.5 g ferric citrate 
15 g agar 
II nutrient broth 
Positive = blackening of the slope. Negative = original grey colour of slope, after 14 days. 
Gelatin hydrolysis. 
3g beef extract 
5g peptone 
120 g gelatin 
II distilled water. 
Stab inoculate the agar and incubate overnight, leave at adjust to room temperature before examining for 
liquefaction. Positive = slope is liquefied. Negative = slope remains solid after 28 days at room temperature. 
Motility - Craigie tubes. Thiotone agar medium 
10 g thiotone, 
3g beef extract 
80 g gelatin 
5g NaCI 
216 
4g Shred agar in II distilled water. 
The medium is distributed in test tubes containing inner tubes which are open at both ends. Ile test 
organisms are stab inoculated into the agar within the inner tube, motile organisms grow down through the 
inner tube and up through the agar outside the inner tube. Positive = ring of growth outside the inner tube. 
Negative = no growth outside inner tube, after 14 days. 
Hugh & Leifison (H & L). Oxidation-fermentation (OF) test. 
2g pcptone 
5g NaCI 
0.3 g K2HP04 
3g agar 
15 mls bromothymol blue (0.2% solution) 
II distilled water, sterilisc. Then add 1% sterile glucose. 
For each test 2 slopes are used. The strain to be tested is stab inoculated into the agar, then one slope is 
covered with soft yellow paraffin. if the strain is OF positive both slopes turn from green to yellow. 
Negative = green, after 7 days. 
Nitrate reduction 
Ig KNO, (Analar - nitrite free) in II nutrient broth. Inoculate nitrate broth and incubate overnight. Add 
0.5 ml solution A and 0.5 ml solution B. Positive = dark pink to red colour. Negative = no change (NB: 
this may be because not only has the nitrate been reduced, but the nitrite has been further reduced. In this 
case add a tiny amount of zinc dust; positive = no change, negative = pink). 
Solution A 
1.5 mls Dimethyl-cc-naphthylamine 
178.5 mls distilled water 
71.5 mls Glacial acetic acid. 
Solution B 
2g sulphanic acid dissolved in 178.5 mIs distilled water 
71.5 mls Glacial acetic acid. 
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Vogues-Proskauer (VP) test (acetylmethylcarbonil production). 
VP medium 
0.1% yeast extract 
0.7% trypticase peptone 
0.5% phytone peptone 
1% glucose 
1% NaCl 
0.3% agar 
II of distilled water, pH 7. 
Stab inoculate VP agar and incubate overnight at 30T. Add 0.2 ml solution A and 0.1 ml solution B, read 
after 15 min at room temperature. Positive = deep red ring. Negative = colourless to yellow. 
Solution A 
5% (x-naphthol in alcohol. 
Solution B 
40% potassium hydroxide, 0.3% creatine in 100 mIs distilled water. 
Oxidase activity 
1% NNN'N' Tetramethyl-p-pheylenediamine dihydrochloride in distilled water. Place drops of reagent on 
filter paper and using a plastic loop smear a little growth onto the impregnated paper. Positive = deep purple 
within 30 secs. Negative = no colour change. 
A. 3 Growth media 
Vibrio Phage Typing Agar. 
30 g Todd Hewitt Broth (Oxoid) 
2g Yeast extract (Oxoid) 
0.01 g Tryptophan 
7g agar No. 1 (Oxoid) 
II distilled water, pH 7.6. 
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Syncase Sucrose broth (SSB) and Syncase Glucose broth (SGB) 
5g Na2l-W04 
5g K2HP04 
1.18 g NH4Cl 
0.089 g Na2S04 
0.042 9 MgC'2.6H20 
0.004 g MnC'2.4H20 
0.005 g FeC'3.6H20 
10 g Casarnino acids (Difco) 
II distilled water. 
For Syncase-glucose 0.5%, add glucose 5g per litre. 
For Syncase-sucrose 0.5%, add sucrose 5g per litre. 
Trypticase Soy Broth (TSB) 
17 g trypticase peptone 
3g phytone peptone 
5g NaCl 
2.5 g K2HP04 
2.5 g glucose 
II distilled water, pH 7.3. 
Casamino Yeast Fxtract broth (CYE) 
20 g Casarnino acids (Difco) 
6g Yeast Extract (Difco) 
2.5 g NaCI 
8.7 g K2HP04 
I ml trace salts solution 
II distilled water, adjust to pH 7.5 with NaOH. 
Trace salts solution is 59 MgS041 0.5 g MnCl2 and 0.5 g FeC13 dissolved in 100 ml H2SO4 (0.001 N). 
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Brain Heart Infusion broth (BH1) 
37 g BHl (Oxoid) in II distilled water. 
Biken (Modified Elek) Test 
Biken Agar 
2g Casamino acids (Difco) 
Ig Yeast extract (Difco) 
0.25 g NaCI 
1.5 g K2HP04 
0.5 g glucose 
0.05 ml Trace salts solution 
1.5 g Noble agar 
100 mls distilled water, pH 7.5. 
Trace salts solution = 5% (W/V) MgS04,2% (W/V) COC12.61-120 and 0.5% (w/v) FeC13. Add 0.1 ml 
lincomycin (13.5 mg/ml) per 15 mls Biken agar. 
Nutrient broth 
20 g Difco Nutrient Broth 
8.5 g NaCl 
II distilled water. 
CFA agar 
2% (w/v) agar 
1% Casamino acids 
0.15% yeast extract 
0-005% MgSO4 
0,0005% 'V'nC'2' 
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Tris-succinate medium 
5.8 g NaCI 
3.7 g KCI 
1-1 9 NH4Cl 
0.15 g CaCl2.2H. 0 
0-10 9 MgC'2.6H20 
0.142 g NaS04 
0.272 g KH2P04 
12.1 g Tris base 
10 g sodium succinate 
800 mls distilled water, adjust pH to 6.8 using conc HCI and make up to I litre. Filter sterilise. 
A. 4 Buffer solutions and miscellaneous reagents 
Phosphate buffered saline (PBS) 
8g MCI 
0.2 g KCI 
1.15 g Na2HP04 
0.2 g KH2po4 
II distilled water, pH 7.3 
Saline 
0.9% w/v NaCl in distilled water. 
Tris EDTA buffer (TE) 
10 mM Tris, I mM EDTA, pH 8 and filter sterilise. 
Ferric perchlorate solution (for detection aerobactin) 
1.52 mls perchloric acid 
0.177 g ferric perchlorate 
100 mls with distilled water. 
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Reagents for detection of enterochelin 
1) 0.5 M HCL 
2) Nitrite/molybdate reagent (10 g sodium nitrite + 10 g sodium molybdate in 100 mis distilled 
water). 
3) 1M NaOH. 
B. Tissue culture 
All reagents for tissue culture were obtained from Flow Laboratories Ltd., Rickmansworth, England. 
B. 1 Tissue culture cell lines 
Yl adrenal cells YI, mouse adrenal cortex tumour, ATCC No. CCL79. 
Culture medium: Ham's FlO. 
To 100 mIs Ham's FIO add; 12.5 mls horse serum 
2 mls foetal bovine serum 
2 mls penicillin/streptomycin (5000 units/ml) 
0.5 ml glutamine (200 mM) 
Amphotericin B (Fungizone) (250 pg/ml). 
Vero cells, African green monkey kidney, ATCC No. CCL81. 
Culture medium: Medium 199 with Earle's salts. 
To 100 mls 199 medium add; 10 mls foetal bovine serum 
2 mls penicillin-streptomycin (5000 units/ml) 
0.5 ml glutamine 
Amphotericin B (Fungizone) (250 pg/ml) 
HeLa cells Hela S3 cells, clone of HeLa cervical carcinoma, A TCC No. CCL2.2. 
Culture medium: Minimal Essential Medium (MEM) with Eagle's salts. 
To 100 mls MEM add; 10 mIs foetal bovine serum 
2 mIs penicillin/streptomycin (5000 units/ml) 
I ml non-essential amino acids (100x) 
0.5 ml glutamine (2OOmM) 
Amphotericin B (Fungizone) (250 pg/ml). 
222 
HEp-2 cells, carcinoma of larynx, A TCC No. CCL23. 
Culture medium: Basal medium eagle (BME) with Hanks salts. 
To 100 mis BME add; 15 mIs foetal bovine serum 
2 mIs penicillin-streptomycin (5000 units/ml) 
0.5 ml glutamine (200 mM) 
Amphotericin D (Fungizone) (250 pg/ml). 
Caco2 cells, a colonic carcinoma cell line. 
Cuture medium: Dulbecco Minimal Eagle Medium (DMEM). 
To 100 mls DMEM add; 20 mls foetal bovine serum 
2 mls penicillin/streptomycin (5000 units/ml) 
I ml glutamine (200 mM) 
I ml non-essential amino acids 
Amphotericin B (Fungizone) (250 pgIml). 
B. 2 Miscellaneous tissue culture reagents 
Trypsin 
0.25% trypsin in EDTA-Versene. 
D-mannose 
Stock solution; 20% w/v D-mannose in distilled water. Dilute to 1% in TCM for adhesion tests. 
Giemsa 
5% v/v in phosphate buffer (5.447 g Na. 11P04,4.752 g K2HP04 M'X in a mortar, then add Ig of 
mix to 21 distilled water pH 7). 
Reagents for mounting adhesion tests 
1) Acetone 
2) Acetone-Xylene (50/50 v/v) 
3) Acetone-Xylene (33/66 v/v) 
4) Xylene 
5) DePex mountant (BDH). 
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Pontamine Blue (for Infant Mouse Testfor S7) 
Pontamine blue 2% w/v in distilled water. 
C. Immunoassays 
ELISA Solutions 
Carbonate Buffer 
10.6 g Na2CO3 (0.05 M) 
0.406 9 MgCl2.6H20 (0.001 M) 
1 distilled water. 
Dissolve salts separately. Adjust to pH 9.8. 
Diethanolamine buffer 
97 mis diethanolamine 
800 mls distilled water 
0.2 g azide (NaN3) 
100 Mg MgC'2.6H20. 
Make up to II and adjust to pH 9.8 with HCI, store at -4*C in the dark. 
Coating Buffer 
Prepare fresh for immediate use; 
1.59 g Na2C03 
2.93 g NaHCO, 
800 mls distilled water, adjust to pH 9.6 and made up to 11. 
PBS-Tween PBS containing Tween-20 (0.5 ml/1). 
Substrate for Alkaline Phosphate-conjugated immunoglobulins 
Immediately before use dissolve Para-nitrophenol phosphate in diethanolamine buffer (I mg/ml). 
Stop solution 3M NaOH (12 g NaOH in 100 mis). 
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D. Solutions for hybridisation 
D. 1 Probe preparation 
QIAGEIV-tip 5 buffers 
Buffer A 400 mM NaCl, 50 mM MOPS, 15% ethanol pH 7.0 
Buffer B 750 mM NaCI, 50 mM MOPS, 15% ethanol pH 7.0 
Buffer F 1500 mM NaCl, 50 mM MOPS, 15% ethanol pH 7.5 
10 x MOPS h uffer 0.2 M 3-[Morpholinol-propane-sulphonic acid 
0.05 M sodium acetate, pH 7.0 
0.01 M EDTA 
D. 2 Solutions for preparation of colony blots 
1) 10% Sodium dodecyl sulphate (see D. 3) 
2) Alkali denaturing solution (0.5 M NaOH, 1.5M NaCl) 
Ig NaOH, 4.4 g NaCI in 50 mls distilled water. 
3) Neutralising solution (1.5 M NaCl, 0.5 M Tris, pH 8) 
43.8 g NaCl, 30.3 g Tris in 400 mIs distilled water, adjust pH using HCI and make up to 
500 mls. 
4) 2x SSPE (see D. 3 below). Dilute 20x SSPE, 1/10. 
D. 3 Stock solutions 
20x SSC 175.3 g NaCI 
88.2 g Na3 citrate in II distilled water, pH 7.0. 
20x SSPE 78 g NaCl 
15.6 g NaH2P04.2H20 
3.7 g EDTA in II distilled water, pH7.4 
10% SDS 50g sodium dodecyl sulphate dissolved in 400 mls distilled water, 
make up to 500 mls. 
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DA Hybridisation buffers 
DIG hybridisation huffer (usedfor CT at high stringency, VTpolynucleotide and GMI oligonucleotide) 
5x SSC 
1% blocking reagent (BCL) 
0.1% sodium-lauroylsarcosine 
0.02% SDS. 
CT hybridisation buffer (low stringency) 
75 mls Fluka formamide 
30 mls 50x Denhardt's solution 1% (w/v) BSA (bovine serum albumin), 1% (w/v) Ficoll 
(Pharmacia), 1% (w/v) PVP (polyvinylpyrollidone) 
30 mls 20x SSPE 
1.5 ml 20% SDS 
115.5 mls distilled water. 
ST hybridisallon buffer 
6x SSC 
0.1% ficoll 
1% BSA 
0.1% polyvinylpyrolidone (PVP) 
I mM EDTA. 
SNAP-LT and SNAP-ST hybridisation buffer 
5x SSC 
1% SDS 
0.5% BSA 
0.5% polyvinylpyrolidone (PVP). 
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D. 5 Immunological detection of hybrids 
Detection of Digoxigenin labelled probes 
Buffer 1 100 mM Maleic acid 
150 rnM NaCt pH 7.5. 
Buffer 2 1% blocking reagent in buffer I (dissolve 50 - 70oC 30 min or make a IOX 
solution, autoclave and store in fridge). 
Buffer 3 100 mM Tris-HCI 
100 mM NaCl, 50 mM MgC12 pH 9.5. 
Buffer 4 10 mM Tris-HCI 
I mM EDTA, pH 8. 
Colour solution 45 gI Nitroblue tetrazolium (NBT) 
35 gI 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) 
10 mls buffer 3. 
Detection of SNAP probes 
66 VI NBT 
50 gl BCIP 
15 mls Alkaline phosphatase buffer (0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgC'2, pH 9-5). 
D. 6 Southern blot analysis 
Solutions for preparation of genomic DNA 
10 mg/Ml proteinase K (Sigma). 
5M NaCl. 
10% CTAB (Sigma) in 0.7 M NaCl dissolve at 65T. 
24: 1 chlorofonn/isoamyl alcohol. 
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25 g: 24: 1 phenol/cholorfomVisoamyl alcohol. 
isopropanol. 
70% ethanol. 
TE/RNase (5 pl 10 mg/ml RNase in I ml TE). 
Restrktion endonucleases (Gibco-BRL) 
EcoRl Buffcr R3 
Hindll Buffer R2 
BgIII Buffer R3 
Psti Buffer R2 
Xbal Buffer R2 
Buffer R2 - 50 mM Tris-HCI pH 8,10 MM 
MgC'2,50 mM NaCl. 
Buffer R3 - 50 mM Tris-HCI pH 8,10 
MM MgC'2,100 mM NaCl. 
Solutions for Southern blotting 
Depurination solution 0.25 M HCI. 
Denaturing solution 0.5 M NaOH, 1.5 M NaCl. 
Neutralising solution 0.5 M Tris, 1.5 M NaCl, pH 7.4. 
Blotting solution 6x SSC 
D. 7 Solutions for Plasmid preparations 
Solution 1 0.05 M Glucose, 0.01 M EDTA, 0.025 M Tris-HCI pH 8 
Solution 2 0.2 N NaOH, 1% SDS 
Solution 33M Sodium acetate, pH 4.8 
Solution 4 0.1 M Na acetate, 0.05 M Tris-HCI, pH 8 
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E. Protein and LPS analysis 
Lysis buffer protein analysis 
8% distilled water 
20% glycerol 
2% mercaptoethanol 
0.8 g SDS 
70% 0.5M Tris-HCI, pH 6.8 
Lysis buffer incorporating bromophenol blue 
5 mls lysis buffer (above) 
5 mls distilled water 
10 pg bromophenol blue. 
Determination ofprotein using Lowry procedure 
Lowry solution A 2% (w/v) Na2C03 in 0.1 M NaOH 
Lowry solution B 0,5% (W/V) CUS04.5H20 in 1% (w/v) NaK Tartrate 
Lowry solution C Mix 50 mls solution A and Iml solution B. 
Lowry solution D IN Folin-Ciocalteau reagent (BDH) 
Calibration curve for protein concentration 
I ml of protein standard containing I mg BSA, was mixed with 4 mls distilled water. 
Standards were prepared by mixing the following: - 
Protein [tg ml Diluted Standard (ml) Water(ml) 
Blank 0.00 1.00 
so 0.25 0.75 
100 0.50 0.50 
150 0.75 0.25 
200 1.00 0.00 
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5 mls of solution C was added, mixed thoroughly and left for 10 min, followed by the addition of 0.5 ml 
solution D, mixed and left for 30 min. Optical density was read at 500nm. For calibration curve, plot OD500 
on IT axis against ýLg Protein on X axis. 
Calculation for 30 tig protein in a final solubilization. buffer volume of 30 ýLl. 
Volume of protein preparation 30 
Protein conc pg/[tl 
Volume of solubilizer 60 - (the above volume x 2) 
This gives you twice the volume you require. 
LPS Solubilization buffer 
10% (v/v) glycerol 
5% (v/v) 2-mercaptoethanol. 
3% (w/v) SDS 
62.5 mM Tris-HCI pH 6.8 
0.01% (w/v) bromophenol blue 
F. Gel buffers and stains 
F. I. Agarose Gel buffers 
Tris acetate buffer 40 mM Tris 
5 mM sodium acetate 
I mM EDTA, pH 7.9 with glacial acetic acid. 
Tris borate buffer 90 mM Tris 
2 mM EDTA 
90 mM Boric acid. 
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F. 2 SDS-Polyacrylamide gel solutions 
Lower gel buffer (LGB) Tris-HCI 1.5 M pH 8.8, SDS 0.4% 
Upper gel buffer (UGB) Tris-HCI 0.5 M pH 6.8, SDS 0.4% 
Acrylamide 30% (w/v) Acrylamide, 0.8% (w/v) bis-acrylamide. 
Ammonium persulphate (APS) 10% (w/v) make fresh in distilled water. 
Tetramethylethlenediamine use undiluted stock (TEMED). 
Running buffer 6.06 g Tris, 28.8 g Glycine, 2g SDS, make up to 21 with distilled water. 
SDS-PAGE Gel 
Resolving get was 5% acrylamide (10 mls LGB, 13.4 mls distilled water, 16.6 mls acrylamide, 120 RI APS, 
10 ýtl TEMED). 
Stacking gel was 5% acrylamide (2.5 mls UGB, 6 mls distilled water, 1.5 mls acrylamide, 30 gl APS, 10 
ýtl TEMED). 
F3 Stains 
Ethidium bromide for staining DNA gels 
Stock solution - 700 gg/ml in TE buffer 
For use dilute 200 gl in 250 ml distilled water (0.56 gg/ml). 
Bromophenol blue electrophoresis marker 
60% sucrose (w/v), 0.25% bromophenol blue (w/v) in TE buffer. 
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Orange G electrophoresis marker 
60% sucrose (w/v), 0.25% orange G (w/v) in TE buffer. 
Coomassie billiant blue 
50% (v/v) Methanol, 5% (v/v) Acetic acid, 0.025% (w/v) Coomassie Brilliant blue 
Silver stain 
Add 2 mis conc. NH40H to 28 mls 0.1 M NaOH. Add 5 mls 20% silver nitrate with agitation, make up to 
150 mls with distilled water. 
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Appendix 2 
Strain catalogue 
Ref. No. 
E0385750 
E0385870 
E0385890 
E0385980 
E0386510 
E0387800 
E0387850 
E0388200 
E0390530 
E0390560 
E0390590 
E0390860 
E0390900 
E0391810 
E0391930 
E0393640 
E0393810 
E0394040 
E0394460 
E0394570 
E0396650 
E0396830 
E0397190 
E0397980 
E0397990 
E0398000 
E0399340 
E0399410 
E0399470 
E0399740 
E0399800 
E0399950 
E0399960 
List of Vcholerae non-01 and Emimicus by reference number 
0-group Source' Country Diarrhoeaý age sex d 
0? ? Y 23 M 
02 Somalia Y 23 F 
02 Somalia Y 4 M 
5609 Thailand Y 24 M. 
07 Middle East ? ? ? 
0? Saudi Arabia Y ? ? 
041 Nepal Y 49 M 
02 Bangladesh Y ? ? 
05 India ? 51 M 
0? Majorca Y 56 M 
02 Portugal Y ? M. 
5609 Pakistan Y <1 M 
034 Malta Y 77 F 
0? India Y 22 M 
0? sea water 
0? Turkey Y 60 F 
05 blood 7 ? 75 F 
07 bile Iran N 84 M 
0? Malta Y 54 M 
0? China Y ? M. 
027 Spain Y 25 F 
076 Turkey Y 25 M 
OR India Y 29 M 
07 Spain Y I F 
0? Spain Y I F 
0? Spain Y I F 
0? India Y 26 F 
OR India Y 56 F 
0? prawn 
022 Majorca 7 50 F 
04 Saudi Arabia Y ? M 
0? Malta Y ? M 
07 Spain Y 50 F 
an asterix after the reference number indicates the strain is a Vmimicus, other strains were Vcholerae. 
site of isolation or environmental source, strains were isolated from facces unless otherwise stated in this 
column. 
b presence or abscence of diarrhoea; Y= diarrhoea present, N =patient did not have diarrhoea, ? =it was not 
stated whether the patient had diarrhoea or not. 
age is stated in years. 
dM =male; F =female; ? --unknown. 
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Ref. No. O-group Source" Country Diarrhoce age sexd 
E0400160 0? Israel Y 60 M 
E0400530 0? Portugal Y 43 F 
E0400600 07 Turkey Y 31 M 
E0400790 OR pond water 
E0400800 07 pond water 
E0400820 OR pond water 
E0400840 0? Ibiza Y 24 F 
E0400920 054 river 
E0400930 076 marina 
E0402020 0? Tunisia Y 2 M 
E0402080 0? prawn 
E0402100 063 ditch water 
E0402130 063 sea water 
E0402131* 0? sea water 
E0403870 0? Gambia Y ? F 
E0404540 0? Gambia Y ? F 
E0406200 0? Hong Kong ? 63 M, 
E0406310 034 Kenya Y 27 ? 
E0406320 013 SriLanka, Y 47 ? 
E0406700 0? India Y 41 F 
E0409470 05 Bali Y ? M 
E0410500 0? Kenya Y 26 F 
E0410510 0 21 Kenya Y 26 F 
E0412310 0? gull liver 
E0415740 0? SriLanka Y 2 F 
E0415750 0? SriLanka Y 2 F 
E0415760 0? Kenya Y 36 M 
E0416490 046 India Y 46 M 
E0418040 0? Brazil Y 47 F 
E0418250 0? Far East Y ? M 
E0418350 OR Pakistan ? ? ? 
E0418620 0? India Y 40 M 
E0419620 0? India Y ? F 
E0420030 0? India Y ? M 
E0420080 0? river 
E0422560 0? India Y ? F 
E0425960 05 water 
E0425970 0? water 
E0427200 034 India ? 24 M 
E0427510 0 41 Y 26 F 
E0428700 0? water 
E0428710 016 water 
E0428780 013 India Y 53 M 
E0429510 0? Tunisia Y 23 F 
E0429560 07 Y 34 F 
E0429930 034 river 
E0429940 0? river 
E0429950 OR river 
E0429960 OR river 
E0429970 0? river 
E0431050 0? Morocco ? ? M 
E0431490 0? Morocco ? ? M 
E0431820 05 India Y 56 F 
E0432570 013 shrimp 
E0432980 OR Y 48 M 
E0433230 0? prawn 
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Ref. No. O-group, Source* Country Diarrhoeaý age seXd 
E0433300 02 Tunisia ? 36 M 
E0434260 0? Malta ? ? F 
E0434330 0? Malta Y ? M 
E0435040 0? appendix Saudi Arabia ? ? ? 
E0435630 0? Morocco ? 60 M 
E0436400 02 Egypt Y 19 F 
E0436530 OR Morocco Y 21 F 
E0437240 OR Spain 7 ? F 
E0437560 0? shrimp 
E0437580 0? prawn 
E0437600 058 prawn 
E0437610 0? prawn 
E0437650 0? prawn 
E0437730 0? India Y 55 M 
E0438120 058 Tenerife Y 52 F 
E0438430 0? India Y ? M 
E0438540 0 11 blood Arab Emirates ? ? ? 
E0438670 0? Africa ? 40 M 
E0438680 0? Africa ? 40 M 
E0438940 0? prawn 
E0439660 06 Spain Y 8 M 
E0440910 0? prawn Thailand 
E0440920 0? prawn Thailand 
E0440940 0? prawn Nigeria 
E0441180 037 Gambia Y 20 M 
E0441640 0? Majorca Y 38 F 
E0442150 0? prawn 
E0442160 03 prawn 
E0442400 031 Kenya Y 30 F 
E0442530 0? India Y 60 F 
E0443160 0? Egypt Y 58 F 
E0444550 0? mussells 
E0444700 0? cockles 
E0445130 041 food 
E0445140 07 food 
E0445150 0? food 
E0445510 04 river 
E0447000 0 39 Spain Y 26 M 
E0449290 0? Egypt Y 22 F 
E0449430 0? food 
E0449460 041 food 
E0452420 0 37 Kenya Y ? M 
E0453060 062 mussells 
E0453120 041 prawn 
E0453180 0? marina 
E0453570 031 Kenya Y 63 M 
E0455110 0? SriLanka Y 28 F 
E0455180 019 prawn 
E0455190 OR prawn 
E0455200 07 prawn 
E0455210* 014 prawn 
E0455220 0? prawn 
E0455230 0? prawn 
E0456250 OR Bahamas Y 29 F 
E0456960 034 Thailand Y 62 M 
E0458810 0 37 Kenya Y 67 M 
Ref. No. O-group 
E0458820 0? 
E0458830 05 
E0460070 0? 
E0461460 OR 
E04615 10 0? 
E0461520 OR 
E0461530 0? 
E0461540 0 49 
E0462340 0 43 
E0462350 0? 
E0462370 OR 
E0462380 0? 
E0462500 09 
E0462510 07 
E0462720 OR 
E0465041 OR 
E0465051 5609 
E0465060 0? 
E0465070 0? 
E0466840 0? 
E0467630 0 63 
E0467640 0 44 
E0467970 05 
E0467980 OR 
E0467990 0 39 
E0468000 0? 
E0468010 0? 
E0468020 0 56 
E0468030 OR 
E0468040 0 11 
E0468050 0? 
E0468060 0? 
E0468080 0 34 
E0468090 OR 
E0468130 0? 
E0468140 0? 
E0468150 07 
E0468160 0? 
E0468170 011 
E0468180 OR 
E0468190 0 34 
E0468200 OR 
E0468210 OR 
E0468220 0 25 
E0468230 0 67 
E0468240 0? 
E0468250 0? 
E0468260 0? 
E0468270 0? 
E0468280 0? 
E0468290 03 
E0468300 OR 
E0468310 02 
E0468320 0 46 
E0468330 0 20 
E0468340 0 21 
Source' 
shellfish 
shellfish 
shellfish 
shellfish 
shellfish 
shellfish 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
Country 
Pakistan 
Burma 
Madeira 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Thailand 
Diarrhoeaý 
y 
y 
Y 
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age' sex d 
37 m 
52 m 
24 
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Ref. No. O-group Source" Country 
E0468350 0? water Thailand 
E0468360 0? water Thailand 
E0468370 068 water Thailand 
E0468380 062 food Thailand 
E0468390 OR food Thailand 
E0468400 0 13 Thailand 
E0468410 OR Thailand 
E0468420 0? Thailand 
E0468430 OR Thailand 
E0468440 05 Thialand 
E0468450 0? Thailand 
E0468460 076 Thailand 
E0468490 OR Thailand 
E0468820 OR Italy 
E0469050 0? Italy 
E0469060 016 Italy 
E0469490 06 India 
E0469890 OR Kenya 
E0470060 0? Kenya 
E0470580 039 prawn 
E0470590 061 prawn 
E0470600 0? prawn 
E0470610 0? prawn 
E0470620* 034 prawn 
E0470630 OR prawn 
E0470640 0? prawn 
E0470650 0? prawn 
E0470660 0? prawn 
E0470930 0? prawn 
E0471640* 0? prawn 
E0471660 0? prawn 
E0471670 0? prawn 
E0471680 0? prawn 
E0471690 0? prawn 
E0471730 0 19 prawn 
E0471740 019 prawn 
E0471750 0 19 prawn 
E0471760 019 prawn 
E0471770 0 19 prawn 
E0471780 019 prawn 
E0471790 0? prawn 
E0471800 019 prawn 
E0472610 0? Thailand 
E0472700 5609 prawn 
E0472710 5609 prawn 
E0472720 019 prawn 
E0472730 5609 prawn 
E0472740 076 prawn 
E0472750 5609 prawn 
E0472760 07 prawn 
E0472770 0? prawn 
E0472780 019 prawn 
E0472790 019 prawn 
E0475340 OR Venezuela 
E0475350 OR Venezuela 
E0475610 05 S. E. Asia 
Diarrhoea' 
y 
Y 
age 
19 
32 
39 
51 
scx' 
m 
F 
F 
F 
M 
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Ref. No. 
E0475710 
E0478310* 
E0478360 
E0478370 
E0478380 
E0479570 
E0480650 
E0482230 
E0482380 
E0485990 
E0486410 
E0486450 
E0486460 
E0487490 
E0487700 
E0487840 
E0488620 
E0488820 
E0488950 
E0489170 
E0489270 
E0489280 
E0489470 
E0489480 
E0489590 
E0489830 
E0490320 
E0490360 
E0490810 
E0491080 
E0492590 
E0495710 
E0495730 
E0497030 
E0500530 
E0501650 
E0501770 
E0517030 
E0517040 
E0517050 
E0517060 
E0517070 
E0517080 
E0517090 
E0517100 
E0517110 
E0517120 
E0517130 
E0517140 
E0521030 
E0521040* 
E0521600 
E0521610 
E0521620 
E0521630 
E0523450 
O-group 
0? 
039 
0? 
0? 
0? 
0? 
06 
024 
08 
OR 
0? 
0? 
09 
024 
0? 
0? 
0? 
05 
08 
02 
02 
013 
0? 
0? 
034 
0? 
04 
0? 
0? 
014 
0? 
076 
OR 
0? 
024 
0? 
013 
07 
0? 
0? 
03 
0? 
0? 
02 
OR 
014 
014 
OR 
OR 
09 
0? 
OR 
0? 
OR 
OR 
0? 
Source' 
prawn 
prawn 
prawn 
prawn 
blood 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
cockles 
cockles 
cockles 
cockles 
cockles 
Country Diarrhoeaý age sexd 
Minorca Y 18 M 
Turkey Y 34 m 
SriLanka Y 25 F 
Turkey Y ? m 
Jordan ? ? ? 
Greece Y 43 F 
Pakistan Y 42 M 
India Y 50 F 
Tunisia Y 47 F 
Phillipines Y 38 M 
Cyprus Y 22 M 
Tunisia Y 36 F 
India Y ? M 
Thailand Y 43 M 
Tunisia Y 47 F 
Barbados Y 26 F 
Portugal Y 28 ? 
India Y 20 M 
Turkey Y 59 M 
Malta Y 52 F 
India Y 49 M 
India Y 29 M 
Central America Y 49 M 
Kenya Y 65 F 
Chile Y 43 M 
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Ref. No. 
E0523460 
E0523470 
E0523480 
E0523490 
E0523660 
E0523670 
E0523680 
E0523690 
E0523700 
E0523710 
E0523720 
E0523910 
E0523920 
E0523930 
E0523940 
E0523950 
E0523960 
E0523970 
E0523980 
E0523990 
E0524000 
E0524010 
E0524020 
E0524030 
E0525180 
E0525520 
E0526480 
E0527700* 
E0527710 
E0527721 
E0527730 
E0527740 
E0527750 
E0527760 
E0527770 
E0527780 
E0527790 
E0528650 
E0528660 
E0528670 
E0528680 
E0528690* 
E0528910 
E0532880 
E0532900 
E0535170 
E0535720 
E0538010 
E0538890 
E0538900 
E0538980 
E0540410 
E0540480 
E0541170 
E0541220* 
E0541360 
O-group 
OR 
0? 
0? 
0? 
0? 
OR 
0? 
0? 
0? 
OR 
OR 
0? 
0? 
0? 
0? 
07 
0? 
0? 
0? 
0? 
0? 
0? 
OR 
07 
0? 
018 
011 
039 
016 
0? 
0? 
03 
0? 
0? 
0? 
076 
018 
0? 
0? 
058 
013 
0? 
0? 
0? 
081 
0? 
0? 
0? 
037 
07 
0? 
0? 
0? 
05 
020 
0? 
Source' 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
water 
water 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
cockles 
water 
water 
water 
water 
water 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
prawn 
shellfish 
shellfish 
shellfish 
shellfish 
shellfish 
seafood 
seafood 
Country 
India 
Kenya 
Kenya 
Nepal 
Diarrhoeaý 
y 
Y 
age 
43 
18 
56 
sex 
m 
F 
m 
F 
Egypt Y 60 m 
India Y 21 F 
India Y 24 m 
Singapore Y 43 F 
Thailand Y 62 m 
Thailand Y 48 F 
Tunisia Y 27 m 
Egypt Y 53 m 
India Y 32 m 
Phillipines Y 17 m 
Tunisia Y 21 F 
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Ref. No. 
E0542340 
E0543110 
E0543120 
E0543800 
E0543810 
E0543820 
E0543830 
E0544020 
E0544180 
E0544370 
E0544680 
E0545010 
E0545890 
E0546220 
E0546650 
E0546660 
E0547580 
E0548040 
E0548200 
E0548210 
E0548710 
E0548730 
E0549140 
E0549150 
E0549160 
E0549170 
E0549180 
E0549190 
E0549200 
E0549220 
E0549230 
E0549240 
E0549260 
E0549270 
E0549280 
E0549290 
E0549300 
E0549310 
E0549320 
E0549330 
E0549390 
E0549400 
E0549410 
E0549420 
E0549440 
E0549460 
E0549470 
E0549480 
E0549490 
E0549500 
E0549510 
EOS49520 
E0549530 
E0549540 
E0549550 
E0549560 
O-group 
OR 
0? 
OR 
037 
037 
0? 
5609 
024 
037 
04 
0? 1 
034 
013 
024 
02 
OR 
OR 
OR 
OR 
0? 
062 
06 
OR 
OR 
OR 
OR 
OR 
OR 
0? 
0? 
0? 
070 
OR 
OR 
0? 
OR 
OR 
014 
OR 
OR 
0? 
0? 
0? 
0? 
OR 
OR 
014 
OR 
OR 
062 
079 
070 
0? 
025 
OR 
025 
Sourcea 
water 
water 
sewage 
sewage 
sewage 
sewage 
sewage 
sewage 
sewage 
sewage 
sewage 
sewage 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
water 
river 
river 
river 
river 
Country Diarrhoeab agec seXd 
Tunisia 
Spain 
Portugal 
India 
Tunisia 
Spain 
India 
Tunisia 
Tunisia 
Egypt 
Kenya 
India 
Malta 
Tunisia 
Tunisia 
Tunisia 
Tunisia 
Tunisia 
India 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
y 57 m 
y 36 F 
? 46 F 
y 27 m 
y is F 
y 48 m 
y 52 m 
y 19 m 
y 5 F 
y 34 F 
y 37 F 
y 53 F 
y 48 m 
y 22 F 
y 22 F 
y 46 m 
y 18 F 
y ? m 
y 29 m 
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Ref. No. O-group, Source" 
E0549570 0? river 
E0549590 0? river 
E0549600 0? sewage 
E0549610 0 32 sewage 
E0549630 064 sewage 
E0549640 OR sewage 
E0549650 032 sewage 
E0549660 OR water 
E0549670 OR water 
E0549680 0? water 
E0549690 034 water 
E0549700 0? water 
E0549710 OR water 
E0549720 041 water 
E0549740 0? water 
E0549830 06 water 
E0549880 04 water 
E0549890 0? water 
E0549900 0? water 
E0549930 OR water 
E0549940 0? water 
E0549960 OR water 
E0549970 0? water 
E0549990 0? water 
E0550000 OR water 
E0550010 OR water 
E0550070 OR 
E0550160 OR 
E0550230 OR 
E0551210 0? 
E0551220 0? 
E0551300 042 blood 
E0551400 0 13 
E0551770 0? 
E0551780 0 58 
E0552690 0? 
E0553120* 0? prawn 
E0553140 07 
E0554130 07 
E0554140 0? ? wound 
E0554150 0? ? wound 
E0554160 0? Uound 
E0555100 07 
E0556620 OR 
E0558790 07 
E0558820 0? fish tank 
E0561090* 0? shrimp 
E0565660 0? 
E0568720 09 prawn 
E0570240 0? prawn 
E0570250 0? prawn 
E0570260 0? prawn 
E0571210 0? 
E0572000 0? prawn 
E0572010* 0? prawn 
E0572020* 0? prawn 
Country Diarrhoea' age' sex' 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
Italy 
India Y 21 F 
Tenerife Y 38 F 
Malta Y ? F 
India Y 20 F 
India Y ? M 
India ? ? ? 
India Y 35 F 
Bali Y 39 F 
Turkey Y 68 F 
India Y 24 M 
Malaysia 
Morocco Y ? F 
Egypt ? 23 M 
46 M 
46 M 
46 m 
Spain Y 23 F 
India Y 66 M 
Egypt Y 22 M 
U. S. A. 
Maldives y 41 F 
Bali ? 36 F 
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Ref. No. O-group Source' Country Diarrhoeaý age' sex 
d 
E0572030 0? prawn 
E0572040* 0? prawn 
E0572050* 0? prawn 
E0572060 032 prawn 
E0572070 0? prawn 
E0572080 079 prawn 
E0572090 0? prawn 
E0572100* 0? prawn 
E0572280 0? Kenya ? ? F E0572760 079 prawn 
E0575890 0? prawn 
E0575900 07 prawn India 
E0575910* 0? prawn India 
E0576910 OR Peru Y 2 F E0576930 OR Peru ? I F E0576990 OR Peru ? <1 M E0577100 OR Peru Y I F E0577120 0? Peru Y 2 M E0578560 0? prawn India 
E0578570 067 prawn India 
E0578740 02 Tenerife Y 24 M E0580170 013 India ? 31 F E0580500 0? India Y 27 F E0580510 043 prawn Malaysia 
E0580520* 0? prawn Malaysia 
E0580600 0? Iraq Y 30 M E0583100 0? S. E. Asia Y ? M E0583450* 0? prawn 
E0583460* 0? prawn 
E0583470* 0? prawn 
E0584120 0? Pakistan Y 35 M E0584630 0? Nepal Y 20 F E0585220 02 Iraq Y 45 M E0585460 0? India Y 13 F E0588150 OR Tunisia Y 26 M E0588470 0? shrimp S. E. Asia 
E0588480 OR shrimp S. E. Asia 
E0588590 0? shrimp S. E. Asia 
E0588600 049 shrimp S. E. Asia 
E0588620 049 shrimp S. E. Asia E0588630 0? shrimp S. E. Asia E0588640 049 shrimp S. E. Asia E0588890* 06 prawn Malaysia 
E0588920* 06 prawn Malaysia 
E0588940* 0? prawn Malaysia 
E0589340 0? Tunisia ? 4 M E0589730* 041 prawn Malaysia E0590530 022 Dominica Y 23 F E0591020 OR Australia Y 42 F E0591440 OR shrimp E0591450 OR shrimp 
E0591460 OR shrimp E0591461 OR shrimp E0591720 0? Tunisia Y 37 M E0593240 0 11 India Y E0594190 0? Spain 
30 F 
Y 10 M 
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E0594240 0? Tunisia Y 24 M 
E0594250 0? Majorca Y 26 M 
E0595200* 0? prawn Malaysia 
E0595210* 0? prawn Malaysia 
E0595220* 0? prawn Malaysia 
E0595230 0? prawn Malaysia 
E0596060 0? Malta Y 30 F 
E0596800 013 India Y 25 F 
E0597160 0? Tunisia Y 49 F 
E0598350 013 Far East Y 32 F 
E0598360 OR Egypt Y ? F 
E0599130 OR Caribbean Y 45 M 
E0601500 034 Egypt Y 50 F 
E0602560 0? Pakistan Y 46 F 
E0602640 0? prawn 
E0602790 OR Canary Islands Y 60 M 
E0603900 039 shrimp 
E0603910 0? shrimp 
E0603920 039 shrimp 
E0603930 0? shrimp 
E0604220 0? Pakistan Y 35 M 
E0605440 OR Ibiza Y 52 M 
E0605940 0? shrimp 
E0608900* 071 prawn 
E0608910* 0? prawn 
E0608920* 0? prawn 
E0609460 061 India Y 55 M 
E0612460 0? shrimp 
E0612470 0? shrimp 
E0616380* 0? prawn 
E0616450 0? sea water 
E0616460 0? sea water 
E0616470 0? sea water 
E0616480 0? sea water 
E0616490 0? sea water 
E0616500 063 sea water 
E0616510 0? sea water 
E0617300 0? prawn 
E0617800 0? prawn 
E0617810 0? prawn 
E0617820 0? prawn 
E0617830 0? prawn 
E0617840 0? prawn 
E0617850 0? prawn 
E0617860 0? prawn 
E0618470 0? prawn 
E0618480 0? prawn 
E0619460 0? prawn 
E0619470 0? prawn 
E0619480 0? prawn 
E0620810 0? prawn 
E0621250 0? prawn 
E0621260 0? prawn 
E0621270 019 prawn 
E0621280 0? prawn 
E0623100 061 sea water Barbados 
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E0625890 0? Thailand Y 65 F E0626030 0? India ? 53 m E0626350 0? Kenya ? 60 F E0626360 0? Kenya Y 60 M E0626750 02 Thailand Y 49 M E0629040 0? Australia ? ? M E0630990 010 Kenya Y 28 F E0634530* 0? Thailand Y 25 F E0635850 02 India Y 26 F E0636240 0 10 Kenya Y 33 F E0637300 0? India Y 32 M E0638070 014 Kenya ? ? F E0638900 0? Caribbean Y 30 M E0638910 0? Kenya Y 20 M E0641090* 0? seafood 
E0644110* 0? seafood 
E0642630 038 S. Africa Y 48 m E0643660 079 Nigeria Y 29 F E0644300 0? Singapore Y 52 m E0644630 0? Cyprus Y 53 M E0645020 0? Kenya Y 64 F E0645710 0? Kenya Y 25 F E0646300 0? Kenya Y ? F E0646920 0 39 Pakistan Y ? M E0647530* 0? prawn 
E0647540* 039 prawn 
E0649950 079 Kenya Y 34 M E0650940 0? Kenya Y 44 F E0651110 09 prawn 
E0651680 0? India Y 26 F E0652490 0? Kenya Y ? F E0653130 02 Morocco Y 24 F E0653140 02 Morocco Y 25 M E0653490 OR Pakistan ? 20 M E0653750 0? St. Lucia Y 23 F E0654150 0? India Y 23 M E0654850 0? Africa Y 43 M E0655400 07 Morocco Y 44 m E0656440 0? India Y 46 m E0656730 0? Turkey Y 37 F E0657770 07 India Y 41 m E0657960 0? Turkey Y 24 F E0658420 0? prawn 
E0658430 0? prawn 
E0658440 0? prawn 
E0658450 0? prawn 
E0658470 0? prawn E0658480 09 prawn E0658490* 0? prawn E0659760 0? Kenya Y 31 M E0660580 0? Pakistan Y 2 M E0660590 0? Kenya Y 35 m E0660600 0? carp E0660830 0? Kenya Y 52 F E0661830 0? India Y 28 M E0662580 0 81 Kenya Y 47 F 
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E0663710 0? Tunisia Y 46 M 
E0665440 0? ? Y 19 M 
E0666160 0? Nigeria 7 30 M. 
E0667360 0? chicken feed 
E0668100 068 food 
E0668110 0? food 
E0668230 0? Morocco Y 58 F 
E0668240 0? Tunisia Y 41 M 
E0668250 039 Tunisia Y 26 F 
E0669520 056 river 
E0672520 0? Thailand Y 25 F 
E0672870 OR river 
E0673430* 0? prawn 
E0674480 0? Kenya Y 28 M 
E0675140 0? Thailand Y ? M 
E0675320 0? Kenya Y 36 F 
E0677930 0? Africa Y 44 M. 
E0679740 07 Kenya Y 27 M 
E0681510 0 11 prawn 
E0681520* 0? prawn 
E0681920 0 51 ear ? 19 M. 
E0682890 OR Thailand Y ? M 
E0685570 0? Kenya Y 20 F 
E0685860 OR SriLanka Y 43 M 
E0686080 0? Kenya Y 43 F 
E0686550 0? prawn 
E0688830 OR river 
E0688840 0? river 
E0688850 OR river 
E0688860 OR river 
E0698550 0? shrimp Far East 
E0698560 081 shrimp Far East 
E0698570 081 shrimp Far East 
E0698580 0? shrimp Far East 
E0698590 0? shrimp Far East 
E0700030 014 Pakistan Y 35 M 
E0703970 0 37 shrimp ? 
E0703980 0 37 shrimp ? 
E0705870 0 38 Africa Y 41 M 
E0706330 0? Ghana Y ? F 
E0706820 0? shrimp ? 
E0707640 0? shrimp ? 
E0707890 0? India Y 37 M 
E0708340 OR India Y 27 F 
E0709640 0? prawn Malaysia 
E0709650* 5609 prawn Malaysia 
E0709660 OR prawn Malaysia 
E0709670* 5609 prawn Malaysia 
E0709680* 043 prawn Malaysia 
E0709690* 0 43 prawn Malaysia 
E0709691* 043 prawn Malsysia 
E0709700* 043 prawn Malaysia 
E0709860 OR India ? 33 F 
E0709870 OR Kenya Y 43 M 
E0709880 0? Kenya Y 26 F 
E0709890 0? Kenya Y 37 F 
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d 
E0711490 0? Kenya Y 22 M 
E0711800 0? sea water 
E07118 10 0? shrimp Ecuador 
E0711820 0? shrimp Ecuador 
E0711830 037 shrimp Ecuador 
E0711840 5609 shrimp Ecuador 
E0712560 0? Thailand Y 36 ? 
E0713280 0? river 
E0713290 02 Egypt Y I M 
E0713300 02 Egypt Y 4 F 
E07133 10 02 Egypt Y 38 F 
E0715670 0? Kenya Y 23 F 
E0716190 0? Dominica Y 66 F 
E0716760 OR Pakistan ? ? ? 
E0716770 0? India ? 27 M 
E0717210 0 38 Kenya Y 40 M 
E0718850 07 India Y ? M 
E0720240 0? Kenya Y 33 F 
E0720600 0? Kenya ? 22 F 
E0722010 0? Kenya Y 39 F 
E0722360 0? river Chile 
E0722370 0? river Chile 
E0722380 0? river Chile 
E0722390 0? river Chile 
E0722400 0? river Chile 
E0722410 0? river Chile 
E0722420 OR river Chile 
E0722430 0? river Chile 
E0722440 0? river Chile 
E0722450 0? river Chile 
E0722460 0? river Chile 
E0722470 0? river Chile 
E0722490 0? canal water Chile 
E0722500 07 canal water Chile 
E0722510 0? canal water Chile 
E0722520 0? canal water Chile 
E0722530 0? water Chile 
E0722540 0? river Chile 
E0722550 0? river Chile 
E0722560 0? swab Chile 
E0722570 0? vegetable Chile 
E0722580 0? water Chile 
E0722590 0? sewage Chile 
E0725910 0? Kenya Y 63 M 
E0726980 0? India Y 33 M E0727750 OR Thailand ? ? F E0727920 010 shrimp 
E0728710 0? Tunisia Y 66 F E0728720 0? India Y 24 M E0728760 OR Mexico Y ? M E0729630 0? Egypt ? 27 M E0730500 0? N. Africa ? 46 F E0730590 022 Tunisia Y 90 M E0731000 0 38 mussels 
E0731010 OR mussels 
E0731540 0? Pakistan Y 53 M 
Ref. No. O-group Source Country Diarrhoeaý a e' d g sex 
E0731550 0? Malta Y 46 F E0731560 0? Malta Y 48 M E0731600 0? Malta Y ? F E0732750 0? ear ? E0733170 0? Kenya Y 
22 F 
E0733180 OR Pakistan ? 
58 F 
E0734670 049 India Y 
? F 
E0734680 0? India Y 
23 F 
E0735030 02 India Y 
25 F 
E0735050 0? Tunisia Y 
7 M 
E0736890 OR Tunisia Y 
44 F 
E0736900 0? Tunisia Y 
34 M 
E0738080 0? Tunisia Y 
40 M 
E0738790 0? Tunisia Y 
26 M 
E0739900 0? India Y 
20 M 
E0739910 0? India Y 
20 F 
E0739920 09 Tunisia ? 
20 F 
E0740300 0? Greece ? 
? F 
E0740960 0? 7 M 
E0741400 0? India 
Y 
Y 
53 F 
E0742220 0? Kenya Y 
12 ? 
E0743700 OR India Y 
29 M 
E0744370 0? Kenya Y 
27 F 
E0744380 OR Kenya Y 
50 M 
E0744640 010 Malta Y 
30 M 
E0745240 07 Kenya Y 
62 M 
E0745250 0? 34 F 
E0745930 0? Cyprus Y 
? M 
E0746750 027 Kenya Y 
59 F 
E0746760 OR Malta ? 
26 F 
E0747000 0? Turkey Y 
66 F 
E0747120 5609 India Y 
68 M 
E0747680 02 Kenya Y 
71 F 
E0747690 0? Kenya Y 
52 F 
E0748540 OR Kenya Y 
31 M 
E0749910 024 Gambia Y 
51 F 
E0751660 OR Africa Y 
27 M 
E0751850 OR Tunisia Y 
53 M 
E0753120 OR Jamaica Y 
30 M 
E0755960 076 45 F 
E0756060 OR Pakistan 
7 
Y 
? M 
E0756400 OR Thailand ? 
? ? 
E0756730 0? ? M 
E0757640* 014 prawn 
Kenya ? 64 F 
E0757650 0? prawn E0757651 0? prawn E0757690 0? prawn E0757710* 020 prawn E0757730* 020 prawn E0758010 0? prawn E0758040 07 prawn E0758820 OR scallops E0758830 OR river E0758840 OR sea water E0758841 0? sea water E0759130 OR Kenya Y 70 F 
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E0761570 OR Kenya Y 34 F 
E0761720 0? Bali Y 27 F 
E0761730 0? mussels 
E0763370* 0? prawn India 
E0764570* 014 prawn India 
E0767960 0? Indonesia Y 43 M 
E0771110* 0? prawn Bangladesh 
E0774660 OR U. S. A. Y 52 M 
E0781150 0? U. S. A. Y 47 M 
E0781160 024 Kenya Y 58 M 
E0783840 048 Mexico Y 
E0783850 07 Mexico Y 
E0783860 05 Mexico Y 
E0783870 0? Mexico Y 
E0783880 0? Mexico Y 
E0783890 024 Mexico Y 
E0786870 0? Kenya Y 34 F 
E0790380 OR Kenya ? 42 F 
E0790390 0 39 India Y 7 M E0790400 0? India Y 31 F E0791240 0? Kenya Y 27 F E0791480 0? Bali ? 27 M E0791920 OR Meditteranean 55 M E0791930 08 Kenya Y 41 F E0793210 OR India Y 62 M E0794310 0? Kenya Y 24 F E0794890 OR Kenya Y 41 M E0795470 0? Kenya Y 21 F E0796790 0? Kenya Y 63 M E0797420 OR Africa Y 49 F E0797770 0? Indonesia ? 51 F E0798240 0? Portugal Y 22 M E0798580 0? Kenya Y 40 F E0799010 OR Saudi Arabia 27 F E0799020 OR Tenerife 41 F E0799410 0? Kenya ? 32 F E0800490 09 India ? 58 M E0801200 0? India Y 64 M E0804190 0 79 Kenya Y 46 F E0806710 0? India Y 38 M E0807120 OR Kenya Y 54 M E0808490 0? Phillipines Y 32 M E0812420 0? Kenya ? 48 F E0812430 026 ? Y 58 M E0813420 0? Caribbean Y 40 M E0814310 0? Kenya Y 30 M E0814810 0? Kenya Y 27 M E0815380 02 Malta Y 27 M E0818000 0? Tunisia Y 35 M E0818420 0? India Y 25 F E0818430 0? Tunisia Y 8 F E0819210 09 Mediteranean Y 65 M E0819260 OR ? Y 30 F E0819600 03 Pakistan ? 60 M E0820820 0? Turkey Y 22 M E0822080 0? ? Y 84 F 
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E0822100 0? India Y 25 M 
E0822110 0? Tunisia Y 51 F 
E0822450* 0? Caribbean Y ? M 
E0822460 0? Kenya Y 30 m 
E0822900 051 Tunisia Y 46 F 
E0824060 0? Kenya ? 3 F 
E0824560 024 India Y 19 F 
E0825070 028 Tunisia Y 46 F 
E0825800 OR Israel Y 59 F 
E0825820 OR Tunisia Y 49 M 
E0826210 0? India Y 20 m 
E0826660 0? Tunisia Y 24 F 
E0827100 079 Tunisia Y ? F 
E0827680 0? Kenya Y 53 M 
E0827900 0? Tunisia Y 41 F 
E0828290 0? prawn 
E0829250 0? Tunisia Y 40 F 
E0829470 0? Portugal Y 50 F 
E0829480 0? Tunisia ? 30 F 
E0830310 0? Tanzania Y 47 F 
E0830320 0? Kenya Y 23 ? 
E0830960 0? Malta Y 53 M 
E0831840 0? India Y 24 F 
E0835300 0? Senegal N 5 M 
E0836520 03 Kenya Y 26 F 
E0837540 036 fish tank 
E0837550 036 fish tank 
E0837560 0? fish tank 
E0837830 0 11 Kenya Y 44 F 
E0838570 0? India ? 30 F 
E0839110 0? Tunisia Y 69 F 
E0839120 09 Malta Y 57 M 
E0839540 07 Malta Y 59 M 
E0842380 0? Kenya Y 53 F 
E0843670 0 20 Kenya Y 43 F 
E0846760 0? Kenya Y 20 m 
E0847480 0? Nepal Y 44 M 
E0849140 0? Kenya Y 40 F 
E0850550 058 pond water 
E0850560 0 58 pond water 
E0850570 02 pond water 
E0850580 0? fish 
E0850590 0? fish 
E0850600 0 50 fish 
E0850610 0 50 fish 
E0850620 0? pond water 
E0850630 0? pond water 
E0850660 079 pond water 
E0850670 079 pond water 
E0850710 0 58 pond water 
E0850720 0 58 pond water 
E0850760 02 pond water 
E0853930 03 India ? 62 F 
E0859150 OR Kenya Y 40 M 
E0859420 0? Kenya Y 67 F 
E0859430 0139 ? Y ? ? 
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E0861310 0? Mexico Y 
E0861320 0? Mexico Y 
E0861330 OR Mexico Y 
E0861340 0? Mexico Y 
E0861350 OR Mexico Y 
E0862520 0? Kenya Y ? ? 
E0862700 0139 Bangladesh Y 36 M 
E0863080 OR Kenya Y 54 M 
E0865290 0? ? 30 F 
E0867320 0? Kenya Y 74 M 
E0867670 07 Egypt Y 26 F 
E0867860 0? Bangladesh Y 32 M 
E0869710 OR S. Africa Y 55 F 
E0869990 09 Kenya Y 28 F 
E0870000 09 Kenya Y 28 F 
E0871850 046 India Y 30 M 
E0871860 OR Kenya Y 31 M 
E0871870 OR blood Caribbean ? 
E0871880 0? Caribbean ? 
E0871890 OR spring Caribbean 
E0871900 0? spring Caribbean 
E0871910 OR spring Caribbean 
E0871920 OR spring Caribbean 
E0871930 OR spring Caribbean 
E0871940 OR spring Caribbean 
E0871950 OR pond water Caribbean 
E0871960 0? water Caribbean 
E0871970 OR water Caribbean 
E0871980 OR water Caribbean 
E0871990 OR water Caribbean 
E0872000 0? Caribbean ? M 
E0872010 OR water Caribbean 
E0872020 02 water Caribbean 
E0872030 OR water Caribbean 
E0875090 0139 India Y 68 ? 
E0875650 0? Kenya Y 31 M 
E0875670 0? Thailand Y 23 M 
E0875680 0? ? ? 36 F 
E0877390 0? blood Saudi Arabia ? 29 F 
E0877560 037 Turkey Y 33 M 
E0877980 065 Dominica Y 28 M 
E0879540 0139 India Y 25 F 
E0881060 0? Tunisia Y ? M 
E0881310 0139 India Y 19 M 
E0881610 0? Kenya ? 60 F 
E0882660 0? India ? 25 F 
E0883660 OR Tunisia Y ? M 
E0883830 076 Egypt Y 47 M 
E0884100 0 11 Far East Y 50 M 
E0885010 OR Tunisia 1? 29 F E0885550 OR Tunisia Y 61 M E0886040 OR Bulgaria ? 47 M E0886590 0? Malta ? 44 F E0886600 0? Malta Y 44 F E0886980 0? Majorca Y ? F E0890050 OR Dominica Y ? M 
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E0890060 OR ? Y 22 F 
E0890070 0139 India Y 30 M 
E0890240 OR Tunisia Y 30 M 
E0893320 0? India Y 45 F 
E0893590 OR Pakistan Y 46 M 
E0893880 OR Tunisia Y 41 F 
E0894160 07 India Y 2 F 
E0894660 0? Gambia Y 35 F 
E0895160 OR Thailand Y 16 F 
E0895360 0? Tunisia Y 47 F 
E0895370 0? Kenya Y ? F 
E0896190 0? Thailand Y 47 F 
E0896730 0? India Y 4 F 
E0896920 0? Egypt Y 23 M 
E0896930 0? Tunisia Y 54 F 
E0897550 014 India Y 23 M 
E0898030 0? Tunisia Y ? M 
E0898590 024 Morocco ? ? 7 
E0898600 07 ? Y 68 F 
E0899080 0? Tunisia Y 60 F 
E0900590 0? Japan Y 53 M 
E0900670 0139 Pakistan Y 
E0900700 0139 Pakistan Y 
E0900701 0139 Pakistan Y 
E0901300 0? Pakistan Y 23 M 
E0901660 0? Mexico 
E0901670 0? Mexico 
E0901680 0? Mexico 
E0901690 0? Mexico 
E0901700 0? Mexico 
E0901710 07 Mexico 
E0901711 0? Mexico 
E0901720 0? Mexico 
E0901730 07 Mexico 
E0901740 0? Mexico 
E0901750 0? Mexico 
E0901751 0? Mexico 
E0901760 0? Mexico 
E0901770 OR Mexico 
E0902510 0139 Thailand Y 25 F 
E0902620 0? Greece Y I F 
E0902920 0? India Y 19 M 
E0905580 5609 Tunisia ? ? ? 
E0905590 0? Tunisia Y 25 M 
E0905900 0? Far East Y 52 F 
E0906290 0? Dominica ? 25 F 
E0906450 0? India Y 21 F 
E0906550 0 38 India Y ? F 
E0906800 0? Tunisia Y 41 M 
E0907270 0? Bali Y 45 F 
E0907280 0? Hong Kong Y 35 M 
E0908110 0? Mexico Y ? ? 
E0909760 051 Tunisia Y 44 M 
E0909970 0? E. Africa Y 74 F 
E0910220 0 58 ? 22 F 
E0910560 0? shrimp 
Ref. No. O-group Sourcea Country Diarrhoeaý age' sex 
d 
E09109 10 0? S. E. Asia ? 68 F E0910960 0? ? Y 38 M E0911730 0? Gambia Y 47 F E0913350 0? Kenya Y 27 F E0913360 0? Kenya Y 27 M E0914060 0? Kenya Y 52 F E0917230 0? ? ? E0918440 066 Kenya Y 
23 
25 
F 
F E0918450 5609 India Y 33 M E0918900 035 Bali Y 26 F E0919260 0? wound ? ? ? E0923140 0? Gambia ? 20 
M 
F E0926260 049 Kenya Y 39 F E0926600 0139 Bangladesh Y 54 M E0928210 09 SriLanka Y 45 M E0930630 038 Peru ? I E0932340 029 India Y 53 
F 
M E0933070 066 Kenya Y 47 F E0933260 027 India Y 38 F E0933430 5609 Middle East Y 61 F E0934720 0? king prawn Thailand 
E0934730 0? red mullet Thailand 
E0935980 0? Kenya Y 73 E0936200 0? Kenya Y 61 
F 
E0936680 0? SriLanka Y ? 
F 
E0938110 0 37 7 ? 
F 
E0938180 0? Kenya Y E0938190 0? shrimp 
55 F 
E0939070 018 India Y E0940650 057 Kenya Y 
38 M 
E0941090 0? Saudi Arabia Y 
26 M 
E0941100 0? India Y 
5 F 
E0941110 0? Bali Y 
23 M 
E0943180 0? India Y 
88 M 
E0943830 OR blood 40 F 
E0944950 0? ? 
? 78 M 
E0948750 0? Kenya 
Y 
Y E0949020 0? Oman ? 
23 F 
E0949030 0? India Y 
? M 
E0949760 0? India Y 
33 M 
E0951350 0? ? 
64 M 
E0954220 0? Kenya 
? 
Y 
62 F 
E0954230 0? Singapore Y 
38 M 
E0955910 0? Pakistan Y 
48 F 
E0957320 0? Kenya Y 
M 
E0959510 0? shrimp 
49 M 
E0961300 0? Pakistan Y E0964380 0? Kenya Y 
? F 
E0965140 09 Kenya Y 
26 F 
E0968040 024 62 F 
E0968320 09 
India Y 19 F 
E0968600 0? 
Morocco Y 64 F 
E0968930 0? 
SriLanka Y 31 F 
E0969040 0? 
Tunisia Y 25 F 
E0969610 0? Tunisia Y ? F 
E0970800 0? India Y 37 M Kenya Y 48 M 
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E0971960 0? Dominica Y 22 M 
E0972150 027 Pakistan Y 40 M 
E0973520 06 Majorca Y 39 F 
E0973600 0? Turkey Y 55 M 
E0973980 034 India Y 21 M 
E0973990 019 Tunisia Y 31 M 
E0975310 0? Pakistan Y I M 
E0976190 0? Tunisia Y 27 M 
E0976710 057 Tunisia Y 48 F 
E0977730 0? India Y 25 M 
E0977740 0? Thailand Y 24 M 
E0977750 0? Dominica Y 24 F 
E0978430 0? India Y 19 F 
E0978730 0? ? Y <1 M 
E0978940 0? Kenya Y 25 F 
E0979500 09 Tunisia Y 44 F 
E0979910 0? Malta Y 70 F 
E0979920 0? India Y 2 F 
E0980230 0? Tunisia Y ? F 
E0981250 09 Tunisia Y 46 M 
E0982340 07 Turkey ? ? F 
E0983040 0? Tunisia Y 45 F 
E0983870 0? India Y 58 M 
E0984680 0? South America Y 29 F 
E0984690 0? Tunisia Y 30 F 
E0985930 0? Thailand Y 26 M 
E0985940 0? India Y 21 M 
E0987320 07 Tunisia Y 52 M 
E0987840 0? Caribbean Y 47 M 
E0988160 0? India Y ? M 
E0988840 0? India Y 21 F 
E0988850 0? Sri Lanka Y 32 F 
E0989000 0? Tunisia Y 44 F 
E0989670 0? Nepal Y 35 F 
E0989680 0? Sri Lanka Y 72 F 
E0989690 07 Turkey Y 28 F 
E0989700 0? fish tank 
E0989940 0? Malta Y 53 F 
E0989950 09 Tunisia Y 55 F 
E0989960 09 Tunisia Y 28 F 
E0990720 0? India Y 32 F 
E099073 0? 7 ? ? F 
E0991350 0? Kenya Y 24 F 
E0991410 0? ? Y 50 F 
E0991900 09 Sri Lanka Y 28 F 
E0992030 065 Greece ? 65 M 
E0992040 028 Kenya Y 52 M 
E0992560 09 shellfish 
E0993170* 0? fozen fish 
E0993420 0 11 Tunisia Y 40 F 
E0994200 0? Kenya Y 25 F 
E0994320 09 Malta Y 51 M 
E0994510 0? India Y 26 F 
E0994920 0? Turkey Y 49 F E0994930 0? Tunisia Y 62 M E0994940 0? Africa Y 29 M 
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E0995570 0? Tunisia Y 56 F E0995580 0? India Y 26 F E0995950 0? Tunisia Y 53 F E0996020 0? Kenya Y 52 F E0996400 0? Tunisia ? 58 F E0997480 0? Turkey Y 24 F E0997560 0? Turkey ? 63 F E0998200 0? Dominica Y ? M E0998910 09 Dominica ? 58 M E0998920 0139 Pakistan Y 33 F E0999170 0? Tunisia Y 35 F E1000670 0? Malta Y 48 F E1000680 0? Turkey Y 54 M E1000690 0139 India Y 33 F E1000950 02 blood N. Africa ? ? M E1003320 OR Kenya Y 64 F E1004220 09 Egypt Y 26 F E1004530 0? Tunisia ? 51 F E1004790* 0? India Y 34 M E1006290 0? Thailand Y 32 F E1008270 07 Kenya Y 40 F E1010660 07 Tenerife Y 3 M E1011200 065 Indonesia Y 27 M E1011480 09 Kenya Y 63 M 
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Abstract 
The polymerase chain reaction has been used to differentiate the gene which encodes the toxin co-regulatedpili (tcpA) of 
the El Tor and classical biotypes of Vibrio cholerae 01. The same PCR primers were applied to strains belonging to non-01 
serogroups that produced cholera toxin. The size of fragment amplified was either identical to the tcpA of biotype EI Tor 
(471 bp) or to the tcpA of biotype classical (617 bp). All strains belonging to the novel epidemic serogroup 0139 generated 
a 471-bp fragment identical to El Tor tcpA. The present study suggests that there may be an association between non-01 
serogroup and tcpA type. 
Keywords: Vibrio cholerae non-01; Toxin co-regulated pilus; Polymerase chain reaction 
1. Introduction 
Vibrio cholerae serogroup 01, biotypes El Tor 
and classical, have traditionally been the causative 
agents of epidemic cholera. V. cholerae non-01 
serogroups have been implicated in sporadic cases 
and outbreaks of gastrointestinal disease which are 
sometimes clinically indistinguishable from cholera 
[2,81. However, there were no recorded epidemics 
caused by non-01 serogroups until 1992, when the 
novel serogroup 0139 was described [1,10]. 
Scrogroup 0139 has become widespread causing 
thousands of cholera cases in the Indian subcontinent 
and adjacent countries. In certain areas 0139 ap- 
* Corresponding author. Tel.: (+44-81) 200 4400 ext. 3172; 
Fax: (+44-81) 905 9929 
peared to be replacing serogroup 01 as the predomi- 
nant cause of cholera. However, recent observations 
indicate epidemics caused by V. cholerae 0139 are 
followed by an endemic situation in which V. 
cholerae 01 subsequently reappears [151. 
Epidemic 01 and 0139 strains produce cholera 
toxin (C17), which is responsible for the secretory 
diarrhoea characteristic of cholera. The toxin co-reg- 
ulated pili (TCP), comprised of a 20.5-kDa pilin 
subunit called TcpA, are involved in the successful 
colonization of V. cholerae in the small intestine 
[121. The TcpA gene, tcpA, and the CT genes, =4 
and ctxB, are coordinately regulated by environmen- 
tal signals requiring a regulatory protein, ToxR [14]. 
ToxR is a transmembrane protein which positively 
regulates these and other virulence factors at the 
level of transcription. All V. cholerae 01 and non-01, 
regardless of whether they are toxigenic or non-toxi- 
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Table I 
Characterization of V. cholerae strains by hybridization with a CrA,. 1, probe and by PCR detection of cIxB and tcpA 
Strain Source Country Serogroup Biotype Probe CrA. B PCR 
caB cpA b 
10954/1 TS Asia 01 Ogawa El Tor + + E 
8457/5 TS Asia 01 Inaba El Tor 
E47021 w ? 01 Inaba El Tor + + E 
E51116 ? Bangladesh 01 Ogawa Classical + + C 
E51165 ? Bangladesh 01 Ogawa El Tor + + E 
N108 w Australia 01 Inaba El Tor + + E 
N122 w Australia 01 Inaba El Tor + + E 
E90164 ? Mexico 01 Inaba El Tor + + E 
E90165 ? Mexico 01 Inaba El Tor + + E 
E46949 D India 06 
E48065 D Sri Unka 06 
E58892 S Malaysia 06 
N2 w Australia 06 ' + + E 
N87 w Australia 06 ' + + E 
317-71 TS Asia 023 
N7 w Australia 023 ' + + C 
N9 w Australia 023 ' + + C 
N92 w Australia 023 ' + + C 
1322-69 TS Asia 037 + + C 
E54380 D India 037 
E54381 D Tunisia 037 
E54418 D Tunisia 037 
1154-74 TS Asia 049 
E58864 S S. E. Asia 049 
WBDV-101E D Thailand 049 d + + 
E73467 D India 049 
E85943 D ? 0139 + + E 
E86270 D Bangladesh 0139 + + E 
E87509 D India 0139 + + E 
M045 TS India 01391 + + E 
E87954 D India 0139 + + E 
E88131 D India 0139 + + E 
E89007 D India 0139 + + E 
E90067 D Pakistan 0139 + + E 
E90070 D Pakistan 0139 + + E 
E90158 D ? 0139 + + E 
E90159 D ? 0139 + + E 
E90251 D Thailand 0139 + + E 
E55413 D Egypt 0? 1 
E55879 D Egypt 0? + + E 
E66371 D Tunisia 0? + + E 
E66824 D Tunisia 0? 
CA385 TS Asia ORough ++ C 
TS, type strain, kindly provided by Dr. R. Sakazaki; W, strain isolated from water; ?, source or country unknown; D, strain isolated fron, b 
a case of diarrhoea; S, strain isolated from shellfish . tcpA PCR results recorded as: Cý 617-bp amplicon identical to tcpA of the classical 
biotype; F, 471-bp amplicon identical to tcpA of the El Tor biotype; -, negative, no amplicons detected. " Strains kindly provided by Dr. 
P. Desmarchelier. d Strain kindly provided by Dr. P. Echeverria. " Strain kindly provided by Dr. T. Shimada. f 0?, untypabic with 
antisera. against 01-083 and 0139. 
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genic, appear to possess toxR regulatory sequences. 
However, all three components, TcpA, CT and ToxR, 
are essential for V. cholerae 01 pathogenesis [6]. 
A multiplex polymerase chain reaction (PCR) as- 
say targeting c1xA and tcpA has been used to differ- 
entiate biotypes of V. cholerae 01 [7]. The oligonu- 
cleotide primers targeting tcpA exploit sequence dif- 
ferences between the tcpA of the El Tor and classical 
biotypes of V. cholerae 01. In the same PCR, V. 
cholerae 0139 amplicons aligned exactly with those 
of El Tor and not with those of classical biotype 
strains [5]. The 0139 serogroup also has the ctxA 
and tcpA genes which are coordinately controlled by 
ToxR [141. The expression of Cr is rare in other 
scrogroups of V. cholerae non-01; in a study which 
examined wild strains and type strains belonging to 
serogroups 02 to 083, less than 1% of strains were 
found to possess ctxA or ctxB [111. Our most recent 
data (unpublished), which includes type strains 02 to 
0138, have confirmed that Cr is uncommon in these 
serogroups; 12 of 1197 (1%) strains tested are CT 
probe-positive. In contrast, 87% of 251 strains of V. 
cholerae 01 and all of 13 strains of V. cholerae 
0139 are CT probe-positive. 
Production of CF and TcpA by strains belonging 
to the 0139 serogroup has led to speculation that 
0139 is a variant of 01 biotype El Tor [5]. However, 
while Cr and TcpA have been found in 0139 strains, 
similar studies have not been reported for other V. 
cholerae non-01. We describe here the characteriza- 
tion of Cr-positive strains of V. cholerae belonging 
to 01,0139 and other non-01 serogroups. 
2. Materials and methods 
2.1. Bacterial strains 
The V. cholerae strains used in this study were 
characterized with respect to the presence of ctrA 
and ctxB genes, and for Cr antigen production using 
digoxigenin-labelled polynucleotide probes and an 
enzyme-linked immunosorbent assay (GM, -ELISA), 
as previously described [11]. Strains which hy- 
bridized with the CTA and Cr. probes and Cr 
probe-negative representatives belonging to the same 
serogroups were used (Table 1). Thirty-four non-01 
strains, of which 22 produced Cr antigen, and nine 
207 
01 strains, of which eight produced Gr antigen, 
were examined by PCR for tcpA. Three of the strains 
shown in Table 1,8457/5 (01), E54418 (037) and 
1154-74 (049), were CT probe-negative, but GMj- 
ELISA-positive [111. 
22 Polymerase chain reaction (PCR) 
For all PCR assays the annealing temperature was 
55OC; the reagents and cycling conditions were those 
described by Fields et al. [4]. A multiplex PCR assay 
targeting the tcpA locus was described by Keasler 
and Hall [7]. Two sets of primers were used: TCP1 
(5' CAC GAT AAG AAA ACC GGT CAA GAG Y) 
and TCP2 (5' ACC AAA TGC AAC GCC GAA 
TGG AGC 39 which amplify a 617-bp fragment of 
the classical tcpA; TCP3 (5' GAA GAA GTT TGT 
AAA AGA AGA ACA 3') and TCP4 (5' GAA AGG 
ACC ITC M CAC GTT G Y) which amplify a 
471-bp region of El Tor tcpA. The presence of ctxB 
was demonstrated using a PCR based on that de- 
scribed by Olsvik et al. [9]. The primers were CTX7 
(5' GGT TGC TTC TCA TCA TCG AAC CAC 3') 
and CI-A9B (5' GAT ACA CAT AAT AGA ATT 
AAG GAT G Y) which amplify a 460-bp segment of 
ctxB. The three sets of primers were not used simul- 
taneously in the same reaction, because it was diffi- 
cult to distinguish the 460-bp ctxB and the 471-bp El 
Tor tqpA amplicons which co-migrate during elec- 
trophoresis. 
3. Results 
All C'F probe-negative strains, including the three 
strains that were positive in the GM, -ELISA, were 
negative by PCR for both ctxB and tcpA. 
The ctxB PCR confirmed the probe results (Table 
1); all CT probe-positive V. cholerae, regardless of 
serogroup, gave an amplicon of 460 bp (Fig. 1, lanes 
6-8). 
It was confirmed that the tcpA genes of serogroup 
01 biotypes El Tor and classical could be differenti- 
ated after PCR amplification by amplicon size (Fig. 
1, lanes I and 2). The non-01 strains could be 
similarly differentiated by type of tcpA PCR product 
into two groups (Fig. 1, lanes 3 and 4). The frag- 
ments amplified from non-01 strains were identical 
108 
bp 
617 
471 
bp 
-460 
Fig. 1. Differentiation of V cholerae tcpA genes by multiplex 
PCR and detection of caB genes. Lanes 1-4 tcpA PCR, (1) 
E51116 01 classical, (2) E51165 01 El Tor, (3) M045 TS 0139, 
(4) 1322-69 TS 037; lane 5, ladder molecular mass markers (bp), 
1114,900,692, (500,489), 404,320,242,190,147,110,67; 
lanes 6-8 ctxB PCR, (6) E51116, (7) M045, (8) 1322-69; lane 9, 
negative control (sterile glass-distilled water). 
in size to the tcpA amplicon generated from biotype 
El Tor or classical. The apparent doublet band in 
lane 3 of Fig. I is thought to be an artefact due to 
overloading of the gel. Serogroups 023,037 and a 
rough strain possessed a tcpA identical to the tcpA 
of classical strains, whereas serogroups 06,0139 
and two strains with untypable 0 antigens possessed 
a tcpA identical to El Tor tcpA (Table 1). Only one 
ctxB-positive strain, WBDV-IOIE, belonging to 
serogroup 049 was negative for tcpA by PCR. This 
strain may either have lost the gene for tCPA or it 
may possess a novel tcpA which is sufficiently 
different from the El Tor and classical tcpA to render 
it undetectable by the primers used in this PCR. 
4. Discussion 
CT-positive V cholerae non-01 serogroups pro- 
duced PCR products which were either identical to 
those of biotype El Tor or those of classical. All 
0139 strains tested possessed a tcpA identical or 
similar to El Tor tcpA and the present study suggests 
that a similar association exists between other non-01 
serogroups and tcpA type. However, confirmation of 
this would require testing greater numbers of CT- 
B. Said ct al. 11-1-MSMicrobtology LeItcrs 125 (1995) 205-210 
positive strains belonging to these serogroups and 
from different geographical origins. 
Toxins other than CT have been implicated in the 
pathogenesis of diarrhoea caused by V. cholerae 
non-01 [2,81. CT probe-negative, GM, -ELISA-posi- 
tive strains produce a putative toxin which may share 
epitopes with CT, [111. It was postulated that they 
may possess related gene sequences, but the present 
study did not support this as three strains tested were 
negative by PCR for both ctxB and tcpA. 
It has been suggested that strains of serogroup 
0139 are El Tor variants based on the results of 
RFLP analysis and on PCR targeting ctxA and tcpA 
[5]. In this study we have shown that ctxB and tcpA 
gene amplicons of 0139,01 biotype El Tor and 
certain 06 and 0? strains are indistinguishable in 
size. Rather than suggesting that CT-positive non-01 
are variants of 01, it may be that transfer of CT and 
TcpA genes has occurred several times from 01 to 
non-01 strains and that CT-positive strains of a 
particular serogroup may be members of a clone 
resulting from this event. 
CT genes are chromosomal and inherited as part 
of a virulence cassette, along with other factors, 
including accessory cholera toxin, zonula occludens 
toxin and TcpA [3,12,131. There are two CT viru- 
lence cassettes which can be differentiated by tcpA 
type and in any one serogroup of V. cholerae it 
appears that only one may be present. Although 
serogroups other than 01 and 0139 have this viru- 
lence cassette, to date none have demonstrated epi- 
demic potential. It is interesting to speculate whether 
there is an as-yet-undiscovered 'epidemic factor'. 
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cephalosporins is common among other enteric bacteria. 1-2 The 
risks associated with the ease for further dissemination 
of resistance markers in -vibrio, as recognised previously, 3.1 
and their likely mediation in the recruitment of resistance genes 
for first-line drugs in cholera treatment deserve close 
surveillance. 
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drug resistance in Vibrio chokrae serogroup 01, biotype El Tor: 
evidence for a point-source outbreak in Bangladesh. ] Infect Dis 1983; 
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Emergence of multiple drug resistance In 
Wbrio cholerae 01 El Tor from Ecuador 
SiR-Vibrio cholerae 01 biotypeEl Tor first appeared in South 
America in January, 1991, in Peru' and by September, 1992, 
had accounted for over 480 000 documented illnesses and 3000 
deaths in that country alone. 2 The disease has rapidly spread 
across South America at the rate of one country per month and 
substantial outbreaks have been reported in several 
countries. 1-2 In Ecuador, strains were first isolated in February, 
1991,1 and outbreaks have subsequently occurred with more 
than 40 000 people known to be affected. 
We have recently received twelve strains of V chokrae 01 
biotype El Tor isolated in Guayaquil, Ecuador, in 1992. Of 
these, two strains were resistant to (mg/L) ampicillin (A): 100; 
chloroamphenicol (C), 125; kanamycin (K), 125; 
sulphonarnides (Su), over 500; tetracyclines (T), 64; and 
trimethoprim (Tm), over 125 (called resistance-type [R-type) 
ACKSuT7m). Ten strains were sensitive to all antimicrobial 
drugs tested. In both resistant strains the complete spectrum of 
resistance was encoded by a conjugative plasmid of 100 MI)a 
belonging to plasmid incompatibility group C (Inc Q. On 
transfer to Eicherichia coli K12, a range of exconjugants coding 
for ACKSuTTm, AKSuTTm, SuTTm, and Su only were 
identified. The ten drug-sensitive strains were plasmid-free. 
All twelve strains tested positive with a DNA probe encoding 
for the A and B subunits of the cholera-toxin gene (CT A+ B). 
The first outbreak of multiresistant V cholerat El Tor 
occurred in Tanzania in 1977. The causative strain was R-type 
ACKSSuT (S=streptomycin) and the widespread use of 
tetracyclines for prophylaxis was thought to have been a major 
contributory factor. 3 Strains with multiple resistance have 
subsequently caused outbreaks in the Matlab area of 
Bangladesh in 1980 and 1981. Ile 1980 strains were R-type 
AKS'I`Tm4 and those in 1981 were R-type AKSuTG 
(G-gentamicin). 5 In both the African6 and Bangladesh" 
outbreaks, resistances were encoded by 100 MI)a Inc C 
plasmids, and results with. the drug-resistant strains from 
Ecuador confinn the affinity of V chokrae 01 for Inc C drug 
resistance plasmids. 
For the treatment of cholera, the WHO Guidelines for 
Cholera Control recommend doxycycline, a long-acting 
form of tetracycline, for adults and co-trimmeazole in tablet or 
liquid formulation for children.? Fur2zolidone, erythromycin, 
and chloramphenicol are considered to be effective alternatives 
for adults and children. It is also recommended that the choice 
of antibiotic should take into account local patterns of 
resistance. 7 However, rehydration is the therapy of choice. 
Doctors in South American countries should be aware that 
strains resistant to three of the drugs of choice for the treatment 
of cholera have now emerged in Ecuador. 
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Tandem repeats of cholera toxln gene In Vibrio 
cholerae 0: 139 
SiR-In November, 1992, a cholera-like outbreak started in 
Madras and soon assumed an epidemic proportion in many 
parts of India' and Bangladesh. 2 Tens of thousands of cases 
were involved with substantial mortality. The causative agent 
was identified as Vibrio cholerae. Serological studies showed 
these outbreak strains to be similar but distinctly different from 
known serogroups and were consequently assigned a new 
serogroup 0139.3 As the clinical manifestations were 
indistinguishable from those of typical cholera, cholera toxin 
(CT) was thought to be the major pathogenic attribute. Indeed, 
all the 0139 strains isolated produced CT and hybridised with 
the CT-gene probe .4 The counterpart of this organism- 
namely V cholerae 01 (classic and El Tor biotypes)--which 
were responsible for the past 7 pandemics over 100 years, varied 
widely in the number of copies of the toxin gene in their 
chromosomes. s We examined the structural characteristics of 
the toxin operon in V chokrae 0139 strains isolated from 
various places. 
Advantage was taken of the fact that restriction enzymes 
Mal and Bg1II cleave V cholerae 01-derived toxin operons 
into fragments carrying more than 95% of the toxin gene. 
Chromosomal DNA prepared from various isolates was 
digested with Xbal and Bg1II, the fragments wereseparated by 
electrophorcsis on agarose gel, transferred to nylon membrane 
(Hybond-N, Amersham, UK), and hybridised with the CT 
probe. 6 Complete digestion of the DNA produced two very 
strong signals, which corresponded to 1-7 kb and 2-5 kb for all 
strains tested, indicating the presence of at least two copies of 
the toxin gene (figure, left-hand side). Surprisingly, when 
digestion was partial, besides the normal 2-5 kb and 1-7 kb 
bands, a large number of fragments of molecular sizes 18,12,9, 
6-6,4-7,4-3, and 2-2 kb also hybridised with the CT-gene 
probe. Examination of the pattern revealed that these products 
of partial digestion could only be generated if the fragments 
containing CT gene were duplicated many times on the 
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Additionally, the narrow aperture encouraged 
sharps to remain vertical and protrude as the bin 
approached fullness. In comparison, the old bin 
had a wide letterhox style aperture comprising a 
shute and flap, which encouraged articles to settle 
horizontally. 
We therefore checked the specifications in 
BS7320 concerning height of lines indicating that 
the container is full. The standard states that "a 
horizontal line to indicate when the sharps con- 
tainer is filled to between 70% and 80% of the 
maximum volume" should be marked on the 
container. When we measured the bin it complied 
with BS7320. 
We suggest that the line indicating that the 
container is full should not be based on a per- 
centage of the volume of the box but instead should 
be a minimum distance below the aperture, irres- 
pective of the size of the bin. 'Me current British 
Standard, on the one hand, does not give adequate 
clearance between the line and the aperture for 
smaller containers and, on the other, could be 
providing excessive clearance for the largest con- 
tainers. Even more critical is the design of the 
aperture, which ideally should be of the wide 
letterbox. In our experience, a bin with a narrow 
aperturS is at worst dangerous and at best wasteful 
of space in the container as it leads to inefficient 
filling. 
We aiso question how effective it is to have a line 
marked on the side of a container. Some manu- 
facturers have the line marked only on the front of 
the bin, although the bin may be turned so that the 
line is not visible in practice. Also, when sharps 
containers are placed on clinical trolleys they 
are often viewed from above, in which case the 
purpose of the line may be negated. Some indica- 
tion inside the container that can be %iewed 
through the aperture would help to prevent over- 
filling. 
Injuries from overfilled sharps containers are 
unlikely to be totally eliminated because of the 
human element. If simple changes in the design of 
containers can help reduce their frequency they 
should be introduced. 
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Using condoms to prevent 
transmission of HIV 
EDrr0R; --In a study of female prostitutes working 
in Undon Helen Ward and Colleagues found that 
the prevalence of HIV infection was less than 1% 
and that reported regular use of condoms with 
commercial clients was high (98%). "Iliis provides 
a striking contrast to studies in sub-Saharan 
Africa. There the prevalence of HIV infection in 
women regularly engaging in $4 one off" sexual 
contacts (including commercial sex workers and 
bar girls) is often high and regular use of condoms 
usually low. ' We have used a pu6lished simulation 
model of the transmission of HIV to examine what 
effect different levels of use of condoms, in one off 
contacts only, might have on the spread of HIV 
infection in rural Uganda. 
Using data from the Medical Research Council 
and Overseas Development Administration's re- 
search programme on AIDS in Uganda and the 
simulation model SimulAIDS (V5.02), we have 
replicated the spread of HIV infection, and other 
characteristics, in a rural population in south west 
Uganda, where the prevalence of HIV infection 
among adults was about 9% in 1990 (N I Robinson 
BMJ VOLUME 307 16 ocrOBER 1993 
et al. IXth intemauonal conference on AIDS, 
Berlin, 7-11 June 1993). For this scenario it was 
assumed that people did not use condoms. When 
simulations were rerun from the introduction of 
HIV, but assurning that condoms were used 
during 90% of one off sexual contacts, the 
prevalence of HIV infection among adults in 1990 
failed to reach 1%. Furthermore, we found that, 
even when HIV infection has become widespread, 
it still seems possible to reduce the future incidence 
of the infection in the general population sub- 
stantially by promoting regular use of condoms, 
even if only in one off sexual contacts (N J 
Robinson et al, IXth international conference on 
AIDS, Berlin, 7-11 June 1993). 
Probably the relatively slow spread of HIV 
infection among heterosexuals in Britain is at least 
partly due to widespread regular use of condoms 
during contacts between sex workers and their 
clients. Ways must be found to increase use of 
condoms among people regularly engaging in one 
off sexual contacts in sub-Saharan Africa. This will 
benefit not only individual people but also entire 
populations. 
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Vibyio cholerae serogroup 
0139 in England and Wales 
EDrroR, -Since the beginning of the year there 
have been several reports from the Indian sub- 
continent of a large outbreak of cholera caused by 
non-01 Vibyio cholerae. The outbreak was first 
reported in Madras last October and was then 
reported in Calcutta in Novembee; hirther reports 
followed from southern Bangladesh in December. 
An outbreak occurred at a religious festival in 
Dhaka in January this year and was followed by 
another major epidemic in Dhaka in the first week 
of February. ' A further major outbreak was 
reported in Calcutta in February. 
Although some strains of non-O IV cholerae 
have been recognised as causing diarrhocal disease 
that is sometimes clinically indistinguishable from 
cholera, previously only V chokrae 01 has been 
considered to be capable of causing epidemic 
cholera. Ile strains from the present outbreaks 
have been placed in a new serogroup, designated V 
chokrae 0139 by Shimada et aLs These strains 
produce cholera toxin., 
In the Laboratory of Enteric Pathogens in 
London ýve have been servityping strains of V 
chokrae since 1985, using the scheme of Sakazaki 
and Donovan, ' with antiserurn for antigens 01- 
083. Since 1985 we have serotyped 1017 isolates. 
Fifty six were V cholerae 01 and 961 were non-0 I V chokrat. Serotyping of the 961 isolates of V 
chokrae non-Ol showed &at 520 could not be 
typed with antiscrum to 0 antigens 01-083. Of 
these 520 isolates, 51 were from travellers known 
to have returned recently from the Indian sub- 
continent and four were from prawns imported 
from the region. We tested these 55 isolates with 
antiscrum to V chokra 0139 (provided by Dr T 
Shimada, National Institute of Health, Tokyo, 
Japan) and found five to be serogroup 0139. We 
also tested these 55 isolates with DNA probes 
encoding for the A and B subunits of the cholera 
toxin gene; only the five isolates of serogroup 0 139 
yielded a positive result. Production of toxin was 
shown in all five strains. 
Tbese five isolates were resistant to strepto- 
mycin 16 mg4, sulphonamides 64 mg4, and trime- 
thoprim 2 mg/l. 7bey were sensitive to tetra- - 
cyclines 8 mg/l, ampicillin 8 mg/l, chloramphenicol 
8 mg/l, and ciprofloxacin I mg/l. Sarkar er al 
reported that the epidemic strains of V chokrae 
non-01 that they had received from different 
locations in India were all sensitive to polymyxin B 
(15 mg4 and 50 mg/1). 1 We tested the five strains of 
Vchokrae 0139 isolated in England and also the 
type strain of Vchokrae 0 139 (M045) provided by 
Dr T Shimada and found that all six strains 
were resistant to polymyxin B, with minimum 
inhibitory concentrations > 2-5 xI 0'U11. 
'Me five strains of V cholerae 0139 were all 
isolated in England since March this year (from 
four adults and one child). 'Mey were isolated 
from three travellers who had recently returned 
from Iadia, one who had recently returned from 
Bangladesh, and one from whose records we were 
unable to establish a history of recent travel. All 
five patients had diarrhoea, and three of them (two 
adults, one child) were admitted to hospital. 
V chokrat serogroup 0 139 is unlikely to pose a 
serious threat in countries with safe drinking water 
and good sanitation. Nevertheless, the severity of 
the disease caused by this serogroup means that 
medical microbiologists should be aware of the 
potential importance of non-0 1V chokrae in 
diarrhoeal disease and should refer all isolates Of 
non-0 IV chokrae to the reference laboratory for 
confirmation, serotyping, and testing for toxins. 
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Ilerapeutic potential of aspirin 
in cancer of the colon 
EDrroN-R FA Logan and colleagues' epidemio- 
logical study supports the growing evidence that 
regular use of aspirin reduces the risk of colorectal 
cancer., Annlia Paganini-Hill, however, advocates 
caution before prophylactic aspirin is considered, 
since long term use of aspirin is associated with 
nephrotoxic and gastrotoxic side effects. ' But other 
valuable lessons can be learnt from the epidemio- 
logical studies. We wish to propose an explanation 
for the epidemiological data and suggest fiinher 
directions for research. 
Aspirin and other non-steroidal anti-inflam- 
matory drugs inhibit and reverse the growth of 
rumours of the colon in animals. This effect 
correlates with the inhibition of prostaglandin E2,1 
a derivative of fatty acid that is produced in 
excessive quantities by these tumours. Prosta- 
glandin E2 derived from turnout seems to further 
growth in the colon by depressing cellular im- 
munity, enhancing local blood flow, and increasing 
metastatic potential. By reversing these patho- 
physiological processes non-steroidal and-inflam- 
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The use of gene probes, immunoassays and tissue culture 
for the detection of toxin in Vibrio cholerae non-01 
BENGO SAID, SYLVIA M. SCOTLAND and B. ROWE 
Laboratory of Enteric Pathogens, Central Public Health Laboratory, 61 Cofindale Avenue, London NW9 5HT 
Summary. Vibrio cholerae non-01 strains were screened for the presence of cholera 
enterotoxin (CT) genes by means of digoxigenin-labelled polynucleotide CT, and CT,, 
probes. In-vitro production of CT was investigated by the YI mouse adrenal cell assay, 
enzyme-linked immunosorbent assay (ELISA) and a commercial, reversed passive latex 
agglutination (RPLA) kit. Only two (0-25 %) of 790 strains tested gave positive results with 
the CTA and CT, probes. The production of other bacterial cytotoxin(s) made it impossible 
to use the characteristic cell-rounding effect on YI cells for the detection of CT. CT 
production by the probe-positive strains was confirmed by the immunoassays. Two hundred 
and fifty-two of the 788 probe-negative strains were tested by both cell assay and 
immunoassays. Of these, 90 % produced cytotoxin(s) in the cell assay. In addition, 37 % gave 
positive results in CT-ELISA, but negative results with LT-ELISA and VET-RPLA. These 
results indicate the presumed presence of a toxin in V. cholerae non-01 that is able to bind 
GM, and react with antisera to CT, but which is not identical to CT. 
Introduction 
Vibrio cholerae can be distinguished serologically on 
the basis of somatic (0) antigens. There are currently 
82 known serogroups in addition to V. cholerae 01, 
the causative agent of epidemic cholera. ' V. cholerae 
non-01 strains are distributed world-wide, often in 
brackish surface waters. Some serogroups have been 
implicated in sporadic cases and outbreaks of gastro- 
intestinal disease. The symptoms vary from bloody 
diarrhoea with fever to a severe watery diarrhoea 
indistinguishable from cholera. ' 
Cholera enterotoxin (CT) is a recognised virulence 
factor of V. cholerae 01 and a heat-labile enterotoxin 
identical or similar to CT has been found in some 
isolates of V. cholerae non-01.3.4 
CT production in strains of V. cholerae non-0 I has 
been reported from both Bangladesh and India; Datta- 
Roy" found 26 % of a small sample of 34 clinical 
isolates and 10% of environmental isolates to give 
positive results in tests for CT production. However, 
the occurrence rate of CT in V. cholerae non-01 in 
other parts of the world is lower. None of 44 human 
isolates and only 2% of environmental isolates from 
Thailand were reported to be CT positive. ' Similarly, 
in a study of 2500 environmental isolates from the 
Louisiana Gulf coast only 0-3 % produced CT. ' 
However, in none of these studies have the serogroups 
of V. cholerae non-01 been reported, nor has a 
correlation of CT production with serogroup been 
attempted. 
The somatic antigens may be useful indicators of 
diarrhoeagenic potential within the non-O I strains. In 
1980, the WHO working group' reported a prevalence 
of serogroups 05 in gastrointestinal disease and 08 in 
the environment, whereas Donovan' found that 
serogroups, 02,05,07 and 037 predominated in 
gastrointestinal disease and 04 in the environment. 
Certain serogroups have also been linked to outbreaks 
of gastrointestinal illness: e. g., serogroup 05 is 
thought to have been responsible for a food-borne 
outbreak, in Czechoslovakia in 196510 and serogroup 
037 for a water-borne outbreak in the Sudan in 
1968.11 Recent reports from India and Bangladesh 
have described large outbreaks due to CT-producing 
V. cholerae non-01.11,11 The strains from India were 
untypable (0? ) and, although serogrouping for the 
Bangladesh outbreak remains to be done, both out- 
breaks may have been caused by strains from the same 
clone. 
The Laboratory of Enteric Pathogens (LEP) has a 
large collection of V. cholerae non-01, belonging to 
many different serogroups, isolated from over 50 
countries. To assess the correlation of CT with 
serogroup, strains from both environmental and 
human sources were examined for the presence of the 
CT genes and for the production of heat-labile entero- 
toxins with the YI cell test and immunoassays. 
Materials and methods 
Bacterial strains 
Received 10 May 1993; accepted 18 June 1993. Seven hundred and eight wild-type strains of 
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V. cholerae non-01, from both human and environ- 
mental sources, were studied; all strains were taken 
from the culture collection of LEP. Of these, 310 
strains belonged to 49 serogroups, 334 strains were 
untypable (0? ) and 64 strains were rough (OR). The 
type strains of V. cholerae non-01 (serogroups 
02-083) were kindly provided by Dr R. Sakazaki. 
The V. cholerae non-Ol control strain WBDV-IOIE 
(serovar 049, CT) was kindly provided by Dr 
P. Echeverria. The V. cholerae 01 control strain 
(E51116, CT) came from the LEP culture collection. 
All V. cholera"e strains were maintained on nutrient- 
agar slopes at room temperature. The control 
Escherichia coli strain B7A (0148: H28), which 
produces both heat-labile enterotoxin and heat-stable 
enterotoxin, (LTI STal) 14 was maintained on a 
Dorset's egg slope at room temperature. 
Preparation and digoxigenin-labelling of 
polynucleotide CTAand CTBprobes 
Strains of E. coli K 12 carrying plasmids with cloned 
CT gene sequences were used to prepare large quan- 
tities of covalently closed circular DNA. 11 The CT 
gene sequence from V. cholerae El Tor 6274611 cloned 
into plasmid pBR325 (pCVD27) was provided by Dr 
J. B. Kaper. A 554-bp CT., probe was cut from 
pCVD27 after digestion with EcoRI (Life Tech- 
nologies Ltd, Uxbridge, Middlesex). The recombinant 
plasmid pCT19 is known to contain CT,, and part of 
CT,; " the gene sequences were cloned and subcloned 
from V. cholerae 1621 into pACYC 184 as described by 
Gennaro et al. " A 550-bp CTB probe was cut from 
plasmid pCT19 after digestion with Xbal and Hincll. 
Probe fragments were separated on and excised from 
agarose gels and purified with the Geneclean Bio 101 
kit (Stratech Scientific Ltd, Luton, Bedfordshire). The 
cloned polynucleotide probes were labelled 'with dig- 
oxigenin according to the manufacturer's instructions 
(Boehringer Corporation Ltd, Lewes, East Sussex). 
Unincorporated nucleotides were removed with 
QIAGEN-tip 5 (Diagen, Dusseldorf, Germany) 
according to the manufacturer's instructions and the 
labelled probe was stored at -20'C. 
Preparation of culturesfor DNA hybridisation 
Bacterial cultures, grown at 37'C with aeration for 
18 h, were spotted on to Hybond N nylon membranes 
(Amersham. International, Aylesbury, Buckingham- 
shire) placed on nutrient agar plates. Colonies were 
grown at 371C for 6h and the cells were lysed and 
DNA denatured as described by Maniatis ef d" 
was carried out at 68C (high stringency conditions 
identifying sequences with > 80 % identity) on colony 
blot membranes. In some experiments, lower strin- 
gency conditions (37*C) were used, allowing the 
hybridisation of sequences with only 60 % identity. 
Colony blot membranes were pre-washed with 10 ml 
of a hybridisation solution per 50 cm' membrane for 
Ih at 68*C. The hybridisation Auid contains; five 
times concentrated SSC (where SSC consists of NaCl 
0.88%, trisodium citrate 0-44%), blocking reagent 
(Boehringer) 0-5 %, N-lauroylsarcosine 0- 1 %, SDS 
0.02 %. ) The membranes were wiped and pre-hybrid- 
ised with fresh solution for 2 h. Hybridisation was 
allowed to proceed for 18 h, with hybridisation solu- 
tion 1.25 MI/50CM2 membrane, containing freshly 
denatured probe 26ng/ml and freshly denatured 
herring sperm DNA loopg/ml. Membranes were 
washed with double strength SSC, SDS 0-1% for 
5 min at room temperature followed by two washes of 
15 min each of, tenth dilution SSC, SDS 0-1 % at 68"C. 
Detection procedures were as descriibed by Boehringer. 
The protocol for hybridisation at 370C did not differ 
from that described above, but the hybridisation 
solution was formamide 25 %, five times concentrated 
SSC, Ficoll 0-01 %, polyvinylpyrrolidine 0-01 %, 
bovine serum albumin 0-0 1 %, SDS 0- 1 %, and I mm 
EDTA. The post-hybridisation washes were with five 
times concentrated SSC, SDS 0-1 % at 54-5*C for I h, 
followed by double strength SSC at room temperature 
for 30 s. 
Bacterial culture and preparation of crude toxin 
For routine testing of CT production by V. cholerae 
0 1, bacteria were grown overnight in Syncase sucrose 
broth" at 37*C with agitation. Initially these con- 
ditions were used to test V. cholerae non-01 strains. 
For further assays of CT production, culture filtrates 
were prepared by growing the organisms in various 
media: Syncase sucrose broth, Syncase glucose 
broth, " Trypticase Soy Broth (Becton Dickinson, 
Cockeysville, USA), " Brain Heart Infusion Broth 
(Unipath Ltd, Basingstoke, Hampshire), " and casa- 
mino yeast extract broth. ", 23 Strains were inoculated 
into 10-ml volumes of the respective broths and 
incubated statically in a 250-ml flask at 30*C and 37*C, 
or with agitation (120 oscillations/min). The overnight 
culture was then centrifuged (17 000 g for 30 min at 
4*Q and the supernate was sterilised by filtration 
through a Millipore filter (pore size 0-2 pm). A sample 
of the culture supernate was also heated at IOOT for 
15 min. The filtrate and the heated sample were used 
for both tissue culture tests and immunoassays. All 
tests were done in duplicate. 
Hybridisation with polynucleotide probes YJ adrenal cell assay for toxin 
Hybridisations were performed in heat-sealed Culture filtrates were tested for CT on monolayers 
plastic bags which were placed in a water bath at the of YI cells. '"' CT and E. coli LT characteristically 
appropriate temperature with shaking. Hybridisation lead to a rounding of the YI cells. The effect of the 
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heated preparation was compared with that of the 
unheated to ensure that rounding was due to a heat- 
labile factor. Doubling dilutions of filtrate were used 
to determine titres of heat-labile enterotoxin and 
cytotoxin. Neutralisation with antiserum against CT 
or LT was performed to confirm the specificity of the 
rounding effect. For the neutralisations, 25-jul volumes 
of filtrate and antiserurn (I in 200) were incubated 
together in 200 pl of growth medium for 3h at 37C 
before being transferred on to YI cells. 
Enzyme-linked immunosorbent assay 
A modification of the GM, -ELISA methods of 
Svennerholm and Holmgren2-' and Sack" was used. A 
solution of ganglioside GM, (2, ug/ml Supelco, 
Bellefonte, USA) 100 pl in PBS was added to micro- 
ELISA plates (Dynatech Laboratories Ltd, Billings- 
hurst, Sussex) and incubated overnight at room 
temperature. Extra binding sites were blocked by 
adding 200 pl of BSA (Sigma, Poole, Dorset) I% w/v 
dissolved in PBS, for 30 min at 37*C. The steps of the 
procedure were as follows. After each step the plates 
were washed three times with PBS containing Tween 
20 (PBST) 0-05 % v/v; 100 pl of the filtrate were added 
and the plates were incubated at room temperature for 
2 h. One hundred pl of the appropriate antiserum, 
diluted I in 200 in PBS were added: for CT-ELISA, 
rabbit anti-CT antiserum (LEP); for CT,, -ELISA, 
goat anti-CTBantiserum (Calbiochem Novabiochem, 
Nottingham); for LT-ELISA, rabbit anti-LT anti- 
serum (LEP). The plates were then incubated for 18 h 
at room temperature. Alkaline phosphatase-conju- 
gated goat anti-rabbit immunoglobulin (Sigma) 100 pl 
or alkaline phosphatase-conjugated rabbit anti-goat 
immunoglobulin (Sigma) 100 pI were added. Antibody 
preparations were diluted I in 7000 and I in 3000 in 
PBS respectively. The plates were incubated at room 
temperature for 2 h. Then 200 pl of p-nitrophenyl 
phosphate (I mg/ml in diethanolamine buffer) were 
added. After 100 min in the dark at room temperature, 
the reaction was stopped with 25 pl of IM NaOH and 
the absorbance was read at 405 nm. A control (strain 
E51116) was included on each plate. 
Reversed passive latex agglutination 
The VET-RPLA kit (Unipath Ltd) was used for the 
detection of CT and LT. Doubling dilutions of filtered 
supernates were tested according to the manufacturer's 
protocol. 
Results 
CT, and CT. probes at high stringency 
nucleotide probes derived from both the CT, and CTI, 
regions of the CT gene sequence. Strains WBDV- 10 1E 
(serogroup 049) and E51116 hybridised with both the 
CT, and CT. probes. Strain 137A did not hybridise 
under high stringency conditions. 
Only two of the 790 V. cholerae non-01 strains were 
probe-positive. These were: a wild-type strain 
(E55879) serogroup 0?, isolated from a 22-year-old 
male recently returned to the UK from Egypt; and 
strain 1322-69, the type strain of serogroup 037. 
Of the 788 probe-negative V. cholerae non-01 
strains, five were serogroup 049 (all from environ- 
mental sources), four were 0? (from patients returning 
from Egypt) and seven were serogroup 037 (all from 
human sources). The remaining typable strains be- 
longed to 47 different serogroups. 
CT 
,, and 
CT,, probes at low stringency 
The heat-labile enterotoxin produced by E. coli is 
known to be related to CT. 2' However, in this study, 
hybridisation experiments showed that LT' E. coli 
hybridised with the CT probes only at low stringency. 
V. cholerae non-01 strains were also tested for 
hybridisation at low stringency with the CT, and CT,, 
probes to determine if a CT/LT-related toxin was 
being produced. A total of 252 strains (representing 37 
different serogroups from both human and environ- 
mental sources) was tested and all were probe-negative 
under low stringency conditions. 
YI mouse adrenal cell assay 
I. The control strains (WBDV-IOIE, E51116 and anti-cholera antiserum. 137A) and 790 V. cholerae non-01 strains were tested The probe-positive V. cholerae strains and E. coli by hybridisation at high stringency with poly- strain B7A were tested for CT (or LT) production 
In all, 226 (89-6 %) of 252 V. cholerae non-0 I strains 
tested in the YI cell assay produced a cytotoxic effect 
on YI cells within 24 h; the remaining 26 strains were 
completely negative. Of the identifiable serogroups 
producing cytotoxin, the most common were: 026 (23 
of 26 strains tested were cytotoxin positive), 02 (10 of 
10), 0 19 (9 of 9), 05 (7 of 7), 013 (4 of 4), 014 (4 of 4), 
049 (4 of 4), 076 (4 of 4) and 037 (3 of 3). It is 
noteworthy that all strains from serogroups 02,05, 
013 and 037 produced cytotoxin, beýause these 
serogroups have been reported to be associated with 
human disease. "-' The probe-positive V. cholerae non- 
01 strains also produced cytotoxin(s) which made it 
impossible to distinguish true rounding from early 
cytotoxic effects. Even when filtrates were diluted to I 
in 156250, cytotoxin was still present. The cytotoxic 
effect present in the filtrates, even as CT, was destroyed 
by heating at 100"C for 15 min, but the cffect was not 
neutralised by antiserurn to cholera toxin. The control 
V. cholerae 01 strain did not produce cytotoxin under 
these conditions, but did cause typical rounding of the 
cells which was confirmed as CT by neutralisation. 
Sin-filarly, E. coli strain B7A produced rounding 
tVDical of LT and this cffcct could be ncutralised with I. 
anti-cholera antiserum. 
The probe-positive V. cholerae strains and E. coli 
strain B7A were tested for CT (or LT) production 
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Table. CT production under different growth conditions 
Culture 
medium 
Aeration/ 
temperature (*C) E55879 
0? 
1322-69 
037 
ELISAO and VET-RPLAt 
WBDV-IOIE E51116 
049 01 
B7A 
Ejeherichia coli 
E55879 
0? 
1322-69 
087 
YI Cell Testl 
WBDV-69 
049 
E51116 
01 
B7A 
E. coli 
Syncase +/37 +(32) +(64) +(64) +(32) +(128) c c c 2560 156250 
sucrose -/37 +(a) +(4) +(8) +(4) +(32) c c c 
40 6250 
broth +/30 +(16) +(32) +(32) +(32) +06) c c c 1280 250 
-/30 +(4) +(4) +(4) +(4) +(16) c c c 40 250 
Syncasa +/37 + (ND) -(ND) + (ND) + (ND) + (ND) c - c 40 6250 
glucose -/37 -(ND) -(ND) -(ND) + (ND) +(ND) - c c 40 31250 
broth +/30 +(ND) +(ND) +(ND) + (ND) + (ND) c c c 1280 250 
-/30 +(ND) +(ND) +(ND) +(ND) +(ND) c c c 320 1250 
Trypticase +/37 +(32) -(0) +(8) +(32) +(128) c c c 160 156250 
soy broth -/37 -(0) -0) -(0) +(32) -(0) - c 320 250 
+/30 +(16) +(4) +(4) +(16) +(16) c c c c 1250 
-/30 +(8) -(0) -(0) +(8) -(0) c c 40 250 
Brain heart +/37 +(ND) -(ND) +(ND) -(ND) +(ND) c c c 20 6250 
infusion broth -/37 +(ND) -(ND) -(ND) -(ND) +(ND) c c - 1250 
+/30 +(ND) -(ND) +(ND) +(ND) -(ND) c c c 40 250 
-/30 +(ND) -(ND) +(ND) +(ND) +(ND) c c c 40 250 
Casamino +/37 +(8) +(8) +(16) +(16) +(32) c c c 160 31250 
yeast -/37 +(4) +(2) +(4) +(8) +(32) c c c 40 6250 
extract broth +/30 +(8) +(8) +(8) +(8) +(4) c c c 80 250 
-/30 +(2) +(2) +(4) +(2) +(4) c c c 20 250 
ND, not done; c, cytotoxin. 
ELISA positive OD 405 nm > 1. 
Figure in parenthesis is titre of reversed passive latex agglutination for CT and LT. 
The final titre is shown for cytotonic response. 
under various growth conditions (table). For the non- 
01 strains, none of the conditions allowed the dif- 
ferentiation of CT from the cytotoxin in the Yl test. 
For strain E51116, the highest CT titre (2560) was 
obtained after overnight incubation with agitation at 
30'C in Syncase sucrose broth. E. coli B7A gave the 
highest titre (156250) after overnight incubation at 
37'C with agitation with either Syncase sucrose broth 
or TSB. 
quantified in this immunoassay; there were conditions 
under which no toxin production could be detected by 
this immunoassay or by the ELISAs. CT production 
was optimal in Syncase sucrose broth and casamino 
yeast extract broth. The highest toxin titres-32 for 
strain E55879 (0? ) and 64 for both type strain 1322-69 
(037) and control strain WBDV-IOIE (049)-were 
obtained with Syncase sucrose broth at 37*C with 
aeration. 
ELISA 
The probe-positive V. cholerae non-01 strains, 
E51116 and B7A were tested in the CT, CIFý and LT- 
ELISA assays. All gave positive results in these three 
ELISAs. 
Ninety-three (36-9%) of 252 probe-negative 
V. cholerae non-01 strains tested in the CT-ELISA 
gave a positive result (OD... > 1). These 93 CT- 
ELISA positive strains also gave positive results in the 
CT,, -ELISA, but all gave negative results in the LT- 
ELISA. Fifty-six (60 %) of these 93 strains could not 
be serogrouped. The commonest of the identifiable 
serogroups were 026 (eight strains) and 019 (seven 
strains); the remaining 22 strains belonged to 17 other 
serogroups. 
VET-RPLA 
The 93 V. cholerae non-0 I strains that gave positive 
results in the CT-ELISA all gave negative results in the 
VET-RPLA. 
The probe-positive strains E55879,1322-69, E51116 
and B7A all gave positive results in this immunoassay. 
The effect of growth conditions on CT production by 
the probe-positive strains could be detected easily and 
Discussion 
In this study, V. cholerae non-01 strains from 50 
countries, isolated from both environmental and 
human sources, were tested for the production of CT 
by four methods. 
Of the V. cholerae non-01 strains which were tested 
with the CT probes, only three gave positive results, 
one belonging to serogroup 049 (this was the control 
strain WBDV-101E), one to 037 and one 0? strain 
(from Egypt). There was no apparent correlation of 
serogroup with CT production. The low occurrence of 
CT probe-positive V. cholerae non-0 I strains (0-25 %) 
is in agreement with previous reports. ', I 
CT and LT are part of a heterogeneous family of 
enterotoxins and different forms of LT have been 
described; i. e., LTh-I, LTp-I, LTIla and LT11b. " The 
suggestion has been made that there may be differences 
in molecular structure between enterotoxins produced 
by different serovars of V. cholerae. " In the present 
study, hybridisation at low stringency with CT, and 
CT. probes provided no evidence for genes in 
V. cholerae non-01 encoding heat-labile enterotoxins 
related to CT or LT. As CTA is the more conserved 
part of the toxin in the CT/LT family of toxins" it was 
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considered possible that some strains might hybridise 
. probe only. 
However, no such strain was with the CT, 
detected in this study. 
All probe-positive strains were confirmed as CT- 
producers by immunoassays. However, the CT-ELISA 
and CT, -ELISA also gave positive results with some 
strains which were negative with the CT probes. The 
ELISA assay depends on the ability of the GM, 
ganglioside to bind heat-labile enterotoxins, with 
bound toxin detected by specific antitoxin antibodies. 
The strains that gave positive CT-ELISA results may 
be producing a heat-labile enterotoxin distinct from 
CýT'23,31,32 but nevertheless able to bind to ganglioside 
GM,. This presumed toxin also appeared to share 
epitopes with CT, and more specifically with CT B' 
Because of the production of cytotoxin, which masks 
cytotonic effects on YI cells, it was not possible to 
show neutralisation of the putative toxin. 
All CT-ELISA-positive strains produced cytotoxin 
in the YI cell assay. However, the CT-ELISA did not 
detect the cytotoxin, since most strains that gave 
negative results in the CT-ELISA produced cytotoxin 
on YI cells. Cytotoxin production may be important 
for virulence, as representatives of all the serogroups 
associated with diarrhoeal illness (02,05,013 and 
037) were found to produce cytotoxin. 
The production of CT by V. cholerae 01 and LT by 
E. coli strain B7A was detected readily by the con- 
ventional YI cell assay and immunoassays. The probe- 
positive V. cholerae non-01 strains produced cyto- 
toxin which effectively masked the CT rounding in the 
Y1 cell assay and varying the growth conditions did 
not affect the result. The immunoassays used could 
detect the presence of CT even in the presence of 
cytotoxin. The optimal condition for CT production, 
as detected by immunoassays, was growth in Syncase 
sucrose broth at 37'C with agitation. 
Recent volunteer studies showed that some 
V. cholerae non-0 I strains, which did not produce CT, 
caused diarrhoea of a similar severity to that seen in 
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cholera. This suggests that factors other than CT, 
such as the presumed toxin identified in this study, 
may be important in the pathogenesis of diarrhoea 
caused by V. cholerae non-01 strains. 
In the present study, <I% of V. cholerae non-01 
strains produced CT immunologically indistinguish- 
able from the CT produced by serogroup 01. Because 
these few strains also produced cytotoxins, CT could 
be detected only by probe, or by immunoassay under 
specific growth conditions. Of the probe-negative 
strains, most (90 %) produced cytotoxin(s) detected by 
YI cells. In addition, 37 % of probe-negative strains 
gave positive results in the ELISA for CT but negative 
results in the ELISA for E. coli LT and VET-RPLA. 
The substance produced was distinct from the cyto- 
toxin(s) detected in the YI cell assay. This substance 
could be detected only in the CT-ELISAs and may be 
a toxin structurally and antigenically similar to CT. 
The role in diarrhoeal disease of both the cytotoxin 
and the substance detected by the CT-ELISA needs to 
be evaluated. 
The help of Dr G. A. Willshaw and Ms A. Thomas with the probe 
work, and of Mr T. Cheasty and Mr N. Stokes with the sero- 
grouping was greatly appreciated. 
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